
<html lang="en"     class="pb-page"  data-request-id="4ea6ce01-5257-4ac8-8d6a-52aecfcf6054"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c00483;issue:issue:10.1021/jmcmar.2020.63.issue-13;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure–Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H1 Receptor Inverse Agonist" /></meta><meta name="dc.Creator" content="Manjinder S.  Lall" /></meta><meta name="dc.Creator" content="Asser  Bassyouni" /></meta><meta name="dc.Creator" content="James  Bradow" /></meta><meta name="dc.Creator" content="Maria  Brown" /></meta><meta name="dc.Creator" content="Mark  Bundesmann" /></meta><meta name="dc.Creator" content="Jinshan  Chen" /></meta><meta name="dc.Creator" content="Gregory  Ciszewski" /></meta><meta name="dc.Creator" content="Anne E.  Hagen" /></meta><meta name="dc.Creator" content="Dennis  Hyek" /></meta><meta name="dc.Creator" content="Stephen  Jenkinson" /></meta><meta name="dc.Creator" content="Bo  Liu" /></meta><meta name="dc.Creator" content="R. Scott  Obach" /></meta><meta name="dc.Creator" content="Senliang  Pan" /></meta><meta name="dc.Creator" content="Usa  Reilly" /></meta><meta name="dc.Creator" content="Neal  Sach" /></meta><meta name="dc.Creator" content="Daniel J.  Smaltz" /></meta><meta name="dc.Creator" content="Douglas K.  Spracklin" /></meta><meta name="dc.Creator" content="Jeremy  Starr" /></meta><meta name="dc.Creator" content="Melissa  Wagenaar" /></meta><meta name="dc.Creator" content="Gregory S.  Walker" /></meta><meta name="dc.Description" content="An experimental approach is described for late-stage lead diversification of frontrunner drug candidates using nanomole-scale amounts of lead compounds for structure–activity relationship developme..." /></meta><meta name="Description" content="An experimental approach is described for late-stage lead diversification of frontrunner drug candidates using nanomole-scale amounts of lead compounds for structure–activity relationship developme..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 28, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00483" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00483" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00483" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00483" /></link>
        
    
    

<title>Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure–Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H1 Receptor Inverse Agonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00483" /></meta><meta property="og:title" content="Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure–Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H1 Receptor Inverse Agonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0026.jpeg" /></meta><meta property="og:description" content="An experimental approach is described for late-stage lead diversification of frontrunner drug candidates using nanomole-scale amounts of lead compounds for structure–activity relationship development. The process utilizes C–H bond activation methods to explore chemical space by transforming candidates into newly functionalized leads. A key to success is the utilization of microcryoprobe nuclear magnetic resonance (NMR) spectroscopy, which permits the use of low amounts of lead compounds (1–5 μmol). The approach delivers multiple analogues from a single lead at nanomole-scale amounts as DMSO-d6 stock solutions with a known structure and concentration for in vitro pharmacology and absorption, distribution, metabolism, and excretion testing. To demonstrate the feasibility of this approach, we have used the antihistamine agent loratadine (1). Twenty-six analogues of loratadine were isolated and fully characterized by NMR. Informative SAR analogues were identified, which display potent affinity for the human histamine H1 receptor and improved metabolic stability." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00483"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00483">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00483&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00483&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00483&amp;href=/doi/10.1021/acs.jmedchem.0c00483" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 7268-7292</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00479" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00369" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure–Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H<sub>1</sub> Receptor Inverse Agonist</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Manjinder S. Lall</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manjinder S. Lall</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#86ebe7e8ecefe8e2e3f4a8eae7eaeac6f6e0effce3f4a8e5e9eb"><span class="__cf_email__" data-cfemail="e68b87888c8f88828394c88a878a8aa696808f9c8394c885898b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manjinder+S.++Lall">Manjinder S. Lall</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2882-8075" title="Orcid link">http://orcid.org/0000-0002-2882-8075</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Asser Bassyouni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Asser Bassyouni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Science Center Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Asser++Bassyouni">Asser Bassyouni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James Bradow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Bradow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Bradow">James Bradow</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Brown</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Brown</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Brown">Maria Brown</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark Bundesmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark Bundesmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Bundesmann">Mark Bundesmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jinshan Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinshan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinshan++Chen">Jinshan Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory Ciszewski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory Ciszewski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory++Ciszewski">Gregory Ciszewski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne E. Hagen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne E. Hagen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne+E.++Hagen">Anne E. Hagen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dennis Hyek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis Hyek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Spectrix Analytical Services, LLC, 410 Sackett Point Road, Bldg 20, North Haven, Connecticut 06473, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis++Hyek">Dennis Hyek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen Jenkinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen Jenkinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Science Center Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Jenkinson">Stephen Jenkinson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bo Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bo Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Spectrix Analytical Services, LLC, 410 Sackett Point Road, Bldg 20, North Haven, Connecticut 06473, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Liu">Bo Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">R. Scott Obach</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">R. Scott Obach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=R.+Scott++Obach">R. Scott Obach</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Senliang Pan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Senliang Pan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Senliang++Pan">Senliang Pan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Usa Reilly</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Usa Reilly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Usa++Reilly">Usa Reilly</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Neal Sach</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Neal Sach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Science Center Drive, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Neal++Sach">Neal Sach</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel J. Smaltz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel J. Smaltz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Smaltz">Daniel J. Smaltz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Douglas K. Spracklin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Douglas K. Spracklin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+K.++Spracklin">Douglas K. Spracklin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3471-1332" title="Orcid link">http://orcid.org/0000-0002-3471-1332</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeremy Starr</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeremy Starr</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy++Starr">Jeremy Starr</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Melissa Wagenaar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melissa Wagenaar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Wagenaar">Melissa Wagenaar</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Gregory S. Walker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory S. Walker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Walker">Gregory S. Walker</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00483&amp;href=/doi/10.1021%2Facs.jmedchem.0c00483" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 7268–7292</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 28, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 March 2020</li><li><span class="item_label"><b>Published</b> online</span>28 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00483" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00483</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7268%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DManjinder%2BS.%2BLall%252C%2BAsser%2BBassyouni%252C%2BJames%2BBradow%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D13%26contentID%3Dacs.jmedchem.0c00483%26title%3DLate-Stage%2BLead%2BDiversification%2BCoupled%2Bwith%2BQuantitative%2BNuclear%2BMagnetic%2BResonance%2BSpectroscopy%2Bto%2BIdentify%2BNew%2BStructure%25E2%2580%2593Activity%2BRelationship%2BVectors%2Bat%2BNanomole-Scale%2BSynthesis%253A%2BApplication%2Bto%2BLoratadine%252C%2Ba%2BHuman%2BHistamine%2BH1%2BReceptor%2BInverse%2BAgonist%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7292%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00483"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2621</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00483" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure–Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H1 Receptor Inverse Agonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Manjinder&quot;,&quot;last_name&quot;:&quot;S. Lall&quot;},{&quot;first_name&quot;:&quot;Asser&quot;,&quot;last_name&quot;:&quot;Bassyouni&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Bradow&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Bundesmann&quot;},{&quot;first_name&quot;:&quot;Jinshan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;Ciszewski&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;E. Hagen&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;Hyek&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Jenkinson&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Scott Obach&quot;},{&quot;first_name&quot;:&quot;Senliang&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Usa&quot;,&quot;last_name&quot;:&quot;Reilly&quot;},{&quot;first_name&quot;:&quot;Neal&quot;,&quot;last_name&quot;:&quot;Sach&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Smaltz&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;K. Spracklin&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;Starr&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Wagenaar&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Walker&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7268-7292&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00483&quot;},&quot;abstract&quot;:&quot;An experimental approach is described for late-stage lead diversification of frontrunner drug candidates using nanomole-scale amounts of lead compounds for structure–activity relationship development. The process utilizes C–H bond activation methods to explore chemical space by transforming candidates into newly functionalized leads. A key to success is the utilization of microcryoprobe nuclear magnetic resonance (NMR) spectroscopy, which permits the use of low amounts of lead compounds (1–5 μmol). The approach delivers multiple analogues from a single lead at nanomole-scale amounts as DMSO-d6 stock solutions with a known structure and concentration for in vitro pharmacology and absorption, distribution, metabolism, and excretion testing. To demonstrate the feasibility of this approach, we have used the antihistamine agent loratadine (1). Twenty-six analogues of loratadine were isolated and fully characterized by NMR. Informative SAR analogues were identified, which display potent affinity for the human hista&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00483&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00483" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00483&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00483" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00483&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00483" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00483&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00483&amp;href=/doi/10.1021/acs.jmedchem.0c00483" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00483" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00483" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00483%26sid%3Dliteratum%253Aachs%26pmid%3D32462865%26genre%3Darticle%26aulast%3DLall%26date%3D2020%26atitle%3DLate-Stage%2BLead%2BDiversification%2BCoupled%2Bwith%2BQuantitative%2BNuclear%2BMagnetic%2BResonance%2BSpectroscopy%2Bto%2BIdentify%2BNew%2BStructure%25E2%2580%2593Activity%2BRelationship%2BVectors%2Bat%2BNanomole-Scale%2BSynthesis%253A%2BApplication%2Bto%2BLoratadine%252C%2Ba%2BHuman%2BHistamine%2BH1%2BReceptor%2BInverse%2BAgonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D13%26spage%3D7268%26epage%3D7292%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/jmcmar.2020.63.issue-13/20200709/jmcmar.2020.63.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">An experimental approach is described for late-stage lead diversification of frontrunner drug candidates using nanomole-scale amounts of lead compounds for structure–activity relationship development. The process utilizes C–H bond activation methods to explore chemical space by transforming candidates into newly functionalized leads. A key to success is the utilization of microcryoprobe nuclear magnetic resonance (NMR) spectroscopy, which permits the use of low amounts of lead compounds (1–5 μmol). The approach delivers multiple analogues from a single lead at nanomole-scale amounts as DMSO-<i>d</i><sub>6</sub> stock solutions with a known structure and concentration for <i>in vitro</i> pharmacology and absorption, distribution, metabolism, and excretion testing. To demonstrate the feasibility of this approach, we have used the antihistamine agent loratadine (<b>1</b>). Twenty-six analogues of loratadine were isolated and fully characterized by NMR. Informative SAR analogues were identified, which display potent affinity for the human histamine H<sub>1</sub> receptor and improved metabolic stability.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">Due to a production error, this article published with an incomplete file for the reaction scheme in Table 5. The corrected version published June 10, 2020.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Late-stage lead diversification (LSLD) is emerging as a powerful synthetic strategy for drug discovery.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This approach leverages unactivated C–H bonds as sites to incorporate functional groups or small substituents late in the synthetic route of a lead molecule by applying biochemical and chemical functionalization methods (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> From a medicinal chemist’s perspective, lead diversification is a highly attractive approach because it does not require chemical prefunctionalization of starting materials or <i>de novo</i> synthesis for each new analogue targeted. Furthermore, because pharmacological activity is already present in the lead molecule, LSLD has the ability to rapidly and cost-effectively incorporate drug-like properties and attributes into promising candidates, allowing the medicinal chemist to expand structure–activity relationship (SAR) knowledge, optimize ligand–target potency and selectivity, alter absorption, distribution, metabolism, and excretion (ADME) properties, improve physicochemical properties like solubility, identify metabolically labile sites to aid drug design, access new and synthetically challenging unexplored chemical space, and uncover novel intellectual property (IP) space. Therefore, this approach can significantly accelerate the drug discovery process with minimal synthetic investment, time, and cost.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Late-stage lead diversification (LSLD) to generate lead diversity in an efficient manner for a specific biological target. (B) Diversity-focused synthesis (DFS) explores related areas of chemical space in proximity to regions known to have useful properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Drug discovery and development are challenging because most drugs are designed through iterative rounds of chemical synthesis and pharmacological testing to incorporate drug-like attributes into lead molecules.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The LSLD approach is appealing, given that drug-like chemical space has been estimated at 10<sup>60</sup> for molecules obeying Lipinski’s rule of five for oral bioavailability and at 10<sup>20</sup>–10<sup>24</sup> for molecules up to 30 atoms.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> To manage these formidable numbers, LSLD lends itself to the methodology that favors diversity-focused synthesis (DFS) where the aim is to explore a dense area of chemical space adjacent to regions known to have useful properties, such as biological activity (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Hence, library size is not as important as libraries with focused diversity with favorable physicochemical properties (e.g., LipE)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> for a particular biological target.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Much attention has recently been focused on late-stage C–H bond activation and functionalization methods to diversify lead molecules in drug discovery.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Incorporating functional groups or small substituents efficiently with a judicious range in size and polarity into drug-like molecules is highly relevant for SAR development, can accelerate analogue preparation, and could potentially reduce high attrition associated with pharmaceutical research.<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> For example, high lipophilicity of drug candidates can lead to poor oral absorption, low compound solubility, and high metabolic turnover.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a> Late-stage C–H bond modification of biologically active compounds is an effective approach to address these issues because the direct replacement of C–H bonds with functional groups or substituents can significantly improve target binding or favorably influence receptor selectivity. Previously, we have described biosynthetic methods to carry out lead diversification and drug metabolite synthesis coupled with quantitative microcryoprobe NMR spectroscopy,<a onclick="showRef(event, 'cit1b cit1c cit1d ref10'); return false;" href="javascript:void(0);" class="ref cit1b cit1c cit1d ref10">(1b−d,10)</a> which laid the foundation for the present work. Herein, we report the operationalization and expansion of an approach to facilitate late-stage lead derivatization and metabolite synthesis for advanced lead molecules using small amounts (i.e., 1–2 mg) of compound to support drug discovery. This approach generates the chemical diversity of lead molecules through an alternative approach to classical medicinal chemistry practices, for rapid SAR knowledge and chemical space exploration. In particular, this approach utilizes direct C–H bond functionalization methods in support of diversity-focused synthesis to transform candidates into newly substituted leads or noteworthy metabolites, using mammalian liver microsomes and cytosols,<a onclick="showRef(event, 'cit1b cit1c cit1d'); return false;" href="javascript:void(0);" class="ref cit1b cit1c cit1d">(1b−d)</a> microorganisms,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> engineered and recombinant P450 enzymes,<a onclick="showRef(event, 'ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref12">(10,12)</a> biomimetic metalloporphyrins,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> electrochemistry,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Minisci chemistry,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> alkyl sulfinate radical precursor chemistry (Baran Diversinates),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and photoredox catalysis.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Therefore, this approach enables (1) synthetic modification of lead compounds to improve biological properties and (2) synthesis of metabolites for <i>in vitro</i> profiling to inform intrinsic clearance (CL<sub>int</sub>) parameters. Key to our method is the underpinning analytical infrastructure, which uses low amounts of lead compounds to carry out screens for hit identification, scale-up of interesting products, purification using liquid chromatography with automated fraction collection for isolation, full structure characterization based on high-resolution mass spectrometry and tandem mass spectrometry (MS/MS), and NMR spectroscopy utilized for both structure elucidation and quantitation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). With little investment upfront (1–2 mg of lead), this approach delivers multiple analogues from a single lead at nanomole-scale amounts (∼5 to 10 μg per product) as DMSO-<i>d</i><sub>6</sub> stock solutions with a known structure and concentration for immediate pharmacology and ADME testing. This approach can rapidly and cost-effectively address multiple medicinal chemistry problems on a miniaturized scale, such as provide valuable +/– SAR information, improve potency and selectivity, identify metabolically labile sites to aid drug design, alter physicochemical properties, and access novel synthetically challenging chemical space. To demonstrate our approach, we have generated compound diversity and drug metabolites using the antihistamine agent loratadine (<b>1</b>) as a prototypical compound to traverse through our workflow with the aim to explore chemical space about the A–D ring systems and identify new SAR vectors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Workflow for late-stage lead diversification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The clinical agent loratadine is a second-generation antihistamine drug used to treat allergic rhinitis, also known as hay fever.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Well known for more than 20 years, loratadine has been subject to extensive SAR.<a onclick="showRef(event, 'cit19a cit19b cit19c cit19d'); return false;" href="javascript:void(0);" class="ref cit19a cit19b cit19c cit19d">(19a−d)</a> Loratadine is a tricyclic nonsedating inverse agonist of the human histamine H<sub>1</sub> receptor (dissociation constant, <i>K</i><sub>d</sub> = 0.19 μM) and is preferred over first-generation antihistamines because of lack of sedation and CNS adverse effects.<a onclick="showRef(event, 'cit19e cit19f cit19g'); return false;" href="javascript:void(0);" class="ref cit19e cit19f cit19g">(19e−g)</a> Loratadine was used as an example compound to test our approach and highlight the ability to generate diverse compounds because the molecule contains drug-like structural features common to typical lead molecules explored during drug discovery, such as sites containing alkyl, <i>O</i>/<i>N</i>-alkyl, aryl, heteroaryl, carbonyl (carbamate), haloarene, and unsaturation functionality (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). To explore loratadine SAR, we envisioned using various C–H bond activation methods to synthetically access and functionalize the A–D ring systems in <b>1</b>. The total synthesis of loratadine is complex and involves seven steps with an overall yield of 37%, after considerable process development.<a onclick="showRef(event, 'cit19a cit19b'); return false;" href="javascript:void(0);" class="ref cit19a cit19b">(19a,b)</a> Preparing SAR analogues of <b>1</b> with systematic and probing modification at all ring systems (A–D) in single transformative steps is challenging but conceivable using our approach.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Functional group distribution of antihistamine drug loratadine (<b>1</b>) and lead diversification technologies employed for LSLD to access A–D ring system SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Liver Microsomes and Recombinant CYP Enzymes</h3><div class="NLM_p">To diversify the alkyl sites in loratadine (A and C rings), compound <b>1</b> was screened against a panel of mammalian liver microsomes (nine systems) and human recombinant cytochrome P450 enzymes (nine CYP isoforms), configured in a 96-well microtiter plate format for automated screening convenience as described in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S1</a> in the Supporting Information section. Despite the large number of C–H bonds in loratadine, CYPs possess the exceptional capability to react at inert C(sp<sup>3</sup>)–H bonds within carbon backbones preferentially over other more chemically reactive sites. Hence, cytochrome P450 enzymes are versatile chemo- and regioselective biocatalysts and are known to catalyze a wide range of reactions including but not exclusive to hydroxylation, O- and N-dealkylation, heteroatom oxidation, dehydrogenation, and epoxidation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Some of these transformations have the unique ability to introduce polarity (e.g., hydroxylation) at synthetically challenging sites and significantly lower lipophilicity; a single hydroxyl group adds 20 Å<sup>2</sup> of the polar surface area (PSA), which can often lead to increased metabolic stability.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Furthermore, the hydroxyl group can behave as a hydrogen bond acceptor (HBA) or hydrogen bond donor (HBD) providing binding energy to biological targets, resulting in increased ligand affinity. With these multifaceted capabilities, this functional group offers medicinal chemists a structural change that can modify a lead molecule behavior at the target site and in the body.<a onclick="showRef(event, 'cit21b'); return false;" href="javascript:void(0);" class="ref cit21b">(21b)</a> As a result, the hydroxyl group is present in many biologically important molecules including ∼20% of drugs<a onclick="showRef(event, 'cit22a cit22b'); return false;" href="javascript:void(0);" class="ref cit22a cit22b">(22a,b)</a> and ∼65% of natural products.<a onclick="showRef(event, 'cit22c'); return false;" href="javascript:void(0);" class="ref cit22c">(22c)</a></div><div class="NLM_p">Accordingly, chromatographic profiles from liver microsome and recombinant CYP screens (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S2</a> in the Supporting Information) were examined by UV and tandem mass spectrometry (MS/MS), and the results were evaluated for acceptable product yield (>10% conversion) and product diversity. It is important to mention that percent conversion to end products and diversity of products are critical factors when considering which system should be selected for scale-up. Also, reaction profiles that provide products in the molecular weight range of the starting material are favored over those that generate lower molecular weight product fragments via heteroatom dealkylation reactions. For loratadine, 13 products were detected by HPLC–MS (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) where M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass). The HPLC–MS results from the liver microsome and recombinant CYP screen show wells 9 and 18 generating good diversity, affording up to 10 unique products with reasonable conversion. Products generated from wells 9 and 18 correspond to incubations with human liver microsomes and recombinant CYP3A4, respectively, which are in good agreement with previous reports that show CYP3A4 and CYP2D6 as the predominant enzymes involved in loratadine <i>in vitro</i> metabolism.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Liver microsome and recombinant CYP HPLC–MS chromatograms for human liver microsomes (well 9), rhCYP3A4 (well 18), and rabbit liver microsomes (well 6). M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Screening lead molecules using liver microsomes in concert with recombinant CYPs, as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S1</a>, also provides a prospective opportunity to forecast CYP liability and determine which isoforms are most active <i>in vitro</i>, offering an early glimpse into metabolite profiling and identification (Met ID).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Furthermore, we have established protein–ligand docking protocols based on known CYP isoform X-ray structures to guide potential binding modes of leads with CYP active sites using binding energy and shape complementarity scores.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Caution should be used when utilizing protein–ligand docking to explain the metabolism because of the highly dynamic nature of the P450 enzyme binding pocket. Thus, these initiatives are predictive but can potentially address drug design approaches to enhance metabolic stability, given that a high rate of metabolism (i.e., high intrinsic clearance, CL<sub>int</sub>) is a function of enzyme maximum velocity (<i>V</i><sub>max</sub>) and the Michaelis constant (<i>K</i><sub>m</sub>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> In view of this, metabolic clearance by P450s can be impacted through lead diversification strategies that block sites of metabolism, alter ligand electronics, or introduce polarity into lead molecules.<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Modeled pose of loratadine with human CYP2D6. The oxygen atom of the CYP2D6 iron(IV)-oxo porphyrin radical cation is 4 Å from one of the methylene hydrogen atoms of the ethyl carbamate moiety in loratadine. (B) Potential strategies to alter a lead molecule intrinsic clearance (CL<sub>int</sub>) value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Microorganisms</h3><div class="NLM_p">Microbes have long been an important source of bioactive natural products for drug discovery, providing a wealth of novel scaffolds as well as marketed drugs.<a onclick="showRef(event, 'ref11 ref27'); return false;" href="javascript:void(0);" class="ref ref11 ref27">(11,27)</a> Most recently, microbial incubations with lead molecules have been investigated to chemically diversify drug candidates to expand SAR knowledge or incorporate chemical handles for further structural modification.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Other virtues of microbial biotransformations include their ability to mimic mammalian metabolism or produce microbe specific metabolites. They often produce multiple products that can generate compounds that are difficult to produce through synthetic chemistry, are scalable processes (mg to kg quantities), produce oxidative (phase I) and conjugative (phase II) metabolites, and are cost-effective.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Thus, loratadine was screened for modification on ring systems A and C using a panel of 79 microorganisms, which included organisms from bacteria, fungi, and actinomycetes (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S3</a> in the Supporting Information).</div><div class="NLM_p">Loratadine was incubated with a microbial panel (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S3</a>) to afford 23 products observed by HPLC–MS (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S4</a> in the Supporting Information). As expected, when using live whole cells, the microbial screen gave many products from phase I and II metabolism of loratadine. In addition, we observed nondrug-related secondary metabolite products (e.g., M + 63, M + 65, M + 84, and 2M + 96), which can be differentiated from <b>1</b> by MS/MS fragmentation patterns. Of the 23 compounds detected, 18 products appeared to be drug-related by HPLC–MS (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'cit30a'); return false;" href="javascript:void(0);" class="ref cit30a">(30a)</a> In considering the chromatographic profiles generated for loratadine using microbial whole cells, it was observed that bacterial organisms (e.g., well 19, <i>Nocardia</i> ATCC 21271a: 10 products detected) were more efficient at generating diversity as compared to fungal strains (e.g., well 65, <i>Mucor rouxii</i> UC7470: 6 products detected).<a onclick="showRef(event, 'cit30b'); return false;" href="javascript:void(0);" class="ref cit30b">(30b)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Microorganism HPLC–MS chromatograms for <i>Nocardia</i> ATCC 21271a (well 19), <i>M. rouxii</i> UC7470 (well 65), and <i>Streptomyces fradiae</i> (well 15).<a onclick="showRef(event, 'cit30a'); return false;" href="javascript:void(0);" class="ref cit30a">(30a)</a> M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Engineered Cytochrome P450 Enzymes</h3><div class="NLM_p">Mammalian cytochrome P450 (CYP) enzymes are a superfamily of membrane-bound heme containing monooxygenases that can insert atmospheric oxygen into unactivated C(sp<sup>3</sup>)–H bonds across an enormous variety of substrates under mild conditions with a high degree of chemo- and regioselectivity.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Despite these noteworthy qualities, mammalian CYP applications are limited because of a low turnover rate and enzyme instability, and they acquire electrons through a complex process involving cytochrome P450 reductase and NADPH. For these reasons, there is considerable interest in utilizing directed evolution<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to engineer bacterial cytochrome P450 enzymes for the synthesis of novel drugs and drug metabolites.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">Bacterial cytochrome P450 enzymes can be evolved to afford new biocatalysts with enhanced synthetic applications to generate unique products not observed by mammalian CYPs and provide valuable +/– SAR for drug discovery. Cytochrome P450 from <i>Bacillus megaterium</i> CYP102A1 (P450 BM3) has characteristics that enable protein engineering for use in synthesis because it is expressed in <i>Escherichia coli</i> at high levels, it is a soluble enzyme, and its electron transfer and reductase domains are fused in one continuous polypeptide chain to efficiently facilitate oxidative transformations.<a onclick="showRef(event, 'ref12 ref34'); return false;" href="javascript:void(0);" class="ref ref12 ref34">(12,34)</a> In this respect, tailoring the functionality of P450 BM3 has enabled its utility as an effective biocatalytic tool in pharmaceutical research with wide-ranging synthetic applicability from early drug discovery on a small scale<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> to late development on a kilogram scale.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> With these salient features in mind, we utilized a cytochrome P450 BM3 panel composed of 45 Codexis<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> variants selected for their ability to cover the reactivity scope of human CYPs by producing mammalian drug metabolites and also to show broad specificity on drug-like substrates to provide new diverse chemical leads (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S5</a> in the Supporting Information).</div><div class="NLM_p">To this end, loratadine was screened against our P450 BM3 panel and evaluated for enzyme functionalization activity and variety in product distribution about the A, C, and D, ring systems. As expected, the reactivity scope of the 45-membered P450 BM3 panel was broad and produced a variety of products when applied against loratadine (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S6</a> in the Supporting Information), providing a product profile that complemented the mammalian liver microsome and recombinant CYP screen by generating different products. Seventeen different products were identified in the HPLC–MS chromatograms of select P450 BM3 reactions with <b>1</b> as the substrate (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The chromatographic traces from wells 40 (MCYP0012) and 47 (MCYP0160) show good diversity profiles, generating up to 16 products. A few of the P450 BM3-derived products have matched retention times and MS/MS fragmentation patterns to those that arose from mammalian CYPs, which speaks to the panel’s capability to prepare authentic drug metabolites. In addition, several BM3 variants gave products not observed when screening liver microsomes and recombinant CYPs underscoring their utility for lead diversification. Several BM3 enzymes displayed good degrees of regioselective hydroxylation as exhibited by yielding five chromatographically different M + 16 products (<i>vide infra</i>). These enzymes, which give rise to single hydroxylation products, are vital to SAR development because they effectively probe the lead molecule’s ability to tolerate polar functionality at various sites, aiding drug design strategies for improved properties (e.g., target potency, solubility, oral bioavailability, etc.).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Furthermore, there was low occurrence of bis-hydroxylation, which reflects the enzyme’s exquisite selectivity for <b>1</b> over its more polar hydroxylated products, limiting the synthesis of unwanted polyhydroxylated compounds.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. BM3 variant HPLC–MS chromatograms for MCYP0160 (well 47), MCYP0012 (well 40), and MCYP-P1.2-C11 (well 29). M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Electrochemistry</h3><div class="NLM_p">Electrochemical transformations are a simple and green method for enabling C–H bond functionalization of lead molecules where the addition or removal of electrons across an electrical potential can bring about lead modification or metabolite synthesis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The advantage of electrochemistry is the ability to precisely control both the potential and rate of the redox process in a manner not possible with conventional chemical oxidants or reductants. For example, electrochemical functionalization has been used to prepare derivatives of the antibiotic tylosin where the modification of the parent compound gives rise to novel desmycosin analogues.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Electrochemical oxidation is also a useful tool to understand and study metabolic pathways, as demonstrated for the antimalarial drug amodiaquine.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> To accommodate our needs, we used a NuVant EZstat Pro potentiostat to acquire cyclic voltammetry (CV) readings to determine redox properties. Of particular interest is the initial anode oxidation potential, which provides voltage parameters for the subsequent electro-oxidation reaction. As a result, a preparative undivided electrochemical cell was used to screen <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S1A</a> in the Supporting Information). Loratadine was subjected to electrolysis with constant potential (5 V) across the two electrodes to modify the olefinic region, which flanks rings A and C in the molecule.</div><div class="NLM_p">After electrochemical initiation, the reaction progress was monitored by HPLC–MS to follow the formation of products. The reaction profile showed the formation of 10 distinct products (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S7</a> in the Supporting Information). The observed electrochemical products appeared unique by HPLC–MS (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) compared to products derived from biological oxidation (i.e., liver microsomes, recombinant CYP, microorganisms, and BM3). This illustrates differences between the transformational methods and shows good complementarity between chemical and biological oxidative technologies to deliver a diverse set of products.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Electrochemistry HPLC–MS chromatogram. Electrolysis reaction conditions: graphite anode, stainless steel cathode, Et<sub>4</sub>NBF<sub>4</sub>, 5 V, MeCN/H<sub>2</sub>O, RT, and 1 h. M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biomimetic Metalloporphyrin Oxidation</h3><div class="NLM_p">Synthetic metalloporphyrins capable of mimicking the selective C–H bond oxidation of heme containing monooxygenase cytochrome P450s have become of increasing significance to drug discovery in recent years.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> These biomimetic metalloporphyrin oxidation (BMO) catalysts have been extensively investigated for lead diversification and metabolite synthesis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Consequently, this method has been utilized for aliphatic hydroxylation,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> O- and N-dealkylation, and S- and N-oxidation and epoxidation, in addition to other transformations.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In view of this, loratadine was screened against a 120-membered BMO panel consisting of two solvent systems (MeOH/DCE or MeCN/DCE), six oxidants (PhIO, H<sub>2</sub>O<sub>2</sub>, Oxone, CHP/imidazole, <i>m</i>CPBA, or CHP/imidazole/HCO<sub>2</sub>H), and nine commercially available metalloporphyrins<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> ((Fe(TNO<sub>2</sub>PP), Mn(TFPP), Fe(TFPP), Cu(TFPP), Co(TFPP), Pd(TDCIPP), Mn(TDCIPP), Cu(TDCIPP), or Co(TDCIPP)) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S8</a> in the Supporting Information). The requisite screen was run under protic (MeOH/DCE, 1:1) and aprotic (MeCN/DCE, 1:1) solvent conditions, in an attempt to diversify the olefinic portion of loratadine and the D ring system. To ensure that metalloporphyrin was actively participating in product formation, a control screen was run with a solvent and oxidant but no metalloporphyrin.</div><div class="NLM_p">Chromatographic profiles from the BMO screen were evaluated by HPLC–MS and showed the formation of six products (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S9</a> in the Supporting Information). Once again, the products derived from the BMO screen appeared distinct by the retention time and MS/MS fragmentation pattern (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) from products derived from biological oxidation, indicating good complementarity between chemical and biological oxidation techniques to enable lead diversification.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Biomimetic metalloporphyrin oxidation HPLC–MS chromatograms. Top chromatogram: reaction conditions with metalloporphyrin Cu(TDCIPP), cumene hydroperoxide, MeOH, and DCM. Bottom chromatogram: reaction conditions without metalloporphyrin, <i>m</i>CPBA, MeOH, and DCM. M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Comparison of Lead Diversification Screens</h3><div class="NLM_p">With the HPLC–MS results in hand from all screens, we were able to compare and contrast chromatographic profiles from the different lead diversification and metabolite synthesis technology screens. Early on, it became apparent that chromatographic profiles derived from biological oxidative methods (i.e., liver microsomes, recombinant CYP, microorganisms, and BM3) gave similar product profiles by LC retention time and MS/MS fragmentation, albeit with different product conversions (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), which are important for scale-up considerations. These results were in stark contrast to chromatographic profiles obtained from EC and BMO screens (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), which gave relatively distinct products. Only one product, as determined by LC–MS analysis, was generated in both the EC and BMO screens (e.g., <i>m/z</i> 399j, M + 16) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Furthermore, the comparable <i>m/z</i> 399j product was generated in the control BMO well without metalloporphyrin, suggesting that loratadine is modified by oxidant <i>m</i>CPBA and not metalloporphyrin.</div><div class="NLM_p">We also compared product similarity and difference relative to each biological technology by using a diversity map where screening panels from all biological systems (e.g., liver microsomes, recombinant CYP, microorganisms, and BM3) are plotted as a function of product detected by HPLC–MS (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_002.xlsx" class="ext-link">Excel S1_Diversity Map</a> in the Supporting Information to view the entire plot). Viewing the data in this manner allowed for systematic identification of transformational systems that gave comparable products and, more importantly, to pinpoint systems that generate good product diversity.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Diversity map of product similarity and difference relative to biological technology screened by HPLC–MS, refer to (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_002.xlsx" class="ext-link">Excel S1_Diversity Map</a>) in the Supporting Information to view the entire map. <i>X</i> axis displays product distribution determined by HPLC-MS, shown in yellow (top); <i>Y</i> axis displays well distribution from each biological screening panel: liver microsomes and recombinant CYP (shown in brown), microorganisms (shown in green), and BM3 variants (shown in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For example, extensive biotransformation of loratadine is observed from the diversity map using human liver microsomes (well 9), which generates nine products by HPLC–MS (<i>m/z</i> 311 (M – 72), 381c (M – 2), 381d (M – 2), 397a (M + 14), 397b (M + 14), 399a (M + 16), 399b (M + 16), 415a (M + 32), and 415b (M + 32)). In a complimentary manner, the map also reveals that four of these products (<i>m/z</i> 381c (M – 2), 381d (M – 2), 399a (M + 16), and 399b (M + 16)) are also made by microorganism <i>Streptomyces violascens</i> ATCC 31560 (well 27) and BM3 variant MCYP0012 (well 40). <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> also uncovers that products <i>m/z</i> 327a (M – 56), 327b (M – 56), and 327c (M – 56) are generated by rabbit liver microsomes (well 6), product <i>m/z</i> 413c (M + 32) is made by microbe <i>Streptomyces setae</i> ATCC 33774<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (well 28), and products <i>m/z</i> 397f (M + 14), 397g (M + 14), 413b (M + 30), and 415e (M + 32) are generated by BM3 variant MCYP0012 (well 40).</div><div class="NLM_p">We further summarized the results from the diversity map to illustrate the distribution of similar products generated from the biological screens. For instance, liver microsome and recombinant CYP products observed by HPLC–MS were compared to those generated by other biological technology screens, e.g., microorganisms and BM3 (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). The results illustrated in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> show that loratadine products generated from liver microsomes and recombinant CYPs have 69% product similarity to products generated from the microbial panel, 46% product similarity to products generated from the BM3 panel, and 46% similarity to all panels. For a more comprehensive breakdown of product similarity relative to the other technologies screened by HPLC–MS refer to <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S10</a> in the Supporting Information.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Ratio of liver microsome and recombinant CYP products observed by HPLC–MS relative to similar products detected from other technology screens (e.g., microbes and BM3). Venn diagram representation (bottom).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Lead Diversification Product Scale-Ups</h3><div class="NLM_p">With the diversity map in place, we shifted our attention to using the plot to select wells for product scale-up with a focus on the lead diversification of loratadine with the specific aim to explore SAR chemical space by isolating products with modifications on rings A–D. For instance, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> shows rabbit liver microsomes (well 6) capable of converting loratadine to three unique products (<i>m/z</i> 327a–c, M – 56), which are not observed in any of the other technology screens. Therefore, male rabbit liver microsomes (New Zealand, XenoTech) were selected for product scale-up, which involved scaling the original liver microsome screen conditions by a factor of 80-fold at a protein concentration of 2 mg/mL and substrate (<b>1</b>) concentration of 20.0 μM. Consequently, loratadine was incubated at 37 °C, utilizing a reactor open to the atmosphere. After 1 h, the reaction mixture was quenched with acetonitrile, centrifuged, and adsorbed onto a C18 HPLC column. The column was transferred to a UHPLC instrument in line with a mass spectrometer, and the products were eluted using a 0.1% formic acid in water/acetonitrile gradient. Fractions containing peaks of interest were analyzed by UHPLC–UV–HRMS and tandem mass spectrometry (MS/MS). The isolated samples were characterized by multidimensional NMR spectroscopy (COSY, HSQC, and HMBC) using a 1.7 mm MicroCryoProbe<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and quantified by external calibration against a benzoic acid standard solution, applying electronic reference to access <i>in vivo</i> concentrations 2 (ERETIC2).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> As a result, descarboethoxy alcohols <b>2</b> (7.98 μg, 24.0 nmol) and <b>3</b> (2.22 μg, 6.8 nmol) were generated where modification occurred on the A and C rings of loratadine (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). It is worth mentioning that the isolable nanomole-scale quantities of <b>2</b> and <b>3</b> are typical and manageable amounts for our workflow, which permit rapid synthesis and pharmacological testing on a miniaturized scale using nominal amounts of staring material (e.g., 306 μg of <b>1</b>), reagents, and solvent. Descarboethoxy alcohols <b>2</b> and <b>3</b> are known human metabolites of loratadine.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>2</b> was found to be a potent inverse agonist of the human histamine H<sub>1</sub> receptor with a dissociation constant of 48 nM, effectively 4-fold more active than loratadine (<i>K</i><sub>d</sub> = 190 nM). Remarkably, the regioisomeric alcohol <b>3</b> (<i>K</i><sub>d</sub> = 28 nM) is 7-fold more potent than loratadine. In addition, compounds <b>2</b> and <b>3</b> show slightly improved human hepatocyte stability compared to loratadine (1.75 and 3.14 μL/min/million cells vs 6.1 μL/min/million cells), possibly the result of decreased lipophilicity reflected by the lower SFlog <i>D</i> values.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Interestingly, we also observed good passive permeability of <b>2</b> and <b>3</b> (RRCK <i>P</i><sub>app</sub> = 79.9 ×10<sup>–6</sup> and 78.4 × 10<sup>–6</sup> cm/s, respectively). It is important to recognize that we did not determine absolute stereochemical configuration of the hydroxyl group for <b>2</b> and <b>3</b> and for all subsequent loratadine analogues generated herein. Nevertheless, from an SAR chemical space viewpoint, analogues <b>2</b> and <b>3</b> indicate that a basic amine is tolerated on the A ring of loratadine and polarity is accepted at the C(sp<sup>3</sup>)–H sites of the C ring.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Loratadine Analogues Generated from Rabbit Liver Microsomes<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0017.gif" alt="" id="gr17" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0018.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Human histamine H<sub>1</sub> receptor dissociation constant (nM). Geometric mean of three replicates.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Human liver microsome intrinsic clearance CL<sub>int</sub> (μL/min/mg).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Human hepatocyte intrinsic clearance CL<sub>int</sub> (μL/min/million cells).</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Apparent passive permeability in the Ralph Russ canine kidney cell line <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s).</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Shake-flask log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">We next focused on isolating a diverse pool of A and C ring analogues generated from our microbial screen. The diversity map shows that microorganisms <i>Cunninghamella elegans</i> ATCC 8688a (well 73), <i>S. violascens</i> ATCC 31560 (well 27), and <i>S. setae</i> ATCC 33774 (well 28) are proficient at producing products (<i>m/z</i> 311, M – 72), (<i>m/z</i> 399a, M + 16), (<i>m/z</i> 399b, M + 16), and (<i>m/z</i> 415c, M + 32). Therefore, we initiated product scale-ups with these three microorganisms, which involved inoculating cultures from the previously mentioned microbes. After 2 days of culture growth, the incubate was charged with <b>1</b> (5 mg, 13 μmol), and the incubation was continued. The reaction mixtures were quenched and subjected to purification and characterization. Consequently, microorganism <i>C. elegans</i> ATCC 8688a gave <b>4</b> (574 μg, 1847 nmol) as the A ring altered descarboethoxy analogue (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>4</b> is recognized as a known metabolite of loratadine<a onclick="showRef(event, 'ref23 ref51'); return false;" href="javascript:void(0);" class="ref ref23 ref51">(23,51)</a> and an approved second-generation tricyclic antihistamine drug identified as desloratadine,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> which displays potent affinity for the H<sub>1</sub> receptor (<i>K</i><sub>d</sub> = 24 nM). The C-ring positional hydroxyl isomers <b>5</b> (27 μg, 67 nmol) and <b>6</b> (11 μg, 27 nmol) were generated from <i>S. violascens</i> ATCC 31560 and are not reported in the literature, which speaks to the ability of our approach to deliver novel chemical matter for drug discovery. Hydroxyl analogue <b>5</b> (<i>K</i><sub>d</sub> = 454 nM) was less active than its regioisomer <b>6</b> (<i>K</i><sub>d</sub> = 257 nM), which maintained H<sub>1</sub> potency. Compound <b>6</b> also shows 2-fold improved permeability RRCK <i>P</i><sub>app</sub> = 26 × 10<sup>–6</sup> cm/s compared to <b>1</b> (RRCK <i>P</i><sub>app</sub> = 11 × 10<sup>–6</sup> cm/s). Based on the SAR results of <b>5</b> and <b>6</b>, it appears that C-ring modification is better tolerated without the A-ring carboethoxy group as previously shown with congeners <b>2</b> and <b>3</b>, which illustrates the receptor’s high degree of selectivity. Lastly, microorganism <i>S. setae</i> ATCC 33774 afforded A-ring-modified dicarbinolamide <b>7</b> (43 μg, 103 nmol), which is an unreported analogue of loratadine. The stability of <b>7</b> was examined at several pH values (e.g., pH 1.2, 7.4, and 10.0), and the compound was found to be unchanged over 24 h by HPLC–MS (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S2</a> in the Supporting Information). The dicarbinolamide functional group can be chemically prepared via the Hofmann rearrangement.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> To our delight, compound <b>7</b> was found to have favorable potency (<i>K</i><sub>d</sub> = 51 nM) and better metabolic stability in human liver microsomes (HLM CL<sub>int</sub> = 21 μL/min/mg) in comparison to loratadine (HLM CL<sub>int</sub> = 137 μL/min/mg). In addition, the human hepatocyte values for <b>7</b> (HHEP CL<sub>int</sub> = 13 μL/min/million cells) and <b>1</b> (6 μL/min/million cells) are similar and reflect good cellular metabolic stability. Importantly, loratadine analogues <b>5</b>, <b>6</b>, and <b>7</b> are new compounds and underscore the capability of our approach to access novel chemical space coupled with new SAR vectors for medicinal chemistry teams to explore from a single transformational step.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Loratadine Analogues Generated from Microorganisms</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0019.gif" alt="" id="gr19" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0020.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Human histamine H<sub>1</sub> receptor dissociation constant (nM). Geometric mean of three replicates.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Human liver microsome intrinsic clearance CL<sub>int</sub> (μL/min/mg).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Human hepatocyte intrinsic clearance CL<sub>int</sub> (μL/min/million cells).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Apparent passive permeability in the Ralph Russ canine kidney cell line <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s).</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Shake-flask log <i>D</i>.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">From <i>C. elegans</i> ATCC 8688a.</p></div><div class="footnote" id="t2fn7"><sup><sup>g</sup></sup><p class="last">From <i>S. violascens</i> ATCC 31560.</p></div><div class="footnote" id="t2fn8"><sup><sup>h</sup></sup><p class="last">From <i>S. setae</i> ATCC 33774.</p></div></div><div></div></div><div class="NLM_p">We applied our protein–ligand docking protocols of known CYP isoforms (e.g., CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) to analogue <b>7</b> with the aim to understand the nature of the improved HLM metabolic stability compared to loratadine. Evaluating the CYP2D6 model with analogue <b>7</b>, as shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, we observe the oxygen atom of the iron(IV)-oxo porphyrin radical cation to be 13 Å from the methylene hydrogen atom of the ethyl carbamate group in <b>7</b>, placing this moiety of the molecule far from the CYP active site, which could explain the lower intrinsic clearance value.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> From a loratadine drug design perspective, the protein–ligand model suggests that introducing polar functionality adjacent to the carbamate nitrogen atom on the A ring can improve metabolic stability. The diversity map shows that compound <b>7</b> was not detected by HPLC–MS in the BM3 or liver microsomes and recombinant CYP screens.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Modeled pose of analogue <b>7</b> with CYP2D6. The oxygen atom of the CYP2D6 iron(IV)-oxo porphyrin radical cation is 13 Å from one of the methylene hydrogen atoms of the ethyl carbamate moiety in <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With access to analogue <b>5</b>, we attempted to explore the C-ring vector and restore activity by synthesizing the fluorinated congener via a deoxyfluorination reaction using the reagent <i>N</i>,<i>N</i>-diethylaminosulfur trifluoride (DAST).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> We have found the deoxyfluorination of hydroxylated compounds an effective strategy for drug design to optimize ligand–target potency and selectivity and improve metabolic stability. Due to fluorine’s small size (van der Waals radius, 1.47 Å) and large electronegativity (3.98 Pauling scale), the introduction of a fluorine atom can dramatically impact the compound conformation, p<i>K</i><sub>a</sub>, and cell permeability.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> For these reasons, fluorine is present in a large and growing number of approved drugs (∼25%).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Moreover, the fluorination at the site of cytochrome P450 modification can lower the rate of metabolic turnover or alter the site of metabolism; hence, fluorine substitution is a viable approach to mitigate drug metabolism.<a onclick="showRef(event, 'cit10a'); return false;" href="javascript:void(0);" class="ref cit10a">(10a)</a> Therefore, alcohol <b>5</b> was treated with DAST (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). After work-up, the crude material was purified to afford C-ring fluorinated analogue <b>8</b> (25 μg, 62 nmol). We were pleased to see the H<sub>1</sub> activity restored in compound <b>8</b> (<i>K</i><sub>d</sub> = 227 nM) with equivalent HLM CL<sub>int</sub> (120 μL/min/mg), RRCK <i>P</i><sub>app</sub> (13 × 10<sup>–6</sup> cm/s) and SFlog <i>D</i> (4.5) to loratadine. However, the human <i>in vitro</i> hepatic metabolic stability of <b>8</b> (HHEP CL<sub>int</sub> = 32 μL/min/million cells) was increased by 5-fold compared to <b>1</b> (HHEP CL<sub>int</sub> = 6 μL/min/million cells), possibly due to a change in the site of metabolism or the result of increased lipophilicity. Also, we cannot overlook the importance of how metabolism rate can be influenced by stereochemistry, bearing in mind that the individual enantiomers of <b>8</b> could have different metabolic rates, which we have not investigated.</div><figure id="sch1" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>8</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 45-membered P450 BM3 screen identified several enzymes that are active against <b>1</b> and capable of functionalizing rings A and C (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). In particular, the diversity map uncovered enzymes MCY0012 (well 40) and MCYP0160 (well 47) as giving a substantial number of products (16 detected) with diverse profiles compared to the other lead diversification screens, as determined by the HPLC product retention time and MS/MS fragmentation pattern. As a result, the BM3 screening conditions for wells 40 (MCY0012) and 47 (MCY0160) were scaled by a factor of 200-fold to give a final protein concentration of 1–2 mg/mL and substrate (<b>1</b>) concentration of 250.0 μM. After the reaction with BM3 enzymes, the crude material was submitted for purification to afford analogues <b>9</b>–<b>17</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) in isolated yields ranging from 10 to 200 μg. As predicted from the diversity map, enzymes MCYP0012 and MCYP0160 provided a generous degree of A-, C-, and D-ring structural diversity. The products isolated included those with alkyl hydroxylation (<b>9</b> and <b>17</b>), heteroarene hydroxylation (<b>11</b>), and unsaturation (<b>14</b>–<b>16</b>) as well as products with hydroxylation and unsaturation (<b>10</b>, <b>12</b>, and <b>13</b>). It is worth mentioning that access to analogues such as <b>9</b>–<b>17</b> using conventional synthetic methods would be challenging. Furthermore, upon structural elucidation, we determined that a handful of these compounds were novel and not reported in the literature (<b>10</b>, <b>12</b>, <b>13</b>–<b>15</b>, and <b>17</b>), in alignment with the goal to prepare analogues, which evaluate unexplored chemical space and provide positive and negative SAR (+/– SAR). The majority of BM3-derived analogues show poor binding affinity for the H<sub>1</sub> receptor apart from alcohol <b>9</b> (<i>K</i><sub>d</sub> = 423 nM) and olefin <b>15</b> (<i>K</i><sub>d</sub> = 454 nM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Loratadine Analogues Generated from BM3 Variants<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0021.gif" alt="" id="gr21" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0022.gif" alt="" id="gr22" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Human histamine H<sub>1</sub> receptor dissociation constant (nM). Geometric mean of three replicates.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Human liver microsome intrinsic clearance CL<sub>int</sub> (μL/min/mg).</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Human hepatocyte intrinsic clearance CL<sub>int</sub> (μL/min/million cells).</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Apparent passive permeability in the Ralph Russ canine kidney cell line <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s).</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Shake-flask log <i>D</i>.</p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">From MCY0012.</p></div><div class="footnote" id="t3fn8"><sup><sup>h</sup></sup><p class="last">From MCYP0160.</p></div></div><div></div></div><div class="NLM_p">From a structural point of view, we were intrigued with heteroaromatic modified analogues <b>11</b>–<b>13</b> and wondered if alternate substituents on the D ring of loratadine might be tolerated. Alkyl sulfinate salts, also known as Baran Diversinates, have recently emerged as radical precursors for the direct incorporation of alkyl substituents onto heteroarene systems to facilitate late-stage functionalization (LSF) of lead compounds.<a onclick="showRef(event, 'ref16 ref58'); return false;" href="javascript:void(0);" class="ref ref16 ref58">(16,58)</a> Accordingly, the synthesis of difluoromethyl analogues of loratadine were pursued by treating <b>1</b> with difluoromethanesulfinate zinc salt in the presence of <i>tert</i>-butyl hydroperoxide (TBHP) oxidant under acidic conditions (TFA). Employing these prescribed conditions, we obtained novel D-ring-substituted regioisomers <b>18</b> (1.0 mg, 2.3 μmol) and <b>19</b> (1.2 mg, 2.7 μmol). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, CHF<sub>2</sub>-substituted analogue <b>18</b> displays no activity against the histamine H<sub>1</sub> receptor (<i>K</i><sub>d</sub> > 1000). However, the positional isomer <b>19</b> exhibits good affinity for H<sub>1</sub> (<i>K</i><sub>d</sub> = 271 nM) and points out the importance of this D-ring SAR vector. However, the metabolic stability of <b>19</b> appears compromised (HLM CL<sub>int</sub> = 283 μL/min/mg; HHEP CL<sub>int</sub> = 40 μL/min/million cells). The CHF<sub>2</sub> group can behave as a lipophilic hydrogen bond donor. From a drug design perspective, we thought that lowering the log <i>D</i> of compounds like <b>19</b> (SFlog <i>D</i> = 3.2) might provide leads with improved intrinsic clearance. In addition, the CHF<sub>2</sub> substituent has been used as a bioisostere for thiols, hydroxamic acids, amides, and hydroxyl groups.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> For that reason, we targeted the addition of a hydroxymethyl group to the D ring of loratadine. Treating <b>1</b> with Rongalite (sodium hydroxymethanesulfinate) under standard reaction conditions furnished the desired hydroxymethyl regioisomer <b>20</b> (142 μg, 344 nmol). As desired, analogue <b>20</b> is less lipophilic (SFlog <i>D</i> = 2.6) than <b>19</b> (SFlog <i>D</i> = 3.2) and impressively maintains potent affinity for the H<sub>1</sub> receptor (<i>K</i><sub>d</sub> = 199 nM). Unfortunately, an improved metabolic profile was not seen with hydroxymethyl <b>20</b> (HLM CL<sub>int</sub> = 283 μL/min/mg; HHEP CL<sub>int</sub> = 59 μL/min/million cells).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Loratadine Analogues Generated from the Alkyl Sulfinate Radical Precursor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0023.gif" alt="" id="gr23" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center">R<sub>8</sub></th><th class="colsep0 rowsep0" align="center">R<sub>9</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>d</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="/">HLM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>/HHEP<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">RRCK<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">SFlog D<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">>1000</td><td class="colsep0 rowsep0" align="char" char="/">108/48.7</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">271</td><td class="colsep0 rowsep0" align="char" char="/">283/39.8</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">199</td><td class="colsep0 rowsep0" align="char" char="/">283/58.6</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Human histamine H<sub>1</sub> receptor dissociation constant (nM). Geometric mean of three replicates.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Human liver microsome intrinsic clearance CL<sub>int</sub> (μL/min/mg).</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Human hepatocyte intrinsic clearance CL<sub>int</sub> (μL/min/million cells).</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Apparent passive permeability in the Ralph Russ canine kidney cell line <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s).</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Shake-flask log <i>D.</i></p></div></div></div><div class="NLM_p">With the successful demonstration of LSF applications to loratadine using Baran Diversinates, we next attempted to apply other known late-stage functionalization chemistries to prepare additional analogues of <b>1</b>. For instance, photoredox catalysis has become a powerful method to efficiently install alkyl and halo groups into complex molecules.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Therefore, we subjected <b>1</b> to photocatalytic decarboxylative alkylation conditions developed by Stephenson et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> This proved unsuccessful in our hands, and we only observed the degradation of the starting material. We also tried direct photocatalytic fluorination conditions pioneered by Britton et al. using the tungsten-based polyoxometalate catalyst (TBADT); again, we only detected starting material fragmentation and complex mixtures.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> It is possible that under these conditions, the olefin moiety within loratadine is not compatible with productive photoredox alkylation or fluorination.</div><div class="NLM_p">We subsequently shifted our attention to scaling products from the BMO and electrochemical screens. The biomimetic oxidative screen identified conditions containing the copper-based Cu(TDCIPP) metalloporphyrin catalyst for scale-up consideration (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S9</a> in the Supporting Information). As a result, the BMO reaction was scaled by treating substrate <b>1</b> with Cu(TDCIPP) at 10 mol % in the presence of the cumene hydroperoxide oxidant. In addition, a control reaction was run on a similar scale without the metalloporphyrin catalyst (Cu(TDCIPP)) in the presence of the oxidant. The crude materials from both reactions were subjected to similar purification and characterization methods employed for the enzyme-based preparations. The control reaction without the Cu(TDCIPP) metalloporphyrin catalyst gave olefin and D-ring altered known products <b>21</b> (0.4 mg, 0.96 μmol), <b>22</b> (1.8 mg, 4.34 μmol), and <b>23</b> (8.4 mg, 20.92 μmol) from <i>m</i>CPBA oxidation.<a onclick="showRef(event, 'cit63a'); return false;" href="javascript:void(0);" class="ref cit63a">(63a)</a> Unfortunately, these three analogues showed poor H<sub>1</sub> receptor affinity (<i>K</i><sub>d</sub> > 1000 nM) (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Apparently, the modification of the olefin group or D-ring nitrogen atom of loratadine is not tolerated as revealed from the SAR of analogues <b>21</b>–<b>23</b>. As for the BMO product in the presence of the metalloporphyrin catalyst Cu(TDCIPP), we isolated the <i>N</i>-methyl formate salt <b>24</b> (1.5 mg, 3.84 μmol), which also displayed poor binding affinity to the H<sub>1</sub> receptor.<a onclick="showRef(event, 'cit63b'); return false;" href="javascript:void(0);" class="ref cit63b">(63b)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of Loratadine Analogues Generated from Biomimetic Metalloporphyrin Oxidation (BMO)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0024.gif" alt="" id="GRAPHIC-d7e2028-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Human histamine H<sub>1</sub> receptor dissociation constant (nM). Geometric mean of three replicates.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Human liver microsome intrinsic clearance CL<sub>int</sub> (μL/min/mg).</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Human hepatocyte intrinsic clearance CL<sub>int</sub> (μL/min/million cells).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Apparent passive permeability in the Ralph Russ canine kidney cell line <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s).</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Shake-flask log <i>D</i>.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Formate salt.</p></div></div><div></div></div><div class="NLM_p">We next focused on scaling the products derived from electrochemistry. Using an undivided electrochemical cell, <b>1</b> was treated with Et<sub>4</sub>NBF<sub>4</sub> solution in acetonitrile and water (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S1A</a> in the Supporting Information). The cell was charged for 1 h at 5.0 V and monitored by HPLC–MS for the formation of products. Treatment of <b>1</b> under the aforementioned electrochemical conditions afforded epoxide <b>21</b> (1.1 mg, 2.75 μmol) and A-ring-expanded ketone <b>25</b> (0.89 mg, 2.23 μmol) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). It is worth mentioning that epoxide <b>21</b> is the same product isolated from the control BMO reaction (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), which turns out to be the <i>m/z</i> 399j product also identified by HPLC–MS during the electrochemistry screen (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="sch2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Loratadine Analogues Using Electrochemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The ring-expanded ketone <b>25</b> is novel and most likely the result of the House–Meinwald type rearrangement from epoxide <b>24</b>;<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> unfortunately, analogue <b>25</b> is not active against the H<sub>1</sub> receptor (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Nevertheless, serendipitous products such as <b>25</b> provide valuable SAR to medicinal chemistry teams and generate new chemical matter in a single step that would be challenging to synthesize using conventional methods.</div><figure id="sch3" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. House–Meinwald Type Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having successfully modified many sites on the loratadine molecule, we next moved to using electrochemistry as a facilitator to modify the B ring of <b>1</b>. Electrochemical trifluoromethylation (ECTFM) initiated by sulfinate-derived radicals has emerged as a method for the synthesis of fluoroalkyl-substituted arenes<a onclick="showRef(event, 'cit66a cit66b'); return false;" href="javascript:void(0);" class="ref cit66a cit66b">(66a,b)</a> and heteroarenes.<a onclick="showRef(event, 'cit66c'); return false;" href="javascript:void(0);" class="ref cit66c">(66c)</a> Accordingly, electrolysis of a solution of <b>1</b> (19 mg, 50 μmol) and sodium trifluoromethanesulfinate (NaTFMS) salt was carried out. Upon completion of the reaction, the crude material was purified to provide novel product <b>26</b> (83 μg, 184 nmol) as a 1:1 mixture of trifluoromethyl regioisomers substituted at the 7- and 9-position of the loratadine B ring (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). In addition, the electrochemical reaction afforded known deschloro-loratadine <b>27</b> (220 μg, 631 nmol). Trifluoromethyl analogue <b>26</b> was tested as a 1:1 mixture of regioisomers and found to be moderately active against the H<sub>1</sub> receptor (<i>K</i><sub>d</sub> = 882 nM), and as expected, the deschloro-loratadine analogue <b>27</b> shows potent H<sub>1</sub> affinity (<i>K</i><sub>d</sub> = 208 nM).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="sch4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Loratadine Analogues Using Electrochemical Trifluoromethylation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Late-stage lead diversification coupled with quantitative NMR spectroscopy supports SAR exploration at the nanomole scale by introducing structural variation to molecules with established pharmacology where the aim is to explore dense areas of chemical space adjacent to regions known to have useful properties. Conventional medicinal chemistry approaches to lead diversification requires multistep synthesis and tens to hundreds of milligrams of starting materials to ensure that adequate amounts of end product are produced for pharmacological testing. We have enabled an approach that utilizes various C–H bond activation methods to diversify lead compounds in a single step at the nanomole scale, minimizing synthetic investment, time, and cost. By design, this approach is promiscuous, resulting in multiple analogues from a single lead, which are isolated and fully characterized at microgram levels. Applying this strategy to loratadine (<b>1</b>), over 40 products were detected by HPLC–MS analysis from lead diversification screens, which are translated to 26 products isolated and characterized by NMR (product yield range: 0.01–1.0 mg). Consequently, nine chemical transformations were observed with the addition of polar and nonpolar substituents across loratadine A–D rings encompassing deacylation, hydroxylation, unsaturation, epoxidation, N-oxidation/methylation, oxidative ring expansion, heteroaryl alkylation, fluoromethylation, and dechlorination. Loratadine’s chemical space was explored, and positive SAR vectors were identified, providing analogues 8× more equipotent than the parent through the modification of the A ring (analogues <b>4</b> and <b>7</b>), B ring (analogue <b>27</b>), C ring (analogues <b>6</b> and <b>8</b>), D ring (analogues <b>19</b> and <b>20</b>), and A/C rings (analogues <b>2</b> and <b>3</b>). In addition, analogues <b>2</b>, <b>3</b>, <b>4</b>, and <b>7</b> display comparable to 4× improved metabolic stability relative to the parent. Furthermore, negative SAR was gained from several analogues, which provides valuable pharmacophore information toward understanding the molecular recognition requirements needed between the ligand and biological target. In summary, this work highlights the ability for late-stage lead diversification to provide valuable +/– SAR information to medicinal chemistry teams and to alter crucial physicochemical properties of compounds for drug discovery. Applications using this approach to contemporary medicinal chemistry programs are underway and will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50401" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50401" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Materials</h3><div class="NLM_p last">All commercially available materials and solvents were used as received unless otherwise stated. Loratadine (<b>1</b>), nicotinamide adenine dinucleotide phosphate (NADPH), <i>N</i>,<i>N</i>-diethylaminosulfur trifluoride (DAST), <i>meta</i>-chloroperoxybenzoic acid (<i>m</i>CPBA), cumene hydroperoxide (CHP, 80 wt % in H<sub>2</sub>O), <i>tert</i>-butyl hydroperoxide (TBHP, 70 wt % in H<sub>2</sub>O), difluoromethanesulfinate zinc salt, trifluoromethanesulfinate sodium salt, hydroxymethanesulfinate sodium salt (Rongalite), tetraethylammonium tetrafluoroborate (Et<sub>4</sub>NBF<sub>4</sub>), and 1,2-dichloroethane (DCE) were purchased from Sigma-Aldrich (St. Louis, MO) and used as is without further purification. Metalloporphyrins Fe(TNO<sub>2</sub>PP), Mn(TFPP), Fe(TFPP), Cu(TFPP), Co(TFPP), Pd(TDCIPP), Mn(TDCIPP), Cu(TDCIPP), and Co(TDCIPP) were obtained from Frontier Scientific (<a href="http://www.frontiersci.com/" class="extLink">http://www.frontiersci.com/</a>). Dimethyl sulfoxide-<i>d</i><sub>6</sub> (DMSO-<i>d</i><sub>6</sub>) was acquired from Cambridge Isotope Laboratories (Tewksbury, MA). Liver microsomes were purchased from the following vendors: female mouse, male rat, male cynomolgus monkey, and nontransfected microsomes (Corning, Woburn, MA); dexamethasone-induced male rat, male hamster, male dog, and pooled male and female human (prepared in-house at Pfizer, Groton, CT); and male guinea pig and male rabbit (XenoTech, Lenexa, KS). Note that human and monkey liver microsomes are considered biohazardous materials, and appropriate precautions should be taken during handling and disposal. Recombinant human P450 enzymes heterologously expressed in microsomes from Sf9 cells were custom prepared by PanVera (Madison, WI). Cytochrome P450 BM3 variants and MCYP-RXN buffer were purchased from Codexis (Redwood City, CA). Sources of microorganisms are as follows: American Type Culture Collection (ATCC), Agricultural Research Service Culture Collection (NRRL, Northern Regional Research Laboratory), Institute for Fermentation (IFO), NITE Biological Resource Center (NBRC), and in-house cultures Ultra Cold (UC) and Calgary.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Equipment</h3><div class="NLM_p last">Experimental procedures were generally carried out under an inert atmosphere using nitrogen where oxygen or moisture-sensitive reagents were used. Commercial solvents including anhydrous solvents and general reagents were used as is without additional purification and purchased from Sigma-Aldrich (St. Louis, MO). The following equipment was utilized in the preparations of final compounds unless otherwise stated: liquid chromatography mass spectrometry data are reported from an AB Sciex TripleTOF 5600+ mass spectrometer (Concord, Ontario, Canada) in line with an Agilent Technologies 1200 Series (Santa Clara, CA) composed of a vacuum degasser, binary pump SL, HiP-ALS high-performance autosampler, TCC SL thermostatted column compartment, and diode array detector (DAD) SL; AB Sciex TripleTOF 5600 mass spectrometer (Concord, Ontario, Canada) in line with a Waters ACQUITY UPLC system (Milford, MA) composed of a photo diode array (PDA) detector, column manager FTN-1, sample organizer, and binary solvent manager; Thermo Fisher Scientific Orbitrap Elite/Velos Pro mass spectrometer in line with an Accela PDA detector, 1250 pump, and open autosampler (Waltham, MA); Thermo Fisher Scientific LTQ Velos mass spectrometer in line with a Waters ACQUITY UPLC system (Milford, MA) composed of a PDA detector, column manager, sample manager, binary solvent manager, and Leap Technologies PAL HCT-xt collector (Morrisville, NC); Thermo Fisher Scientific LTQ XL mass spectrometer in line with an Agilent 1100 Series HPLC system (Santa Clara, CA) composed of a vacuum degasser, quaternary pump, ALS autosampler, COLCOM column compartment, diode array detector (DAD), and 1260 Infinity FC-AS fraction collector. The following equipment were used: JASCO PU-1580 Intelligent HPLC pumps (Easton, MD), Eppendorf Thermomixer R (Hamburg, Germany), Thermo Fisher Scientific (Waltham, MA) Precision reciprocal shaking bath and Dubnoff metabolic shaking incubator, Genevac EZ-2 Elite and HT-4X (Ipswich, Suffolk, England), Beckman Coulter Allegra 64R centrifuge (Brea, CA), Eppendorf 5424 and 5810R centrifuge (Hamburg, Germany), Thermo Fisher Scientific (Waltham, MA) HAAKE A10 circulating chiller with SC100 immersion circulator, IKA RCT basic magnetic stir plate (Wilmington, NC), J-KEM Scientific DTC-4 multichannel temperature controller with single-element thermocouple (St. Louis, MO), Wheaton Celstir jacketed flask 25–500 mL (Millville, NJ), Thermo Fisher Scientific MaxQ 2000 benchtop orbital shaker (Waltham, MA), New Brunswick Innova 4900 incline platform rotary shaker (Edison, NJ), and Tecan Freedom EVO 150 automated liquid handler (Mannedorf, Switzerland).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Screening Protocol Using Automated Liquid Handler</h3><div class="NLM_p last">A Tecan Freedom EVO 150 automated liquid handler (Mannedorf, Switzerland) was used to streamline high-throughput screening, refer to the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Tecan Protocol for Screening</a> section in the Supporting Information.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General High-Performance Liquid Chromatography with Tandem Mass Spectrometry (HPLC–MS) Method for Screen Analysis</h3><div class="NLM_p last">Screen samples were analyzed by HPLC–MS for acceptable conversion (>10%) and diversification of products using an AB Sciex TripleTOF 5600+ mass spectrometer in line with an Agilent Technologies 1200 Series HPLC instrument composed of a vacuum degasser, binary pump SL, HiP-ALS high-performance autosampler, TCC SL thermostatted column compartment, and diode array detector (DAD) SL. Test samples were injected (5.0 μL) onto a C18 UHPLC column (HALO C18 UHPLC 3.0 × 50.0 mm, 2.7 μm), and 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B) gradients were applied at a flow rate of 0.5 mL/min and maintained at 23 °C with a total run time of 6.5 min. The initial composition of 95%A/5%B was held for 0.3 min followed by a linear gradient to 5%A/95%B at 3.8 min, which was held to 5.0 min. The column was then re-equilibrated to the initial composition over 1.5 min. Chromatograms of extracted λ = 286–291 nm were reconstructed from the diode array spectra for analysis. The mass spectrometer was operated in the positive ion electrospray mode. Analyst TF software (AB Sciex, version 1.7.1) was used to control the LC–MS system. Source gases 1 and 2 were set to 50, DP = 70, capillary voltage = 5500 V, and source temperature = 500 °C. Full scan data were collected over 100–1000 amu at ∼35,000 resolution, and Information Dependent Acquisition (IDA) Scan function criteria were used to collect the product ion spectra of the four most intense ions found in each survey scan. Data-dependent scanning was used to trigger MS2 analysis of molecular ions over a threshold intensity of 100 counts. Product ion spectra were acquired over a mass range of 100–1000 <i>m/z</i> with CE = 40 eV with a collision energy spread = 20 eV. Mass defect filters of potential loratadine analogues and cleavage products, based on elemental compositions, were prepared in MetabolitePilot (AB Sciex, version 1.5) and transferred to the acquisition method. These MDF windows for loratadine analogue specific ions were placed in an inclusion list and applied during data acquisition to prioritize the collection of MS/MS spectra for those molecular ions meeting the MDF criteria, thereby focusing on the drug-related material to prioritize the acquisition of ions of interest. PeakView (AB Sciex, version 2.2) software was used to process data.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Ultraperformance Liquid Chromatography Mass Spectrometry (UPLC–MS) Reaction Monitoring Conditions</h3><div class="NLM_p last">Unless stated, reaction progress was monitored using a Waters SQ detector 2 single-quadrupole atmospheric pressure ionization (API) mass spectrometer (ZSpray ESI/APCI/ESCi) in line with a Waters ACQUITY UPLC instrument composed of a sample organizer, column manager, sample manager, binary solvent manager, photodiode array (PDA) detector λ = 200–400 nm TWC scan, and evaporative light-scattering (ELS) detector. Test samples were injected (2.0 μL) onto a Waters ACQUITY C18 UHPLC column (BEH 2.1 × 50.0 mm, 1.7 μm), and 0.05% trifluoroacetic acid in water (A) and 0.05% trifluoroacetic acid in acetonitrile (B) gradients were applied at a flow rate of 0.8 mL/min and maintained at 23 °C with a total run time of 6.0 min. The initial composition of 5% B was increased by a linear gradient to 100% B over 4.0 min, which was held for 1.0 min. The column was then re-equilibrated to the initial composition over 1.0 min. Standalone ACQUITY Console and MassLynx V4.1 were used to control the UPLC–MS system.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Chromatographic Purification Method 1</h3><div class="NLM_p last">The 50 mL supernatant clear solution was adsorbed onto a C18 HPLC column (Zorbax Polaris, C18-A 250 × 4.6 mm, 5.0 μm) using a JASCO PU-1580 HPLC pump at a flow rate of 0.8 mL/min over ∼60 min. The HPLC column was transferred to a Thermo LTQ Velos mass spectrometer in line with a Waters ACQUITY UHPLC instrument composed of a quaternary pump, autosampler, and photodiode array UV/vis detector. A gradient of 0.1% formic acid in water (A) and acetonitrile (B) was applied with a flow rate of 0.8 mL/min and run time of 110 min to separate products of interest. The initial conditions of 2% B were increased to 10% B over 1.0 min and held for 4.0 min followed by an increase to 50% B over 85 min, then an increase to 95% B over 10 min, and then return to the initial conditions over 10.0 min. After passing through the PDA detector, the eluent was split at a ratio of approximately 1:15 using a flow splitter (Advantage Flow Splitter model 62-4114, Analytical Sales and Services, Inc.) with the smaller portion going to the mass spectrometer and the larger portion to a fraction collector (Collect PAL, Leap Technologies); fractions were collected every 20 s. The collected fractions were analyzed by UHPLC–UV–HRMS using a Thermo Orbitrap Elite high-resolution ion trap mass spectrometer in line with a Thermo Accela UHPLC and diode array UV/vis detector with a CTC Analytics Leap autoinjector (Thermo Fisher). Samples were injected (2.0 μL) onto a C18 UHPLC column (Phenomenex Kinetex, C18 50 × 2.1 mm, 1.7 μm) and a gradient of 0.1% formic acid in water (A) and acetonitrile (B) was applied at a flow rate of 0.4 mL/min and maintained at 45 °C. After UHPLC–UV–HRMS analysis, fractions of interest were pooled, and the solvent was removed using an EZ-2 Elite Genevac (3 hr HPLC setting, 34 °C/238 mbar to 41 °C/7 mbar). Purity of all products was ≥95% unless otherwise noted.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Chromatographic Purification Method 2</h3><div class="NLM_p last">Crude samples were purified by preparative HPLC using an Agilent (Santa Clara, CA, USA) 1260 Infinity Prep LC–MS with the following components: two Agilent G1361A preparative pumps, an isocratic pump, refractive index detector, diode array detector VL, dual loop autosampler, single-quadrupole mass spectrometer with JetStream installed, universal interface box II, and active splitter. The instrument was controlled by ChemStation version C.01.05. A Phenomenex Gemini NX-C18 column (21.1 × 250 mm, 5.0 μm) was used with a flow rate of 25.0 mL/min at ambient temperature. A gradient consisting of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B) was employed with the following gradient: initial conditions 5% B, hold for 1.50 min, then increase solvent B to 90% over 24.5 min, hold for 3.0 min, and then return to initial conditions over 1.0 min. The UV data were collected at 210 or 215 nm, and mass spectrometry data (ESi+) were collected using selected ion monitoring on the target mass. Purity of all products was ≥95% unless otherwise noted.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Chromatographic Purification Method 3</h3><div class="NLM_p last">Crude samples were purified using preparative HPLC using a Waters (Milford, MA, USA) AutoPurification FractionLynx LC-MS, coupled to a Waters 2545 binary gradient pump, 2767 fraction collector, 996 PDA, and SQ2 single-quadrupole mass spectroscopy detector. The instrument was controlled by MassLynx version 4.1. A Waters SunFire C18 column (19 × 150 mm, 5.0 μm) was used with a flow rate of 25.0 mL/min at ambient temperature. A gradient consisting of 0.05% trifluoroacetic acid in water (A) and 0.05% trifluoroacetic acid in acetonitrile (B) was employed with the following gradient: initial conditions 25% B to 37% B over 23.5 min, then 37% B to 100% B over 0.5 min, hold for 1.0 min, and then return to initial conditions over 1.0 min. The UV data were collected at 210 or 215 nm, and mass spectrometry data (ESi+) were collected using the extracted ion on the target mass (ESi+; scan range, 160–1000 Da). Purity of all products was ≥95% unless otherwise noted.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Nuclear Magnetic Resonance Spectroscopy</h3><div class="NLM_p last">All samples were placed in a vacuum chamber connected to a Vacuum Atmospheres NEXUS II glovebox and held at (−30 psi) for 1 h or longer and then transferred to the glovebox. The glovebox was maintained under an atmosphere of argon with positive pressure. NMR samples were dissolved in “100%” DMSO-<i>d</i><sub>6</sub> (45 μL) and charged into a 1.7 mm NMR tube. A Bruker AVANCE 600 MHz (Bruker BioSpin Corporation, Billerica, MA) NMR instrument equipped with a 1.7 mm TCI MicroCryoProbe was used and controlled by TopSpin V3.2. One-dimensional spectra were recorded with an approximate sweep width of 8400 Hz and total recycle time of approximately 7 s. To enhance adequate signal to noise, the resulting time-averaged free induction decays were transformed using an exponential broadening of 1.0 Hz. Two-dimensional spectra were recorded with the standard pulse sequence offered by Bruker. <sup>1</sup>H Proton and <sup>13</sup>C carbon spectra were referenced using residual DMSO-<i>d</i><sub>6</sub> (<sup>1</sup>H δ = 2.50 ppm relative to TMS, δ = 0.00; <sup>13</sup>C δ = 39.50 ppm relative to TMS, δ = 0.00). Chemical shift data are expressed in parts per million (ppm, δ) with multiplicities given as s (singlet), d (doublet), t (triplet), dt (doublet of triplets), q (quintet), m (multiple), and br (broad). Processing of post-acquisition data was completed with TopSpin V3.2 or MestReNova V9.1 (Mestrelab Research, Santiago de Compostela, Spain). NMR samples were quantitated using the <sup>1</sup>H NMR spectrum of benzoic acid (5.0 mM) as the external standard calibrant against the ERETIC2 function in TopSpin V3.2.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Liver Microsome and Recombinant CYP Enzyme Screen Procedure</h3><div class="NLM_p last">Loratadine (20.0 μM, 10.0 nmol) was incubated with nine mammalian liver microsomes (2.0 mg/mL) and nine human recombinant P450 enzymes (2.0 mg/mL), as displayed in the plate format in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S1</a> of the Supporting Information. The total volume in each well was 0.5 mL, which contained potassium phosphate buffer (0.1 M, pH 7.4), MgCl<sub>2</sub> (3.3 mM, 1.65 μmol), and acetonitrile (0.4% v/v). The reaction was initiated with the addition of NADPH (1.3 mM, 0.65 μmol) and agitated at 37 °C in a reciprocal shaking bath at 1″ throw for 1 h. The incubation was quenched with the addition of acetonitrile (1.5 mL) followed by centrifugation (1700<i>g</i>, 5 min). The supernatant was removed, and the solvent was reduced using a Genevac centrifuge evaporator. The residue was reconstituted in 0.1 mL of 1% formic acid in H<sub>2</sub>O/20% acetonitrile followed by centrifugation (1700<i>g</i>, 5 min). The samples were analyzed using the General HPLC–MS Method for Screen Analysis.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Liver Microsome Scale-Up Procedure for the Synthesis of Analogues <b>2</b> and <b>3</b></h3><div class="NLM_p">A 500 mL Erlenmeyer flask was charged with deionized water (27.04 mL) and treated with 1.0 M potassium phosphate buffer solution at pH 7.5 (4.0 mL), 0.165 M magnesium chloride solution (0.8 mL, 132 μmol), and a 0.005 M solution of compound <b>1</b> (0.16 mL, 0.8 μmol) in acetonitrile/water (1:1). The mixture was treated with liver microsomes (4.0 mL at 20 mg/mL) followed by the addition of a freshly prepared 0.013 M aqueous solution of NADPH (4.0 mL, 52 μmol). The uncapped Erlenmeyer flask was shaken using a Thermo Scientific Precision reciprocal shaker with a 1″ throw at 37 °C for 1 h. The reaction mixture was divided into equal portions (20 mL each) and poured into two 50 mL Falcon conical centrifuge tubes. The solutions were quenched by adding acetonitrile (20 mL) to each Falcon tube. The Falcon tubes were vortexed and centrifuged at 1700<i>g</i> for 5 min using a Centrifuge CT422 instrument. The supernatant was decanted and transferred in equal portions (20 mL each) to two 50 mL Falcon conical centrifuge tubes, and the solvent was evaporated using a Genevac EZ-2 Elite (1 h HPLC setting, 34 °C/238 mbar to 41 °C/7 mbar). The remaining aqueous solutions were combined (∼20 mL) into a 50 mL Falcon conical centrifuge tube, treated with acetonitrile (0.5 mL) and neat formic acid (0.5 mL), and charged with deionized water to have a final volume of 50 mL. The solution was divided into equal portions (25 mL each) and poured into two high speed centrifuge tubes and centrifuged at 40,000<i>g</i> for 30 min using a Beckman Coulter Allegra 64R (26,200 speed, 24 °C) instrument. The supernatant was decanted into a 50 mL glass conical tube, and the clear solution was subjected to General Chromatographic Purification Method 1. The dried samples were analyzed by NMR spectroscopy and quantified by external calibration against the <sup>1</sup>H NMR spectrum of a 5.0 mM benzoic acid standard solution in DMSO-<i>d</i><sub>6</sub> using the ERETIC2 function within TopSpin V3.2.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-6-ol (<b>2</b>) and 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-5-ol (<b>3</b>)</h4><div class="NLM_p last">Prepared from male rabbit liver microsomes (4.0 mL at 2 mg/mL, New Zealand, XenoTech) and a 5.0 mM solution of compound <b>1</b> (0.16 mL, 0.8 μmol) in acetonitrile/water (1:1). Yield of <b>2</b>: 7.98 μg, 24.0 nmol, 3%. Mixture of conformational isomers.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.41–8.38 (m, 1H), 7.86–7.79 (m, 1H), 7.33–7.17 (m, 3H), 7.13–7.11 (m, 1H), 5.20 (dd, <i>J</i> = 10.2, 4.6 Hz, 1H), 3.52 (dd, <i>J</i> = 16.6, 4.7 Hz, 1H), 3.15–3.08 (m, 2H), 2.85–2.80 (m, 3H), 2.51–2.23 (m, 3H), 2.22–2.19 (m, 1H). HRMS (TOF) calcd for 327.1264; found, 327.1267. Purity by HPLC–UV (288 nm) 97% using General Chromatographic Purification Method 1 (retention time = 2.643 min). Yield of <b>3</b>: 2.22 μg, 6.8 nmol, 0.9%. Mixture of conformational isomers.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44–8.35 (m, 1H), 7.90–7.77 (m, 1H), 7.36–7.18 (m, 3H), 7.17–7.09 (m, 1H), 5.20 (dd, <i>J</i> = 9.1, 4.5 Hz, 1H), 3.50 (dd, <i>J</i> = 17.3, 4.9 Hz, 1H), 3.19–3.05 (m, 2H), 2.94–2.78 (m, 3H), 2.54–2.34 (m, 3H), 2.28–2.15 (m, 1H). HRMS (TOF) calcd for 327.1264; found, 327.1272. Purity by HPLC–UV (288 nm) 95% using General Chromatographic Purification Method 1 (retention time = 2.832 min).</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Microorganism Screen Procedure</h3><div class="NLM_p">Microbial screening 96-well plates were prepared by adding previously grown or sporulated stocks of various actinomycetes, bacteria, or fungi, as shown in the plate format in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S3</a> of the Supporting Information to a sterile 96-well (2 mL each) plate. Plates were covered with a sterile cap mat and stored at −80 °C until use. Sterile Iowa medium was prepared by combining dextrose (20.0 g, 0.1 mol), NutriSoy flour (5.0 g), NaCl (5.0 g, 0.085 mol), yeast extract (5.0 g), K<sub>2</sub>HPO<sub>4</sub> (5.0 g, 0.029 mol), P2000 antifoam (1.0 mL), and deionized water (1.0 L, 55.3 mol) followed by adjusting the pH to 7.0 with 1.0 M HCl. The mixture was autoclaved to sterilize the media (25 min/L).</div><div class="NLM_p last">The 96-well microbial screening plate was thawed to room temperature (23 °C), and each well was treated with sterile Iowa medium (0.5 mL). The plate was covered with a sterile porous adhesive film (Thermo #241205: Nunc sealing tape; white rayon, breathable) and incubated using an Innova 4900 incline platform rotary shaker at 2″ throw and 210 rpm, at a temperature of 30 °C, for 2 days. A 13.0 mM solution of <b>1</b> (0.01 mL, 0.13 mmol) in DMSO was added to each well, and the plate was covered with sterile adhesive porous film (Thermo #241205). The incubation was continued with rotary shaking (2″ throw, 210 rpm) at 30 °C for an additional 4 days. The reaction was terminated with the addition of acetonitrile (0.5 mL/well) followed by pipette aspiration and mixing using an Eppendorf Thermomixer R (650 rpm) at 30 °C for ∼20 min. The plate was centrifuged with a Beckman Coulter Allegra instrument at 4000<i>g</i> for 20 min, and the supernatant was transferred to a new 96-well plate. The samples were analyzed using the General HPLC-MS Method for Screen Analysis.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Microorganism Scale-Up Procedure for the Synthesis of Analogues <b>4</b>–<b>7</b></h3><div class="NLM_p">Sterile Iowa medium (25 mL, as prepared above) was added to a sterile ventilated Nalgene flask (250 mL, #4116-0250) with baffle, which was then inoculated with a stock suspension of microorganism culture (0.25 mL, contains 20% glycerol). The flask was capped and agitated on a 2″ throw rotary shaker (Innova 4900, 210 rpm) at 30 °C for 2 days. After 48 h, the suspension was treated with a 13.0 mM solution of <b>1</b> (1.0 mL, 13.0 μmol) in DMSO. The flask was recapped, and the incubation was continued as above for an additional 5 days. The incubation mixture was extracted with two volumes of ethyl acetate (2 × 50 mL) using a separatory funnel. The combined extracts were filtered through a bed of anhydrous magnesium sulfate, and the filter cake was washed with ethyl acetate (20 mL). The solvent was removed using a rotary evaporator (42 °C) to a volume of less than 10 mL, and the crude material was dried overnight <i>in vacuo</i>. The crude material was purified using General Chromatographic Purification Method 2. The dried samples were analyzed by NMR spectroscopy and quantified by external calibration against the <sup>1</sup>H NMR spectrum of a 5.0 mM benzoic acid standard solution in DMSO-<i>d</i><sub>6</sub> using the ERETIC2 function within TopSpin V3.2.</div><div id="sec4_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridine (<b>4</b>)</h4><div class="NLM_p last">Prepared from <i>C. elegans</i> ATCC 8688a (0.25 mL stock suspension, contains 20% glycerol) and 13.0 mM solution of <b>1</b> (1.0 mL, 13.0 μmol) in DMSO. Yield of <b>4</b>: 574 μg, 1847 nmol, 14%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.35 (d, <i>J</i> = 5.1 Hz, 1H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.31 (s, 1H), 7.25–7.17 (m, 2H), 7.14–7.07 (m, 1H), 3.40–3.24 (m, 2H), 3.11–2.93 (m, 2H), 2.90–2.69 (m, 4H), 2.48–2.32 (m, 2H), 2.31–2.19 (m, 2H). HRMS (TOF) calcd for 311.1315; found, 311.1306. Purity by HPLC–UV (215 nm) 95% using General Chromatographic Purification Method 2 (retention time = 3.444 min).</div></div><div id="sec4_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Ethyl 4-(8-Chloro-5-hydroxy-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>5</b>) and Ethyl 4-(8-Chloro-6-hydroxy-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>6</b>)</h4><div class="NLM_p last">Prepared from <i>S. violascens</i> ATCC 31560 (0.25 mL stock suspension, contains 20% glycerol) and 13.0 mM solution of <b>1</b> (1.0 mL, 13.0 μmol) in DMSO. Yield of <b>5</b>: 27 μg, 68 nmol, 0.5%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.42–8.36 (m, 1H), 7.88–7.76 (m, 1H), 7.32–7.19 (m, 3H), 7.14–7.07 (m, 1H), 6.11–5.55 (m, br, 1H), 5.19–5.17 (m, 1H), 4.08–4.00 (m, 2H), 3.70–3.55 (m, 2H), 3.50–3.45 (m, 1H), 3.27–3.11 (m, 2H), 3.07–2.74 (m, 1H), 2.43–2.01 (m, 4H), 1.21–1.14 (m, 3H). HRMS (TOF) calcd for 399.1475; found, 399.1474. Purity by HPLC–UV (215 nm) 99% using General Chromatographic Purification Method 2 (retention time = 3.910 min). Yield of <b>6</b>: 11 μg, 28 nmol, 0.2%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.38–8.30 (m, 1H), 7.77–7.43 (m, 2H), 7.27 (d, <i>J</i> = 8.0 Hz, 1H), 7.23–7.17 (m, 1H), 7.13–7.06 (m, 1H), 5.29–4.56 (m, 1H), 4.04 (q, <i>J</i> = 7.1 Hz, 2H), 3.76–3.56 (m, 2H), 3.50–3.33 (m, 1H), 3.27–3.12 (m, 2H), 3.06–2.73 (m, 1H), 2.46–2.35 (m, 1H), 2.28–2.16 (m, 2H), 2.14–1.99 (m, 1H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 399.1475; found, 399.1470. Purity by HPLC–UV (215 nm) 95% using General Chromatographic Purification Method 2 (retention time = 3.818 min).</div></div><div id="sec4_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Ethyl 4-(8-Chloro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-2,6-dihydroxypiperidine-1-carboxylate (<b>7</b>)</h4><div class="NLM_p last">Prepared from <i>S. setae</i> ATCC 33774 (0.25 mL stock suspension, contains 20% glycerol) and 13.0 mM solution of <b>1</b> (1.0 mL, 13.0 μmol) in DMSO. Yield of <b>7</b>: 43 μg, 104 nmol, 0.8%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.32–8.25 (m, 1H), 8.06–7.99 (m, 1H), 7.91–7.76 (m, 1H), 7.25–7.18 (m, 1H), 7.18–7.13 (m, 1H), 7.03–6.96 (m, 1H), 5.18–5.11 (m, 2H), 4.05 (q, <i>J</i> = 7.1 Hz, 2H), 3.79–3.66 (m, 2H), 3.21–3.05 (m, 2H), 2.34–2.12 (m, 4H), 1.18 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (TOF) calcd for 415.1425; found, 415.1415. Purity by HPLC–UV (215 nm) 98% using General Chromatographic Purification Method 2 (retention time = 3.700 min).</div></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis of Analogue <b>8</b></h3><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Ethyl 4-(8-Chloro-5-fluoro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>8</b>)</h4><div class="NLM_p">A vented 100 mL jacketed Wheaton reactor equipped with an overhead stirrer and Thermo Scientific HAAKE A10 circulating chiller with SC100 immersion circulator was charged with Codexis MicroCyp lyophile MCYP-P1.2-D07 (135.13 mg, 50.0 nmol; P450 concentration, 0.37 nmol/mg) followed by 0.1 M potassium phosphate buffer solution (4.0 mL) at pH 8.0. The reactor was treated with a stock solution of Codexis MCYP-RXN buffer (43.5 mL), prepared by dissolving solid MCYP-RXN buffer (5.46 g) in deionized water (190.0 mL). The reactor was stirred at ambient temperature for 10 min and then treated with a solution of <b>1</b> (4.79 mg, 12.5 μmol) dissolved in a mixture of DMSO (2 mL) and 0.1 M potassium phosphate buffer solution (0.5 mL) at pH 8.0. The reaction mixture was stirred at 30 °C for 12 h, open to the atmosphere. The progress of the reaction was monitored by UPLC–MS. The reaction mixture was quenched by the addition of ethyl acetate (40.0 mL) and centrifuged using an Eppendorf 5810 R at 4000 rpm for 10 min. The organic layer was removed and passed through a pad of Celite. The aqueous layer was treated with ethyl acetate (40.0 mL) and centrifuged at 4000 rpm for 10 min. The layers were allowed to separate, and the organic layer was removed and passed through a pad of Celite. The ethyl acetate from the combined organic layers was removed using a rotary evaporator. The crude material was purified using General Chromatographic Purification Method 2. The dried samples were analyzed by NMR spectroscopy and quantified by external calibration against the <sup>1</sup>H NMR spectrum of a 5.0 mM benzoic acid standard solution in DMSO-<i>d</i><sub>6</sub> using the ERETIC2 function within TopSpin V3.2, providing ethyl 4-(8-chloro-5-hydroxy-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>5</b>) as a white solid.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Yield of <b>5</b>: 1.24 mg, 3.1 μmol, 25%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.42–8.36 (m, 1H), 7.88–7.76 (m, 1H), 7.32–7.19 (m, 3H), 7.14–7.07 (m, 1H), 6.11–5.55 (m, br, 1H), 5.19–5.17 (m, 1H), 4.08–4.00 (m, 2H), 3.70–3.55 (m, 2H), 3.50–3.45 (m, 1H), 3.27–3.11 (m, 2H), 3.07–2.74 (m, 1H), 2.43–2.01 (m, 4H), 1.21–1.14 (m, 3H). HRMS (TOF) calcd for 399.1475; found, 399.1468. Purity by HPLC–UV (215 nm) 99% using General Chromatographic Purification Method 2 (retention time = 3.910 min).</div><div class="NLM_p last">A 1.5 mL reaction vial equipped with a magnetic stir bar under an atmosphere of nitrogen was treated with <b>5</b> (1.24 mg, 3.1 μmol, prepared from MCYP-P1.2-D07) followed by the addition of anhydrous dichloromethane (0.2 mL). The reaction vial was cooled to −78 °C using an acetone dry ice bath, temperature monitored with a J-KEM thermocouple. The clear solution was stirred at −78 °C for 15 min and then treated with <i>N</i>,<i>N</i>-diethylaminosulfur trifluoride (2.06 μL, 15.6 μmol). The reaction mixture was stirred for 3 h at −78 °C, and the progress of the reaction was monitored by UPLC–MS. The clear solution was quenched by the addition of aqueous 1.0 M NaHCO<sub>3</sub> (0.3 mL), transferred to a 1.5 mL Eppendorf tube, vortexed, and centrifuged. The layers were allowed to separate, and the bottom organic layer was removed. The aqueous layer was extracted with dichloromethane (3 × 0.3 mL), and the combined dichloromethane solvent was removed <i>in vacuo</i>. The crude material was purified using General Chromatographic Purification Method 2. Yield of <b>8</b>: 25 μg, 62 nmol, 2%. Mixture of conformational isomers.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.57–8.50 (m, 1H), 7.87–7.79 (m, 1H), 7.58–7.39 (m, 1H), 7.39–7.33 (m, 1H), 7.31–7.25 (m, 1H), 7.18–7.12 (m, 1H), 6.11–5.98 (m, 1H), 4.11–3.98 (m, 2H), 3.69–3.48 (m, 3H), 3.25–3.16 (m, 3H), 2.29–2.08 (m, 4H), 1.21–1.13 (m, 3H). HRMS (TOF) calcd for 401.1432; found, 401.1427. Purity by HPLC–UV (215 nm): Column Waters Atlantis C18 4.6 × 50 mm, 5 μm; retention time = 2.420 min; peak area, 99%; mobile phase A, 0.05% TFA in water (v/v); mobile phase B, 0.05% TFA in acetonitrile (v/v); gradient, 95.0% water/5.0% acetonitrile linear to 5.0% water/95.0% acetonitrile in 4.0 min, hold at 5.0% water/95.0% acetonitrile to 5.0 min; flow rate, 2 mL/min; column temperature, 60 °C (retention time = 2.454 min).</div></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Cytochrome P450 BM3 Screen Procedure</h3><div class="NLM_p">Cytochrome P450 BM3 variants were purchased as MicroCyp lyophiles in bulk quantities from Codexis (Redwood City, CA). Deep-well microtiter screening plates were prepared by adding a 5.0 μM stock solution of enzyme (50.0 μL) in 0.1 M potassium phosphate buffer (pH 8.0) to the appropriate well, as indicated in the plate format in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Table S5</a> in the Supporting Information. Plates were covered with a PlateMax aluminum sealing film (Axygen, Corning, NY) and stored at −80 °C until use.</div><div class="NLM_p last">The 96-well BM3 screening plate was thawed to room temperature (23 °C), and each well was treated with a stock solution of Codexis MCYP-RXN buffer (437.5 μL), prepared by dissolving solid MCYP-RXN buffer (358 mg) in deionized water (25.27 mL). Each well was treated with a 5.0 mM solution of <b>1</b> (12.5 μL, 62.5 nmol) in DMSO, and the uncovered plate was agitated using an Eppendorf Thermomixer R shaker (300 rpm) at 30 °C for 12 h. The reaction was terminated with the addition of acetonitrile (0.5 mL/well) followed by pipette aspiration and mixing using an Eppendorf Thermomixer R (950 rpm) for 20 min. The plate was centrifuged with a Beckman Coulter Allegra instrument at 4000<i>g</i> for 20 min, and the supernatant was transferred to a new 96-well plate. The samples were analyzed using the General HPLC-MS Method for Screen Analysis.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Cytochrome P450 BM3 (MicroCyp) Scale-Up Procedure for the Synthesis of Analogues <b>9</b>–<b>17</b></h3><div class="NLM_p">A vented 100 mL jacketed Wheaton reactor equipped with an overhead stirrer and Thermo Scientific HAAKE A10 circulating chiller with SC100 immersion circulator was charged with MicroCyp lyophile followed by 0.1 M potassium phosphate buffer solution (4.0 mL) at pH 8.0. The reactor was treated with a stock solution of MCYP-RXN buffer(43.5 mL), prepared by dissolving solid Codexis MCYP-RXN buffer (5.46 g) in deionized water (190.0 mL). The reactor was stirred at ambient temperature for 10 min and then treated with a solution of <b>1</b> (4.79 mg, 12.5 μmol) dissolved in a mixture of DMSO (2 mL) and 0.1 M potassium phosphate buffer solution (0.5 mL) at pH 8.0. The reaction mixture was stirred at 30 °C for 12 h, open to the atmosphere. The progress of the reaction was monitored by UPLC–MS. The reaction mixture was quenched by the addition of ethyl acetate (40.0 mL) and centrifuged using an Eppendorf 5810 R at 4000 rpm for 10 min. The organic layer was removed and passed through a pad of Celite. The aqueous layer was treated with ethyl acetate (40.0 mL) and centrifuged at 4000 rpm for 10 min. The layers were allowed to separate, and the organic layer was removed and passed through a pad of Celite. The ethyl acetate from the combined organic layers was removed using a rotary evaporator. The crude material was purified using General Chromatographic Purification Method 2. The dried samples were analyzed by NMR spectroscopy and quantified by external calibration against the <sup>1</sup>H NMR spectrum of a 5.0 mM benzoic acid standard solution in DMSO-<i>d</i><sub>6</sub> using the ERETIC2 function within TopSpin V3.2.</div><div id="sec4_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Ethyl (<i>E</i>)-4-(8-Chloro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-3-hydroxypiperidine-1-carboxylate (<b>9</b>), Ethyl (<i>E</i>)-4-(8-Chloro-5-hydroxy-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>10</b>), Ethyl 4-(8-Chloro-3-hydroxy-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>11</b>), Ethyl (<i>Z</i>)-4-(8-Chloro-3-hydroxy-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>12</b>), Ethyl (<i>E</i>)-4-(8-Chloro-3-hydroxy-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>13</b>), Ethyl (<i>E</i>)-4-(8-Chloro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>14</b>), and Ethyl 4-(8-Chloro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-3,5-dihydroxypiperidine-1-carboxylate (<b>17</b>)</h4><div class="NLM_p last">Prepared from MCYP0012 (48.5 mg, 50.0 nmol; P450 concentration, 1.03 nmol/mg) and <b>1</b> (4.79 mg, 12.5 μmol) dissolved in a mixture of DMSO (2 mL) and 0.1 M potassium phosphate buffer solution (0.5 mL) at pH 8.0. Yield of <b>9</b>: 39 μg, 98 nmol. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.35 (d, <i>J</i> = 4.7 Hz, 1H), 7.64–7.54 (m, 1H), 7.41–7.04 (m, 4H), 5.38–4.82 (m, 1H), 4.42–3.86 (m, 7H), 3.38–3.24 (m, 2H), 2.89–2.73 (m, 2H), 2.58–2.12 (m, 2H), 1.20–1.10 (m, 3H). HRMS (TOF) calcd for 399.1475; found, 399.1475. Purity by HPLC–UV (210 nm) 95% using General Chromatographic Purification Method 2 (retention time = 4.125 min). Yield of <b>10</b>: 16 μg, 40 nmol, 0.3%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.46–8.37 (m, 1H), 7.89–7.77 (m, 1H), 7.50–7.21 (m, 3H), 7.21–7.11 (m, 1H), 7.00–6.83 (m, 1H), 6.06–5.28 (m, 2H), 5.11–4.56 (m, 1H), 4.21–4.09 (m, 2H), 3.86–2.12 (m, 6H), 1.25–1.21 (m, 3H). HRMS (TOF) calcd for 397.1319; found, 397.1312. Purity by HPLC–UV (210 nm) >99% using General Chromatographic Purification Method 2 (retention time = 4.203 min). Yield of <b>11</b>: 95 μg, 238 nmol, 2%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.90 (d, <i>J</i> = 2.6 Hz, 1H), 7.29 (d, <i>J</i> = 2.3 Hz, 1H), 7.19 (dd, <i>J</i> = 8.1, 2.3 Hz, 1H), 7.05 (d, <i>J</i> = 8.1 Hz, 1H), 6.93 (d, <i>J</i> = 2.7 Hz, 1H), 4.04 (q, <i>J</i> = 7.1 Hz, 2H), 3.65–3.55 (m, 2H), 3.37–3.11 (m, 4H), 2.83–2.68 (m, 2H), 2.36–2.29 (m, 1H), 2.28–2.21 (m, 1H), 2.21–2.10 (m, 2H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 399.1475; found, 399.1478. Purity by HPLC–UV (215 nm) 99% using General Chromatographic Purification Method 2 (retention time = 4.077 min). Yield of <b>12</b>: 226 μg, 569 nmol, 5%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.92 (d, <i>J</i> = 2.7 Hz, 1H), 7.29 (d, <i>J</i> = 2.3 Hz, 1H), 7.20 (dd, <i>J</i> = 8.1, 2.3 Hz, 1H), 7.11 (d, <i>J</i> = 8.1 Hz, 1H), 6.95 (d, <i>J</i> = 2.7 Hz, 1H), 6.81 (s, 1H), 5.67 (s, 1H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 3.88–3.78 (m, 1H), 3.42–3.08 (m, 3H), 2.83–2.67 (m, 2H), 2.66–2.55 (m, 1H), 2.34–2.24 (m, 1H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 397.1319; found, 397.1324. Purity by HPLC–UV (215 nm) 97% using General Chromatographic Purification Method 2 (retention time = 4.168 min). Yield of <b>13</b>: 8 μg, 20 nmol, 0.2%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.94 (d, <i>J</i> = 2.7 Hz, 1H), 7.32 (d, <i>J</i> = 2.2 Hz, 1H), 7.25–7.20 (m, 1H), 7.15–7.09 (m, 1H), 6.93 (d, <i>J</i> = 2.7 Hz, 1H), 6.84 (d, <i>J</i> = 8.2 Hz, 1H), 5.42 (s, 1H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 3.75–3.65 (m, 1H), 3.54–3.45 (m, 1H), 3.22–3.10 (m, 2H), 2.91–2.81 (m, 1H), 2.81–2.69 (m, 2H), 2.35–2.25 (m, 1H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 397.1319; found, 397.1311. Purity by HPLC–UV (215 nm) 96% using General Chromatographic Purification Method 1 (retention time = 6.222 min). Yield of <b>14</b>: 15 μg, 39 nmol, 0.3%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.37 (d, <i>J</i> = 4.7 Hz, 1H), 7.58 (d, <i>J</i> = 7.6 Hz, 1H), 7.34 (s, 1H), 7.27–7.23 (m, 1H), 7.23–7.18 (m, 1H), 7.16 (d, <i>J</i> = 8.2 Hz, 1H), 6.90 (s, 1H), 5.54–5.35 (m, 1H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 3.73–3.62 (m, 1H), 3.60–3.51 (m, 1H), 3.29–3.16 (m, 2H), 2.93–2.77 (m, 3H), 2.33–2.22 (m, 1H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 381.1370; found, 381.1368. Purity by HPLC–UV (210 nm) 97% using General Chromatographic Purification Method 1 (retention time = 6.779 min). Yield of <b>17</b>: 226 μg, 545 nmol, 4%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.40–8.35 (m, 1H), 7.64–7.62 (m, 1H), 7.43–7.25 (m, 3H), 7.07–7.05 (m, 1H); 5.57–5.11 (m, 2H), 4.65–3.92 (m, 6H), 3.44–3.08 (m, 4H), 2.98–2.77 (m, 2H), 1.22–1.12 (m, 3H). HRMS (TOF) calcd for 415.1425; found, 415.1423. Purity by HPLC–UV (210 nm) >99% using General Chromatographic Purification Method 2 (retention time = 4.413 min).</div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Ethyl (<i>Z</i>)-4-(8-Chloro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>15</b>) and Ethyl 4-(8-Chloro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>16</b>)</h4><div class="NLM_p last">Prepared from MCYP0160 (100.0 mg; P450 concentration, 2.0 mg/mL) and <b>1</b> (4.79 mg, 12.5 μmol) dissolved in a mixture of DMSO (2 mL) and 0.1 M potassium phosphate buffer solution (0.5 mL) at pH 8.0. Yield of <b>15</b>: 98 μg, 257 nmol, 2%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.37 (dd, <i>J</i> = 4.8, 1.7 Hz, 1H), 7.60 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.30 (d, <i>J</i> = 2.2 Hz, 1H), 7.24–7.19 (m, 2H), 7.15 (d, <i>J</i> = 8.2 Hz, 1H), 6.84 (s, 1H), 5.63 (s, 1H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 3.92–3.82 (m, 1H), 3.39–3.16 (m, 3H), 2.87–2.77 (m, 2H), 2.71–2.59 (m, 1H), 2.40–2.29 (m, 1H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 381.1370; found, 381.1368. Purity by HPLC–UV (288 nm) 97% using General Chromatographic Purification Method 1 (retention time = 6.457 min). Yield of <b>16</b>: 20 μg, 53 nmol, 0.4%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.32–9.21 (m, 2H), 8.18 (d, <i>J</i> = 7.5 Hz, 1H), 8.15 (d, <i>J</i> = 6.6 Hz, 1H), 7.97 (t, <i>J</i> = 7.0 Hz, 1H), 7.55 (s, 1H), 7.40 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 8.3 Hz, 1H), 3.86–3.78 (m, 2H), 3.62–3.55 (m, 2H), 3.33–3.20 (m, 4H), 3.02–2.97 (m, 2H), 1.07 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 381.1370; found, 381.1373. Purity by HPLC–UV (210 nm) >99% using General Chromatographic Purification Method 2 (retention time = 3.935 min).</div></div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Synthesis of Analogues <b>18</b> and <b>19</b></h3><div id="sec4_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Ethyl 4-(8-Chloro-2-(difluoromethyl)-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>18</b>) and Ethyl 4-(8-Chloro-4-(difluoromethyl)-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>19</b>)</h4><div class="NLM_p last">A 1.5 mL reaction vial equipped with a magnetic stir bar under an atmosphere of nitrogen was charged with <b>1</b> (20.0 mg, 52.2 μmol) followed by the addition of dimethyl sulfoxide (0.2 mL). At ambient temperature, the clear solution was treated with difluoromethanesulfinate zinc salt (46.3 mg, 156.7 μmol) followed by trifluoroacetic acid (8.0 μL, 104.3 μmol) and 70% aqueous <i>tert</i>-butyl hydroperoxide (36.2 μL, 261.0 μmol). The yellow mixture was heated at 50 °C for 15 h, and the progress of the reaction was monitored by UPLC–MS. The reaction mixture was diluted with dimethyl sulfoxide (0.5 mL) and filtered to remove solids. The crude material was purified using General Chromatographic Purification Method 2. Yield of <b>18</b>: 1.0 mg, 2.31 μmol, 4%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.62 (d, <i>J</i> = 7.9 Hz, 1H), 7.48 (d, <i>J</i> = 7.9 Hz, 1H), 7.20 (d, <i>J</i> = 2.2 Hz, 1H), 7.19–7.16 (m, 2H), 6.62 (t, <i>J</i> = 55.6 Hz, 1H), 4.16 (q, <i>J</i> = 7.1 Hz, 2H), 3.91–3.72 (m, 2H), 3.50–3.34 (m, 2H), 3.25–3.10 (m, 2H), 3.02–2.76 (m, 2H), 2.56–2.23 (m, 4H), 1.28 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 433.1494; found, 433.1486. Purity by HPLC–UV (288 nm) 96% using General Chromatographic Purification Method 1 (retention time = 8.017 min). Yield of <b>19</b>: 1.2 mg, 2.77 μmol, 5%. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 8.71 (d, <i>J</i> = 5.4 Hz, 1H), 7.60 (d, <i>J</i> = 5.4 Hz, 1H), 7.21–7.15 (m, 3H), 6.84 (t, <i>J</i> = 54.2 Hz, 1H), 4.17 (q, <i>J</i> = 7.1 Hz, 2H), 3.92–3.69 (m, 2H), 3.54–3.37 (m, 2H), 3.36–3.19 (m, 2H), 3.18–3.07 (m, 1H), 2.99–2.86 (m, 1H), 2.58–2.33 (m, 3H), 2.20–2.04 (m, 1H), 1.28 (t, <i>J</i> = 7.1 Hz, 3H). UPLC–MS <i>m/z</i>: 433.3 (M + 1). HRMS (TOF) calcd for 433.1494; found, 433.1494. Purity by HPLC–UV (288 nm) 95% using General Chromatographic Purification Method 1 (retention time = 7.629 min).</div></div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Synthesis of Analogue <b>20</b></h3><div id="sec4_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Ethyl 4-(8-Chloro-4-(hydroxymethyl)-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>20</b>)</h4><div class="NLM_p last">A 1.5 mL reaction vial equipped with a magnetic stir bar under an atmosphere of nitrogen was charged with <b>1</b> (10.7 mg, 28.0 μmol) followed by the addition of dimethyl sulfoxide (0.3 mL). At ambient temperature, the clear solution was treated with sodium hydroxymethanesulfinate salt (13.1 mg, 85.0 μmol) followed by trifluoroacetic acid (5.0 μL, 57.7 μmol) and the dropwise addition of 70% aqueous <i>tert</i>-butyl hydroperoxide (19.6 μL, 141.5 μmol). The yellow mixture was heated at 50 °C for 2 h, and the progress of the reaction was monitored by UPLC–MS. The crude material was purified using General Chromatographic Purification Method 2. Yield of <b>20</b>: 141.3 μg, 342.9 nmol, 1%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.33 (d, <i>J</i> = 5.0 Hz, 1H), 7.32 (d, <i>J</i> = 4.9 Hz, 1H), 7.29 (d, <i>J</i> = 2.3 Hz, 1H), 7.21 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.09 (d, <i>J</i> = 8.1 Hz, 1H), 4.52 (q, <i>J</i> = 15.0 Hz, 2H), 4.05 (q, <i>J</i> = 7.1 Hz, 2H), 3.68–3.55 (m, 2H), 3.39–3.30 (m, 1H), 3.25–3.15 (m, 2H), 3.14–3.06 (m, 1H), 2.89–2.77 (m, 2H), 2.38–2.24 (m, 2H), 2.23–2.13 (m, 2H), 1.18 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 413.1632; found, 413.1632. Purity by HPLC–UV (288 nm) 96% using General Chromatographic Purification Method 1 (retention time = 4.564 min).</div></div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Biomimetic Metalloporphyrin Oxidation (BMO) Screen Procedure</h3><div class="NLM_p">A high-throughput BMO screen was completed on a miniature scale, examining the key variables of metalloporphyrin, oxidant, and solvent. Nine different metalloporphyrins and control without metalloporphyrin, six oxidants, and two solvents were screened in a matrix of 120 combinations. The remaining variables were held constant according to the standard protocol described below. The reactions were set up in two 96-well arrays using miniature 8 × 20 mm (0.2 mL) glass vials under standard glovebox conditions (H<sub>2</sub>O and O<sub>2</sub>, <20 ppm).</div><div class="NLM_p last">A 8 ×20 mm (0.2 mL) glass vial equipped with a stir bar was dispensed the reaction solvent (100 μL, 4.0 mM) followed by a solution of <b>1</b> (5.0 μL, 0.4 μmol), added as a 0.1 M solution in dichloroethane. Stirring was initiated before the metalloporphyrin (4.0 μL, 0.04 μmol) was charged, as a 10.0 mM solution in dichloroethane. The vial was treated with a 0.1 M solution of imidazole (2.4 mL, 0.24 μmol) in H<sub>2</sub>O followed by a 0.4 M solution of formic acid (4.0 μL, 0.16 μmol) in H<sub>2</sub>O. Finally, the oxidant (8.0 μL, 0.08 μmol) was added as a 0.1 M solution in dichloroethane. The reaction vial was crimp-sealed with PTFE/silicone/PTFE septa to the glovebox environment before the reaction was left to stir at 25 °C for 18 h. After this time period, the reaction was diluted with acetonitrile (0.2 mL) and analyzed directly by UPLC–MS. The UPLC–MS method used a 0.1% AcOH/NH<sub>4</sub>CO<sub>2</sub>H/H<sub>2</sub>O gradient over 0.8 min, running from 5 to 95% acetonitrile using a Waters ACQUITY UPLC BEH C18 30 × 2.1 mm column at 100 °C with a flow rate of 2.5 mL/min and detection wavelength of 210–360 nm. Injections (0.5 μL) were made directly from diluted reaction mixtures and ionization monitored in the positive mode.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> BMO Scale-Up Procedure for the Synthesis of Analogues <b>21</b>–<b>23</b></h3><div id="sec4_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Ethyl 8-Chloro-5,6-dihydrodispiro[benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridine-11,2′-oxirane-3′,4″-piperidine]-1″-carboxylate (<b>21</b>), 8-Chloro-1″-(ethoxycarbonyl)-5,6-dihydrodispiro[benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridine-11,2′-oxirane-3′,4″-piperidine]-1-oxide (<b>22</b>), and 8-Chloro-11-(1-(ethoxycarbonyl)piperidin-4-ylidene)-6,11-dihydro-5<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridine 1-oxide (<b>23</b>)</h4><div class="NLM_p last">A 4 dram glass vial (10 mL) equipped with a stir bar was treated with <b>1</b> (38.0 mg, 0.1 mmol) followed by a 1:1 solvent mixture of methanol and dichloroethane (10 mL). The reaction mixture was stirred for 5.0 min and then treated with <i>meta</i>-chloroperoxybenzoic acid (45.0 mg, 0.2 mmol). The reaction vial was screw-cap sealed with PTFE/silicone/PTFE septa to the glovebox environment before the reaction was left to stir at 25 °C for 18 h. After this time period, the reaction was diluted with acetonitrile (0.2 mL) and analyzed directly by UPLC–MS. The crude material was purified using General Chromatographic Purification Method 2. Yield of <b>21</b>: 380.0 μg, 952.7 nmol, 1%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.34 (d, <i>J</i> = 4.7 Hz, 1H), 7.65 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (d, <i>J</i> = 8.4 Hz, 1H), 7.31–7.23 (m, 3H), 4.01 (q, <i>J</i> = 7.1 Hz, 2H), 3.96–3.84 (m, 2H), 3.38–3.22 (m, 2H), 3.11–2.96 (m, 2H), 2.96–2.87 (m, 2H), 1.78–1.59 (m, 2H), 1.14 (t, <i>J</i> = 7.1 Hz, 3H), 1.02–0.79 (m, 2H). HRMS (TOF) calcd for 399.1475; found, 399.1462. Purity by HPLC–UV (215 nm) 99% using General Chromatographic Purification Method 2 (retention time = 4.280 min). Yield of <b>22</b>: 1.8 mg, 4.33 μmol, 4%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.05–8.00 (m, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.32–7.25 (m, 3H), 7.23–7.18 (m, 1H), 4.14–3.88 (m, 4H), 3.39–3.31 (m, 1H), 3.20–3.09 (m, 1H), 3.05–2.89 (m, 3H), 2.88–2.78 (m, 1H), 1.90–1.76 (m, 2H), 1.16 (t, <i>J</i> = 7.1 Hz, 3H), 0.87 (d, <i>J</i> = 14.0 Hz, 1H), 0.75 (d, <i>J</i> = 13.4 Hz, 1H). HRMS (TOF) calcd for 415.1425; found, 415.1411. Purity by HPLC–UV (215 nm) 95% using General Chromatographic Purification Method 2 (retention time = 4.290 min). Yield of <b>23</b>: 8.35 mg, 20.93 μmol, 21%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.13–8.07 (m, 1H), 7.27–7.18 (m, 4H), 7.14 (d, <i>J</i> = 8.0 Hz, 1H), 4.04 (q, <i>J</i> = 7.1 Hz, 2H), 3.69–3.56 (m, 2H), 3.36–3.20 (m, 4H), 2.91–2.80 (m, 2H), 2.44–2.33 (m, 1H), 2.30–2.20 (m, 1H), 2.14–2.03 (m, 1H), 1.92–1.80 (m, 1H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 399.1475; found, 399.1468. Purity by HPLC–UV (215 nm) 95% using General Chromatographic Purification Method 2 (retention time = 4.526 min).</div></div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> BMO Scale-Up Procedure for the Synthesis of Analogue <b>24</b></h3><div id="sec4_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 8-Chloro-11-(1-(ethoxycarbonyl)piperidin-4-ylidene)-1-methyl-6,11-dihydro-5<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-1-ium Formate Salt (<b>24</b>)</h4><div class="NLM_p last">A 4 dram glass vial (10 mL) equipped with a stir bar was treated with <b>1</b> (38.0 mg, 0.1 mmol) followed by a 1:1 solvent mixture of methanol and dichloroethane (10 mL). The reaction mixture was stirred for 5.0 min and then treated with Cu(TDCIPP) (9.5 mg, 0.01 mmol), imidazole (4.0 mg, 0.06 mmol), formic acid (0.015 mL, 0.4 mmol) followed by oxidant cumene hydroperoxide (0.038 mL, 0.2 mmol, 80 wt % in H<sub>2</sub>O). The reaction vial was screw-cap sealed with PTFE/silicone/PTFE septa to the glovebox environment before the reaction was left to stir at 25 °C for 18 h. After this time period, the reaction was diluted with acetonitrile (0.2 mL) and analyzed directly by UPLC–MS. The crude material was purified using General Chromatographic Purification Method 2. Yield of <b>24</b>: 1.53 mg, 3.45 μmol, 3%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.91 (s, 1H), 8.58 (d, <i>J</i> = 7.3 Hz, 1H), 8.10–7.95 (m, 1H), 7.37 (d, <i>J</i> = 8.3 Hz, 1H), 7.34 (d, <i>J</i> = 8.1 Hz, 1H), 7.29 (s, 1H), 4.21 (s, 3H), 4.06 (q, <i>J</i> = 7.1 Hz, 2H), 3.86–3.77 (m, 1H), 3.77–3.67 (m, 1H), 3.52–3.36 (m, 2H), 3.27–3.01 (m, 3H), 2.98–2.85 (m, 1H), 2.48–2.41 (m, 1H), 2.41–2.34 (m, 1H), 2.29–2.19 (m, 1H), 1.96–1.86 (m, 1H), 1.19 (t, <i>J</i> = 7.1 Hz, 3H). HRMS (TOF) calcd for 397.1677; found, 397.1670. Purity by HPLC–UV (215 nm) 98% using General Chromatographic Purification Method 2 (retention time = 3.941 min).</div></div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Electrochemical Screen and Scale-Up Procedure for the Synthesis of Analogues <b>21</b> and <b>25</b></h3><div id="sec4_22_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Ethyl 8-Chloro-5,6-dihydrodispiro[benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridine-11,2′-oxirane-3′,4″-piperidine]-1″-carboxylate (<b>21</b>) and Ethyl 8′-chloro-5-oxo-5′,6′-dihydrospiro[azepane-4,11′-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridine]-1-carboxylate (<b>25</b>)</h4><div class="NLM_p">An undivided electrochemical cell equipped with a magnetic stir bar was treated with a 0.5 M solution of Et<sub>4</sub>NBF<sub>4</sub> (2.0 mL, 1.0 mmol) in acetonitrile followed by H<sub>2</sub>O (0.1 mL, 5.5 mmol). The solution was stirred at room temperature for 5.0 min and then charged with <b>1</b> (19.0 mg, 0.05 mmol). A fitted reticulated vitreous carbon (RVC) anode electrode coupled to a stainless steel mesh cathode electrode was inserted into the cell. The mixture was subjected to electrolysis with constant potential (5 V) across the two electrodes for 1 h (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S1A</a> in the Supporting Information), and the progress of the reaction was monitored by UPLC–MS. The reaction mixture was diluted with dichloromethane (30.0 mL), washed with brine (30.0 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was filtered and concentrated <i>in vacuo</i>, and the crude material was purified using General Chromatographic Purification Method 3. Yield of <b>21</b>: 1.1 mg, 2.76 μmol, 5%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.35 (d, <i>J</i> = 4.7 Hz, 1H), 7.65 (d, <i>J</i> = 7.6 Hz, 1H), 7.36 (d, <i>J</i> = 8.3 Hz, 1H), 7.30–7.24 (m, 3H), 4.01 (q, <i>J</i> = 7.1 Hz, 2H), 3.97–3.83 (m, 2H), 3.38–3.22 (m, 2H), 3.11–2.96 (m, 2H), 2.95–2.88 (m, 2H), 1.80–1.56 (m, 2H), 1.15 (t, <i>J</i> = 7.1 Hz, 3H), 1.02–0.78 (m, 2H). HRMS (TOF) calcd for 399.1475; found, 399.1467. Purity by HPLC–UV (210 nm) 98% using General Chromatographic Purification Method 3 (retention time = 3.908 min). Yield of <b>25</b>: 0.89 mg, 2.23 μmol, 4%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.32 (d, <i>J</i> = 4.7 Hz, 1H), 7.52 (d, <i>J</i> = 7.6 Hz, 1H), 7.38 (d, <i>J</i> = 7.9 Hz, 1H), 7.33 (s, 1H), 7.27–7.19 (m, 2H), 4.09–3.97 (m, 2H), 3.87–3.76 (m, 1H), 3.66–3.54 (m, 1H), 3.37–3.25 (m, 2H), 3.11–2.92 (m, 4H), 2.84–2.72 (m, 2H), 2.71–2.62 (m, 1H), 2.62–2.53 (m, 1H), 1.23–1.12 (m, 3H). HRMS (TOF) calcd for 399.1475; found, 399.1472. Purity by HPLC–UV (210 nm) 97% using General Chromatographic Purification Method 3 (retention time = 4.425 min).</div><div class="NLM_p last">Note that the electrochemical scale-up procedure also served as the electrochemical screening procedure for loratadine.</div></div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Synthesis of Analogues <b>26</b> and <b>27</b></h3><div id="sec4_23_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Ethyl 4-(8-Chloro-7-(trifluoromethyl)-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate and Ethyl 4-(8-Chloro-9-(trifluoromethyl)-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>26</b>, 1:1 Mixture of Regioisomers) and Ethyl 4-(5,6-Dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)piperidine-1-carboxylate (<b>27</b>)</h4><div class="NLM_p last">An undivided electrochemical cell equipped with a magnetic stir bar was treated with a 0.5 M solution of Et<sub>4</sub>NBF<sub>4</sub> (0.4 mL, 0.2 mmol) in dimethyl sulfoxide followed by a 0.5 M solution of H<sub>2</sub>SO<sub>4</sub> (0.4 mL, 0.2 mmol) in dimethyl sulfoxide. The solution was stirred at room temperature for 5.0 min and then charged with <b>1</b> (19.0 mg, 0.05 mmol) and sodium trifluoromethanesulfinate (NaTFMS) salt (39.0 mg, 0.25 mmol). A fitted reticulated vitreous carbon (RVC) anode electrode coupled to a stainless steel mesh cathode electrode was inserted into the cell. The mixture was subjected to electrolysis with constant potential (5 V) across the two electrodes for 10 h (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S1A,B</a> in the Supporting Information), and the progress of the reaction was monitored by UPLC–MS. The reaction mixture was diluted with ethyl acetate (20.0 mL), washed with saturated aqueous NaHCO<sub>3</sub> (20.0 mL), and dried over MgSO<sub>4</sub>. The solution was filtered and concentrated <i>in vacuo</i>, and the crude material was purified using General Chromatographic Purification Method 3. Yield of <b>26</b> as a 1:1 mixture of regioisomers: 83.0 μg, 184.0 nmol, 0.4%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) (regioisomer-1, CF<sub>3</sub> at 7-position): δ 8.40–8.35 (m, 1H), 7.55–7.49 (m, 2H), 7.37 (d, <i>J</i> = 8.1 Hz, 1H), 7.26–7.19 (m, 1H), 4.10–4.00 (m, 2H), 3.75–3.09 (m, 6H), 3.00–2.80 (m, 2H), 2.39–2.05 (m, 4H), 1.18 (m, 3H). HRMS (TOF) calcd for 451.1400; found, 451.1388. Purity by HPLC–UV (215 nm) 96% using General Chromatographic Purification Method 3 (retention time = 4.598 min). Yield of <b>27</b>: 220.0 μg, 631.4 nmol, 1%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) (regioisomer-2, CF<sub>3</sub> at 9-position): δ 8.40–8.35 (m, 1H), 7.65–7.60 (m, 2H), 7.46 (s, 1H), 7.26–7.19 (m, 1H), 4.10–4.00 (m, 2H), 3.75–3.09 (m, 6H), 3.00–2.80 (m, 2H), 2.39–2.05 (m, 4H), 1.18 (m, 3H). HRMS (TOF) calcd for 349.1916; found, 349.1899. Purity by HPLC–UV (215 nm) 95% using General Chromatographic Purification Method 3 (retention time = 4.021 min).</div></div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Histamine H<sub>1</sub> Receptor Functional Assay</h3><div class="NLM_p last">Compound activity at the human histamine H<sub>1</sub> receptor was determined by measuring receptor-mediated intracellular calcium release using a FLIPR Tetra system (Molecular Devices, Sunnyvale, CA). Chinese hamster ovary cells stably transfected to express the human histamine H<sub>1</sub> receptor were plated into black clear bottom 384-well plates (7500 cells per well) 24 h prior to the start of the study. The culture media were removed from the wells and were replaced by 80 μL of Hanks’ balanced salt solution (HBSS), containing 2-[4-(2-hydroxyethyl)piperazin-1-yl] ethanesulfonic acid (HEPES) (20 mM) and Calcium 5 dye as per the manufacturer’s directions (Molecular Devices, Sunnyvale, CA). The plates were incubated at 37 °C for 1 h to allow the dye to load into the cells. Subsequently, the plate was transferred to the FLIPR instrument. Diluted compounds were added to the plate by the FLIPR instrument, and the change in fluorescence of each well was measured to determine potential agonist activity. Following an additional 15 min incubation, an EC<sub>80</sub> concentration of histamine was added to each well to produce an agonist response. Compounds with antagonist activity blocked this response, measured as a change in fluorescence by the FLIPR instrument. IC<sub>50</sub> values were calculated for each active compound, and apparent <i>K</i><sub>d</sub> values were calculated from this IC<sub>50</sub> value using the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> A geometric mean of three replicates was used to determine final human histamine H<sub>1</sub> receptor dissociation constants (<i>K</i><sub>d</sub>).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Human Liver Microsome Stability Assay<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></h3><div class="NLM_p last">Pooled human liver microsomes from XenoTech (Kansas City, KS) at a protein concentration of 0.7 mg/mL were incubated with test compounds (1.0 μM) at 37 °C, and the total volume was 0.03 mL. A Beckman Coulter Biomek FX (Indianapolis, IN) 384-well workstation was used for liquid handling and sample incubation. The addition of NADPH was used to initiate the reaction, and treatment with ice-cold acetonitrile (75 μL) at the following timepoints (0, 5, 10, 20, 30, and 60 min) was utilized to terminate the reaction. The plates containing the sample were centrifuged at 3000 rpm for 5 min. A total of seven sample wells containing eight test compounds were pooled (i.e., seven test analytes and buspirone as the internal standard). An aliquot was removed (45 μL sample/compound) at each timepoint and dried under nitrogen. The samples were reconstituted in 120 μL (0.1% formic acid in water/0.1% formic acid in acetonitrile, 95:5) and analyzed by LC–MS/MS. An AB Sciex 5500 Triple Quad (Concord, Ontario, Canada) mass spectrometer was used in line with an Agilent 1290 Infinity Series (Santa Clara, CA) consisting of an LS-1 autosampler and LC pumping system. A standard LC method was used, along with a 2 × 20 mm, 2.7 μm, C18 HALO column and flow rate of 0.8 mL/min (60 s, cycle time).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Human Hepatocyte Metabolic Stability Assay</h3><div class="NLM_p last">Test compounds (0.2 nmol) in DMSO-<i>d</i><sub>6</sub> were added to a 96-well plate, and the solvent was removed <i>in vacuo</i>. To each well was added Williams’ E medium (0.05 mL) followed by vortex mixing. A suspension of pooled human hepatocytes in Williams’ E medium was added to each well to yield a final volume of 0.2 mL at a hepatocyte concentration of 0.5 million cells/mL. The plate was incubated on a rotating shaker at 37 °C inside a humidified incubator at 90% humidity (95% O<sub>2</sub>/5% CO<sub>2</sub>). At the following timepoints (0, 30, 60, 90, 120, and 240 min), aliquots (0.025 mL) were removed and quenched with H<sub>2</sub>O/acetonitrile (2:1) with 2% formic acid and internal standard naloxone (1.0 μM). The mixtures were centrifuged at 1700<i>g</i> for 5 min, and the supernatants were analyzed by LC–MS/MS. The regression line must have an <i>r</i><sup>2</sup> ≥ 0.85 to report <i>in vitro</i> CL<sub>int</sub> and <i>T</i><sub>1/2</sub>. Incubation time/<i>in vitro T</i><sub>1/2</sub> must be ≥0.4 to afford meaningful assessment of liability. Hepatocyte viability as measured by trypan blue exclusion (TBE) should not decline >30% during the course of a 4 h incubation. Equations used to calculate <i>in vitro T</i><sub>1/2</sub> and CL<sub>int</sub><span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_m001.gif" alt="" id="_i62" /></img></span></div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Apparent Passive Permeability in Ralph Russ Canine Kidney (RRCK) Cell Line Assay</h3><div class="NLM_p last">RRCK apparent passive permeability values were determined using a previously described method.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> SFlog <i>D</i> Assay</h3><div class="NLM_p">The shake-flask log <i>D</i> (SFlog <i>D</i>) assay is a method designed to minimize the amount of compound used to determine a molecule octanol–water partition coefficient at pH 7.4, providing a measure of lipophilicity. Liquid handling steps were performed on a Beckman Coulter Biomek FX (Fullerton, CA) using a 96-channel pod. Samples are analyzed using a triple-quadrupole mass spectrometer (AB Sciex API 3000; Concord, Ontario, Canada) in both positive and negative ion multiple reaction monitoring (MRM) modes.</div><div class="NLM_p last">A solution of 1-octanol (20 mL, 0.13 mol) was treated with a 0.1 M solution of sodium phosphate (2.0 L, 0.2 mol) buffer at pH 7.4 to give Sol-1. The Sol-1 mixture was vigorously shaken and left to stand overnight at room temperature (23 °C). A solution of 0.1 M sodium phosphate (20 mL, 0.002 mol) buffer at pH 7.4 was treated with 1-octanol (2.0 L, 13.0 mol) to give Sol-2. The Sol-2 mixture was vigorously shaken and left to stand overnight at room temperature (23 °C). An internal standard solution was prepared by dissolving CP-628374<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> in acetonitrile to give Sol-3 at a concentration of 2.5 mg/mL. A 1-octanol internal standard solution was prepared by treating Sol-3 (3.5 mL) with 1:1 methanol/H<sub>2</sub>O (1000 mL) to give Sol-4. An internal standard buffer solution was prepared by treating Sol-3 (3.5 mL) with 1-octanol (5.0 mL, 0.032 mol) and 1:1 methanol/H<sub>2</sub>O (1000 mL) to give Sol-5. A 10.0 mM stock solution of test compound in DMSO was prepared, and 2.0 μL was added to 149.0 μL of Sol-2 in a 96-well plate followed by the addition of 149.0 μL of Sol-1. The plate was sealed with a silicone well cap mat and vigorously mixed for 1 h at 23 °C using a plate shaker followed by plate centrifugation at 2500 rpm (1006<i>g</i>) for 15 min. The cap mat was detached from the plate, and an aliquot (4.0 μL) was removed from the 1-octanol phase and transferred into a new 1.0 mL capacity 96-well plate containing Sol-4 (796 μL). In addition, an aliquot (10 μL) from the buffer phase was transferred into the 1.0 mL well capacity plate containing Sol-5 (190 μL). Sample analysis was performed using a triple-quadrupole mass spectrometer (AB Sciex API 3000) in both positive and negative ion MRM modes). Samples (2 μL) were injected onto a small cartridge HPLC column using an aqueous isocratic solvent loading and then flushed into the mass spectrometer with an organic elusion solvent. Peak areas were corrected by dilution factors and incorporating the internal standard, and the ratios of corrected peak areas were used to calculate the SFlog <i>D</i>.<span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_m002.gif" alt="" id="_i65" /></img></span></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00483" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00483?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00483</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Lead diversification screening panels; HPLC–MS screening results; cyclic voltammetry reading; protein–ligand docking protocols; and <sup>1</sup>H NMR, COSY, HSQC, HMBC, and NOE spectra of intermediates and final products (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">PDF</a>)</p><p>Diversity map (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_002.xlsx" class="ext-link">XLSX</a>)</p><p>Molecular formula strings of compounds <b>1</b>–<b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_003.xlsx" class="ext-link">XLSX</a>)</p><p class="last">HPLC–MS chromatograms of compounds <b>1</b>–<b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_004.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf">jm0c00483_si_001.pdf (13.27 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_002.xlsx">jm0c00483_si_002.xlsx (35.65 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_003.xlsx">jm0c00483_si_003.xlsx (13.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_004.pdf">jm0c00483_si_004.pdf (1.72 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00483" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manjinder S. Lall</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2882-8075" title="Orcid link">http://orcid.org/0000-0002-2882-8075</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d0bdb1bebab9beb4b5a2febcb1bcbc90a0b6b9aab5a2feb3bfbd"><span class="__cf_email__" data-cfemail="f09d919e9a999e949582de9c919c9cb08096998a9582de939f9d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Asser Bassyouni</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Science Center Drive, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Bradow</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Brown</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Bundesmann</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinshan Chen</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory Ciszewski</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne E. Hagen</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis Hyek</span> - <span class="hlFld-Affiliation affiliation">Spectrix
Analytical Services, LLC, 410 Sackett Point Road, Bldg 20, North Haven, Connecticut 06473, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Jenkinson</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Science Center Drive, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Liu</span> - <span class="hlFld-Affiliation affiliation">Spectrix
Analytical Services, LLC, 410 Sackett Point Road, Bldg 20, North Haven, Connecticut 06473, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Scott Obach</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Senliang Pan</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Usa Reilly</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neal Sach</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Science Center Drive, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Smaltz</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas K. Spracklin</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3471-1332" title="Orcid link">http://orcid.org/0000-0002-3471-1332</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy Starr</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Wagenaar</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Walker</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge the extended Lead Diversification Team for collaborative efforts and helpful discussion. In particular, we are indebted to Michael A. Brodney, Adam M. Gilbert, and Mark C. Noe for helpful discussion regarding this work. For their technical expertise, we extend our gratitude to Ben Burke, Anthony A. Carlo, Laurence Philippe, Raman Sharma, Mark A. West, Kim Wilson, Hui Zhang, Gilles H. Goetz, and James J. Federico. We thank Matthew F. Brown for manuscript review and providing useful feedback.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Nonstandard Abbreviations Used</td></tr><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American Type Culture Collection</p></td></tr><tr><td class="NLM_term">BMO</td><td class="NLM_def"><p class="first last">biomimetic metalloporphyrin oxidation</p></td></tr><tr><td class="NLM_term">BM3</td><td class="NLM_def"><p class="first last"><i>Bacillus megaterium</i> CYP102A1</p></td></tr><tr><td class="NLM_term">CHP</td><td class="NLM_def"><p class="first last">cumene hydroperoxide</p></td></tr><tr><td class="NLM_term">ECTFM</td><td class="NLM_def"><p class="first last">electrochemical trifluoromethylation</p></td></tr><tr><td class="NLM_term">ERETIC2</td><td class="NLM_def"><p class="first last">electronic reference to access <i>in vivo</i> concentrations 2</p></td></tr><tr><td class="NLM_term">H<sub>1</sub> receptor</td><td class="NLM_def"><p class="first last">human histamine H<sub>1</sub> receptor</p></td></tr><tr><td class="NLM_term">HHEP CL<sub>int</sub></td><td class="NLM_def"><p class="first last">human hepatocyte intrinsic clearance CL<sub>int</sub> (μL/min/million cells)</p></td></tr><tr><td class="NLM_term">HLM CL<sub>int</sub></td><td class="NLM_def"><p class="first last">human liver microsome intrinsic clearance CL<sub>int</sub> (μL/min/mg)</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">LM</td><td class="NLM_def"><p class="first last">liver microsomes</p></td></tr><tr><td class="NLM_term">LSF</td><td class="NLM_def"><p class="first last">late-stage functionalization</p></td></tr><tr><td class="NLM_term">LSLD</td><td class="NLM_def"><p class="first last">late-stage lead diversification</p></td></tr><tr><td class="NLM_term">M +/– number</td><td class="NLM_def"><p class="first last">average mass change difference between the parent and analogue (i.e., Δmass)</p></td></tr><tr><td class="NLM_term">Met ID</td><td class="NLM_def"><p class="first last">metabolite identification</p></td></tr><tr><td class="NLM_term">Oxone</td><td class="NLM_def"><p class="first last">potassium peroxymonosulfate</p></td></tr><tr><td class="NLM_term">P450 BM3</td><td class="NLM_def"><p class="first last">cytochrome P450 from <i>Bacillus megaterium</i> CYP102A1</p></td></tr><tr><td class="NLM_term">PhIO</td><td class="NLM_def"><p class="first last">iodosobenzene</p></td></tr><tr><td class="NLM_term">rhCYP</td><td class="NLM_def"><p class="first last">recombinant cytochrome P450</p></td></tr><tr><td class="NLM_term">RRCK <i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent passive permeability in the Ralph Russ canine kidney cell line <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)</p></td></tr><tr><td class="NLM_term">RVC</td><td class="NLM_def"><p class="first last">reticulated vitreous carbon</p></td></tr><tr><td class="NLM_term">SFlog <i>D</i></td><td class="NLM_def"><p class="first last">shake-flask logarithm of distribution coefficient</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 72 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fessner, N. D.</span></span> <span> </span><span class="NLM_article-title">P450 Monooxygenases Enable Rapid Late-Stage Diversification of Natural Products <i>via</i> C–H Bond Activation</span>. <i>ChemCatChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2226</span>– <span class="NLM_lpage">2242</span>, <span class="refDoi"> DOI: 10.1002/cctc.201801829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fcctc.201801829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=31423290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BB3MvptVChsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=2226-2242&author=N.+D.+Fessner&title=P450+Monooxygenases+Enable+Rapid+Late-Stage+Diversification+of+Natural+Products+via+C%E2%80%93H+Bond+Activation&doi=10.1002%2Fcctc.201801829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">P450 Monooxygenases Enable Rapid Late-Stage Diversification of Natural Products via C-H Bond Activation</span></div><div class="casAuthors">Fessner Nico D</div><div class="citationInfo"><span class="NLM_cas:title">ChemCatChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2226-2242</span>
        ISSN:<span class="NLM_cas:issn">1867-3880</span>.
    </div><div class="casAbstract">The biological potency of natural products has been exploited for decades.  Their inherent structural complexity and natural diversity might hold the key to efficiently address the urgent need for the development of novel pharmaceuticals.  At the same time, it is that very complexity, which impedes necessary chemical modifications such as structural diversification, to improve the effectiveness of the drug.  For this purpose, Cytochrome P450 enzymes, which possess unique abilities to activate inert sp(3)-hybridised C-H bonds in a late-stage fashion, offer an attractive synthetic tool.  In this review the potential of cytochrome P450 enzymes in chemoenzymatic lead diversification is illustrated discussing studies reporting late-stage functionalisations of natural products and other high-value compounds.  These enzymes were proven to extend the synthetic toolbox significantly by adding to the flexibility and efficacy of synthetic strategies of natural product chemists, and scientists of other related disciplines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKA6ELzGwc_Be4jJGKT5N0fW6udTcc2eY6hq8LPXwcPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvptVChsQ%253D%253D&md5=5b696d1a586a701591911afdc153ea5a</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1002%2Fcctc.201801829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcctc.201801829%26sid%3Dliteratum%253Aachs%26aulast%3DFessner%26aufirst%3DN.%2BD.%26atitle%3DP450%2520Monooxygenases%2520Enable%2520Rapid%2520Late-Stage%2520Diversification%2520of%2520Natural%2520Products%2520via%2520C%25E2%2580%2593H%2520Bond%2520Activation%26jtitle%3DChemCatChem%26date%3D2019%26volume%3D11%26spage%3D2226%26epage%3D2242%26doi%3D10.1002%2Fcctc.201801829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span> <span> </span><span class="NLM_article-title">Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3626</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00116</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1artbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3626-3640&author=R.+S.+Obachauthor=G.+S.+Walkerauthor=R.+Sharmaauthor=S.+Jenkinsonauthor=T.+P.+Tranauthor=A.+F.+Stepan&title=Lead+Diversification+at+the+Nanomole+Scale+Using+Liver+Microsomes+and+Quantitative+Nuclear+Magnetic+Resonance+Spectroscopy%3A+Application+to+Phosphodiesterase+2+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 Inhibitors</span></div><div class="casAuthors">Obach, R. Scott; Walker, Gregory S.; Sharma, Raman; Jenkinson, Stephen; Tran, Tuan P.; Stepan, Antonia F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3626-3640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we describe a method whereby lead mols. can be converted into several new analogs each using liver microsomes.  Less than one micromole of substrate is incubated with liver microsomes (mouse, rat, hamster, guinea pig, rabbit, dog, monkey, or human) to produce multiple products which are isolated and analyzed by quant. cryomicroprobe NMR (qNMR) spectroscopy.  The solns. from qNMR anal. were then used as stocks that were dild. into biochem. assays.  Nine human phosphodiesterase-2 (PDE2) inhibitors yielded 36 new analogs.  Products were tested for PDE2 inhibition, intrinsic clearance in human hepatocytes, and membrane permeability.  Two of the products (2c and 4b) were 3-10× more potent than their resp. parent compds. and also had improved metabolic stability.  Others offered insights into structure-activity relationships.  Overall, this process of using liver microsomes at a submicromole scale of substrate is a useful approach to rapid and cost-effective late-stage lead diversification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-VoZNHBKsXbVg90H21EOLACvtfcHk0ljE9Ntv_jXrlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1artbs%253D&md5=10c4e199e4c58bd90661851fdc3bc1a6</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00116%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26atitle%3DLead%2520Diversification%2520at%2520the%2520Nanomole%2520Scale%2520Using%2520Liver%2520Microsomes%2520and%2520Quantitative%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%253A%2520Application%2520to%2520Phosphodiesterase%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3626%26epage%3D3640%26doi%3D10.1021%2Facs.jmedchem.8b00116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Late-Stage Microsomal Oxidation Reduces Drug–Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00343</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00343" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Wqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=68-72&author=A.+F.+Stepanauthor=T.+P.+Tranauthor=C.+J.+Helalauthor=M.+S.+Brownauthor=C.+Changauthor=R.+E.+O%E2%80%99Connorauthor=M.+De+Vivoauthor=S.+D.+Doranauthor=E.+L.+Fisherauthor=S.+Jenkinsonauthor=D.+Karanianauthor=B.+L.+Kormosauthor=R.+Sharmaauthor=G.+S.+Walkerauthor=A.+S.+Wrightauthor=E.+X.+Yangauthor=M.+A.+Brodneyauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=R.+S.+Obach&title=Late-Stage+Microsomal+Oxidation+Reduces+Drug%E2%80%93Drug+Interaction+and+Identifies+Phosphodiesterase+2A+Inhibitor+PF-06815189&doi=10.1021%2Facsmedchemlett.7b00343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189</span></div><div class="casAuthors">Stepan, Antonia F.; Tran, Tuan P.; Helal, Christopher J.; Brown, Maria S.; Chang, Cheng; O'Connor, Rebecca E.; De Vivo, Michael; Doran, Shawn D.; Fisher, Ethan L.; Jenkinson, Stephen; Karanian, David; Kormos, Bethany L.; Sharma, Raman; Walker, Gregory S.; Wright, Ann S.; Yang, Edward X.; Brodney, Michael A.; Wager, Travis T.; Verhoest, Patrick R.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-72</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Late-stage oxidn. using liver microsomes was applied to phosphodiesterase 2 inhibitor 1 to reduce its clearance by cytochrome P 450 enzymes, introduce renal clearance and minimize the risk for victim drug-drug interactions.  This approach yielded PF-06815189 with improved physicochem. properties and a mixed metabolic profile.  This example highlights the importance of C-H diversification methods to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdLF3o73q1nrVg90H21EOLACvtfcHk0lhTyJd8xUACMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Wqsg%253D%253D&md5=86a976a3eebf2bbbb9865ae655909ab7</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00343%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBrown%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DFisher%26aufirst%3DE.%2BL.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKaranian%26aufirst%3DD.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DYang%26aufirst%3DE.%2BX.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DLate-Stage%2520Microsomal%2520Oxidation%2520Reduces%2520Drug%25E2%2580%2593Drug%2520Interaction%2520and%2520Identifies%2520Phosphodiesterase%25202A%2520Inhibitor%2520PF-06815189%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D68%26epage%3D72%26doi%3D10.1021%2Facsmedchemlett.7b00343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Harnessing Biosynthesis and Quantitative NMR for Late Stage Functionalization of Lead Molecules: Application to the M1 Positive Allosteric Modulator (PAM) Program</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.04.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2018.04.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29716781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosl2js7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2068-2073&author=M.+A.+Brodneyauthor=R.+Sharmaauthor=J.+T.+Lazzaroauthor=G.+S.+Walkerauthor=R.+S.+Obach&title=Harnessing+Biosynthesis+and+Quantitative+NMR+for+Late+Stage+Functionalization+of+Lead+Molecules%3A+Application+to+the+M1+Positive+Allosteric+Modulator+%28PAM%29+Program&doi=10.1016%2Fj.bmcl.2018.04.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing biosynthesis and quantitative NMR for late stage functionalization of lead molecules: Application to the M1 positive allosteric modulator (PAM) program</span></div><div class="casAuthors">Brodney, Michael A.; Sharma, Raman; Lazzaro, John T.; Walker, Gregory S.; Scott Obach, R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2068-2073</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A facile method for late stage diversification of lead mols. for the M1 PAM program using biosynthesis is described.  Liver microsomes from several species are screened to identify a high turnover system.  Subsequent incubations using less than 1mg of substrate generate nanomole quantities of drug metabolites that are purified, characterized by microcryoprobe NMR spectroscopy, and quantified to known concns. to enable rapid biol. testing.  The late-stage diversification of lead compds. provides rapid SAR feedback to the medicinal chem. design cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzgoofLECNXrVg90H21EOLACvtfcHk0lhj1yZE-tIYbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosl2js7o%253D&md5=c6756179776bd4fe9e00aed42aa08acf</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.04.054%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DHarnessing%2520Biosynthesis%2520and%2520Quantitative%2520NMR%2520for%2520Late%2520Stage%2520Functionalization%2520of%2520Lead%2520Molecules%253A%2520Application%2520to%2520the%2520M1%2520Positive%2520Allosteric%2520Modulator%2520%2528PAM%2529%2520Program%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2068%26epage%3D2073%26doi%3D10.1016%2Fj.bmcl.2018.04.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The Medicinal Chemist’s Toolbox for Late Stage Functionalization of Drug-Like Molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26507237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+Medicinal+Chemist%E2%80%99s+Toolbox+for+Late+Stage+Functionalization+of+Drug-Like+Molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemist's toolbox for late stage functionalization of drug-like molecules</span></div><div class="casAuthors">Cernak, Tim; Dykstra, Kevin D.; Tyagarajan, Sriram; Vachal, Petr; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">546-576</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The advent of modern C-H functionalization chemistries has enabled medicinal chemists to consider a synthetic strategy, late stage functionalization (LSF), which utilizes the C-H bonds of drug leads as points of diversification for generating new analogs.  LSF approaches offer the promise of rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the prepn. of biol. probes.  This review details a toolbox of intermol. C-H functionalization chemistries with proven applicability to drug-like mols., classified by regioselectivity patterns, and gives guidance on how to systematically develop LSF strategies using these patterns and other considerations.  In addn., a no. of examples illustrate how LSF approaches have been used to impact actual drug discovery and chem. biol. efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7N9sPaaVAQbVg90H21EOLACvtfcHk0ljI5mfcxqOZlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN&md5=a52fc5692f5515e5cadab0f2746fd6f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520Medicinal%2520Chemist%25E2%2580%2599s%2520Toolbox%2520for%2520Late%2520Stage%2520Functionalization%2520of%2520Drug-Like%2520Molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gesmundo, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauvagnat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandliker, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Nanoscale Synthesis and Affinity Ranking</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>557</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0056-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fs41586-018-0056-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29686415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=557&publication_year=2018&pages=228-232&author=N.+J.+Gesmundoauthor=B.+Sauvagnatauthor=P.+J.+Curranauthor=M.+P.+Richardsauthor=C.+L.+Andrewsauthor=P.+J.+Dandlikerauthor=T.+Cernak&title=Nanoscale+Synthesis+and+Affinity+Ranking&doi=10.1038%2Fs41586-018-0056-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoscale synthesis and affinity ranking</span></div><div class="casAuthors">Gesmundo, Nathan J.; Sauvagnat, Berengere; Curran, Patrick J.; Richards, Matthew P.; Andrews, Christine L.; Dandliker, Peter J.; Cernak, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">557</span>
        (<span class="NLM_cas:issue">7704</span>),
    <span class="NLM_cas:pages">228-232</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Most drugs are developed through iterative rounds of chem. synthesis and biochem. testing to optimize the affinity of a particular compd. for a protein target of therapeutic interest.  This process is challenging because candidate mols. must be selected from a chem. space of more than 1060 drug-like possibilities1, and a single reaction used to synthesize each mol. has more than 107 plausible permutations of catalysts, ligands, additives and other parameters2.  The merger of a method for high-throughput chem. synthesis with a biochem. assay would facilitate the exploration of this enormous search space and streamline the hunt for new drugs and chem. probes.  Miniaturized high-throughput chem. synthesis3-7 has enabled rapid evaluation of reaction space, but so far the merger of such syntheses with bioassays has been achieved with only low-d. reaction arrays, which analyze only a handful of analogs prepd. under a single reaction condition8-13.  High-d. chem. synthesis approaches that have been coupled to bioassays, including on-bead14, on-surface15, on-DNA16 and mass-encoding technologies17, greatly reduce material requirements, but they require the covalent linkage of substrates to a potentially reactive support, must be performed under high diln. and must operate in a mixt. format.  These reaction attributes limit the application of transition-metal catalysts, which are easily poisoned by the many functional groups present in a complex mixt., and of transformations for which the kinetics require a high concn. of reactant.  Here the authors couple high-throughput nanomole-scale synthesis with a label-free affinity-selection mass spectrometry bioassay.  Each reaction is performed at a 0.1-M concn. in a discrete well to enable transition-metal catalysis while consuming less than 0.05 mg of substrate per reaction.  The affinity-selection mass spectrometry bioassay is then used to rank the affinity of the reaction products to target proteins, removing the need for time-intensive reaction purifn.  This method enables the primary synthesis and testing steps that are crit. to the invention of protein inhibitors to be performed rapidly and with minimal consumption of starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxLWYiSL7lvrVg90H21EOLACvtfcHk0ljI5mfcxqOZlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgu7s%253D&md5=f4679d44210c46865e3267896b0170de</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0056-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0056-8%26sid%3Dliteratum%253Aachs%26aulast%3DGesmundo%26aufirst%3DN.%2BJ.%26aulast%3DSauvagnat%26aufirst%3DB.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DRichards%26aufirst%3DM.%2BP.%26aulast%3DAndrews%26aufirst%3DC.%2BL.%26aulast%3DDandliker%26aufirst%3DP.%2BJ.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DNanoscale%2520Synthesis%2520and%2520Affinity%2520Ranking%26jtitle%3DNature%26date%3D2018%26volume%3D557%26spage%3D228%26epage%3D232%26doi%3D10.1038%2Fs41586-018-0056-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, C. M.</span></span> <span> </span><span class="NLM_article-title">Chemical Space and Biology</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1038/nature03192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnature03192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=15602547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=824-828&author=C.+M.+Dobson&title=Chemical+Space+and+Biology&doi=10.1038%2Fnature03192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical space and biology</span></div><div class="casAuthors">Dobson, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7019</span>),
    <span class="NLM_cas:pages">824-828</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. space - which encompasses all possible small org. mols., including those present in biol. systems - is vast.  So vast, in fact, that so far only a tiny fraction of it has been explored.  Nevertheless, these explorations have greatly enhanced our understanding of biol., and have led to the development of many of today's drugs.  The discovery of new bioactive mols., facilitated by a deeper understanding of the nature of the regions of chem. space that are relevant to biol., will advance our knowledge of biol. processes and lead to new strategies to treat disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolNmRTVWoSDrVg90H21EOLACvtfcHk0liuvXlktIL3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jN&md5=b951fff4aa4877682756fb1831bff09d</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnature03192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03192%26sid%3Dliteratum%253Aachs%26aulast%3DDobson%26aufirst%3DC.%2BM.%26atitle%3DChemical%2520Space%2520and%2520Biology%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D824%26epage%3D828%26doi%3D10.1038%2Fnature03192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span> <span> </span><span class="NLM_article-title">Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1021/ci0255782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci0255782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Cmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=374-380&author=P.+Ertl&title=Cheminformatics+Analysis+of+Organic+Substituents%3A+Identification+of+the+Most+Common+Substituents%2C+Calculation+of+Substituent+Properties%2C+and+Automatic+Identification+of+Drug-like+Bioisosteric+Groups&doi=10.1021%2Fci0255782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups</span></div><div class="casAuthors">Ertl, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">374-380</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A large set of more than 3 million mols. was processed to find all the org. substituents contained in the set and to identify the most common ones.  During the anal., 849 574 unique substituents were found.  Extrapolated to the no. of known org. mols., this result suggests that about 3.1 million substituents are known.  Based on these findings the size of virtual org. chem. space accessible using currently known synthetic methods is estd. to be between 1020 and 1024 mols.  The extd. substituents were characterized by calcd. electronic, hydrophobic, steric, and hydrogen bonding properties as well as by the drug-likeness index.  Various possible applications of such a large database of drug-like substituents characterized by calcd. properties are discussed and illustrated by ref. to a Web-based tool for automatic identification of bioisosteric groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqODLrwzH2t4LVg90H21EOLACvtfcHk0liPbQgIRV875Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Cmtbs%253D&md5=9debc7ddfbb1c57ff85b7ff55c44a7d0</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fci0255782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0255782%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26atitle%3DCheminformatics%2520Analysis%2520of%2520Organic%2520Substituents%253A%2520Identification%2520of%2520the%2520Most%2520Common%2520Substituents%252C%2520Calculation%2520of%2520Substituent%2520Properties%252C%2520and%2520Automatic%2520Identification%2520of%2520Drug-like%2520Bioisosteric%2520Groups%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2003%26volume%3D43%26spage%3D374%26epage%3D380%26doi%3D10.1021%2Fci0255782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0liPbQgIRV875Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">A Planning Strategy for Diversity-Oriented Synthesis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1002/anie.200300626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.200300626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=14694470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVeksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=46-58&author=M.+D.+Burkeauthor=S.+L.+Schreiber&title=A+Planning+Strategy+for+Diversity-Oriented+Synthesis&doi=10.1002%2Fanie.200300626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A planning strategy for diversity-oriented synthesis</span></div><div class="casAuthors">Burke, Martin D.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  In contrast to target-oriented synthesis (TOS) and medicinal or combinatorial chem., which aim to access precise or dense regions of chem. space, diversity-oriented synthesis (DOS) populates chem. space broadly with small-mols., having diverse structures.  The goals of DOS include the development of pathways leading to the efficient (three- to five-step) synthesis of collections of small mols. having skeletal and stereochem. diversity with defined coordinates in chem. space.  Ideally, these pathways also yield compds. having the potential to attach appendages site- and stereoselectively to a variety of attachment sites during a post-screening, maturation stage.  The diverse skeletons and stereochemistries ensure that the appendages can be positioned in multiple orientations about the surface of the mols.  TOS as well as medicinal and combinatorial chemistries have been advanced by the development of retrosynthetic anal.  Although the distinct goals of DOS do not permit the application of retrosynthetic concepts and thinking, these foundations are being built on, by using parallel logic, to develop a complementary procedure known as forward-synthetic anal.  This anal. facilitates synthetic planning, communication, and teaching in this evolving discipline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8zavQvQH3GLVg90H21EOLACvtfcHk0lhKs_qpOEgFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVeksQ%253D%253D&md5=e556604e2e248ff7a86121d8c2383182</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200300626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200300626%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DM.%2BD.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DA%2520Planning%2520Strategy%2520for%2520Diversity-Oriented%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D46%26epage%3D58%26doi%3D10.1002%2Fanie.200300626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Diversity-Oriented Synthesis; A Challenge for Synthetic Chemists</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">3867</span>– <span class="NLM_lpage">3870</span>, <span class="refDoi"> DOI: 10.1039/b310752n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fb310752n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=14664374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=3867-3870&author=D.+R.+Spring&title=Diversity-Oriented+Synthesis%3B+A+Challenge+for+Synthetic+Chemists&doi=10.1039%2Fb310752n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity-oriented synthesis; a challenge for synthetic chemists</span></div><div class="casAuthors">Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3867-3870</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The efficient, simultaneous synthesis of structurally diverse compds., better known as diversity-oriented synthesis (DOS), is not obvious, and remains a challenge to synthetic chem.  This account details why DOS has such enormous implications for the discovery of small mols. with desired properties, such as catalysts, synthetic reagents, biol. probes and new drugs.  Also, the evolution behind the current state-of-play of DOS was described.  A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxtlduQ_YJhrVg90H21EOLACvtfcHk0lhKs_qpOEgFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslyjsL8%253D&md5=5e15b4e967f4631adfd4ce6aa56ce303</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1039%2Fb310752n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb310752n%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DDiversity-Oriented%2520Synthesis%253B%2520A%2520Challenge%2520for%2520Synthetic%2520Chemists%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D3867%26epage%3D3870%26doi%3D10.1039%2Fb310752n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Lipophilic Efficiency as an Important Metric in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6401</span>– <span class="NLM_lpage">6420</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6401-6420&author=T.+W.+Johnsonauthor=R.+A.+Gallegoauthor=M.+P.+Edwards&title=Lipophilic+Efficiency+as+an+Important+Metric+in+Drug+Design&doi=10.1021%2Facs.jmedchem.8b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic Efficiency as an Important Metric in Drug Design</span></div><div class="casAuthors">Johnson, Ted W.; Gallego, Rebecca A.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6401-6420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chem. lead optimization programs.  In this perspective, using literature drug discovery examples, we discuss the concept of rigorously applying LipE to guide medicinal chem. lead optimization toward drug candidates with potential for superior in vivo efficacy and safety, esp. when guided by physiochem. property-based optimization (PPBO).  Also highlighted are examples of small structural modifications such as addn. of single atoms, small functional groups, and cyclizations that produce large increases in LipE.  Understanding the factors that may contribute to LipE changes through anal. of ligand-protein crystal structures and using structure-based drug design (SBDD) to increase LipE by design is also discussed.  Herein we advocate for use of LipE anal. coupled with PPBO and SBDD as an efficient mechanism for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ8DOcOj6GrVg90H21EOLACvtfcHk0lhBAs-bWYXWlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D&md5=29f38880914fa75c33be3a640ace4309</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DGallego%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DLipophilic%2520Efficiency%2520as%2520an%2520Important%2520Metric%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6401%26epage%3D6420%26doi%3D10.1021%2Facs.jmedchem.8b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, W. R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isidro-Llobet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Diversity-Oriented Synthesis as a Tool for the Discovery of Novel Biologically Active Small Molecules</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">80</span>, <span class="refDoi"> DOI: 10.1038/ncomms1081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fncomms1081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=20865796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BC3cfks1Wkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=80&author=W.+R.+J.+D.+Gallowayauthor=A.+Isidro-Llobetauthor=D.+R.+Spring&title=Diversity-Oriented+Synthesis+as+a+Tool+for+the+Discovery+of+Novel+Biologically+Active+Small+Molecules&doi=10.1038%2Fncomms1081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules</span></div><div class="casAuthors">Galloway Warren R J D; Isidro-Llobet Albert; Spring David R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Biologically active molecules can be identified through the screening of small-molecule libraries.  Deficiencies in current compound collections are evidenced by the continuing decline in drug-discovery successes.  Typically, such collections are comprised of large numbers of structurally similar compounds.  A general consensus has emerged that library size is not everything; library diversity, in terms of molecular structure and thus function, is crucial.  Diversity-oriented synthesis (DOS) aims to generate such structural diversity in an efficient manner.  Recent years have witnessed significant achievements in the field, which help to validate the usefulness of DOS as a tool for the discovery of novel, biologically interesting small molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYIC7Rtvwk7pPq5LRczm8ffW6udTcc2ebMoK2bCxYmdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfks1Wkuw%253D%253D&md5=acc40b2415f866b55aa684f0608c3b68</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fncomms1081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1081%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DW.%2BR.%2BJ.%2BD.%26aulast%3DIsidro-Llobet%26aufirst%3DA.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DDiversity-Oriented%2520Synthesis%2520as%2520a%2520Tool%2520for%2520the%2520Discovery%2520of%2520Novel%2520Biologically%2520Active%2520Small%2520Molecules%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D80%26doi%3D10.1038%2Fncomms1081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, W. R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Is Synthesis the Main Hurdle for the Generation of Diversity in Compound Libraries for Screening?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1517/17460440902916606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1517%2F17460440902916606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23485081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Srtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=467-472&author=W.+R.+J.+D.+Gallowayauthor=D.+R.+Spring&title=Is+Synthesis+the+Main+Hurdle+for+the+Generation+of+Diversity+in+Compound+Libraries+for+Screening%3F&doi=10.1517%2F17460440902916606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Is synthesis the main hurdle for the generation of diversity in compound libraries for screening?</span></div><div class="casAuthors">Galloway, Warren R. J. D.; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">467-472</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  'Diversity' is often cited as a crucial consideration when generating compd. collections for biol. screening.  However, what exactly does one mean by 'diversity' and why is it important.  How can diversity be incorporated into compd. collections and what are the theor. and tech. challenges this poses.  In this editorial, we comment on various factors involved in the creation of structurally, and most crucially, functionally diverse compd. libraries.  In particular, we highlight the central role played by org. synthesis and discuss the value of diversity-driven synthetic approaches in the search for new biol. active mols. with potentially exciting and unusual biol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMN31tpuOvPrVg90H21EOLACvtfcHk0liQMeVNGyEMQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Srtbg%253D&md5=5348abee4faa4bea326069ee96f2f096</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1517%2F17460440902916606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460440902916606%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DW.%2BR.%2BJ.%2BD.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DIs%2520Synthesis%2520the%2520Main%2520Hurdle%2520for%2520the%2520Generation%2520of%2520Diversity%2520in%2520Compound%2520Libraries%2520for%2520Screening%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2009%26volume%3D4%26spage%3D467%26epage%3D472%26doi%3D10.1517%2F17460440902916606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span> <span> </span><span class="NLM_article-title">Expanding the Medicinal Chemistry Synthetic Toolbox</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnrd.2018.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=30140018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=709-727&author=J.+Bostr%C3%B6mauthor=D.+G.+Brownauthor=R.+J.+Youngauthor=G.+M.+Keser%C3%BC&title=Expanding+the+Medicinal+Chemistry+Synthetic+Toolbox&doi=10.1038%2Fnrd.2018.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the medicinal chemistry synthetic toolbox</span></div><div class="casAuthors">Bostrom Jonas; Brown Dean G; Young Robert J; Keseru Gyorgy M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">709-727</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The key objectives of medicinal chemistry are to efficiently design and synthesize bioactive compounds that have the potential to become safe and efficacious drugs.  Most medicinal chemistry programmes rely on screening compound collections populated by a range of molecules derived from a set of known and robust chemistry reactions.  Analysis of the role of synthetic organic chemistry in subsequent hit and lead optimization efforts suggests that only a few reactions dominate.  Thus, the uptake of new synthetic methodologies in drug discovery is limited.  Starting from the known limitations of reaction parameters, synthesis design tools, synthetic strategies and innovative chemistries, here we highlight opportunities for the expansion of the medicinal chemists' synthetic toolbox.  More intense crosstalk between synthetic and medicinal chemists in industry and academia should enable enhanced impact of new methodologies in future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy8c_ueHSwcYMcDoIzZtNkfW6udTcc2eaemfXx4aNRmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D&md5=d87e988602808139597576ced56faa88</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.116%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DExpanding%2520the%2520Medicinal%2520Chemistry%2520Synthetic%2520Toolbox%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D709%26epage%3D727%26doi%3D10.1038%2Fnrd.2018.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Organic Synthesis Provides Opportunities to Transform Drug Discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0021-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fs41557-018-0021-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29568051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=383-394&author=D.+C.+Blakemoreauthor=L.+Castroauthor=I.+Churcherauthor=D.+C.+Reesauthor=A.+W.+Thomasauthor=D.+M.+Wilsonauthor=A.+Wood&title=Organic+Synthesis+Provides+Opportunities+to+Transform+Drug+Discovery&doi=10.1038%2Fs41557-018-0021-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis provides opportunities to transform drug discovery</span></div><div class="casAuthors">Blakemore, David C.; Castro, Luis; Churcher, Ian; Rees, David C.; Thomas, Andrew W.; Wilson, David M.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite decades of ground-breaking research in academia, org. synthesis is still a rate-limiting factor in drug-discovery projects.  Here we present some current challenges in synthetic org. chem. from the perspective of the pharmaceutical industry and highlight problematic steps that, if overcome, would find extensive application in the discovery of transformational medicines.  Significant synthesis challenges arise from the fact that drug mols. typically contain amines and N-heterocycles, as well as unprotected polar groups.  There is also a need for new reactions that enable non-traditional disconnections, more C-H bond activation and late-stage functionalization, as well as stereoselectively substituted aliph. heterocyclic ring synthesis, C-X or C-C bond formation.  We also emphasize that syntheses compatible with biomacromols. will find increasing use, while new technologies such as machine-assisted approaches and artificial intelligence for synthesis planning have the potential to dramatically accelerate the drug-discovery process.  We believe that increasing collaboration between academic and industrial chemists is crucial to address the challenges outlined here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqR_RxjClS7Vg90H21EOLACvtfcHk0lgnqVEJbkUVig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D&md5=f6269ea8193e28416fd86fe8afbcea3f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0021-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0021-z%26sid%3Dliteratum%253Aachs%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOrganic%2520Synthesis%2520Provides%2520Opportunities%2520to%2520Transform%2520Drug%2520Discovery%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D383%26epage%3D394%26doi%3D10.1038%2Fs41557-018-0021-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandrell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span> <span> </span><span class="NLM_article-title">An Analysis of the Attrition of Drug Candidates from Four Major Pharmaceutical Companies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nrd4609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnrd4609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26091267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=475-486&author=M.+J.+Waringauthor=J.+Arrowsmithauthor=A.+R.+Leachauthor=P.+D.+Leesonauthor=S.+Mandrellauthor=R.+M.+Owenauthor=G.+Pairaudeauauthor=W.+D.+Pennieauthor=S.+D.+Pickettauthor=J.+Wangauthor=O.+Wallaceauthor=A.+Weir&title=An+Analysis+of+the+Attrition+of+Drug+Candidates+from+Four+Major+Pharmaceutical+Companies&doi=10.1038%2Fnrd4609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span></div><div class="casAuthors">Waring, Michael J.; Arrowsmith, John; Leach, Andrew R.; Leeson, Paul D.; Mandrell, Sam; Owen, Robert M.; Pairaudeau, Garry; Pennie, William D.; Pickett, Stephen D.; Wang, Jibo; Wallace, Owen; Weir, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmaceutical industry remains under huge pressure to address the high attrition rates in drug development.  Attempts to reduce the no. of efficacy- and safety-related failures by analyzing possible links to the physicochem. properties of small-mol. drug candidates have been inconclusive because of the limited size of data sets from individual companies.  Here, we describe the compilation and anal. of combined data on the attrition of drug candidates from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline and Pfizer.  The anal. reaffirms that control of physicochem. properties during compd. optimization is beneficial in identifying compds. of candidate drug quality and indicates for the first time a link between the physicochem. properties of compds. and clin. failure due to safety issues.  The results also suggest that further control of physicochem. properties is unlikely to have a significant effect on attrition rates and that addnl. work is required to address safety-related failures.  Further cross-company collaborations will be crucial to future progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsLfBWrLC3ZLVg90H21EOLACvtfcHk0lgnqVEJbkUVig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM&md5=1fdc374d32816b1e91438152299dd1b1</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnrd4609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4609%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DMandrell%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPennie%26aufirst%3DW.%2BD.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWeir%26aufirst%3DA.%26atitle%3DAn%2520Analysis%2520of%2520the%2520Attrition%2520of%2520Drug%2520Candidates%2520from%2520Four%2520Major%2520Pharmaceutical%2520Companies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D475%26epage%3D486%26doi%3D10.1038%2Fnrd4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving Drug Candidates by Design: A Focus on Physicochemical Properties as a Means of Improving Compound Disposition and Safety</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+Drug+Candidates+by+Design%3A+A+Focus+on+Physicochemical+Properties+as+a+Means+of+Improving+Compound+Disposition+and+Safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0liFN7Mxwrz7Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520Drug%2520Candidates%2520by%2520Design%253A%2520A%2520Focus%2520on%2520Physicochemical%2520Properties%2520as%2520a%2520Means%2520of%2520Improving%2520Compound%2520Disposition%2520and%2520Safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of Fluorinated Analogs of Drugs Using Human Cytochrome P450 Enzymes Followed by Deoxyfluorination and Quantitative Nuclear Magnetic Resonance Spectroscopy to Improve Metabolic Stability</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.069310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.116.069310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26921388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFelurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=634-646&author=R.+S.+Obachauthor=G.+S.+Walkerauthor=M.+A.+Brodney&title=Biosynthesis+of+Fluorinated+Analogs+of+Drugs+Using+Human+Cytochrome+P450+Enzymes+Followed+by+Deoxyfluorination+and+Quantitative+Nuclear+Magnetic+Resonance+Spectroscopy+to+Improve+Metabolic+Stability&doi=10.1124%2Fdmd.116.069310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of fluorinated analogs of drugs using human cytochrome P450 enzymes followed by deoxyfluorination and quantitative nuclear magnetic resonance spectroscopy to improve metabolic stability</span></div><div class="casAuthors">Obach, R. Scott; Walker, Gregory S.; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">634-646</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Replacement of hydrogen with fluorine is a useful drug design strategy when decreases in cytochrome P 450 (P 450) metabolic lability are needed.  In this paper, a facile two-step method of inserting fluorine into metabolically labile sites of drug mols. is described that utilizes less than 1 mg of starting material and quant. NMR spectroscopy to ascertain the structures and concns. of products.  In the first step, hydroxyl metabolites are biosynthesized using human P 450 enzymes, and in the second step these metabolites are subjected to deoxyfluorination using diethylaminosulfur trifluoride (DAST).  The method is demonstrated using midazolam, celecoxib, ramelteon, and risperidone as examples and CYP3A5, 2C9, 1A2, and 2D6 to catalyze the hydroxylations.  The drugs and their fluoro analogs were tested for metabolic lability. 9-Fluororisperidone and 49-fluorocelecoxib were 16 and 4 times more metabolically stable than risperidone and celecoxib, resp., and 2-fluororamelteon and ramelteon were metabolized at the same rate. 19-Fluoromidazolam wasmetabolized at the same rate as midazolam by CYP3A4 but was more stable in CYP3A5 incubations.  The P 450-catalyzed sites of metab. of the fluorine-contg. analogs were detd.  Some of themetabolites arose via metab. at the fluorine-substituted carbon, wherein the fluorine was lost to yield aldehydes.  In summary, this method offers an approach whereby fluorine can be substituted in metabolically labile sites, and the products can be tested to det. whether an enhancement in metabolic stability was obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8_453Jbx0VrVg90H21EOLACvtfcHk0ljqF24tJL1JvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFelurvI&md5=ec9f4046db98d96b7cd2b7bd16c8d3d4</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.069310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.069310%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DBiosynthesis%2520of%2520Fluorinated%2520Analogs%2520of%2520Drugs%2520Using%2520Human%2520Cytochrome%2520P450%2520Enzymes%2520Followed%2520by%2520Deoxyfluorination%2520and%2520Quantitative%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%2520to%2520Improve%2520Metabolic%2520Stability%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D634%26epage%3D646%26doi%3D10.1124%2Fdmd.116.069310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of Drug Metabolites and Quantitation Using NMR Spectroscopy for Use in Pharmacologic and Drug Metabolism Studies</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.059204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.114.059204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25053618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1627-1639&author=G.+S.+Walkerauthor=J.+N.+Baumanauthor=T.+F.+Ryderauthor=E.+B.+Smithauthor=D.+K.+Spracklinauthor=R.+S.+Obach&title=Biosynthesis+of+Drug+Metabolites+and+Quantitation+Using+NMR+Spectroscopy+for+Use+in+Pharmacologic+and+Drug+Metabolism+Studies&doi=10.1124%2Fdmd.114.059204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies</span></div><div class="casAuthors">Walker, Gregory S.; Bauman, Jonathan N.; Ryder, Tim F.; Smith, Evan B.; Spracklin, Douglas K.; Scott Obach, R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1627-1639, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The contribution of drug metabolites to the pharmacol. and toxicol. activity of a drug can be important; however, for a variety of reasons metabolites can frequently be difficult to synthesize.  To meet the need of having samples of drug metabolites for further study, we have developed biosynthetic methods coupled with quant. NMR spectroscopy (qNMR) to generate solns. of metabolites of known structure and concn.  These quant. samples can be used in a variety of ways when a synthetic sample is unavailable, including pharmacol. assays, stds. for in vitro work to help establish clearance pathways, and/or as anal. stds. for bioanal. work to ascertain exposure, among others.  We illustrate five examples of metabolite biosynthesis and qNMR.  The types of metabolites include one glucuronide and four oxidative products.  Concns. of the isolated metabolite stock solns. ranged from 0.048 to 8.3 mM, with vols. from approx. 0.04 to 0.150 mL in hexadeutarated dimethylsulfoxide.  These specific quantified isolates were used as stds. in the drug discovery setting as substrates in pharmacol. assays, for bioanal. assays to establish exposure, and in variety of routine absorption, distribution, metab., and excretion assays, such as protein binding and detg. blood-toplasma ratios.  The methods used to generate these materials are described in detail with the objective that these methods can be generally used for metabolite biosynthesis and isolation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIcWqizvGukLVg90H21EOLACvtfcHk0ljqF24tJL1JvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N&md5=8d763ea8c23f07f680949c005e2ea7c7</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.059204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.059204%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DBiosynthesis%2520of%2520Drug%2520Metabolites%2520and%2520Quantitation%2520Using%2520NMR%2520Spectroscopy%2520for%2520Use%2520in%2520Pharmacologic%2520and%2520Drug%2520Metabolism%2520Studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1627%26epage%3D1639%26doi%3D10.1124%2Fdmd.114.059204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumpp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gindro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfender, J.-L.</span></span> <span> </span><span class="NLM_article-title">Metabolite Induction via Microorganism Co-Culture: A Potential Way to Enhance Chemical Diversity for Drug Discovery</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1204</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2014.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.biotechadv.2014.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=24651031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2gsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1180-1204&author=S.+Bertrandauthor=N.+Bohniauthor=S.+Schneeauthor=O.+Schumppauthor=K.+Gindroauthor=J.-L.+Wolfender&title=Metabolite+Induction+via+Microorganism+Co-Culture%3A+A+Potential+Way+to+Enhance+Chemical+Diversity+for+Drug+Discovery&doi=10.1016%2Fj.biotechadv.2014.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolite induction via microorganism co-culture: A potential way to enhance chemical diversity for drug discovery</span></div><div class="casAuthors">Bertrand, Samuel; Bohni, Nadine; Schnee, Sylvain; Schumpp, Olivier; Gindro, Katia; Wolfender, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1180-1204</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Microorganisms have a long track record as important sources of novel bioactive natural products, particularly in the field of drug discovery.  While microbes have been shown to biosynthesize a wide array of mols., recent advances in genome sequencing have revealed that such organisms have the potential to yield even more structurally diverse secondary metabolites.  Thus, many microbial gene clusters may be silent under std. lab. growth conditions.  In the last ten years, several methods have been developed to aid in the activation of these cryptic biosynthetic pathways.  In addn. to the techniques that demand prior knowledge of the genome sequences of the studied microorganisms, several genome sequence-independent tools have been developed.  One of these approaches is microorganism co-culture, involving the cultivation of two or more microorganisms in the same confined environment.  Microorganism co-culture is inspired by the natural microbe communities that are omnipresent in nature.  Within these communities, microbes interact through signaling or defense mols.  Such compds., produced dynamically, are of potential interest as new leads for drug discovery.  Microorganism co-culture can be achieved in either solid or liq. media and has recently been used increasingly extensively to study natural interactions and discover new bioactive metabolites.  Because of the complexity of microbial exts., advanced anal. methods (e.g., mass spectrometry methods and metabolomics) are key for the successful detection and identification of co-culture-induced metabolites.This review focuses on co-culture studies that aim to increase the diversity of metabolites obtained from microbes.  The various strategies are summarized with a special emphasis on the multiple methods of performing co-culture expts.  The anal. approaches for studying these interaction phenomena are discussed, and the chem. diversity and biol. activity obsd. among the induced metabolites are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFaWmpVIckBLVg90H21EOLACvtfcHk0ljqF24tJL1JvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2gsbw%253D&md5=45abf8847b4e28778064914bc6b3f49d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2014.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2014.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBohni%26aufirst%3DN.%26aulast%3DSchnee%26aufirst%3DS.%26aulast%3DSchumpp%26aufirst%3DO.%26aulast%3DGindro%26aufirst%3DK.%26aulast%3DWolfender%26aufirst%3DJ.-L.%26atitle%3DMetabolite%2520Induction%2520via%2520Microorganism%2520Co-Culture%253A%2520A%2520Potential%2520Way%2520to%2520Enhance%2520Chemical%2520Diversity%2520for%2520Drug%2520Discovery%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2014%26volume%3D32%26spage%3D1180%26epage%3D1204%26doi%3D10.1016%2Fj.biotechadv.2014.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawayama, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulanthaivel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">A Panel of Cytochrome P450 BM3 Variants To Produce Drug Metabolites and Diversify Lead Compounds</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">11723</span>– <span class="NLM_lpage">11729</span>, <span class="refDoi"> DOI: 10.1002/chem.200900643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fchem.200900643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=19774562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlansL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=11723-11729&author=A.+M.+Sawayamaauthor=M.+M.+Y.+Chenauthor=P.+Kulanthaivelauthor=M.-S.+Kuoauthor=H.+Hemmerleauthor=F.+H.+Arnold&title=A+Panel+of+Cytochrome+P450+BM3+Variants+To+Produce+Drug+Metabolites+and+Diversify+Lead+Compounds&doi=10.1002%2Fchem.200900643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds</span></div><div class="casAuthors">Sawayama, Andrew M.; Chen, Michael M. Y.; Kulanthaivel, Palaniappan; Kuo, Ming-Shang; Hemmerle, Horst; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">11723-11729, S11723/1-S11723/9</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein we demonstrate that a small panel of variants of cytochrome P 450 BM3 from Bacillus megaterium covers the breadth of reactivity of human P450s by producing 12 of 13 mammalian metabolites for two marketed drugs, verapamil and astemizole, and one research compd.  The most active enzymes support prepn. of individual metabolites for preclin. bioactivity and toxicol. evaluations.  Underscoring their potential utility in drug lead diversification, engineered P 450 BM3 variants also produce novel metabolites by catalyzing reactions at carbon centers beyond those targeted by animal and human P450s.  Prodn. of a specific metabolite can be improved by directed evolution of the enzyme catalyst.  Some variants are more active on the more hydrophobic parent drug than on its metabolites, which limits prodn. of multiply-hydroxylated species, a preference that appears to depend on the evolutionary history of the P 450 variant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVDy3kQSK4I7Vg90H21EOLACvtfcHk0ljqF24tJL1JvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlansL3E&md5=0808a8225260167607422a1cfc62596a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fchem.200900643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200900643%26sid%3Dliteratum%253Aachs%26aulast%3DSawayama%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DM.%2BM.%2BY.%26aulast%3DKulanthaivel%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DM.-S.%26aulast%3DHemmerle%26aufirst%3DH.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DA%2520Panel%2520of%2520Cytochrome%2520P450%2520BM3%2520Variants%2520To%2520Produce%2520Drug%2520Metabolites%2520and%2520Diversify%2520Lead%2520Compounds%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D11723%26epage%3D11729%26doi%3D10.1002%2Fchem.200900643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvete, M. J. F.</span></span> <span> </span><span class="NLM_article-title">Metalloporphyrins: Bioinspired Oxidation Catalysts</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">10784</span>– <span class="NLM_lpage">10808</span>, <span class="refDoi"> DOI: 10.1021/acscatal.8b01871</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.8b01871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2rs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=10784-10808&author=M.+M.+Pereiraauthor=L.+D.+Diasauthor=M.+J.+F.+Calvete&title=Metalloporphyrins%3A+Bioinspired+Oxidation+Catalysts&doi=10.1021%2Facscatal.8b01871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloporphyrins: Bioinspired Oxidation Catalysts</span></div><div class="casAuthors">Pereira, Mariette M.; Dias, Lucas D.; Calvete, Mario J. F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10784-10808</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The use of metalloporphyrins as bioinspired oxidn. catalysts is an evolving topic of research.  By understanding the cytochrome P 450 mechanism of action, chemists were able to mimic several types of oxidn. reactions using metalloporphyrins as catalysts.  At 1st, homogeneous systems presented the most amenable strategy for oxidizing a vast array of substrates; however, current environmental concerns have directed research in this field to the design, synthesis, and application of heterogeneous catalysts, as well as avoiding the use of highly pollutant cooxidants and/or co-catalysts.  The past decade (from 2008) was reviewed concerning the use of solely mol. O2 as an environmentally benign oxidant source, in oxidn. reactions catalyzed by bioinspired metalloporphyrin analogs.  A comprehensive review was not intended; instead the most important and illustrative examples for this period are highlighted.  The application of such catalysts on the oxidn. reactions of many relevant substrates using homogeneous and heterogeneous metalloporphyrin-based catalysts, mostly using inorg. supports for more accessible re-use protocols are emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp636vrj7-PY7Vg90H21EOLACvtfcHk0lh_S7tnOOG4mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2rs77J&md5=268ba517841cd7645848e121b547d0f4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facscatal.8b01871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.8b01871%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DM.%2BM.%26aulast%3DDias%26aufirst%3DL.%2BD.%26aulast%3DCalvete%26aufirst%3DM.%2BJ.%2BF.%26atitle%3DMetalloporphyrins%253A%2520Bioinspired%2520Oxidation%2520Catalysts%26jtitle%3DACS%2520Catal.%26date%3D2018%26volume%3D8%26spage%3D10784%26epage%3D10808%26doi%3D10.1021%2Facscatal.8b01871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">13230</span>– <span class="NLM_lpage">13319</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=13230-13319&author=M.+Yanauthor=Y.+Kawamataauthor=P.+S.+Baran&title=Synthetic+Organic+Electrochemical+Methods+Since+2000%3A+On+the+Verge+of+a+Renaissance&doi=10.1021%2Facs.chemrev.7b00397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span></div><div class="casAuthors">Yan, Ming; Kawamata, Yu; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13230-13319</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses advances in synthetic org. electrochem. since 2000.  Enabling methods and synthetic applications are analyzed alongside innate advantages as well as future challenges of electroorg. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoosmLKvAW1Z7Vg90H21EOLACvtfcHk0lh_S7tnOOG4mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ&md5=21205e55da92db4e7d27aa393fed486d</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00397%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DM.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DSynthetic%2520Organic%2520Electrochemical%2520Methods%2520Since%25202000%253A%2520On%2520the%2520Verge%2520of%2520a%2520Renaissance%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D13230%26epage%3D13319%26doi%3D10.1021%2Facs.chemrev.7b00397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandić, Z.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Methods in Drug Discovery and Development</span>. <i>Bulg. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=65-73&author=Z.+Mandi%C4%87&title=Electrochemical+Methods+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandi%25C4%2587%26aufirst%3DZ.%26atitle%3DElectrochemical%2520Methods%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DBulg.%2520Chem.%2520Commun.%26date%3D2017%26volume%3D49%26spage%3D65%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duncton, M. A. J.</span></span> <span> </span><span class="NLM_article-title">Minisci Reactions: Versatile CH-Functionalizations for Medicinal Chemists</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1039/C1MD00134E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fc1md00134e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1135-1161&author=M.+A.+J.+Duncton&title=Minisci+Reactions%3A+Versatile+CH-Functionalizations+for+Medicinal+Chemists&doi=10.1039%2FC1MD00134E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Minisci reactions. Versatile CH-functionalizations for medicinal chemists</span></div><div class="casAuthors">Duncton, Matthew A. J.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1135-1161</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The addn. of a radical to a heteroarom. base is commonly referred to as a Minsici reaction.  Such reactions constitute a broad-set of selective CH-functionalization processes.  This review described some of the major applications of Minisci reactions and related processes to medicinal or biol. chem., and highlights some potential developments within this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4rms5MglIuLVg90H21EOLACvtfcHk0lh_S7tnOOG4mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E&md5=49d9076c79e5caf19d21b8fbd74ff0c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2Fc1md00134e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00134e%26sid%3Dliteratum%253Aachs%26aulast%3DDuncton%26aufirst%3DM.%2BA.%2BJ.%26atitle%3DMinisci%2520Reactions%253A%2520Versatile%2520CH-Functionalizations%2520for%2520Medicinal%2520Chemists%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D1135%26epage%3D1161%26doi%3D10.1039%2FC1MD00134E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2256</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2256-2264&author=J.+M.+Smithauthor=J.+A.+Dixonauthor=J.+N.+deGruyterauthor=P.+S.+Baran&title=Alkyl+Sulfinates%3A+Radical+Precursors+Enabling+Drug+Discovery&doi=10.1021%2Facs.jmedchem.8b01303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span></div><div class="casAuthors">Smith, Joel M.; Dixon, Janice A.; deGruyter, Justine N.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2256-2264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The modern constraints of drug discovery demand a rigorous validation process of all new reactions prior to widespread implementation.  To this end, sulfinates (now marketed as Diversinates) have seen alacritous adoption by the medicinal chem. community, as evidenced by the recent outpour of both patent and primary reports.  Featuring more than 50 examples, this review seeks to highlight those particularly compelling cases published in the past 5 years, with an eye toward the identification of robust and predictable trends in reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7GM4tNW5QcLVg90H21EOLACvtfcHk0ljMc9QEqTcuzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I&md5=2c10a6e03d53de995f00614fb8c4bd85</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01303%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DDixon%26aufirst%3DJ.%2BA.%26aulast%3DdeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DAlkyl%2520Sulfinates%253A%2520Radical%2520Precursors%2520Enabling%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2256%26epage%3D2264%26doi%3D10.1021%2Facs.jmedchem.8b01303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAtee, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">Illuminating Photoredox Catalysis</span>. <i>Trends Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.trechm.2019.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.trechm.2019.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2019&pages=111-125&author=R.+C.+McAteeauthor=E.+J.+McClainauthor=C.+R.+J.+Stephenson&title=Illuminating+Photoredox+Catalysis&doi=10.1016%2Fj.trechm.2019.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating Photoredox Catalysis</span></div><div class="casAuthors">McAtee, Rory C.; McClain, Edward J.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-125</span>CODEN:
                <span class="NLM_cas:coden">TCRHBQ</span>;
        ISSN:<span class="NLM_cas:issn">2589-5974</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Over the past decade, photoredox catalysis has risen to the forefront of synthetic org. chem. as an indispensable tool for selective small-mol. activation and chem.-bond formation.  This cutting-edge platform allows photosensitizers to convert visible light into chem. energy, prompting generation of reactive radical intermediates.  In this , we highlight some of the recent key contributions in the field, including elucidating the impact of the chosen light arrays, promoting fundamental cross-coupling steps, selectively functionalizing aliph. amines, engaging complementary mechanistic paradigms, and applications in industry.  With such a wide breadth of reactivity already realized, the presence of photoredox catalysis in all sectors of org. chem. is expected for years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQ-TKUkBDa7Vg90H21EOLACvtfcHk0ljMc9QEqTcuzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK&md5=45ffb329a2d146cc8caa3a75b4b5a6d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.trechm.2019.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trechm.2019.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DR.%2BC.%26aulast%3DMcClain%26aufirst%3DE.%2BJ.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DIlluminating%2520Photoredox%2520Catalysis%26jtitle%3DTrends%2520Chem.%26date%3D2019%26volume%3D1%26spage%3D111%26epage%3D125%26doi%3D10.1016%2Fj.trechm.2019.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenn, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steacy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, A. K.</span></span> <span> </span><span class="NLM_article-title">Onset of Action for Loratadine Tablets for the Symptomatic Control of Seasonal Allergic Rhinitis in Adults Challenged with Ragweed Pollen in the Environmental Exposure Unit: A Post Hoc Analysis of Total Symptom Score</span>. <i>Allergy, Asthma, Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s13223-017-0227-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1186%2Fs13223-017-0227-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29371864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsFeqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=5&author=M.+W.+Tennauthor=L.+M.+Steacyauthor=C.+C.+Ngauthor=A.+K.+Ellis&title=Onset+of+Action+for+Loratadine+Tablets+for+the+Symptomatic+Control+of+Seasonal+Allergic+Rhinitis+in+Adults+Challenged+with+Ragweed+Pollen+in+the+Environmental+Exposure+Unit%3A+A+Post+Hoc+Analysis+of+Total+Symptom+Score&doi=10.1186%2Fs13223-017-0227-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom score</span></div><div class="casAuthors">Tenn, Mark W.; Steacy, Lisa M.; Ng, Charlene C.; Ellis, Anne K.</div><div class="citationInfo"><span class="NLM_cas:title">Allergy, Asthma, & Clinical Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5/1-5/7</span>CODEN:
                <span class="NLM_cas:coden">AACIB3</span>;
        ISSN:<span class="NLM_cas:issn">1710-1492</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Loratadine is a second-generation, non-sedating antihistamine used for the relief of allergic rhinitis symptoms.  Previous studies reported that when loratadine was encapsulated, the onset of action for symptom relief was 180 min.  However, unmodified loratadine tablets were not evaluated at that time.  Using data from a previously published Environmental Exposure Unit (EEU) study comparing azelastine nasal spray with loratadine tablets, cetirizine tablets, and placebo, this post hoc anal. dets. the onset of action of loratadine tablets (i.e. unmodified) by analyzing the total symptom score for the relief of nasal and ocular seasonal allergic rhinitis (SAR) symptoms.  Methods: A Phase IV, randomized, single-center, double-blind, placebo-controlled, double-dummy, four-way crossover study was conducted in the EEU.  Seventy participants were randomized sequentially into one of the four treatments during ragweed pollen exposure.  Nasal and ocular symptom scores were self-reported by the participants and recorded.  The original study anal. was carried out by evaluating the nasal symptom scores only.  For this post hoc anal., both nasal and ocular data from the loratadine and placebo treatment arms were analyzed.  The primary endpoint for this anal. was the onset of action of loratadine as measured by the change in total symptom score (TSS) from baseline in comparison to placebo.  The onset of ocular symptom relief using the total ocular symptom score (TOSS) was also reported.  Results: Loratadine tablets demonstrated a significant and durable improvement in both TSS (P = .005) and TOSS (P = .013) at 75 min post-treatment administration compared to placebo.  The mean proportion of participants reporting none or mild for all component symptoms of TSS and TOSS at 75 min and thereafter was significantly higher in the loratadine (TSS, P = .0005; TOSS, P ≤ .0001) vs. placebo treatment arm.  Conclusions: The onset of action of loratadine tablets was 75 min for the relief of nasal and ocular symptoms in adults with SAR.  These results suggest a faster onset of action for loratadine tablets (75 min) compared to previously reported studies which were conducted with modified (i.e. gelatin-encapsulated) loratadine tablets (180 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz16AQrvmeLrVg90H21EOLACvtfcHk0ljMc9QEqTcuzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsFeqtLc%253D&md5=9b31d0ae41472cecb46ded2529834600</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs13223-017-0227-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13223-017-0227-4%26sid%3Dliteratum%253Aachs%26aulast%3DTenn%26aufirst%3DM.%2BW.%26aulast%3DSteacy%26aufirst%3DL.%2BM.%26aulast%3DNg%26aufirst%3DC.%2BC.%26aulast%3DEllis%26aufirst%3DA.%2BK.%26atitle%3DOnset%2520of%2520Action%2520for%2520Loratadine%2520Tablets%2520for%2520the%2520Symptomatic%2520Control%2520of%2520Seasonal%2520Allergic%2520Rhinitis%2520in%2520Adults%2520Challenged%2520with%2520Ragweed%2520Pollen%2520in%2520the%2520Environmental%2520Exposure%2520Unit%253A%2520A%2520Post%2520Hoc%2520Analysis%2520of%2520Total%2520Symptom%2520Score%26jtitle%3DAllergy%252C%2520Asthma%252C%2520Clin.%2520Immunol.%26date%3D2018%26volume%3D14%26spage%3D5%26doi%3D10.1186%2Fs13223-017-0227-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahbaz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, T. A.</span></span> <span> </span><span class="NLM_article-title">Superacid Cyclodehydration of Ketones in the Production of Tricyclic Antihistamines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2242</span>– <span class="NLM_lpage">2244</span>, <span class="refDoi"> DOI: 10.1021/jo00270a041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00270a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaL1MXhvFalsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=2242-2244&author=D.+P.+Schumacherauthor=B.+L.+Murphyauthor=J.+E.+Clarkauthor=P.+Tahbazauthor=T.+A.+Mann&title=Superacid+Cyclodehydration+of+Ketones+in+the+Production+of+Tricyclic+Antihistamines&doi=10.1021%2Fjo00270a041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Superacid cyclodehydration of ketones in the production of tricyclic antihistamines</span></div><div class="casAuthors">Schumacher, Doris P.; Murphy, Bruce L.; Clark, Jon E.; Tahbaz, Pete; Mann, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2242-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A novel and practical synthesis of loratadine is described.  2-Cyano-3-methylpyridine is alkylated, converted to a piperidyl ketone and, in the key step, cyclized by a superacid to the tricyclic ring structure common to azatadine-related antihistamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq852FoEwXY_bVg90H21EOLACvtfcHk0ljMc9QEqTcuzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvFalsLc%253D&md5=f8184eccec313400a56630d1847a1b06</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjo00270a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00270a041%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DD.%2BP.%26aulast%3DMurphy%26aufirst%3DB.%2BL.%26aulast%3DClark%26aufirst%3DJ.%2BE.%26aulast%3DTahbaz%26aufirst%3DP.%26aulast%3DMann%26aufirst%3DT.%2BA.%26atitle%3DSuperacid%2520Cyclodehydration%2520of%2520Ketones%2520in%2520the%2520Production%2520of%2520Tricyclic%2520Antihistamines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D2242%26epage%3D2244%26doi%3D10.1021%2Fjo00270a041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Doran, H. J.</span>; <span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">Process for Preparing Tricyclic Compounds Having Antihistaminic Activity</span>. PCT Int. Appl., <span class="NLM_patent">US 6,271,378B1</span>, Jun 29, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=H.+J.+Doran&author=P.+M.+O%E2%80%99Neill&title=Process+for+Preparing+Tricyclic+Compounds+Having+Antihistaminic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DH.%2BJ.%26atitle%3DProcess%2520for%2520Preparing%2520Tricyclic%2520Compounds%2520Having%2520Antihistaminic%2520Activity%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cuboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devigny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogeland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomplun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsboer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">Loratadine and Analogues: Discovery and Preliminary Structure–Activity Relationship of Inhibitors of the Amino Acid Transporter B<sup>0</sup>AT2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9473</span>– <span class="NLM_lpage">9479</span>, <span class="refDoi"> DOI: 10.1021/jm501086v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501086v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9473-9479&author=S.+Cuboniauthor=C.+Devignyauthor=B.+Hoogelandauthor=A.+Strasserauthor=S.+Pomplunauthor=B.+Haugerauthor=G.+H%C3%B6fnerauthor=K.+T.+Wannerauthor=M.+Ederauthor=A.+Buschauerauthor=F.+Holsboerauthor=F.+Hausch&title=Loratadine+and+Analogues%3A+Discovery+and+Preliminary+Structure%E2%80%93Activity+Relationship+of+Inhibitors+of+the+Amino+Acid+Transporter+B0AT2&doi=10.1021%2Fjm501086v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B0AT2</span></div><div class="casAuthors">Cuboni, Serena; Devigny, Christian; Hoogeland, Bastiaan; Strasser, Andrea; Pomplun, Sebastian; Hauger, Barbara; Hoefner, Georg; Wanner, Klaus T.; Eder, Matthias; Buschauer, Armin; Holsboer, Florian; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9473-9479</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">B0AT2, encoded by the SLC6A15 gene, is a transporter for neutral amino acids that has recently been implicated in mood and metabolic disorders.  It is predominantly expressed in the brain, but little is otherwise known about its function.  To identify inhibitors for this transporter, the authors screened a library of 3133 different bioactive compds.  Loratadine, a clin. used histamine H1 receptor antagonist, was identified as a selective inhibitor of B0AT2 with an IC50 of 4 μM while being less active or inactive against several other members of the SLC6 family.  Reversible inhibition of B0AT2 was confirmed by electrophysiol.  A series of loratadine analogs were synthesized to gain insight into the structure-activity relationships.  The studies provide the first chem. tool for B0AT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpckWwJiFRLgbVg90H21EOLACvtfcHk0lgIHzyWZheEuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgtrnJ&md5=278c20af492323a57bd7c4004a6dcc72</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm501086v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501086v%26sid%3Dliteratum%253Aachs%26aulast%3DCuboni%26aufirst%3DS.%26aulast%3DDevigny%26aufirst%3DC.%26aulast%3DHoogeland%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DPomplun%26aufirst%3DS.%26aulast%3DHauger%26aufirst%3DB.%26aulast%3DH%25C3%25B6fner%26aufirst%3DG.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DHolsboer%26aufirst%3DF.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DLoratadine%2520and%2520Analogues%253A%2520Discovery%2520and%2520Preliminary%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Inhibitors%2520of%2520the%2520Amino%2520Acid%2520Transporter%2520B0AT2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9473%26epage%3D9479%26doi%3D10.1021%2Fjm501086v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si-Ma, L.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.-K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antihistamine Evaluations of Novel Loratadine Analogues</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">4456</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2011.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21733682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVSkur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4454-4456&author=Y.+Wangauthor=J.+Wangauthor=Y.+Linauthor=L.-F.+Si-Maauthor=D.-h.+Wangauthor=L.-G.+Chenauthor=D.-K.+Liu&title=Synthesis+and+Antihistamine+Evaluations+of+Novel+Loratadine+Analogues&doi=10.1016%2Fj.bmcl.2011.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antihistamine evaluations of novel loratadine analogues</span></div><div class="casAuthors">Wang, Yue; Wang, Juan; Lin, Yan; Si-Ma, Li-Feng; Wang, Dong-hua; Chen, Li-Gong; Liu, Deng-Ke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4454-4456</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of loratadine analogs I( R = HOCH2CH2, HOCH2CH2CH2, R-HOCH2CHCH3, S-HOCH2CHCH3, R-HOCH2CHCH2CH3, S-HOCH2CHCH2CH3, R-C6H5CHCH3, S-C6H5CHCH3) contg. hydroxyl group and chiral center were synthesized.  The effect of the synthesized compds. on the histamine-induced contractions of guinea-pig ileum muscles was studied.  In addn., the in vivo asthma-relieving effect of the analogs in the histamine induced asthmatic reaction in guinea-pigs was detd.  Most of the compds. exhibited definite H1 antihistamine activity.  The S-enantiomers, compds. I(R = S-HOCH2CHCH3, S-HOCH2CHCH2CH3, S-C6H5CHCH3) are more potent than the R-enantiomers, compds. I( R = R-HOCH2CHCH3, R-HOCH2CHCH2CH3, R-C6H5CHCH3).  Compd. I( R = HOCH2CH2CH2) was the most active one among the eight synthesized compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD50B7M8Uf0bVg90H21EOLACvtfcHk0lgIHzyWZheEuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVSkur4%253D&md5=725b91d834bd7103afd66185a65daa1c</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DSi-Ma%26aufirst%3DL.-F.%26aulast%3DWang%26aufirst%3DD.-h.%26aulast%3DChen%26aufirst%3DL.-G.%26aulast%3DLiu%26aufirst%3DD.-K.%26atitle%3DSynthesis%2520and%2520Antihistamine%2520Evaluations%2520of%2520Novel%2520Loratadine%2520Analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4454%26epage%3D4456%26doi%3D10.1016%2Fj.bmcl.2011.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, C. A.</span></span> <span> </span><span class="NLM_article-title">Antihistamines and Allergy</span>. <i>Aust. Prescr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.18773/austprescr.2018.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.18773%2Faustprescr.2018.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=42-45&author=K.+L.+Randallauthor=C.+A.+Hawkins&title=Antihistamines+and+Allergy&doi=10.18773%2Faustprescr.2018.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=10.18773%2Faustprescr.2018.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18773%252Faustprescr.2018.013%26sid%3Dliteratum%253Aachs%26aulast%3DRandall%26aufirst%3DK.%2BL.%26aulast%3DHawkins%26aufirst%3DC.%2BA.%26atitle%3DAntihistamines%2520and%2520Allergy%26jtitle%3DAust.%2520Prescr.%26date%3D2018%26volume%3D41%26spage%3D42%26epage%3D45%26doi%3D10.18773%2Faustprescr.2018.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Church, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of Antihistamines</span>. <i>Indian J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.4103/0019-5154.110832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.4103%2F0019-5154.110832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23723474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BC3snotl2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=219-224&author=M.+K.+Churchauthor=D.+S.+Church&title=Pharmacology+of+Antihistamines&doi=10.4103%2F0019-5154.110832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19fR"><div class="casContent"><span class="casTitleNuber">19f</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of antihistamines</span></div><div class="casAuthors">Church Martin K; Church Diana S</div><div class="citationInfo"><span class="NLM_cas:title">Indian journal of dermatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">H1-antihistamines, the mainstay of treatment for urticaria, were developed from anticholinergic drugs more than 70 years ago.  They act as inverse agonists rather than antagonists of histamine H1-receptors which are members of the G-protein family.  The older first generation H1-antihistamines penetrate readily into the brain to cause sedation, drowsiness, fatigue and impaired concentration and memory causing detrimental effects on learning and examination performance in children and on impairment of the ability of adults to work and drive.  Their use should be discouraged.  The newer second-generation H1-antihistamines are safer, cause less sedation and are more efficacious.  Three drugs widely used for symptomatic relief in urticaria, desloratadine, levocetirizine and fexofenadine are highlighted in this review.  Of these levocetirizine and fexofenadine are the most potent in humans in vivo.  However, levocetirizine may cause somnolence in susceptible individuals, whereas fexofenadine has a relatively short duration of action and may be required to be given twice daily for all round daily protection.  Although desloratadine is less potent, it has the advantages of rarely causing somnolence and having a long duration of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkA18dqept1EH3Rlp_k91zfW6udTcc2eaXWyWpp4vtRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snotl2hsA%253D%253D&md5=867adc1094106d91708347063af8a9d9</span></div><a href="/servlet/linkout?suffix=cit19f&amp;dbid=16384&amp;doi=10.4103%2F0019-5154.110832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0019-5154.110832%26sid%3Dliteratum%253Aachs%26aulast%3DChurch%26aufirst%3DM.%2BK.%26aulast%3DChurch%26aufirst%3DD.%2BS.%26atitle%3DPharmacology%2520of%2520Antihistamines%26jtitle%3DIndian%2520J.%2520Dermatol.%26date%3D2013%26volume%3D58%26spage%3D219%26epage%3D224%26doi%3D10.4103%2F0019-5154.110832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anthes, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrest, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfeder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span> <span> </span><span class="NLM_article-title">Biochemical Characterization of Desloratadine, a Potent Antagonist of the Human Histamine H<sub>1</sub> Receptor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/s0014-2999(02)02049-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2FS0014-2999%2802%2902049-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=12167464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVWltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2002&pages=229-237&author=J.+C.+Anthesauthor=H.+Gilchrestauthor=C.+Richardauthor=S.+Eckelauthor=D.+Heskauthor=R.+E.+Westauthor=S.+M.+Williamsauthor=S.+Greenfederauthor=M.+Billahauthor=W.+Kreutnerauthor=R.+W.+Egan&title=Biochemical+Characterization+of+Desloratadine%2C+a+Potent+Antagonist+of+the+Human+Histamine+H1+Receptor&doi=10.1016%2Fs0014-2999%2802%2902049-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19gR"><div class="casContent"><span class="casTitleNuber">19g</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor</span></div><div class="casAuthors">Anthes, John C.; Gilchrest, Helen; Richard, Christian; Eckel, Stephen; Hesk, Dave; West, Robert E.; Williams, Shirley M.; Greenfeder, Scott; Billah, Motasim; Kreutner, William; Egan, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-237</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have characterized desloratadine (5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene), CAS 100643-71-8) as a potent antagonist of the human histamine H1 receptor.  [3H]Desloratadine bound to membranes expressing the recombinant human histamine H1 receptor in Chinese hamster ovary cells (CHO-H1) in a specific and saturable manner with a Kd of 1.1±0.2 nM, a Bmax of 7.9±2.0 pmol/mg protein, and an assocn. rate const. of 0.011 nM-1 min-1.  The Kd calcd. from the kinetic measurements was 1.5 nM.  Dissocn. of [3H]desloratadine from the human histamine H1 receptor was slow, with only 37% of the binding reversed at 6 h in the presence of 5 μM unlabeled desloratadine.  Seventeen histamine H1-receptor antagonists were evaluated in competition-binding studies.  Desloratadine had a Ki of 0.9±0.1 nM in these competition studies.  In CHO-H1 cells, histamine stimulation resulted in a concn.-dependent increase in [Ca2+]i with an EC50 of 170±30 nM.  After a 90-min preincubation with desloratadine, the histamine-stimulated increase in [Ca2+]i was shifted to the right, with a depression of the maximal response at higher concns. of antagonist.  The apparent Kb value was 0.2±0.14 nM with a slope of 1.6±0.1.  The slow dissocn. from the receptor and noncompetitive antagonism suggests that desloratadine may be a pseudoirreversible antagonist of the human histamine H1 receptor.  The mechanism of desloratadine antagonism of the human histamine H1 receptor may help to explain the high potency and 24-h duration of action obsd. in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6H8IJZE7hrbVg90H21EOLACvtfcHk0lgKo_Kmdyfy8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVWltbo%253D&md5=cd55fee981b04e2ec5ee45c339f4a37c</span></div><a href="/servlet/linkout?suffix=cit19g&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902049-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902049-6%26sid%3Dliteratum%253Aachs%26aulast%3DAnthes%26aufirst%3DJ.%2BC.%26aulast%3DGilchrest%26aufirst%3DH.%26aulast%3DRichard%26aufirst%3DC.%26aulast%3DEckel%26aufirst%3DS.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DWest%26aufirst%3DR.%2BE.%26aulast%3DWilliams%26aufirst%3DS.%2BM.%26aulast%3DGreenfeder%26aufirst%3DS.%26aulast%3DBillah%26aufirst%3DM.%26aulast%3DKreutner%26aufirst%3DW.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26atitle%3DBiochemical%2520Characterization%2520of%2520Desloratadine%252C%2520a%2520Potent%2520Antagonist%2520of%2520the%2520Human%2520Histamine%2520H1%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D449%26spage%3D229%26epage%3D237%26doi%3D10.1016%2Fs0014-2999%2802%2902049-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, R.</span></span> <span> </span><span class="NLM_article-title">Cytochromes P450 as Versatile Biocatalysts</span>. <i>J. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.jbiotec.2006.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.jbiotec.2006.01.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=16516322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltl2isLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=128-145&author=R.+Bernhardt&title=Cytochromes+P450+as+Versatile+Biocatalysts&doi=10.1016%2Fj.jbiotec.2006.01.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochromes P 450 as versatile biocatalysts</span></div><div class="casAuthors">Bernhardt, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-145</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 isoforms are ubiquitously distributed enzymes, which were discovered ∼50 yr ago and which possess high complexity and display a broad field of activity.  They are hemoproteins encoded by a superfamily of genes converting a broad variety of substrates and catalyzing a variety of interesting chem. reactions.  This enzyme family is involved in the biotransformation of drugs, the bioconversion of xenobiotics, the metab. of chem. carcinogens, the biosynthesis of physiol. important compds. such as steroids, fatty acids, eicosanoids, fat-sol. vitamins, bile acids, the conversion of alkanes, terpenes, and arom. compds. as well as the degrdn. of herbicides and insecticides.  There is also a broad versatility of reactions catalyzed by cytochromes P 450 (P 450) such as carbon hydroxylation, heteroatom oxygenation, dealkylation, epoxidn., arom. hydroxylation, redn., and dehalogenation.  More than 5000 different P 450 genes have been cloned to date.  Members of the same gene family are defined as usually having ≥40% sequence identity to a P 450 protein from any other family.  Mammalian sequences within the same subfamily are always >55% identical.  The nos. of individual P 450 enzymes in different species differ significantly, showing the highest nos. obsd. so far in plants.  The structure-function relations of cytochromes P 450 are far from being well understood and their catalytic power has so far hardly been used for biotechnol. processes.  Nevertheless, the set of interesting reactions being catalyzed by these systems and the availability of new genetic engineering techniques allowing investigators to heterologously express them and to improve and change their activity, stability, and selectivity, as well as the increasing interest of industry in life sciences makes them promising candidates for biotechnol. application in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsLIpgi6AM7Vg90H21EOLACvtfcHk0lgKo_Kmdyfy8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltl2isLw%253D&md5=f43290591c64c0559af7c8fbd57807e2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2006.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2006.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DBernhardt%26aufirst%3DR.%26atitle%3DCytochromes%2520P450%2520as%2520Versatile%2520Biocatalysts%26jtitle%3DJ.%2520Biotechnol.%26date%3D2006%26volume%3D124%26spage%3D128%26epage%3D145%26doi%3D10.1016%2Fj.jbiotec.2006.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacologically Active Metabolites of Currently Marketed Drugs: Potential Resources for New Drug Discovery and Development</span>. <i>Yakugaku Zasshi</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1337</span>, <span class="refDoi"> DOI: 10.1248/yakushi.130.1325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1248%2Fyakushi.130.1325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=20930485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2010&pages=1325-1337&author=M.+J.+Kangauthor=W.+H.+Songauthor=B.+H.+Shimauthor=S.+Y.+Ohauthor=H.+Y.+Leeauthor=E.+Y.+Chungauthor=Y.+Sohnauthor=J.+Lee&title=Pharmacologically+Active+Metabolites+of+Currently+Marketed+Drugs%3A+Potential+Resources+for+New+Drug+Discovery+and+Development&doi=10.1248%2Fyakushi.130.1325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmaceutical active metabolites of currently marketed drugs: potential resources for new drug discovery and development</span></div><div class="casAuthors">Kang, Myung Joo; Song, Woo Heon; Shim, Byung Ho; Oh, Seung Youn; Lee, Hyun Young; Chung, Eun Young; Sohn, Yesung; Lee, Jaehwi</div><div class="citationInfo"><span class="NLM_cas:title">Yakugaku Zasshi</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1325-1337</span>CODEN:
                <span class="NLM_cas:coden">YKKZAJ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6903</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Biotransformation is the major clearance mechanism of therapeutic agents from the body.  Biotransformation is known not only to facilitate the elimination of drugs by changing the mol. structure to more hydrophilic, but also lead to pharmacol. inactivation of therapeutic compds.  However, in some cases, the biotransformation of drugs can lead to the generation of pharmacol. active metabolites, responsible for the pharmacol. actions.  This review provides an update of the kinds of pharmacol. active metabolites and some of their individual pharmacol. and pharmacokinetic aspects, and describes their importance as resources for drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNPw5yjo1kLVg90H21EOLACvtfcHk0lgWt6rf5J-_uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhtrbM&md5=a575b7cd528e35b325829fbdd5a1ceb8</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1248%2Fyakushi.130.1325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fyakushi.130.1325%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DM.%2BJ.%26aulast%3DSong%26aufirst%3DW.%2BH.%26aulast%3DShim%26aufirst%3DB.%2BH.%26aulast%3DOh%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DChung%26aufirst%3DE.%2BY.%26aulast%3DSohn%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DPharmacologically%2520Active%2520Metabolites%2520of%2520Currently%2520Marketed%2520Drugs%253A%2520Potential%2520Resources%2520for%2520New%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DYakugaku%2520Zasshi%26date%3D2010%26volume%3D130%26spage%3D1325%26epage%3D1337%26doi%3D10.1248%2Fyakushi.130.1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span>; <span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Chapter 10. Alcohols and Phenols: Absorption, Distribution, Metabolism and Excretion</span>. In  <i>Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, T.</span></span> Ed.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>, <span class="NLM_year">2010</span>; Chapter 10, pp  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">485</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2F9781849731102-00460" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=460-485&author=Z.+Miao&author=R.+S.+Obachauthor=T.+David&title=Metabolism%2C+Pharmacokinetics+and+Toxicity+of+Functional+Groups%3A+Impact+of+Chemical+Building+Blocks+on+ADMET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1039%2F9781849731102-00460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731102-00460%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%26atitle%3DChapter%252010.%2520Alcohols%2520and%2520Phenols%253A%2520Absorption%252C%2520Distribution%252C%2520Metabolism%2520and%2520Excretion%26btitle%3DMetabolism%252C%2520Pharmacokinetics%2520and%2520Toxicity%2520of%2520Functional%2520Groups%253A%2520Impact%2520of%2520Chemical%2520Building%2520Blocks%2520on%2520ADMET%26aulast%3DDavid%26aufirst%3DT.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2010%26spage%3D460%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.3390/molecules21010075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.3390%2Fmolecules21010075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26771590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCiu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=75&author=F.+Maoauthor=W.+Niauthor=X.+Xuauthor=H.+Wangauthor=J.+Wangauthor=M.+Jiauthor=J.+Li&title=Chemical+Structure-Related+Drug-Like+Criteria+of+Global+Approved+Drugs&doi=10.3390%2Fmolecules21010075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical structure-related drug-like criteria of global approved drugs</span></div><div class="casAuthors">Mao, Fei; Ni, Wei; Xu, Xiang; Wang, Hui; Wang, Jing; Ji, Min; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75/1-75/18</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The chem. structure of a drug dets. its physicochem. properties, further dets. its ADME/Tox properties, and ultimately affects its pharmacol. activity.  Medicinal chemists can regulate the pharmacol. activity of drug mols. by modifying their structure.  Ring systems and functional groups are important components of a drug.  The proportion of non-hydrocarbon atoms among non-hydrogen atoms reflects the heavy atoms proportion of a drug.  The three factors have considerable potential for the assessment of the drug-like properties of org. mols.  However, to the best of our knowledge, there have been no studies to systematically analyze the simultaneous effects of the no. of arom. and non-arom. rings, the no. of some special functional groups and the proportion of heavy atoms on the drug-like properties of an org. mol.  To this end, the nos. of arom. and non-arom. rings, the nos. of some special functional groups and the heavy atoms proportion of 6891 global approved small drugs have been comprehensively analyzed.  We first uncovered three important structure-related criteria closely related to drug-likeness, namely: (1) the best nos. of arom. and non-arom. rings are 2 and 1, resp.; (2) the best functional groups of candidate drugs are usually -OH, -COOR and -COOH in turn, but not -CONHOH, -SH, -CHO and -SO3H.  In addn., the -F functional group is beneficial to CNS drugs, and -NH2 functional group is beneficial to anti-infective drugs and anti-cancer drugs; (3) the best R value intervals of candidate drugs are in the range of 0.05-0.50 (preferably 0.10-0.35), and R value of the candidate CNS drugs should be as small as possible in this interval.  We envision that the three chem. structure-related criteria may be applicable in a prospective manner for the identification of novel candidate drugs and will provide a theor. foundation for designing new chem. entities with good drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkob7QCZSGz7Vg90H21EOLACvtfcHk0lhK0uE56CQI0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCiu7bN&md5=70082d974f1a4da534cd662708751c88</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21010075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21010075%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DChemical%2520Structure-Related%2520Drug-Like%2520Criteria%2520of%2520Global%2520Approved%2520Drugs%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D75%26doi%3D10.3390%2Fmolecules21010075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunne, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, F.</span></span> <span> </span><span class="NLM_article-title">Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic Compounds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFarsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=643-647&author=T.+Henkelauthor=R.+M.+Brunneauthor=H.+M%C3%BCllerauthor=F.+Reichel&title=Statistical+Investigation+into+the+Structural+Complementarity+of+Natural+Products+and+Synthetic+Compounds&doi=10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Statistical investigation into the structural complementarity of natural products and synthetic compounds</span></div><div class="casAuthors">Henkel, Thomas; Brunne, Roger M.; Muller, Hartwig; Reichel, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-647</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A first effort to describe statistical the differences between the structural properties of natural products and synthetic substances so as to derive statements into the complementarity of these pools of structures is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKkl3JHxGCrVg90H21EOLACvtfcHk0lhK0uE56CQI0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFarsL4%253D&md5=80db970c39804f8e9ad80f3ec90f824c</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990301%252938%253A5%253C643%253A%253AAID-ANIE643%253E3.0.CO%253B2-G%26sid%3Dliteratum%253Aachs%26aulast%3DHenkel%26aufirst%3DT.%26aulast%3DBrunne%26aufirst%3DR.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DReichel%26aufirst%3DF.%26atitle%3DStatistical%2520Investigation%2520into%2520the%2520Structural%2520Complementarity%2520of%2520Natural%2520Products%2520and%2520Synthetic%2520Compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D643%26epage%3D647%26doi%3D10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Hydroxyl Group Transformation: An Elusive Target</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2484</span>– <span class="NLM_lpage">2493</span>, <span class="refDoi"> DOI: 10.1039/c2mb25122a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fc2mb25122a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=22695722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ygtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=2484-2493&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Chemoselective+Hydroxyl+Group+Transformation%3A+An+Elusive+Target&doi=10.1039%2Fc2mb25122a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective hydroxyl group transformation: an elusive target</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2484-2493</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The selective reaction of one functional group in the presence of others is not a trivial task.  A noteworthy amt. of research has been dedicated to the chemoselective reaction of the hydroxyl moiety.  This group is prevalent in many biol. important mols. including natural products and proteins.  However, targeting the hydroxyl group is difficult for many reasons including its relatively low nucleophilicity in comparison to other ubiquitous functional groups such as amines and thiols.  Addnl., many of the developed chemoselective reactions cannot be used in the presence of water.  Despite these complications, chemoselective transformation of the hydroxyl moiety has been utilized in the synthesis of complex natural product derivs., the reaction of tyrosine residues in proteins, the isolation of natural products and is the mechanism of action of myriad drugs.  Here, methods for selective targeting of this group, as well as applications of several devised methods, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorgmeIXY9utrVg90H21EOLACvtfcHk0lhWBretKLNX1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ygtbjE&md5=8043a8039b2a72b28424285b2e6af793</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1039%2Fc2mb25122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2mb25122a%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DChemoselective%2520Hydroxyl%2520Group%2520Transformation%253A%2520An%2520Elusive%2520Target%26jtitle%3DMol.%2520BioSyst.%26date%3D2012%26volume%3D8%26spage%3D2484%26epage%3D2493%26doi%3D10.1039%2Fc2mb25122a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbaida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Loratadine and Further Characterization of its In Vitro Metabolites</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.2174/187231209789352067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.2174%2F187231209789352067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=19702548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=162-170&author=A.+Ghosalauthor=S.+Guptaauthor=R.+Ramanathanauthor=Y.+Yuanauthor=X.+Luauthor=A.+D.+Suauthor=N.+Alvarezauthor=S.+Zbaidaauthor=S.+K.+Chowdhuryauthor=K.+B.+Alton&title=Metabolism+of+Loratadine+and+Further+Characterization+of+its+In+Vitro+Metabolites&doi=10.2174%2F187231209789352067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of loratadine and further characterization of its in vitro metabolites</span></div><div class="casAuthors">Ghosal, Anima; Gupta, Samir; Ramanathan, Ragu; Yuan, Yuan; Lu, Xiaowen; Su, Ai Duen; Alvarez, Narciso; Zbaida, Shmuel; Chowdhury, Swapan K.; Alton, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The present study demonstrated that in addn. to CYP3A4 and CYP2D6, the metab. of loratadine is also catalyzed by CYP1A1, CYP2C19, and to a lesser extent by CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP3A5.  The biotransformation of loratadine was assocd. with the formation of desloratadine (DL) and further hydroxylation of both DL and the parent drug (loratadine).  Based on the inhibition and correlation studies contribution of CYP2C19 in the formation of the major circulating metabolite DL seems to be minor.  Reported clin. results suggest that the steady state mean (%CV) blood plasma Cmax and AUC24h of loratadine were 4.73 ng/mL (119%) and 24.1 ng/h/mL (157%), resp., after dosing with 10 mg loratadine tablets for 10 days.  High inter-subject variability in loratadine steady-state data is probably due to the phenotypical characteristics of CYP2D6, CYP2C19, and CYP3A4.  The relative abundance of CYP3A4 in the human liver exceeds that of CYP2C19 and CYP2D6 and therefore the contribution of CYP3A4 in the metab. of loratadine should be major (∼70%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol66G9K5W8mbVg90H21EOLACvtfcHk0lhWBretKLNX1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtL3L&md5=16479ac7032473e758af940ecf238940</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F187231209789352067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231209789352067%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DRamanathan%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DA.%2BD.%26aulast%3DAlvarez%26aufirst%3DN.%26aulast%3DZbaida%26aufirst%3DS.%26aulast%3DChowdhury%26aufirst%3DS.%2BK.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26atitle%3DMetabolism%2520of%2520Loratadine%2520and%2520Further%2520Characterization%2520of%2520its%2520In%2520Vitro%2520Metabolites%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2009%26volume%3D3%26spage%3D162%26epage%3D170%26doi%3D10.2174%2F187231209789352067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, W. G.</span></span> <span> </span><span class="NLM_article-title">Drug Metabolite Profiling and Identification by High-Resolution Mass Spectrometry</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">25419</span>– <span class="NLM_lpage">25425</span>, <span class="refDoi"> DOI: 10.1074/jbc.R110.200055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1074%2Fjbc.R110.200055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21632546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=25419-25425&author=M.+Zhuauthor=H.+Zhangauthor=W.+G.+Humphreys&title=Drug+Metabolite+Profiling+and+Identification+by+High-Resolution+Mass+Spectrometry&doi=10.1074%2Fjbc.R110.200055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Metabolite Profiling and Identification by High-resolution Mass Spectrometry</span></div><div class="casAuthors">Zhu, Mingshe; Zhang, Haiying; Humphreys, W. Griffith</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">25419-25425</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mass spectrometry plays a key role in drug metabolite identification, an integral part of drug discovery and development.  The development of high-resoln. (HR) MS instrumentation with improved accuracy and stability, along with new data processing techniques, has improved the quality and productivity of metabolite identification processes.  In this minireview, HR-MS-based targeted and non-targeted acquisition methods and data mining techniques (e.g. mass defect, product ion, and isotope pattern filters and background subtraction) that facilitate metabolite identification are examd.  Methods are presented that enable multiple metabolite identification tasks with a single LC/HR-MS platform and/or anal.  Also, application of HR-MS-based strategies to key metabolite identification activities and future developments in the field are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7PH0QxYyoe7Vg90H21EOLACvtfcHk0lhH-RBfiqtJpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCksbg%253D&md5=ca2ea7f00927382051c12bc3f0f62abf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R110.200055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R110.200055%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DDrug%2520Metabolite%2520Profiling%2520and%2520Identification%2520by%2520High-Resolution%2520Mass%2520Spectrometry%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D25419%26epage%3D25425%26doi%3D10.1074%2Fjbc.R110.200055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gehlhaar, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhivker, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejto, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freer, S. T.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of the Inhibitor AG-1343 by HIV-1 Protease: Conformationally Flexible Docking by Evolutionary Programming</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/1074-5521(95)90050-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+R.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+Recognition+of+the+Inhibitor+AG-1343+by+HIV-1+Protease%3A+Conformationally+Flexible+Docking+by+Evolutionary+Programming&doi=10.1016%2F1074-5521%2895%2990050-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0lhH-RBfiqtJpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BR.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520Recognition%2520of%2520the%2520Inhibitor%2520AG-1343%2520by%2520HIV-1%2520Protease%253A%2520Conformationally%2520Flexible%2520Docking%2520by%2520Evolutionary%2520Programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324%26doi%3D10.1016%2F1074-5521%2895%2990050-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luty, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. W.</span></span> <span> </span><span class="NLM_article-title">Discovering High-Affinity Ligands from the Computationally Predicted Structures and Affinities of Small Molecules Bound to a Target: A Virtual Screening Approach</span>. <i>Perspect. Drug Discovery Des.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1023/A:1008741308684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1023%2FA%3A1008741308684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=209-230&author=T.+J.+Marroneauthor=B.+A.+Lutyauthor=P.+W.+Rose&title=Discovering+High-Affinity+Ligands+from+the+Computationally+Predicted+Structures+and+Affinities+of+Small+Molecules+Bound+to+a+Target%3A+A+Virtual+Screening+Approach&doi=10.1023%2FA%3A1008741308684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span></div><div class="casAuthors">Marrone, Tami J.; Luty, Brock A.; Rose, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-230</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We describe a "virtual NMR screening" method to assist in the design of inhibitors that occupy different sites within a target.  We dock small mols. into the active site of an enzyme and score them.  Keeping the tightest-binding lead fixed in space, we dock and score other small mols. in its presence.  Using this approach, linker groups are used to join the compds. together to form a high-affinity inhibitor.  We present validation of our computational approach by reproducing exptl. results for FKBP and stromelysin.  Docking simulations are not subject to exptl. problems such as proteolysis, protein or compd. insoly., or enzyme size.  Because docking is fast and our scoring method can distinguish between high- and low-affinity inhibitors, this docking procedure shows promise as integral part of a drug-design strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql26ToXhh4jbVg90H21EOLACvtfcHk0ljwlDGcqEAczQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSg&md5=cea3010bea46c3636970ece8ee764ae2</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008741308684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008741308684%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DT.%2BJ.%26aulast%3DLuty%26aufirst%3DB.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26atitle%3DDiscovering%2520High-Affinity%2520Ligands%2520from%2520the%2520Computationally%2520Predicted%2520Structures%2520and%2520Affinities%2520of%2520Small%2520Molecules%2520Bound%2520to%2520a%2520Target%253A%2520A%2520Virtual%2520Screening%2520Approach%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D20%26spage%3D209%26epage%3D230%26doi%3D10.1023%2FA%3A1008741308684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Polak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribiere, G.</span></span> <span> </span><span class="NLM_article-title">Note sur la Convergence de Methodes de Directions Conjuguees</span>. <i>Revue Francaise Inf. Rech. Oper., Serie Rouge</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_fpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1969&pages=35&author=E.+Polakauthor=G.+Ribiere&title=Note+sur+la+Convergence+de+Methodes+de+Directions+Conjuguees"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolak%26aufirst%3DE.%26aulast%3DRibiere%26aufirst%3DG.%26atitle%3DNote%2520sur%2520la%2520Convergence%2520de%2520Methodes%2520de%2520Directions%2520Conjuguees%26jtitle%3DRevue%2520Francaise%2520Inf.%2520Rech.%2520Oper.%252C%2520Serie%2520Rouge%26date%3D1969%26spage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, N. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caufield, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Still, W. C.</span></span> <span> </span><span class="NLM_article-title">Macromodel—An Integrated Software System for Modeling Organic and Bioorganic Molecules Using Molecular Mechanics</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1002/jcc.540110405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fjcc.540110405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK3cXktl2msLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+J.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=Macromodel%E2%80%94An+Integrated+Software+System+for+Modeling+Organic+and+Bioorganic+Molecules+Using+Molecular+Mechanics&doi=10.1002%2Fjcc.540110405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">MacroModel - an integrated software system for modeling organic and bioorganic molecules using molecular mechanics</span></div><div class="casAuthors">Mohamadi, Fariborz; Richards, Nigel G. J.; Guida, Wayne C.; Liskamp, Rob; Lipton, Mark; Caufield, Craig; Chang, George; Hendrickson, Thomas; Still, W. Clark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">440-67</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    </div><div class="casAbstract">An integrated mol. modeling system for designing and studying org. and bioorg. mols. and their mol. complexes using mol. mechanics is described.  The graphically controlled, atom-based system allows the construction, display and manipulation of mols. and complexes having as many as 10,000 atoms and provides interactive, state-of-the-art mol. mechanics on any subset of up to 1000 atoms.  The system semiautomates the graphical construction and anal. of complex structures ranging from polycyclic org. mols. to biopolymers to mixed mol. complexes.  Emphasis was placed on providing effective searches of conformational space by a no. of different methods and on highly optimized mol. mechanics energy calcns. using widely used force fields which are supplied as external files.  Little experience is required to operate the system effectively and even novices can use it to carry out sophisticated modeling operations.  The software has been designed to run on Digital Equipment Corporation VAX computers interfaced to a variety of graphics devices ranging from inexpensive monochrome terminals to the sophisticated graphics displays of the Evans & Sutherland PS300 series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_k-tSmgbgvrVg90H21EOLACvtfcHk0ljwlDGcqEAczQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktl2msLw%253D&md5=c3fdf59a2e97bbdd48dbb10cfc90fc91</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1002%2Fjcc.540110405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.540110405%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%2BJ.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacromodel%25E2%2580%2594An%2520Integrated%2520Software%2520System%2520for%2520Modeling%2520Organic%2520and%2520Bioorganic%2520Molecules%2520Using%2520Molecular%2520Mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467%26doi%3D10.1002%2Fjcc.540110405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sjögren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernäs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gråsjö, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredberg, U.</span></span> <span> </span><span class="NLM_article-title">The Multiple Depletion Curves Method Provides Accurate Estimates of Intrinsic Clearance (CLint), Maximum Velocity of the Metabolic Reaction (Vmax), and Michaelis Constant (Km): Accuracy and Robustness Evaluated Through Experimental Data and Monte Carlo Simulations</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.021477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.108.021477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=18824525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FgtFyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=47-58&author=E.+Sj%C3%B6grenauthor=H.+Lennern%C3%A4sauthor=T.+B.+Anderssonauthor=J.+Gr%C3%A5sj%C3%B6author=U.+Bredberg&title=The+Multiple+Depletion+Curves+Method+Provides+Accurate+Estimates+of+Intrinsic+Clearance+%28CLint%29%2C+Maximum+Velocity+of+the+Metabolic+Reaction+%28Vmax%29%2C+and+Michaelis+Constant+%28Km%29%3A+Accuracy+and+Robustness+Evaluated+Through+Experimental+Data+and+Monte+Carlo+Simulations&doi=10.1124%2Fdmd.108.021477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple depletion curves method provides accurate estimates of intrinsic clearance (CLint), maximum velocity of the metabolic reaction (Vmax), and Michaelis constant (Km): accuracy and robustness evaluated through experimental data and Monte Carlo simulations</span></div><div class="casAuthors">Sjogren Erik; Lennernas Hans; Andersson Tommy B; Grasjo Johan; Bredberg Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Drug metabolism and disposition: the biological fate of chemicals</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The use of multiple depletion curves for the estimation of maximum velocity of the metabolic reaction (V(max)), the Michaelis constant (K(m)), and intrinsic clearance (CL(int)) was thoroughly evaluated by means of experimental data and through a series of Monte Carlo simulations.  The enzyme kinetics of seven compounds were determined using the multiple depletion curves method (MDCM), the traditional initial formation rate of metabolite method (IFRMM), and the "in vitro t(1/2)" method, and the parameter estimates that were derived from the three methods were compared.  The impact of a change in enzyme activity during the incubation period on the parameter estimates and the possibility to correct for this were also investigated.  The MDCM was in good overall agreement with the IFRMM.  Correction for a change in enzyme activity was possible and resulted in a better concordance in CL(int) estimates.  The robustness of the method in coping with different rates of substrate turnover and variable starting concentrations were also demonstrated through Monte Carlo simulations.  Furthermore, the limitations imposed by assumptions inherent in the in vitro t(1/2) method were demonstrated both experimentally and by simulations.  This study demonstrates that the MDCM is a robust and efficient method for estimating enzyme kinetic variables with high accuracy and precision.  The method may potentially be used in a wide range of applications, from pure enzyme kinetics to in vitro-based predictions of the pharmacokinetics of compounds with multiple and/or unknown metabolic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGu__Ax4NV_cvLc4ARHEmzfW6udTcc2eaRtXR7hakTXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FgtFyjtA%253D%253D&md5=dfc3250aa3e0c75c6eccdd667d0e0884</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.021477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.021477%26sid%3Dliteratum%253Aachs%26aulast%3DSj%25C3%25B6gren%26aufirst%3DE.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26aulast%3DAndersson%26aufirst%3DT.%2BB.%26aulast%3DGr%25C3%25A5sj%25C3%25B6%26aufirst%3DJ.%26aulast%3DBredberg%26aufirst%3DU.%26atitle%3DThe%2520Multiple%2520Depletion%2520Curves%2520Method%2520Provides%2520Accurate%2520Estimates%2520of%2520Intrinsic%2520Clearance%2520%2528CLint%2529%252C%2520Maximum%2520Velocity%2520of%2520the%2520Metabolic%2520Reaction%2520%2528Vmax%2529%252C%2520and%2520Michaelis%2520Constant%2520%2528Km%2529%253A%2520Accuracy%2520and%2520Robustness%2520Evaluated%2520Through%2520Experimental%2520Data%2520and%2520Monte%2520Carlo%2520Simulations%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D47%26epage%3D58%26doi%3D10.1124%2Fdmd.108.021477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A.-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarimont, C.</span></span> <span> </span><span class="NLM_article-title">Improving the Decision-Making Process in the Structural Modification of Drug Candidates: Enhancing Metabolic Stability</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A.-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+Decision-Making+Process+in+the+Structural+Modification+of+Drug+Candidates%3A+Enhancing+Metabolic+Stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0lh6sw28KlD5vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520Decision-Making%2520Process%2520in%2520the%2520Structural%2520Modification%2520of%2520Drug%2520Candidates%253A%2520Enhancing%2520Metabolic%2520Stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Demain, A. L.</span></span> <span> </span><span class="NLM_article-title">Importance of Microbial Natural Products and the Need to Revitalize Their Discovery</span>. <i>J. Ind. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1007/s10295-013-1325-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1007%2Fs10295-013-1325-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23990168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2qtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=185-201&author=A.+L.+Demain&title=Importance+of+Microbial+Natural+Products+and+the+Need+to+Revitalize+Their+Discovery&doi=10.1007%2Fs10295-013-1325-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of microbial natural products and the need to revitalize their discovery</span></div><div class="casAuthors">Demain, Arnold L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Industrial Microbiology & Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-201</span>CODEN:
                <span class="NLM_cas:coden">JIMBFL</span>;
        ISSN:<span class="NLM_cas:issn">1367-5435</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Microbes are the leading producers of useful natural products.  Natural products from microbes and plants make excellent drugs.  Significant portions of the microbial genomes are devoted to prodn. of these useful secondary metabolites.  A single microbe can make a no. of secondary metabolites, as high as 50 compds.  The most useful products include antibiotics, anticancer agents, immunosuppressants, but products for many other applications, e.g., antivirals, anthelmintics, enzyme inhibitors, nutraceuticals, polymers, surfactants, bioherbicides, and vaccines were commercialized.  Unfortunately, due to the decrease in natural product discovery efforts, drug discovery has decreased in the past 20 years.  The reasons include excessive costs for clin. trials, too short a window before the products become generics, difficulty in discovery of antibiotics against resistant organisms, and short treatment times by patients for products such as antibiotics.  Despite these difficulties, technol. to discover new drugs has advanced, e.g., combinatorial chem. of natural product scaffolds, discoveries in biodiversity, genome mining, and systems biol.  Of great help would be government extension of the time before products become generic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmSFHGHgLym7Vg90H21EOLACvtfcHk0lhHgqWbic8KSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2qtrrI&md5=657e82af420b3e01942df70b6f691c59</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1007%2Fs10295-013-1325-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10295-013-1325-z%26sid%3Dliteratum%253Aachs%26aulast%3DDemain%26aufirst%3DA.%2BL.%26atitle%3DImportance%2520of%2520Microbial%2520Natural%2520Products%2520and%2520the%2520Need%2520to%2520Revitalize%2520Their%2520Discovery%26jtitle%3DJ.%2520Ind.%2520Microbiol.%2520Biotechnol.%26date%3D2014%26volume%3D41%26spage%3D185%26epage%3D201%26doi%3D10.1007%2Fs10295-013-1325-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span> <span> </span><span class="NLM_article-title">Natural Products: A Continuing Source of Novel Drug Leads</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1830</i></span>,  <span class="NLM_fpage">3670</span>– <span class="NLM_lpage">3695</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bbagen.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23428572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=3670-3695&author=G.+M.+Craggauthor=D.+J.+Newman&title=Natural+Products%3A+A+Continuing+Source+of+Novel+Drug+Leads&doi=10.1016%2Fj.bbagen.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products: A continuing source of novel drug leads</span></div><div class="casAuthors">Cragg, Gordon M.; Newman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3670-3695</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nature has been a source of medicinal products for millennia, with many useful drugs developed from plant sources.  Following discovery of the penicillins, drug discovery from microbial sources occurred and diving techniques in the 1970s opened the seas.  Combinatorial chem. (late 1980s), shifted the focus of drug discovery efforts from Nature to the lab. bench.  This review traces natural products drug discovery, outlining important drugs from natural sources that revolutionized treatment of serious diseases.  It is clear Nature will continue to be a major source of new structural leads, and effective drug development depends on multidisciplinary collaborations.  The explosion of genetic information led not only to novel screens, but the genetic techniques permitted the implementation of combinatorial biosynthetic technol. and genome mining.  The knowledge gained has allowed unknown mols. to be identified.  These novel bioactive structures can be optimized by using combinatorial chem. generating new drug candidates for many diseases.  The advent of genetic techniques that permitted the isolation /expression of biosynthetic cassettes from microbes may well be the new frontier for natural products lead discovery.  It is now apparent that biodiversity may be much greater in those organisms.  The nos. of potential species involved in the microbial world are many orders of magnitude greater than those of plants and multi-celled animals.  Coupling these nos. to the no. of currently unexpressed biosynthetic clusters now identified (> 10 per species) the potential of microbial diversity remains essentially untapped.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zi-u3aGY-7Vg90H21EOLACvtfcHk0ljEY8xaKLaIWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D&md5=f3242db81842ceeaca0dc51a0c741c23</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520Products%253A%2520A%2520Continuing%2520Source%2520of%2520Novel%2520Drug%2520Leads%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1830%26spage%3D3670%26epage%3D3695%26doi%3D10.1016%2Fj.bbagen.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hypha
Discovery</span> <i>Lead Compound Diversification
and Late Stage Functionalization</i>. <a href="https://www.hyphadiscovery.co.uk/our-services/lead-diversification/" class="extLink">https://www.hyphadiscovery.co.uk/our-services/lead-diversification/</a> (accessed May 19, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hypha%0ADiscovery+Lead+Compound+Diversification%0Aand+Late+Stage+Functionalization.+https%3A%2F%2Fwww.hyphadiscovery.co.uk%2Four-services%2Flead-diversification%2F+%28accessed+May+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DLead%2520Compound%2520Diversification%250Aand%2520Late%2520Stage%2520Functionalization" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchini, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arruda, M. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campelo, P. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grégio, A. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, E. A. R.</span></span> <span> </span><span class="NLM_article-title">Microbial Biotransformation to Obtain New Antifungals</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2015.01433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.3389%2Ffmicb.2015.01433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25653648" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-12&author=L.+F.+Bianchiniauthor=M.+F.+C.+Arrudaauthor=S.+R.+Vieiraauthor=P.+M.+S.+Campeloauthor=A.+M.+T.+Gr%C3%A9gioauthor=E.+A.+R.+Rosa&title=Microbial+Biotransformation+to+Obtain+New+Antifungals&doi=10.3389%2Ffmicb.2015.01433"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2015.01433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2015.01433%26sid%3Dliteratum%253Aachs%26aulast%3DBianchini%26aufirst%3DL.%2BF.%26aulast%3DArruda%26aufirst%3DM.%2BF.%2BC.%26aulast%3DVieira%26aufirst%3DS.%2BR.%26aulast%3DCampelo%26aufirst%3DP.%2BM.%2BS.%26aulast%3DGr%25C3%25A9gio%26aufirst%3DA.%2BM.%2BT.%26aulast%3DRosa%26aufirst%3DE.%2BA.%2BR.%26atitle%3DMicrobial%2520Biotransformation%2520to%2520Obtain%2520New%2520Antifungals%26jtitle%3DFront.%2520Microbiol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D12%26doi%3D10.3389%2Ffmicb.2015.01433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hegazy, M.-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ElShamy, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, A.-E.-H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalel, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reda, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaheen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawfik, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahat, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shams, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Azim, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammouda, F. M.</span></span> <span> </span><span class="NLM_article-title">Microbial Biotransformation as a Tool for Drug Development Based on Natural Products From Mevalonic Acid Pathway: A Review</span>. <i>J. Adv. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.jare.2014.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.jare.2014.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25685541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFehtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=17-33&author=M.-E.+F.+Hegazyauthor=T.+A.+Mohamedauthor=A.+I.+ElShamyauthor=A.-E.-H.+H.+Mohamedauthor=U.+A.+Mahalelauthor=E.+H.+Redaauthor=A.+M.+Shaheenauthor=W.+A.+Tawfikauthor=A.+A.+Shahatauthor=K.+A.+Shamsauthor=N.+S.+Abdel-Azimauthor=F.+M.+Hammouda&title=Microbial+Biotransformation+as+a+Tool+for+Drug+Development+Based+on+Natural+Products+From+Mevalonic+Acid+Pathway%3A+A+Review&doi=10.1016%2Fj.jare.2014.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial biotransformation as a tool for drug development based on natural products from mevalonic acid pathway: A review</span></div><div class="casAuthors">Hegazy, Mohamed-Elamir F.; Mohamed, Tarik A.; El Shamy, Abdelsamed I.; Mohamed, Abou-El-Hamd H.; Mahalel, Usama A.; Reda, Eman H.; Shaheen, Alaa M.; Tawfik, Wafaa A.; Shahat, Abdelaaty A.; Shams, Khalid A.; Abdel-Azim, Nahla S.; Hammouda, Fayza M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Advanced Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-33</span>CODEN:
                <span class="NLM_cas:coden">JAROES</span>;
        ISSN:<span class="NLM_cas:issn">2090-1224</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Natural products are structurally and biol. interesting metabolites, but they have been isolated in minute amts.  The syntheses of such natural products help in obtaining them in bulk amts.  The recognition of microbial biotransformation as important manufg. tool has increased in chem. and pharmaceutical industries.  In recent years, microbial transformation is increasing significantly from limited interest into highly active area in green chem. including prepn. of pharmaceutical products.  This is the first review published on the usage of microbial biocatalysts for some natural product classes and natural product drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fFrRQU_OcbVg90H21EOLACvtfcHk0li98wpOhMPoCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFehtb0%253D&md5=901531913943ef0eed1bf8de9a8c54e0</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.jare.2014.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jare.2014.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DHegazy%26aufirst%3DM.-E.%2BF.%26aulast%3DMohamed%26aufirst%3DT.%2BA.%26aulast%3DElShamy%26aufirst%3DA.%2BI.%26aulast%3DMohamed%26aufirst%3DA.-E.-H.%2BH.%26aulast%3DMahalel%26aufirst%3DU.%2BA.%26aulast%3DReda%26aufirst%3DE.%2BH.%26aulast%3DShaheen%26aufirst%3DA.%2BM.%26aulast%3DTawfik%26aufirst%3DW.%2BA.%26aulast%3DShahat%26aufirst%3DA.%2BA.%26aulast%3DShams%26aufirst%3DK.%2BA.%26aulast%3DAbdel-Azim%26aufirst%3DN.%2BS.%26aulast%3DHammouda%26aufirst%3DF.%2BM.%26atitle%3DMicrobial%2520Biotransformation%2520as%2520a%2520Tool%2520for%2520Drug%2520Development%2520Based%2520on%2520Natural%2520Products%2520From%2520Mevalonic%2520Acid%2520Pathway%253A%2520A%2520Review%26jtitle%3DJ.%2520Adv.%2520Res.%26date%3D2015%26volume%3D6%26spage%3D17%26epage%3D33%26doi%3D10.1016%2Fj.jare.2014.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Restaino, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marseglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrilli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiraldi, C.</span></span> <span> </span><span class="NLM_article-title">Biotechnological Transformation of Hydrocortisone to 16α-Hydroxy Hydrocortisone by Streptomyces roseochromogenes</span>. <i>Appl. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1299</span>, <span class="refDoi"> DOI: 10.1007/s00253-013-5384-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1007%2Fs00253-013-5384-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=24327211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFeis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2014&pages=1291-1299&author=O.+F.+Restainoauthor=M.+Marsegliaauthor=C.+De+Castroauthor=P.+Dianaauthor=P.+Forniauthor=M.+Parrilliauthor=M.+De+Rosaauthor=C.+Schiraldi&title=Biotechnological+Transformation+of+Hydrocortisone+to+16%CE%B1-Hydroxy+Hydrocortisone+by+Streptomyces+roseochromogenes&doi=10.1007%2Fs00253-013-5384-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29cR"><div class="casContent"><span class="casTitleNuber">29c</span><div class="casTitle"><span class="NLM_cas:atitle">Biotechnological transformation of hydrocortisone to 16α-hydroxy hydrocortisone by Streptomyces roseochromogenes</span></div><div class="casAuthors">Restaino, Odile Francesca; Marseglia, Mariacarmela; De Castro, Cristina; Diana, Paola; Forni, Pasquale; Parrilli, Michelangelo; De Rosa, Mario; Schiraldi, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Applied Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1291-1299</span>CODEN:
                <span class="NLM_cas:coden">AMBIDG</span>;
        ISSN:<span class="NLM_cas:issn">0175-7598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Streptomyces roseochromogenes is able to hydroxylate steroid compds. in different positions of their cycloalkane rings thanks to a cytochrome P 450 multi-enzyme complex.  In this paper, the hydroxylation of the hydrocortisone in the 16α position, performed by bacterial whole cells, was investigated in both shake flask and fermn. conditions; the best settings for both cellular growth and transformation reaction were studied by investigating the optimal medium compn., the kinetic of conversion, the most suitable substrate concn. and the preferred addn. timing.  Using newly formulated malt ext.- and yeast ext.-based media, a 16α-hydrohydrocortisone concn. of 0.2 ± 0.01 g L-1 was reached in shake flasks.  Batch expts. in a 2-L fermentor established the reproducibility and robustness of the biotransformation, while a pulsed batch fermn. strategy allowed the prodn. to increase up to 0.508 ± 0.01 g L-1.  Byproduct formation was investigated, and two new derivates of the hydrocortisone obtained during the bacterial transformation reaction and unknown so far, a C-20 hydroxy derivate and a C-21 N-acetamide one, were detd. by NMR analyses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoojZceq7clt7Vg90H21EOLACvtfcHk0ljkFoVFVfR_Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFeis7vP&md5=f4e737dd477925095c7b58ef3d84d6ad</span></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1007%2Fs00253-013-5384-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00253-013-5384-x%26sid%3Dliteratum%253Aachs%26aulast%3DRestaino%26aufirst%3DO.%2BF.%26aulast%3DMarseglia%26aufirst%3DM.%26aulast%3DDe%2BCastro%26aufirst%3DC.%26aulast%3DDiana%26aufirst%3DP.%26aulast%3DForni%26aufirst%3DP.%26aulast%3DParrilli%26aufirst%3DM.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DSchiraldi%26aufirst%3DC.%26atitle%3DBiotechnological%2520Transformation%2520of%2520Hydrocortisone%2520to%252016%25CE%25B1-Hydroxy%2520Hydrocortisone%2520by%2520Streptomyces%2520roseochromogenes%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2014%26volume%3D98%26spage%3D1291%26epage%3D1299%26doi%3D10.1007%2Fs00253-013-5384-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note">a<p class="last">Product <i>m/z</i> 413c (M + 30) is observed in well 28 generated from <i>Streptomyces setae</i> ATCC 33774, not shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>.</p></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, W. d. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durán-Patrón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonato, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collado, I. G.</span></span> <span> </span><span class="NLM_article-title">Stereoselective Biotransformations Using Fungi as Biocatalysts</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2009.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.tetasy.2009.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1SgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=385-397&author=K.+B.+Borgesauthor=W.+d.+S.+Borgesauthor=R.+Dur%C3%A1n-Patr%C3%B3nauthor=M.+T.+Pupoauthor=P.+S.+Bonatoauthor=I.+G.+Collado&title=Stereoselective+Biotransformations+Using+Fungi+as+Biocatalysts&doi=10.1016%2Fj.tetasy.2009.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective biotransformations using fungi as biocatalysts</span></div><div class="casAuthors">Borges, Keyller Bastos; Borges, Warley de Souza; Duran-Patron, Rosa; Pupo, Monica Tallarico; Bonato, Pierina Sueli; Collado, Isidro Gonzalez</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-397</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  The development of novel biocatalytic methods is a continuously growing area of chem., microbiol., and genetic engineering due to the fact that biocatalysts are selective, easy-to-handle, and environmentally friendly.  A wide range of reactions are catalyzed by microorganisms.  Fungi can be considered as a promising source of new biocatalysts, mainly for chiral reactions.  Chemo-, regio-, and stereoselective processes are very important in the synthesis of many chem., pharmaceutical, and agrochem. intermediates; active pharmaceuticals; and food ingredients.  This report reviews stereoselective reactions mediated by fungi, such as stereoselective hydroxylation, sulfoxidn., epoxidn., Baeyer-Villiger oxidn., deracemization, and stereo- and enantioselective redn. of ketones, published between 2000 and 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1f0sZFMm4erVg90H21EOLACvtfcHk0li3gjXeMfcVUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1SgsLY%253D&md5=12e54b1a8b219488bd92f55a8083f9d8</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2009.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2009.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DBorges%26aufirst%3DK.%2BB.%26aulast%3DBorges%26aufirst%3DW.%2Bd.%2BS.%26aulast%3DDur%25C3%25A1n-Patr%25C3%25B3n%26aufirst%3DR.%26aulast%3DPupo%26aufirst%3DM.%2BT.%26aulast%3DBonato%26aufirst%3DP.%2BS.%26aulast%3DCollado%26aufirst%3DI.%2BG.%26atitle%3DStereoselective%2520Biotransformations%2520Using%2520Fungi%2520as%2520Biocatalysts%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2009%26volume%3D20%26spage%3D385%26epage%3D397%26doi%3D10.1016%2Fj.tetasy.2009.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manikandan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 Structure, Function and Clinical Significance: A Review</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.2174/1389450118666170125144557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.2174%2F1389450118666170125144557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=28124606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Okuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=38-54&author=P.+Manikandanauthor=S.+Nagini&title=Cytochrome+P450+Structure%2C+Function+and+Clinical+Significance%3A+A+Review&doi=10.2174%2F1389450118666170125144557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 Structure, Function and Clinical Significance: A Review</span></div><div class="casAuthors">Manikandan, Palrasu; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-54</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: The cytochrome P 450 (CYP) enzymes are membrane-bound hemoproteins that play a pivotal role in the detoxification of xenobiotics, cellular metab. and homeostasis.  Induction or inhibition of CYP enzymes is a major mechanism that underlies drug-drug interactions.  CYP enzymes can be transcriptionally activated by various xenobiotics and endogenous substrates through receptor-dependent mechanisms.  CYP enzyme inhibition is a principal mechanism for metab.- based drug-drug interactions.  Many chemotherapeutic drugs can cause drug interactions due to their ability to either inhibit or induce the CYP enzyme system.  Predictions based on in silico analyses followed by validation have identified several microRNAs that regulate CYPs.  Genetic polymorphisms and epigenetic changes in CYP genes may be responsible for inter-individual and interethnic variations in disease susceptibility and the therapeutic efficacy of drugs.  Objective: The present review is a comprehensive compilation of cytochrome P 450 structure, function, pharmacogenetics, pharmacoepigenetics and clin. significance.  Conclusion: Knowledge about the substrates, inducers, and inhibitors of CYP isoforms, as well as the polymorphisms of CYP enzymes may be used as an aid by clinicians to det. therapeutic strategy, and treatment doses for drugs that are metabolized by CYP gene products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrATPQ72JwoKrVg90H21EOLACvtfcHk0ljKfBKNT9c0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Okuro%253D&md5=5e51feccd96c123917b1ff46c8235b5b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1389450118666170125144557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450118666170125144557%26sid%3Dliteratum%253Aachs%26aulast%3DManikandan%26aufirst%3DP.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DCytochrome%2520P450%2520Structure%252C%2520Function%2520and%2520Clinical%2520Significance%253A%2520A%2520Review%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2018%26volume%3D19%26spage%3D38%26epage%3D54%26doi%3D10.2174%2F1389450118666170125144557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span> <i>Directed Evolution of Enzymes and Binding Proteins</i>. <a href="https://www.nobelprize.org/uploads/2018/10/advanced-chemistryprize-2018.pdf" class="extLink">https://www.nobelprize.org/uploads/2018/10/advanced-chemistryprize-2018.pdf</a> (accessed May 24, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Directed+Evolution+of+Enzymes+and+Binding+Proteins.+https%3A%2F%2Fwww.nobelprize.org%2Fuploads%2F2018%2F10%2Fadvanced-chemistryprize-2018.pdf+%28accessed+May+24%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DDirected%2520Evolution%2520of%2520Enzymes%2520and%2520Binding%2520Proteins" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Directed Evolution: Bringing New Chemistry to Life</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4143</span>– <span class="NLM_lpage">4148</span>, <span class="refDoi"> DOI: 10.1002/anie.201708408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201708408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOjsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=4143-4148&author=F.+H.+Arnold&title=Directed+Evolution%3A+Bringing+New+Chemistry+to+Life&doi=10.1002%2Fanie.201708408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Directed evolution: Bringing new chemistry to life</span></div><div class="casAuthors">Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4143-4148</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Directed evolution mimics evolution by artificial selection, and is accelerated in the lab. setting by focusing on individual genes expressed in fast-growing microorganisms.  We start with existing proteins (sourced from Nature or engineered), introduce mutations, and then screen for the progeny proteins with enhanced activity (or other desirable traits).  We use the improved enzymes as parents for the next round of mutation and screening, recombining beneficial mutations as needed, and continuing until we reach the target level of performance.  Thus, the evolution of Nature's enzymes can lead to the discovery of new reactivity, transformations not known in biol., and reactivity inaccessible by small-mol. catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJP45IjkyderVg90H21EOLACvtfcHk0lj3Bv-IMjfA2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOjsrvO&md5=d174f0faf8c21667000cdf19ed7c14e8</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201708408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201708408%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DDirected%2520Evolution%253A%2520Bringing%2520New%2520Chemistry%2520to%2520Life%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D4143%26epage%3D4148%26doi%3D10.1002%2Fanie.201708408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Behrendorff, J. B. Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, E. M. J.</span></span> <span> </span><span class="NLM_article-title">Directed Evolution of Cytochrome P450 Enzymes for Biocatalysis: Exploiting the Catalytic Versatility of Enzymes with Relaxed Substrate Specificity</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>467</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1042/BJ20141493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1042%2FBJ20141493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25793416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVOrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2015&pages=1-15&author=J.+B.+Y.+H.+Behrendorffauthor=W.+Huangauthor=E.+M.+J.+Gillam&title=Directed+Evolution+of+Cytochrome+P450+Enzymes+for+Biocatalysis%3A+Exploiting+the+Catalytic+Versatility+of+Enzymes+with+Relaxed+Substrate+Specificity&doi=10.1042%2FBJ20141493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity</span></div><div class="casAuthors">Behrendorff, James B. Y. H.; Huang, Weiliang; Gillam, Elizabeth M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 enzymes are renowned for their ability to insert oxygen into an enormous variety of compds. with a high degree of chemo- and regio-selectivity under mild conditions.  This property has been exploited in Nature for an enormous variety of physiol. functions, and representatives of this ancient enzyme family have been identified in all kingdoms of life.  The catalytic versatility of P450s makes them well suited for repurposing for the synthesis of fine chems. such as drugs.  Although these enzymes have not evolved in Nature to perform the reactions required for modern chem. industries, many P450s show relaxed substrate specificity and exhibit some degree of activity towards non-natural substrates of relevance to applications such as drug development.  Directed evolution and other protein engineering methods can be used to improve upon this low level of activity and convert these promiscuous generalist enzymes into specialists capable of mediating reactions of interest with exquisite regio- and stereo-selectivity.  Although there are some notable successes in exploiting P450s from natural sources in metabolic engineering, and P450s have been proven repeatedly to be excellent material for engineering, there are few examples to date of practical application of engineered P450s.  The purpose of the present review is to illustrate the progress that has been made in altering properties of P450s such as substrate range, cofactor preference and stability, and outline some of the remaining challenges that must be overcome for industrial application of these powerful biocatalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpohdYIZZzqirVg90H21EOLACvtfcHk0lj3Bv-IMjfA2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVOrsrw%253D&md5=918c99e8dbf124e03b4a56956c016607</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1042%2FBJ20141493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20141493%26sid%3Dliteratum%253Aachs%26aulast%3DBehrendorff%26aufirst%3DJ.%2BB.%2BY.%2BH.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DGillam%26aufirst%3DE.%2BM.%2BJ.%26atitle%3DDirected%2520Evolution%2520of%2520Cytochrome%2520P450%2520Enzymes%2520for%2520Biocatalysis%253A%2520Exploiting%2520the%2520Catalytic%2520Versatility%2520of%2520Enzymes%2520with%2520Relaxed%2520Substrate%2520Specificity%26jtitle%3DBiochem.%2520J.%26date%3D2015%26volume%3D467%26spage%3D1%26epage%3D15%26doi%3D10.1042%2FBJ20141493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Heel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodani, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerowitz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Non-Natural Olefin Cyclopropanation Catalyzed by Diverse Cytochrome P450s and Other Hemoproteins</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2556</span>– <span class="NLM_lpage">2562</span>, <span class="refDoi"> DOI: 10.1002/cbic.201402286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fcbic.201402286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25294253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVaksbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=2556-2562&author=T.+Heelauthor=J.+A.+McIntoshauthor=S.+C.+Dodaniauthor=J.+T.+Meyerowitzauthor=F.+H.+Arnold&title=Non-Natural+Olefin+Cyclopropanation+Catalyzed+by+Diverse+Cytochrome+P450s+and+Other+Hemoproteins&doi=10.1002%2Fcbic.201402286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Non-natural Olefin Cyclopropanation Catalyzed by Diverse Cytochrome P450s and Other Hemoproteins</span></div><div class="casAuthors">Heel, Thomas; McIntosh, John A.; Dodani, Sheel C.; Meyerowitz, Joseph T.; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2556-2562</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Recent work has shown that engineered variants of cytochrome P 450BM3 (CYP102A1) efficiently catalyze non-natural reactions, including carbene and nitrene transfer reactions.  Given the broad substrate range of natural P 450 enzymes, we set out to explore if this diversity could be leveraged to generate a broad panel of new catalysts for olefin cyclopropanation (i.e., carbene transfer).  Here, we took a step towards this goal by characterizing the carbene transfer activities of four new wild-type P450s that have different native substrates.  All four were active and exhibited a range of product selectivities in the model reaction: cyclopropanation of styrene by using Et diazoacetate (EDA).  Previous work on P 450BM3 demonstrated that mutation of the axial coordinating cysteine, universally conserved among P 450 enzymes, to a serine residue, increased activity for this non-natural reaction.  The equivalent mutation in the selected P450s was found to activate carbene transfer chem. both in vitro and in vivo.  Furthermore, serum albumins complexed with hemin were also found to be efficient in vitro cyclopropanation catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE9hmIWPy6WbVg90H21EOLACvtfcHk0liN8VYwxrbVDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVaksbvL&md5=e7d61896a5b164d705c2516367a784da</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402286%26sid%3Dliteratum%253Aachs%26aulast%3DHeel%26aufirst%3DT.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BA.%26aulast%3DDodani%26aufirst%3DS.%2BC.%26aulast%3DMeyerowitz%26aufirst%3DJ.%2BT.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DNon-Natural%2520Olefin%2520Cyclopropanation%2520Catalyzed%2520by%2520Diverse%2520Cytochrome%2520P450s%2520and%2520Other%2520Hemoproteins%26jtitle%3DChemBioChem%26date%3D2014%26volume%3D15%26spage%3D2556%26epage%3D2562%26doi%3D10.1002%2Fcbic.201402286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Engineering Cytochrome P450 Biocatalysts for Biotechnology, Medicine and Bioremediation</span>. <i>Expert Opin. Drug. Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1517/17425250903431040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1517%2F17425250903431040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=20064075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=115-131&author=S.+Kumar&title=Engineering+Cytochrome+P450+Biocatalysts+for+Biotechnology%2C+Medicine+and+Bioremediation&doi=10.1517%2F17425250903431040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33dR"><div class="casContent"><span class="casTitleNuber">33d</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation</span></div><div class="casAuthors">Kumar, Santosh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-131</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Cytochrome P 450 enzymes comprise a superfamily of heme monooxygenases that are of considerable interest for the: (i) synthesis of novel drugs and drug metabolites; (ii) targeted cancer gene therapy; (iii) biosensor design; and (iv) bioremediation.  However, their applications are limited because cytochrome P 450, esp. mammalian P 450 enzymes, show a low turnover rate and stability, and require a complex source of electrons through cytochrome P 450 reductase and NADPH.  Areas covered in this review: In this review, we discuss the recent progress towards the use of P 450 enzymes in a variety of the above-mentioned applications.  We also present alternate and cost-effective ways to perform P 450-mediated reaction, esp. using peroxides.  Furthermore, we expand upon the current progress in P 450 engineering approaches describing several recent examples that are utilized to enhance heterologous expression, stability, catalytic efficiency and utilization of alternate oxidants.What the reader will gain: The review provides a comprehensive knowledge in the design of P 450 biocatalysts for potentially practical purposes.  Finally, we provide a prospective on the future aspects of P 450 engineering and its applications in biotechnol., medicine and bioremediation.  Take home message: Because of its wide applications, academic and pharmaceutical researchers, environmental scientists and healthcare providers are expected to gain current knowledge and future prospects of the practical use of P 450 biocatalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9w0ZIMkOQXrVg90H21EOLACvtfcHk0lgyBkwfFaB9XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyhs70%253D&md5=39cb4ecda860ae801373e3c2a684916b</span></div><a href="/servlet/linkout?suffix=cit33d&amp;dbid=16384&amp;doi=10.1517%2F17425250903431040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903431040%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DEngineering%2520Cytochrome%2520P450%2520Biocatalysts%2520for%2520Biotechnology%252C%2520Medicine%2520and%2520Bioremediation%26jtitle%3DExpert%2520Opin.%2520Drug.%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D115%26epage%3D131%26doi%3D10.1517%2F17425250903431040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rentmeister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasan, R.</span></span> <span> </span><span class="NLM_article-title">Chemo-Enzymatic Fluorination of Unactivated Organic Compounds</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1038/nchembio.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnchembio.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=19011638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=26-28&author=A.+Rentmeisterauthor=F.+H.+Arnoldauthor=R.+Fasan&title=Chemo-Enzymatic+Fluorination+of+Unactivated+Organic+Compounds&doi=10.1038%2Fnchembio.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33eR"><div class="casContent"><span class="casTitleNuber">33e</span><div class="casTitle"><span class="NLM_cas:atitle">Chemo-enzymatic fluorination of unactivated organic compounds</span></div><div class="casAuthors">Rentmeister, Andrea; Arnold, Frances H.; Fasan, Rudi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-28</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A versatile strategy that combines cytochrome P 450-catalyzed oxygenation with deoxofluorination to achieve mono- and polyfluorination of nonactive sites in a variety of org. scaffolds, was described.  This procedure was applied for the rapid identification of fluorinated derivs. with enhanced membrane permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCBe4hN_oEC7Vg90H21EOLACvtfcHk0lilLqnEnpYd8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fJ&md5=9fa9f13be2acbc1a2ec3ba826a1576d0</span></div><a href="/servlet/linkout?suffix=cit33e&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.128%26sid%3Dliteratum%253Aachs%26aulast%3DRentmeister%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26aulast%3DFasan%26aufirst%3DR.%26atitle%3DChemo-Enzymatic%2520Fluorination%2520of%2520Unactivated%2520Organic%2520Compounds%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D26%26epage%3D28%26doi%3D10.1038%2Fnchembio.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Cytochromes P450 and Drug Discovery</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2007.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.copbio.2007.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=18006294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislOrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=504-512&author=D.+C.+Lambauthor=M.+R.+Watermanauthor=S.+L.+Kellyauthor=F.+P.+Guengerich&title=Cytochromes+P450+and+Drug+Discovery&doi=10.1016%2Fj.copbio.2007.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33fR"><div class="casContent"><span class="casTitleNuber">33f</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochromes P450 and drug discovery</span></div><div class="casAuthors">Lamb, David C.; Waterman, Michael R.; Kelly, Steven L.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">504-512</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cytochromes P 450 (CYP) are a superfamily of haem-contg. proteins distributed widely throughout nature.  Historically, they have a central role in drug metab. and following the advent of genomics they have been shown to have key roles in the biosynthesis of natural products which are used as medicines.  Herein, we provide an overview of CYP systems with particular emphasis on their role as drug targets, their involvement in drug biosynthesis and potential strategies for developing new derivs. of drugs based on CYP engineering.  The applied importance of CYPs for medicinal and biotechnol. applications will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfIt8WFtdfv7Vg90H21EOLACvtfcHk0lilLqnEnpYd8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislOrtw%253D%253D&md5=387294e46f8975cddc369a1198c033c3</span></div><a href="/servlet/linkout?suffix=cit33f&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2007.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2007.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DD.%2BC.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26aulast%3DKelly%26aufirst%3DS.%2BL.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DCytochromes%2520P450%2520and%2520Drug%2520Discovery%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2007%26volume%3D18%26spage%3D504%26epage%3D512%26doi%3D10.1016%2Fj.copbio.2007.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffreys, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poddar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golovanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girvan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voice, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, A. W.</span></span> <span> </span><span class="NLM_article-title">Novel Insights into P450 BM3 Interactions with FDA-Approved Antifungal Azole Drugs</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1577</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-37330-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fs41598-018-37330-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=30733479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BB3cfgsVSltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1577&author=L.+N.+Jeffreysauthor=H.+Poddarauthor=M.+Golovanovaauthor=C.+W.+Levyauthor=H.+M.+Girvanauthor=K.+J.+McLeanauthor=M.+W.+Voiceauthor=D.+Leysauthor=A.+W.+Munro&title=Novel+Insights+into+P450+BM3+Interactions+with+FDA-Approved+Antifungal+Azole+Drugs&doi=10.1038%2Fs41598-018-37330-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs</span></div><div class="casAuthors">Jeffreys Laura N; Poddar Harshwardhan; Golovanova Marina; Girvan Hazel M; McLean Kirsty J; Leys David; Munro Andrew W; Levy Colin W; Voice Michael W</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1577</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Flavocytochrome P450 BM3 is a natural fusion protein constructed of cytochrome P450 and NADPH-cytochrome P450 reductase domains.  P450 BM3 binds and oxidizes several mid- to long-chain fatty acids, typically hydroxylating these lipids at the ω-1, ω-2 and ω-3 positions.  However, protein engineering has led to variants of this enzyme that are able to bind and oxidize diverse compounds, including steroids, terpenes and various human drugs.  The wild-type P450 BM3 enzyme binds inefficiently to many azole antifungal drugs.  However, we show that the BM3 A82F/F87V double mutant (DM) variant binds substantially tighter to numerous azole drugs than does the wild-type BM3, and that their binding occurs with more extensive heme spectral shifts indicative of complete binding of several azoles to the BM3 DM heme iron.  We report here the first crystal structures of P450 BM3 bound to azole antifungal drugs - with the BM3 DM heme domain bound to the imidazole drugs clotrimazole and tioconazole, and to the triazole drugs fluconazole and voriconazole.  This is the first report of any protein structure bound to the azole drug tioconazole, as well as the first example of voriconazole heme iron ligation through a pyrimidine nitrogen from its 5-fluoropyrimidine ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVcbY-xv2TiAWRJ3OJdH_qfW6udTcc2eagI8UKF3TLSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfgsVSltw%253D%253D&md5=caa30f8e61dc8fdeeb70a336c2a6a5c0</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-37330-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-37330-y%26sid%3Dliteratum%253Aachs%26aulast%3DJeffreys%26aufirst%3DL.%2BN.%26aulast%3DPoddar%26aufirst%3DH.%26aulast%3DGolovanova%26aufirst%3DM.%26aulast%3DLevy%26aufirst%3DC.%2BW.%26aulast%3DGirvan%26aufirst%3DH.%2BM.%26aulast%3DMcLean%26aufirst%3DK.%2BJ.%26aulast%3DVoice%26aufirst%3DM.%2BW.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DMunro%26aufirst%3DA.%2BW.%26atitle%3DNovel%2520Insights%2520into%2520P450%2520BM3%2520Interactions%2520with%2520FDA-Approved%2520Antifungal%2520Azole%2520Drugs%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D1577%26doi%3D10.1038%2Fs41598-018-37330-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Catalysts on Demand: Selective Oxidations by Laboratory-Evolved Cytochrome P450 BM3</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.2533/chimia.2009.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.2533%2Fchimia.2009.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=309-312&author=J.+C.+Lewisauthor=F.+H.+Arnold&title=Catalysts+on+Demand%3A+Selective+Oxidations+by+Laboratory-Evolved+Cytochrome+P450+BM3&doi=10.2533%2Fchimia.2009.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Catalysts on demand: selective oxidations by laboratory-evolved cytochrome P450 BM3</span></div><div class="casAuthors">Lewis, Jared C.; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">309-312</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review of the authors on research.  Efficient catalysts for selective oxidn. of C-H bonds using atm. oxygen are highly desirable to decrease the economic and environmental costs assocd. with conventional oxidn. processes.  We have used methods of directed evolution to generate variants of bacterial cytochrome P 450 BM3 that catalyze hydroxylation and epoxidn. of a wide range of non-native substrates.  This fatty acid hydroxylase was converted to a propane monooxygenase (PMO) capable of hydroxylating propane at rates comparable to that of BM3 on its natural substrates.  Variants along the PMO evolutionary lineage showed broadened substrate scope; these became the starting points for evolution of a wide array of enzymes that can hydroxylate and derivatize org. scaffolds.  This work demonstrates how a single member of enzyme family is readily converted by evolution into a whole family of catalysts for org. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq53979gJHgCrVg90H21EOLACvtfcHk0lilLqnEnpYd8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVylu7w%253D&md5=b5c1099a2b4eb4e0e7ff30415cacd97a</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2009.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2009.309%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BC.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DCatalysts%2520on%2520Demand%253A%2520Selective%2520Oxidations%2520by%2520Laboratory-Evolved%2520Cytochrome%2520P450%2520BM3%26jtitle%3DChimia%26date%3D2009%26volume%3D63%26spage%3D309%26epage%3D312%26doi%3D10.2533%2Fchimia.2009.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit34c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Otey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Preparation of Human Metabolites of Propranolol Using Laboratory-Evolved Bacterial Cytochromes P450</span>. <i>Biotechnol. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1002/bit.20744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fbit.20744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=16224788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2006&pages=494-499&author=C.+R.+Oteyauthor=G.+Bandaraauthor=J.+Lalondeauthor=K.+Takahashiauthor=F.+H.+Arnold&title=Preparation+of+Human+Metabolites+of+Propranolol+Using+Laboratory-Evolved+Bacterial+Cytochromes+P450&doi=10.1002%2Fbit.20744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34cR"><div class="casContent"><span class="casTitleNuber">34c</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450</span></div><div class="casAuthors">Otey, Christopher R.; Bandara, Geethani; Lalonde, James; Takahashi, Katsuyuki; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology and Bioengineering</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">494-499</span>CODEN:
                <span class="NLM_cas:coden">BIBIAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3592</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Testing the toxicities and biol. activities of the human metabolites of drugs is important for development of safe and effective pharmaceuticals.  Producing these metabolites using human cytochrome P450s is difficult, however, because the human enzymes are costly, poorly stable, and slow.  We have used directed evolution to generate variants of P 450 BM3 from Bacillus megaterium that function via the "peroxide shunt" pathway, using hydrogen peroxide in place of the reductase domain, oxygen and NADPH.  Here, we report further evolution of the P 450 BM3 heme domain peroxygenase to enhance prodn. of the authentic human metabolites of propranolol by this biocatalytic route.  This system offers a versatile, cost-effective, and scaleable route to the synthesis of drug metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHhXZ5DpXo7LVg90H21EOLACvtfcHk0liu8l7ansU97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KrsLk%253D&md5=88c4e34d4d1b7a770fa165077c2dc727</span></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1002%2Fbit.20744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbit.20744%26sid%3Dliteratum%253Aachs%26aulast%3DOtey%26aufirst%3DC.%2BR.%26aulast%3DBandara%26aufirst%3DG.%26aulast%3DLalonde%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DPreparation%2520of%2520Human%2520Metabolites%2520of%2520Propranolol%2520Using%2520Laboratory-Evolved%2520Bacterial%2520Cytochromes%2520P450%26jtitle%3DBiotechnol.%2520Bioeng.%26date%3D2006%26volume%3D93%26spage%3D494%26epage%3D499%26doi%3D10.1002%2Fbit.20744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Di Nardo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilardi, G.</span></span> <span> </span><span class="NLM_article-title">Optimization of the Bacterial Cytochrome P450 BM3 System for the Production of Human Drug Metabolites</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">15901</span>– <span class="NLM_lpage">15924</span>, <span class="refDoi"> DOI: 10.3390/ijms131215901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.3390%2Fijms131215901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23443101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyisbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=15901-15924&author=G.+Di+Nardoauthor=G.+Gilardi&title=Optimization+of+the+Bacterial+Cytochrome+P450+BM3+System+for+the+Production+of+Human+Drug+Metabolites&doi=10.3390%2Fijms131215901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites</span></div><div class="casAuthors">Di Nardo, Giovanna; Gilardi, Gianfranco</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15901-15924</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Drug metab. in human liver is a process involving many different enzymes.  Among them, a no. of cytochromes P 450 isoforms catalyze the oxidn. of most of the drugs com. available.  Each P 450 isoform acts on more than one drug, and one drug may be oxidized by more than one enzyme.  As a result, multiple products may be obtained from the same drug, and as the metabolites can be biol. active and may cause adverse drug reactions (ADRs), the metabolic profile of a new drug has to be known before this can be commercialized.  Therefore, the metabolites of a certain drug must be identified, synthesized and tested for toxicity.  Their synthesis must be in sufficient quantities to be used for metabolic tests.  This review focuses on the progresses done in the field of the optimization of a bacterial self-sufficient and efficient cytochrome P 450, P 450 BM3 from Bacillus megaterium, used for the prodn. of metabolites of human enzymes.  The progress made in the improvement of its catalytic performance towards drugs, the substitution of the costly NADPH cofactor and its immobilization and scale-up of the process for industrial application are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRaEnf4Mm3HbVg90H21EOLACvtfcHk0liu8l7ansU97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyisbzL&md5=8643ee1e3efe25b968d196e221dc88bd</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.3390%2Fijms131215901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms131215901%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BNardo%26aufirst%3DG.%26aulast%3DGilardi%26aufirst%3DG.%26atitle%3DOptimization%2520of%2520the%2520Bacterial%2520Cytochrome%2520P450%2520BM3%2520System%2520for%2520the%2520Production%2520of%2520Human%2520Drug%2520Metabolites%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26spage%3D15901%26epage%3D15924%26doi%3D10.3390%2Fijms131215901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Fueyo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Biocatalytic Oxidation Reactions: A Chemist’s Perspective</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9238</span>– <span class="NLM_lpage">9261</span>, <span class="refDoi"> DOI: 10.1002/anie.201800343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201800343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KqtLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=9238-9261&author=J.+Dongauthor=E.+Fern%C3%A1ndez-Fueyoauthor=F.+Hollmannauthor=C.+E.+Paulauthor=M.+Pesicauthor=S.+Schmidtauthor=Y.+Wangauthor=S.+Younesauthor=W.+Zhang&title=Biocatalytic+Oxidation+Reactions%3A+A+Chemist%E2%80%99s+Perspective&doi=10.1002%2Fanie.201800343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Biocatalytic Oxidation Reactions: A Chemist's Perspective</span></div><div class="casAuthors">Dong, JiaJia; Fernandez-Fueyo, Elena; Hollmann, Frank; Paul, Caroline E.; Pesic, Milja; Schmidt, Sandy; Wang, Yonghua; Younes, Sabry; Zhang, Wuyuan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9238-9261</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Oxidn. chem. using enzymes is approaching maturity and practical applicability in org. synthesis.  Oxidoreductases (enzymes catalyzing redox reactions) enable chemists to perform highly selective and efficient transformations ranging from simple alc. oxidns. to stereoselective halogenations of non-activated C-H bonds.  For many of these reactions, no "classical" chem. counterpart is known.  Hence oxidoreductases open up shorter synthesis routes based on a more direct access to the target products.  The generally very mild reaction conditions may also reduce the environmental impact of biocatalytic reactions compared to classical counterparts.  In this Review, we critically summarize the most important recent developments in the field of biocatalytic oxidn. chem. and identify the most pressing bottlenecks as well as promising solns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU2yAEnskYFLVg90H21EOLACvtfcHk0ljyp71Y1A2dRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KqtLnK&md5=5e219249fd4b424279f569e70d5c26b1</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201800343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201800343%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DFern%25C3%25A1ndez-Fueyo%26aufirst%3DE.%26aulast%3DHollmann%26aufirst%3DF.%26aulast%3DPaul%26aufirst%3DC.%2BE.%26aulast%3DPesic%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYounes%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DBiocatalytic%2520Oxidation%2520Reactions%253A%2520A%2520Chemist%25E2%2580%2599s%2520Perspective%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D9238%26epage%3D9261%26doi%3D10.1002%2Fanie.201800343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaluzna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitges, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straatman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Tegelen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schürmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mink, D.</span></span> <span> </span><span class="NLM_article-title">Enabling Selective and Sustainable P450 Oxygenation Technology. Production of 4-Hydroxy-α-isophorone on Kilogram Scale</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.5b00282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.5b00282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFejs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=814-819&author=I.+Kaluznaauthor=T.+Schmitgesauthor=H.+Straatmanauthor=D.+van+Tegelenauthor=M.+M%C3%BCllerauthor=M.+Sch%C3%BCrmannauthor=D.+Mink&title=Enabling+Selective+and+Sustainable+P450+Oxygenation+Technology.+Production+of+4-Hydroxy-%CE%B1-isophorone+on+Kilogram+Scale&doi=10.1021%2Facs.oprd.5b00282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Enabling Selective and Sustainable P450 Oxygenation Technology. Production of 4-Hydroxy-α-isophorone on Kilogram Scale</span></div><div class="casAuthors">Kaluzna, Iwona; Schmitges, Thomas; Straatman, Harrie; van Tegelen, Dennis; Mueller, Monika; Schuermann, Martin; Mink, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">814-819</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of P 450 platform technol. has enabled the sustainable prodn. of an oxygenated intermediate, 4-hydroxy-α-isophorone, on kilogram scale.  Application of a cytochrome P 450 enzyme resulted in an unprecedented product concn. of 10 g/L and a space-time yield of 1.5 g/L/h.  These findings are highly relevant for the economical evaluation of cytochrome P 450 technol. and, addnl., provide access to an alternative and cost-effective route toward 4-hydroxy-α-isophorone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGWLZLVX3Fq7Vg90H21EOLACvtfcHk0ljyp71Y1A2dRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFejs7g%253D&md5=4f5aa8df3faa0abcd18fe1a26d1cb1b4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.5b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.5b00282%26sid%3Dliteratum%253Aachs%26aulast%3DKaluzna%26aufirst%3DI.%26aulast%3DSchmitges%26aufirst%3DT.%26aulast%3DStraatman%26aufirst%3DH.%26aulast%3Dvan%2BTegelen%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DSch%25C3%25BCrmann%26aufirst%3DM.%26aulast%3DMink%26aufirst%3DD.%26atitle%3DEnabling%2520Selective%2520and%2520Sustainable%2520P450%2520Oxygenation%2520Technology.%2520Production%2520of%25204-Hydroxy-%25CE%25B1-isophorone%2520on%2520Kilogram%2520Scale%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2016%26volume%3D20%26spage%3D814%26epage%3D819%26doi%3D10.1021%2Facs.oprd.5b00282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span> <i>Codexis Screening Kits and Biocatalysts</i>. <a href="https://www.codexis.com/products/screening-kits/" class="extLink">https://www.codexis.com/products/screening-kits/</a>(accessed May 25, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Codexis+Screening+Kits+and+Biocatalysts.+https%3A%2F%2Fwww.codexis.com%2Fproducts%2Fscreening-kits%2F%28accessed+May+25%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCodexis%2520Screening%2520Kits%2520and%2520Biocatalysts" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritz, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baska, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnghar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnia, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelleymounter, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of Pyrazine Carboxamide CB1 Antagonists: The Introduction of a Hydroxyl Group Improves the Pharmaceutical Properties and In Vivo Efficacy of the Series</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3978</span>– <span class="NLM_lpage">3982</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2007.04.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=17513109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVClu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3978-3982&author=B.+A.+Ellsworthauthor=Y.+Wangauthor=Y.+Zhuauthor=A.+Pendriauthor=S.+W.+Gerritzauthor=C.+Sunauthor=K.+E.+Carlsonauthor=L.+Kangauthor=R.+A.+Baskaauthor=Y.+Yangauthor=Q.+Huangauthor=N.+T.+Burfordauthor=M.+J.+Cullenauthor=S.+Johngharauthor=K.+Behniaauthor=M.+A.+Pelleymounterauthor=W.+N.+Washburnauthor=W.+R.+Ewing&title=Discovery+of+Pyrazine+Carboxamide+CB1+Antagonists%3A+The+Introduction+of+a+Hydroxyl+Group+Improves+the+Pharmaceutical+Properties+and+In+Vivo+Efficacy+of+the+Series&doi=10.1016%2Fj.bmcl.2007.04.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series</span></div><div class="casAuthors">Ellsworth, Bruce A.; Wang, Ying; Zhu, Yeheng; Pendri, Annapurna; Gerritz, Samuel W.; Sun, Chongqing; Carlson, Kenneth E.; Kang, Liya; Baska, Rose A.; Yang, Yifan; Huang, Qi; Burford, Neil T.; Cullen, Mary Jane; Johnghar, Susan; Behnia, Kamelia; Pelleymounter, Mary Ann; Washburn, William N.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3978-3982</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Structure-activity relationships for a series of pyrazine carboxamide CB1 antagonists are reported.  Pharmaceutical properties of the series are improved via inclusion of hydroxyl-contg. sidechains.  This structural modification sufficiently improved ADME properties of an orally inactive series such that food intake redn. was achieved in rat feeding models.  Compd. 35 (I) elicits a 46% redn. in food intake in ad libitum fed rats 4-h post-dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqp2iSxEZT2bVg90H21EOLACvtfcHk0lgPaRHFmKgcrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVClu7k%253D&md5=723258b8fb296b9d23ff228d0ce7d15d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.087%26sid%3Dliteratum%253Aachs%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DKang%26aufirst%3DL.%26aulast%3DBaska%26aufirst%3DR.%2BA.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DJohnghar%26aufirst%3DS.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DPelleymounter%26aufirst%3DM.%2BA.%26aulast%3DWashburn%26aufirst%3DW.%2BN.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DDiscovery%2520of%2520Pyrazine%2520Carboxamide%2520CB1%2520Antagonists%253A%2520The%2520Introduction%2520of%2520a%2520Hydroxyl%2520Group%2520Improves%2520the%2520Pharmaceutical%2520Properties%2520and%2520In%2520Vivo%2520Efficacy%2520of%2520the%2520Series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3978%26epage%3D3982%26doi%3D10.1016%2Fj.bmcl.2007.04.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brajša, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivekovic, D.</span></span> <span> </span><span class="NLM_article-title">New Derivatives of Tylosin: Chemical and Electrochemical Oxidation Products of Desmycosin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.55.807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.7164%2Fantibiotics.55.807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=12458770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2002&pages=807-813&author=Z.+Mandicauthor=A.+Narandaauthor=P.+Novakauthor=K.+Braj%C5%A1aauthor=M.+Derekauthor=D.+Ivekovic&title=New+Derivatives+of+Tylosin%3A+Chemical+and+Electrochemical+Oxidation+Products+of+Desmycosin&doi=10.7164%2Fantibiotics.55.807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">New derivatives of tylosin: chemical and electrochemical oxidation products of desmycosin</span></div><div class="casAuthors">Mandic, Z.; Naranda, A.; Novak, P.; Brajsa, K.; Derek, M.; Ivekovic, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">807-813</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Chem. and electrochem. oxidn. of dienonic moiety of desmycosin were carried out.  Successive chem. oxidn. of desmycosin with m-chloroperbenzoic acid afforded a family of 12,13-dihydro-12,13-dihydroxy derivs.  Indirect electrochem. oxidn. via hypobromite as an intermediate gave rise to the new bicyclo deriv. of desmycosin, 13-hydroxy-3-dehydroxy-3,12-oxa-desmycosin (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZAakAAYyf0rVg90H21EOLACvtfcHk0lgPaRHFmKgcrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFGrt70%253D&md5=004e04e7e82534ff099e36481ab20a87</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.55.807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.55.807%26sid%3Dliteratum%253Aachs%26aulast%3DMandic%26aufirst%3DZ.%26aulast%3DNaranda%26aufirst%3DA.%26aulast%3DNovak%26aufirst%3DP.%26aulast%3DBraj%25C5%25A1a%26aufirst%3DK.%26aulast%3DDerek%26aufirst%3DM.%26aulast%3DIvekovic%26aufirst%3DD.%26atitle%3DNew%2520Derivatives%2520of%2520Tylosin%253A%2520Chemical%2520and%2520Electrochemical%2520Oxidation%2520Products%2520of%2520Desmycosin%26jtitle%3DJ.%2520Antibiot.%26date%3D2002%26volume%3D55%26spage%3D807%26epage%3D813%26doi%3D10.7164%2Fantibiotics.55.807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopotar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivekovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkalcec, M.</span></span> <span> </span><span class="NLM_article-title">Tylosin Derivatives. V. Electrochemical Opening of Oxirane Ring</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1145</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.7164%2Fantibiotics.52.1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10695679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1143-1145&author=Z.+Mandicauthor=A.+Narandaauthor=N.+Lopotarauthor=L.+Duicauthor=D.+Ivekovicauthor=M.+Tkalcec&title=Tylosin+Derivatives.+V.+Electrochemical+Opening+of+Oxirane+Ring&doi=10.7164%2Fantibiotics.52.1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Tylosin derivatives V. Electrochemical opening of oxirane ring</span></div><div class="casAuthors">Mandic, Z.; Naranda, A.; Lopotar, N.; Duic, Lj.; Ivekovic, D.; Tkalcec, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1143-1145</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">The authors report the electrochem. redn. of 12,13-epoxy-12,13-dihydrotylosin at a mercury electrode.  The mechanism of redn. is investigated by cyclic voltammetry and preparative scale electrolysis is carried out for the isolation and identification of products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx8w-pKhG-B7Vg90H21EOLACvtfcHk0ljv0YHY1jXCvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslGgtw%253D%253D&md5=4e5aa916f83be37483a85d4e77cd85bc</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.1143%26sid%3Dliteratum%253Aachs%26aulast%3DMandic%26aufirst%3DZ.%26aulast%3DNaranda%26aufirst%3DA.%26aulast%3DLopotar%26aufirst%3DN.%26aulast%3DDuic%26aufirst%3DL.%26aulast%3DIvekovic%26aufirst%3DD.%26aulast%3DTkalcec%26aufirst%3DM.%26atitle%3DTylosin%2520Derivatives.%2520V.%2520Electrochemical%2520Opening%2520of%2520Oxirane%2520Ring%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D1143%26epage%3D1145%26doi%3D10.7164%2Fantibiotics.52.1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jurva, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Generation of Drug Metabolites with Applications in Drug Discovery and Development</span>. <i>TrAC, Trends Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.trac.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.trac.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=92-99&author=U.+Jurvaauthor=L.+Weidolf&title=Electrochemical+Generation+of+Drug+Metabolites+with+Applications+in+Drug+Discovery+and+Development&doi=10.1016%2Fj.trac.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical generation of drug metabolites with applications in drug discovery and development</span></div><div class="casAuthors">Jurva, Ulrik; Weidolf, Lars</div><div class="citationInfo"><span class="NLM_cas:title">TrAC, Trends in Analytical Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-99</span>CODEN:
                <span class="NLM_cas:coden">TTAEDJ</span>;
        ISSN:<span class="NLM_cas:issn">0165-9936</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Detailed understanding of the biotransformation of drugs into stable or reactive metabolites is important during all stages of drug discovery and development.  Structural characterization of metabolites in the early stages allows for design of new mols. with, e.g., reduced metabolic clearance or decreased risk to form reactive metabolites.  In the later stages, detailed understanding of metabolic pathways is equally important for, e.g., safety assessment.  Over the past decade, we explored the potential of electrochem. (EC) in drug discovery and development.  One consequence of the mechanistic differences between EC and enzymic oxidns. is that some, but not all, metabolic pathways can be mimicked by EC.  We therefore conclude that EC cannot replace traditional metab. studies in biol. systems.  Instead, we see EC as a particularly useful complementary technique for synthesis of metabolite stds., investigations of bioactivation pathways, and study of interactions of reactive metabolites with biol. macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc-5rhXZnnErVg90H21EOLACvtfcHk0ljv0YHY1jXCvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCjt7c%253D&md5=56d07d01b49d25ed7baca82cacdc5312</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.trac.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trac.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DJurva%26aufirst%3DU.%26aulast%3DWeidolf%26aufirst%3DL.%26atitle%3DElectrochemical%2520Generation%2520of%2520Drug%2520Metabolites%2520with%2520Applications%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DTrAC%252C%2520Trends%2520Anal.%2520Chem.%26date%3D2015%26volume%3D70%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.trac.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fődi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignácz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decsi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Béni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Túrós, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszthy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, G. T.</span></span> <span> </span><span class="NLM_article-title">Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">9385</span>– <span class="NLM_lpage">9392</span>, <span class="refDoi"> DOI: 10.1002/chem.201800892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fchem.201800892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29736963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFalt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=9385-9392&author=T.+F%C5%91diauthor=G.+Ign%C3%A1czauthor=B.+Decsiauthor=Z.+B%C3%A9niauthor=G.+I.+T%C3%BAr%C3%B3sauthor=J.+Kupaiauthor=D.+B.+Weiserauthor=I.+Greinerauthor=P.+Huszthyauthor=G.+T.+Balogh&title=Biomimetic+Synthesis+of+Drug+Metabolites+in+Batch+and+Continuous-Flow+Reactors&doi=10.1002%2Fchem.201800892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors</span></div><div class="casAuthors">Fodi, Tamas; Ignacz, Gergo; Decsi, Balazs; Beni, Zoltan; Turos, Gyoergy I.; Kupai, Jozsef; Weiser, Diana Balogh; Greiner, Istvan; Huszthy, Peter; Balogh, Gyoergy T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9385-9392</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A medium-throughput screening (MTS) of biomimetic drug metabolite synthesis is developed by using an iron porphyrin catalyst.  The microplate method, in combination with HPLC-MS anal., was a useful tool for process development and parameter optimization in the prodn. of targeted metabolites and/or oxidn. products of forty-three different drug substances.  In the case of the biomimetic oxidn. of amiodarone, the high quantity and purity of the isolated products enabled detailed HRMS and NMR spectroscopic studies.  In addn. to identification of known metabolites, several new oxidn. products of the drug that was studied were characterized.  Fast degrdn. and poor recovery of the catalyst under batch conditions was overcome by immobilization of 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrin iron(III) chloride (FeTSPP) on the surface of 3-aminopropyl-functionalized silica by electrostatic interaction.  The supported catalyst was successfully applied in a packed-bed reactor under continuous-flow reaction conditions for the large-scale synthesis of amiodarone metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCv5flyf3P2bVg90H21EOLACvtfcHk0ljv0YHY1jXCvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFalt7zJ&md5=d7b360c29349b507262409d5f112ec86</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201800892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201800892%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C5%2591di%26aufirst%3DT.%26aulast%3DIgn%25C3%25A1cz%26aufirst%3DG.%26aulast%3DDecsi%26aufirst%3DB.%26aulast%3DB%25C3%25A9ni%26aufirst%3DZ.%26aulast%3DT%25C3%25BAr%25C3%25B3s%26aufirst%3DG.%2BI.%26aulast%3DKupai%26aufirst%3DJ.%26aulast%3DWeiser%26aufirst%3DD.%2BB.%26aulast%3DGreiner%26aufirst%3DI.%26aulast%3DHuszthy%26aufirst%3DP.%26aulast%3DBalogh%26aufirst%3DG.%2BT.%26atitle%3DBiomimetic%2520Synthesis%2520of%2520Drug%2520Metabolites%2520in%2520Batch%2520and%2520Continuous-Flow%2520Reactors%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2018%26volume%3D24%26spage%3D9385%26epage%3D9392%26doi%3D10.1002%2Fchem.201800892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baglia, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaragoza, J. P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. P.</span></span> <span> </span><span class="NLM_article-title">Biomimetic Reactivity of Oxygen-Derived Manganese and Iron Porphyrinoid Complexes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">13320</span>– <span class="NLM_lpage">13352</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wntb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=13320-13352&author=R.+A.+Bagliaauthor=J.+P.+T.+Zaragozaauthor=D.+P.+Goldberg&title=Biomimetic+Reactivity+of+Oxygen-Derived+Manganese+and+Iron+Porphyrinoid+Complexes&doi=10.1021%2Facs.chemrev.7b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic Reactivity of Oxygen-Derived Manganese and Iron Porphyrinoid Complexes</span></div><div class="casAuthors">Baglia, Regina A.; Zaragoza, Jan Paulo T.; Goldberg, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13320-13352</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review; heme proteins utilize the heme cofactor, an iron porphyrin, to perform a diverse range of reactions including dioxygen binding and transport, electron transfer, and oxidn./oxygenations.  These reactions share several key metalloporphyrin intermediates, typically derived from dioxygen and its congeners such as hydrogen peroxide.  These species are composed of metal-dioxygen, metal-superoxo, metal-peroxo, and metal-oxo adducts.  A wide variety of synthetic metalloporphyrinoid complexes have been synthesized to generate and stabilize these intermediates.  These complexes have been studied to det. the spectroscopic features, structures, and reactivities of such species in controlled and well-defined environments.  In this Review, we summarize recent findings on the reactivity of these species with common porphyrinoid scaffolds employed for biomimetic studies.  The proposed mechanisms of action are emphasized.  This Review is organized by structural type of metal-oxygen intermediate and broken into subsections based on the metal (manganese and iron) and porphyrinoid ligand (porphyrin, corrole, and corrolazine).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTYCfdgfpjJrVg90H21EOLACvtfcHk0ljv0YHY1jXCvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wntb%252FL&md5=5f122ca5811a8dd96927f32dc9c98e82</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00180%26sid%3Dliteratum%253Aachs%26aulast%3DBaglia%26aufirst%3DR.%2BA.%26aulast%3DZaragoza%26aufirst%3DJ.%2BP.%2BT.%26aulast%3DGoldberg%26aufirst%3DD.%2BP.%26atitle%3DBiomimetic%2520Reactivity%2520of%2520Oxygen-Derived%2520Manganese%2520and%2520Iron%2520Porphyrinoid%2520Complexes%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D13320%26epage%3D13352%26doi%3D10.1021%2Facs.chemrev.7b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit41c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, V. K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-S.</span></span> <span> </span><span class="NLM_article-title">Selective Functionalisation of Saturated C–H Bonds with Metalloporphyrincatalysts</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1950</span>– <span class="NLM_lpage">1975</span>, <span class="refDoi"> DOI: 10.1039/c0cs00142b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fc0cs00142b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21387046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFegsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=1950-1975&author=C.-M.+Cheauthor=V.+K.-Y.+Loauthor=C.-Y.+Zhouauthor=J.-S.+Huang&title=Selective+Functionalisation+of+Saturated+C%E2%80%93H+Bonds+with+Metalloporphyrincatalysts&doi=10.1039%2Fc0cs00142b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">Selective functionalisation of saturated C-H bonds with metalloporphyrin catalysts</span></div><div class="casAuthors">Che, Chi-Ming; Lo, Vanessa Kar-Yan; Zhou, Cong-Ying; Huang, Jie-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1950-1975</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This crit. review focused on metalloporphyrin-catalyzed satd. C-H bond functionalization reported since the year 2000, including C-O, C-N and C-C bond formation via hydroxylation, amination, and carbenoid insertion, resp., together with a brief description of previous achievements in this area.  Among the metalloporphyrin-catalyzed reactions highlighted herein are the hydroxylation of steroids, cycloalkanes, and benzylic hydrocarbons; intermol. amination of steroids, cycloalkanes, and benzylic or allylic hydrocarbons; intramol. amination of sulfamate esters and org. azides; intermol. carbenoid insertion into benzylic, allylic or alkane C-H bonds; and intramol. carbenoid C-H insertion of tosylhydrazones.  These metalloporphyrin-catalyzed satd. C-H bond functionalization reactions feature high regio-, diastereo- or enantioselectivity and/or high product turnover nos.  Mechanistic studies suggest the involvement of metal-oxo, -imido (or nitrene), and -carbene porphyrin complexes in the reactions.  The reactivity of such metal-ligand multiple bonded species towards satd. C-H bonds, including mechanistic studies through both exptl. and theor. means, is also discussed (244 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgRmpGNgIGbbVg90H21EOLACvtfcHk0ljGlRKNshLtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFegsb4%253D&md5=47eb169a66277be18fbfa3e38285ba60</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1039%2Fc0cs00142b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cs00142b%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DC.-M.%26aulast%3DLo%26aufirst%3DV.%2BK.-Y.%26aulast%3DZhou%26aufirst%3DC.-Y.%26aulast%3DHuang%26aufirst%3DJ.-S.%26atitle%3DSelective%2520Functionalisation%2520of%2520Saturated%2520C%25E2%2580%2593H%2520Bonds%2520with%2520Metalloporphyrincatalysts%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D1950%26epage%3D1975%26doi%3D10.1039%2Fc0cs00142b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abid Masood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morao, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancy, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span> <span> </span><span class="NLM_article-title">Lead Diversification. Application to Existing Drug Molecules: Mifepristone 1 and Antalarmin 8</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2011.10.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=22104142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XivV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=723-728&author=M.+Abid+Masoodauthor=E.+Farrantauthor=I.+Moraoauthor=M.+Bazinauthor=M.+Perezauthor=M.+E.+Bunnageauthor=S.-A.+Fancyauthor=T.+Peakman&title=Lead+Diversification.+Application+to+Existing+Drug+Molecules%3A+Mifepristone+1+and+Antalarmin+8&doi=10.1016%2Fj.bmcl.2011.10.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Lead diversification. Application to existing drug molecules: Mifepristone 2 and antalarmin 8</span></div><div class="casAuthors">Abid Masood, M.; Farrant, Elizabeth; Morao, Inaki; Bazin, Marc; Perez, Manuel; Bunnage, Mark E.; Fancy, Sally-Ann; Peakman, Torren</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">723-728</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of C-H functionalization plate-based chem. screens and other C-H activation protocols were developed for the chem. diversification of drug mols.  In this Letter, metalloporphyrin and other catalytic oxidn. systems are described in addn. to chlorination.  Mifepristone and antalarmin are used as substrates.  The products obtained and the biol. data demonstrate the potential utility of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQ8bpgUtDZ7Vg90H21EOLACvtfcHk0ljGlRKNshLtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivV2isQ%253D%253D&md5=37b5441091b585585a19428e1b8f20e2</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.066%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%2BMasood%26aufirst%3DM.%26aulast%3DFarrant%26aufirst%3DE.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DBazin%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DFancy%26aufirst%3DS.-A.%26aulast%3DPeakman%26aufirst%3DT.%26atitle%3DLead%2520Diversification.%2520Application%2520to%2520Existing%2520Drug%2520Molecules%253A%2520Mifepristone%25201%2520and%2520Antalarmin%25208%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D723%26epage%3D728%26doi%3D10.1016%2Fj.bmcl.2011.10.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Masood, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancy, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitzel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span> <span> </span><span class="NLM_article-title">Lead Diversification 2: Application to P38, gMTP and Lead Compounds</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2011.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=22172703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1255-1262&author=M.+A.+Masoodauthor=M.+Bazinauthor=M.+E.+Bunnageauthor=A.+Calabreseauthor=M.+Coxauthor=S.-A.+Fancyauthor=E.+Farrantauthor=D.+W.+Pearceauthor=M.+Perezauthor=L.+Hitzelauthor=T.+Peakman&title=Lead+Diversification+2%3A+Application+to+P38%2C+gMTP+and+Lead+Compounds&doi=10.1016%2Fj.bmcl.2011.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Diversification 2: Application to P38, gMTP and lead compounds</span></div><div class="casAuthors">Masood, M. Abid; Bazin, Marc; Bunnage, Mark E.; Calabrese, Andrew; Cox, Mark; Fancy, Sally-Ann; Farrant, Elizabeth; Pearce, David W.; Perez, Manuel; Hitzel, Laure; Peakman, Torren</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1255-1262</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lead Diversification is a new technol. platform developed at Pfizer for the functionalization of drug mols. using C-H activation.  We describe its application to some drug programs such as P38 and gMTP and the development of some new plate based screens including a fluorination screen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaEWGowjCGerVg90H21EOLACvtfcHk0ljGlRKNshLtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFartA%253D%253D&md5=2437212fcc6cde93ac62ddf669cd8d95</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DMasood%26aufirst%3DM.%2BA.%26aulast%3DBazin%26aufirst%3DM.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DM.%26aulast%3DFancy%26aufirst%3DS.-A.%26aulast%3DFarrant%26aufirst%3DE.%26aulast%3DPearce%26aufirst%3DD.%2BW.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DHitzel%26aufirst%3DL.%26aulast%3DPeakman%26aufirst%3DT.%26atitle%3DLead%2520Diversification%25202%253A%2520Application%2520to%2520P38%252C%2520gMTP%2520and%2520Lead%2520Compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1255%26epage%3D1262%26doi%3D10.1016%2Fj.bmcl.2011.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murahashi, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirabayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komiya, N.</span></span> <span> </span><span class="NLM_article-title">Manganese-Catalyzed Enantioselective Oxidation of C–H Bonds of Alkanes and Silyl Ethers to Optically Active Ketones</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3527</span>– <span class="NLM_lpage">3535</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2005.08.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.tetasy.2005.08.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1GitbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=3527-3535&author=S.+I.+Murahashiauthor=S.+Nojiauthor=T.+Hirabayashiauthor=N.+Komiya&title=Manganese-Catalyzed+Enantioselective+Oxidation+of+C%E2%80%93H+Bonds+of+Alkanes+and+Silyl+Ethers+to+Optically+Active+Ketones&doi=10.1016%2Fj.tetasy.2005.08.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Manganese-catalyzed enantioselective oxidation of C-H bonds of alkanes and silyl ethers to optically active ketones</span></div><div class="casAuthors">Murahashi, Shun-Ichi; Noji, Satoru; Hirabayashi, Tatsuo; Komiya, Naruyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3527-3535</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The (salen)manganese(III) complex-catalyzed oxidn. of C-H bonds of sym. alkanes and sym. 1,3- and 1,4-disilyl ethers with iodosylbenzene gave the corresponding optically active ketones (≤ 70% ee) and β- and γ-siloxy ketones (≤ 93% ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0e4HI2JX17Vg90H21EOLACvtfcHk0ljeH5X0_PbGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1GitbzP&md5=4210b99108dc91ea5a61ff80feb4fac4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2005.08.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2005.08.056%26sid%3Dliteratum%253Aachs%26aulast%3DMurahashi%26aufirst%3DS.%2BI.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DHirabayashi%26aufirst%3DT.%26aulast%3DKomiya%26aufirst%3DN.%26atitle%3DManganese-Catalyzed%2520Enantioselective%2520Oxidation%2520of%2520C%25E2%2580%2593H%2520Bonds%2520of%2520Alkanes%2520and%2520Silyl%2520Ethers%2520to%2520Optically%2520Active%2520Ketones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2005%26volume%3D16%26spage%3D3527%26epage%3D3535%26doi%3D10.1016%2Fj.tetasy.2005.08.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernadou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, B.</span></span> <span> </span><span class="NLM_article-title">Biomimetic Chemical Catalysts in the Oxidative Activation of Drugs</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1002/adsc.200303191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fadsc.200303191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1ensb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2004&pages=171-184&author=J.+Bernadouauthor=B.+Meunier&title=Biomimetic+Chemical+Catalysts+in+the+Oxidative+Activation+of+Drugs&doi=10.1002%2Fadsc.200303191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic chemical catalysts in the oxidative activation of drugs</span></div><div class="casAuthors">Bernadou, Jean; Meunier, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">2+3</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  An overview of the biomimetic catalysts used in the oxidative activation of drugs is given, with an emphasis on the use of synthetic metalloporphyrins as models of cytochrome P 450 to mimic the in vivo metab. of pharmaceuticals.  In addn., a special focus is directed towards the recent results from the authors' group on the oxidative activation of isoniazid, an antitubercular drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeyVJ-gPZePrVg90H21EOLACvtfcHk0ljeH5X0_PbGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1ensb0%253D&md5=f42510049c4ee8e0a498d9d2028cf6ed</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200303191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200303191%26sid%3Dliteratum%253Aachs%26aulast%3DBernadou%26aufirst%3DJ.%26aulast%3DMeunier%26aufirst%3DB.%26atitle%3DBiomimetic%2520Chemical%2520Catalysts%2520in%2520the%2520Oxidative%2520Activation%2520of%2520Drugs%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2004%26volume%3D346%26spage%3D171%26epage%3D184%26doi%3D10.1002%2Fadsc.200303191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Frontier Scientific</span> <i>Pure and (not so) simple</i>; <a href="http://www.frontiersci.com/" class="extLink">http://www.frontiersci.com/</a> (accessed Jul 2, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Frontier+Scientific+Pure+and+%28not+so%29+simple%3B+http%3A%2F%2Fwww.frontiersci.com%2F+%28accessed+Jul+2%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DPure%2520and%2520%2528not%2520so%2529%2520simple" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="note"><p class="first last">Product (<i>m/z</i> 413c (M + 32) was also observed by HPLC–MS in the BM3 screen by variants MCYP0012, MCYP0036, MCYP0052, MCYP0057, and MCYP-P1.2-A07.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span> <i>TCI 1.7 mm MicroCryoProbe</i>. <a href="https://www.bruker.com/products/mr/nmr/probes/cryoprobes/microcryoprobe.html" class="extLink">https://www.bruker.com/products/mr/nmr/probes/cryoprobes/microcryoprobe.html</a> (accessed June 7, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+TCI+1.7+mm+MicroCryoProbe.+https%3A%2F%2Fwww.bruker.com%2Fproducts%2Fmr%2Fnmr%2Fprobes%2Fcryoprobes%2Fmicrocryoprobe.html+%28accessed+June+7%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DTCI%25201.7%2520mm%2520MicroCryoProbe" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, D. C.</span></span> <span> </span><span class="NLM_article-title">Survey of ERETIC2 NMR for Quantification</span>. <i>J. Korean Magn. Reson. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.6564/JKMRS.2013.17.2.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.6564%2FJKMRS.2013.17.2.098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=98-104&author=R.+S.+Hongauthor=K.+H.+Hwangauthor=S.+Kimauthor=H.+E.+Choauthor=H.+J.+Leeauthor=J.+T.+Hongauthor=D.+C.+Moon&title=Survey+of+ERETIC2+NMR+for+Quantification&doi=10.6564%2FJKMRS.2013.17.2.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.6564%2FJKMRS.2013.17.2.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6564%252FJKMRS.2013.17.2.098%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DR.%2BS.%26aulast%3DHwang%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DH.%2BE.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DJ.%2BT.%26aulast%3DMoon%26aufirst%3DD.%2BC.%26atitle%3DSurvey%2520of%2520ERETIC2%2520NMR%2520for%2520Quantification%26jtitle%3DJ.%2520Korean%2520Magn.%2520Reson.%2520Soc.%26date%3D2013%26volume%3D17%26spage%3D98%26epage%3D104%26doi%3D10.6564%2FJKMRS.2013.17.2.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A. K.</span></span> <span> </span><span class="NLM_article-title">Hydroxylated Metabolites of Loratadine: An Example of Conformational Diastereomers Due to Atropisomerism</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3350</span>, <span class="refDoi"> DOI: 10.1021/jo00297a065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00297a065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK3cXitFKlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=3341-3350&author=J.+J.+Piwinskiauthor=J.+K.+Wongauthor=T.+M.+Chanauthor=M.+J.+Greenauthor=A.+K.+Ganguly&title=Hydroxylated+Metabolites+of+Loratadine%3A+An+Example+of+Conformational+Diastereomers+Due+to+Atropisomerism&doi=10.1021%2Fjo00297a065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylated metabolites of loratadine:  an example of conformational diastereomers due to atropisomerism</span></div><div class="casAuthors">Piwinski, John J.; Wong, Jesse K.; Chan, Tze Ming; Green, Michael J.; Ganguly, Ashit K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3341-50</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The structures of two metabolites of the nonsedating antihistamine loratadine were confirmed by synthesis.  The metabolites I (R = H, R1 = OH; R = OH, R1 = H) were prepd. from tricyclic ketone II in seven steps.  Each of these compds. exist as a pair of conformational diastereomers which interconvert slowly at room temp.  These conformers arise due to the restricted conformational mobility inherent to the diaryl[a,d]cycloheptane ring system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMQum_KO-t9LVg90H21EOLACvtfcHk0ljeH5X0_PbGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFKlt7w%253D&md5=a9fe6a4632a582ce5cea198b78b6ee5e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo00297a065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00297a065%26sid%3Dliteratum%253Aachs%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26aulast%3DWong%26aufirst%3DJ.%2BK.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DGanguly%26aufirst%3DA.%2BK.%26atitle%3DHydroxylated%2520Metabolites%2520of%2520Loratadine%253A%2520An%2520Example%2520of%2520Conformational%2520Diastereomers%2520Due%2520to%2520Atropisomerism%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D3341%26epage%3D3350%26doi%3D10.1021%2Fjo00297a065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Jean, D. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6020</span>, <span class="refDoi"> DOI: 10.1021/jm300343m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&author=D.+J.+St.%0AJeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery&doi=10.1021%2Fjm300343m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0lgUqTmD5cJJBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6002%26epage%3D6020%26doi%3D10.1021%2Fjm300343m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyderman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulmatycki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statkevich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, J. E.</span></span> <span> </span><span class="NLM_article-title">Disposition of Loratadine in Healthy Volunteers</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">769</span>, <span class="refDoi"> DOI: 10.1080/00498250701463317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1080%2F00498250701463317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=753-769&author=R.+Ramanathanauthor=L.+Reydermanauthor=K.+Kulmatyckiauthor=A.-D.+Suauthor=N.+Alvarezauthor=S.+K.+Chowdhuryauthor=K.+B.+Altonauthor=M.+A.+Wirthauthor=R.+P.+Clementauthor=P.+Statkevichauthor=J.+E.+Patrick&title=Disposition+of+Loratadine+in+Healthy+Volunteers&doi=10.1080%2F00498250701463317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1080%2F00498250701463317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250701463317%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DR.%26aulast%3DReyderman%26aufirst%3DL.%26aulast%3DKulmatycki%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DA.-D.%26aulast%3DAlvarez%26aufirst%3DN.%26aulast%3DChowdhury%26aufirst%3DS.%2BK.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26aulast%3DWirth%26aufirst%3DM.%2BA.%26aulast%3DClement%26aufirst%3DR.%2BP.%26aulast%3DStatkevich%26aufirst%3DP.%26aulast%3DPatrick%26aufirst%3DJ.%2BE.%26atitle%3DDisposition%2520of%2520Loratadine%2520in%2520Healthy%2520Volunteers%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D37%26spage%3D753%26epage%3D769%26doi%3D10.1080%2F00498250701463317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">See, S.</span></span> <span> </span><span class="NLM_article-title">Desloratadine for Allergic Rhinitis</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2015</span>– <span class="NLM_lpage">2016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=14655812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BD3srntl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=2015-2016&author=S.+See&title=Desloratadine+for+Allergic+Rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52aR"><div class="casContent"><span class="casTitleNuber">52a</span><div class="casTitle"><span class="NLM_cas:atitle">Desloratadine for allergic rhinitis</span></div><div class="casAuthors">See Sharon</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2015-6</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAe2RuMd0aiEPI-fCgwosgfW6udTcc2eYXXUCC6vuzA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srntl2gtw%253D%253D&md5=cb4348d12859dfbc4f18c86ff56f8333</span></div><a href="/servlet/linkout?suffix=cit52a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSee%26aufirst%3DS.%26atitle%3DDesloratadine%2520for%2520Allergic%2520Rhinitis%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2003%26volume%3D68%26spage%3D2015%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit52b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, F. E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prenner, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fin, A.,  Jr.</span></span>; <span class="NLM_contrib-group">Desloratadine Study Group</span> <span> </span><span class="NLM_article-title">Efficacy and Safety of Desloratadine in the Treatment of Perennial Allergic Rhinitis</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1067/mai.2003.168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1067%2Fmai.2003.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=12642846" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2003&pages=617-622&author=F.+E.+R.+Simonauthor=B.+M.+Prennerauthor=A.+Finauthor=Desloratadine+Study+Group&title=Efficacy+and+Safety+of+Desloratadine+in+the+Treatment+of+Perennial+Allergic+Rhinitis&doi=10.1067%2Fmai.2003.168"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52b&amp;dbid=16384&amp;doi=10.1067%2Fmai.2003.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2003.168%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DF.%2BE.%2BR.%26aulast%3DPrenner%26aufirst%3DB.%2BM.%26aulast%3DFin%26aufirst%3DA.%26aulast%3D%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520Desloratadine%2520in%2520the%2520Treatment%2520of%2520Perennial%2520Allergic%2520Rhinitis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2003%26volume%3D111%26spage%3D617%26epage%3D622%26doi%3D10.1067%2Fmai.2003.168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkop, B.</span></span> <span> </span><span class="NLM_article-title">Rearrangements of Dehydroproline Derivatives</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1715</span>, <span class="refDoi"> DOI: 10.1021/ja00868a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00868a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaF38XktlKhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1962&pages=1709-1715&author=A.+V.+Robertsonauthor=J.+E.+Francisauthor=B.+Witkop&title=Rearrangements+of+Dehydroproline+Derivatives&doi=10.1021%2Fja00868a043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Rearrangements of dehydroproline derivatives</span></div><div class="casAuthors">Robertson, Alexander V.; Francis, John E.; Witkop, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1709-15</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. ibid. 1702-9. With 2 moles N-bromosuccinimide (I) at pH 7-9, N-carbobenzyloxy-3,4dehydro-DL-prolinamide (II) was converted to N-carbobenzyloxy-2,5-dihydroxy-Δ3-pyrroline (III).  The postulated mechanism for the reaction involved Hofmann rearrangement, C-bromination, and hydrolysis.  II with alkali yielded 3,4-dehydro-DL-proline hydantoin (IV).  The position of the double bond in the product was established by nuclear magnetic resonance measurements and by retention of optical activity with L-II.  N-(p-Tolylsulfonyl)-3,4dehydroproline Me ester (V) with NaOMe gave Me pyrrole2-carboxylate (VI).  3,4-Dehydro-DL-proline (VII) with MeI and NaOH yielded 2,3-dehydro-DL-stachydrine (VIII).  With Ag2O, the methylation was accomplished without migration of the double bond.  II(4.0g.), 152. Na2HPO4, 120 ml. MeCN, and 400 ml. H2O stirred and treated portionwise with 6.0 g. I gave 15.0 millimoles NH3 (ninhydrin analysis) and 62% III, m. 81-2° (EtOAc-cyclohexane), or after storage 122-4°, characterized by infrared, ultraviolet, and nuclear magnetic resonance analysis.  The 2 forms showed minor differences in the infrared and nuclear magnetic resonance spectra.  III diacetate (IX), prepd. with Ac2O in C5H5N, m. 94-5° (ether-cyclohexane).  IX gave a higher acetyl value than calcd., owing to decompn. of III to volatile acids during analysis.  III (1 g.) in CHCl3 and 10 g. MnO2 stirred 3 days and the product hydrogenated over Pd gave 108 mg. succinimide.  III (2 g.) in tetrahydrofuran treated with 400 mg. LiBH4 yielded 780 mg. benzyl carbamate, m. 82-4° (ether-hexane).  III (2 g.) in AcOH and 1.2 g. CrO3 in H2O cooled and kept 1 hr.gave 90 mg. N-carbobenzyloxymaleamic acid, m. 150-1° (C6H6), hydrogenated over Pd to succinamic acid, m, 152-5° (EtOH).  II (500 mg.) and 10 ml. N NaOH heated on a steam bath yielded 117 mg. IV m. 153-4° (C6H6), also prepd. from VII and KCNO.  L-VII and KCNO gave L-IV, [α]20D - 191° (EtOH), hydrogenated over Pd to L-proline hydantoin, [α]20D -128° (EtOH).  V (281 mg.) and 5 ml. N NaOMe in MeOH refluxed 1 hr. gave, with elimination of p-toluenesulfinate, 115 mg. VI, m. 71.53°.  N-Benzoyldehydro-DL-proline Me ester (IXa) with NaOMe yielded N-benzoyldehydroproline. N-(p-Tolylsulfonyl)-3,4-dehydro-DL-prolinamide and N-(p-tolylsulfonyl)-3,4-dehydro-DL-prolylglycine, but not N-(p-tolylsulfonyl)-3,4-dehydroproline with aq. NaOH were aromatized, as indicated by the appearance of an ultraviolet peak at 265 mμ.  VII (5.0 g.) in MeOH with dry HCl at 4° gave 5.67 g. Me ester hydrochloride, m. 134-6° (sublimed), which (682 mg.) in 10 ml. C5H5N at 60° with 1.7 g. p-phenylazobenzoyl chloride gave 345 mg. orange powder, m. above 260°, and red p-phenylazobenzoyldehydro-DL-proline Meester (X), m. 112-14° (Me2CO-ether).  X with NH3 in MeOH gave 81% orange-red amide, m. 204.5° (MeOH-Me2CO).  Neither aromatization or migration of the double bond in IXa or X could be induced, even with NaH in refluxing toluene.  DL-Proline Me ester hydrochloride m. 121-2.5° (MeOH-C6H6). p-Phenylazobenzoyl-DL-proline Me ester, m. 104-6°.  VII(1.3 g.), 1.3 g. NaOH, 20ml. MeOH, and 3 ml. MeI refluxed 24 hrs. with addnl. portions of MeI yielded VIII, isolated as the hydrochloride, m. 180-2° (decompn.) (MeOH-Me2CO).  VIII picrate m. 173-5°. Hydrogenation of VIII.HCl in H2O over Adams catalyst gave DL-stachydrine, isolated as the picrate, m. 190-2° (decompn.) (197-8° prepd. from DL-proline).  VII (1.0 g.), 2.00 g. Ag2O, and 20 ml. anhyd. MeOH agitated 30 min., treated with 6 ml. MeI, and stirred 1 hr. gave 3,4-dehydro-DL-stachydrine (XI), sepd. as 1.68 g. picrate, m. 140-1° and 173-5° (EtOH).  XI.HCl m. 180-2° (decompn.) (MeOHMe2CO).  XI picrate heated to 150° yielded VIII picrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlv2zQOkTAI7Vg90H21EOLACvtfcHk0lhdB_omdOyJEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38XktlKhsbo%253D&md5=925a208bab5d066f4c36e967c0bba0c6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja00868a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00868a043%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DA.%2BV.%26aulast%3DFrancis%26aufirst%3DJ.%2BE.%26aulast%3DWitkop%26aufirst%3DB.%26atitle%3DRearrangements%2520of%2520Dehydroproline%2520Derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1962%26volume%3D84%26spage%3D1709%26epage%3D1715%26doi%3D10.1021%2Fja00868a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="note"><p class="first last">Stereoconfiguration of analogue <b>7</b> in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> is represented by ethyl (2<i>R</i>,6<i>S</i>,<i>E</i>)-4-(8-chloro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-2,6-dihydroxypiperidine-1-carboxylate. The other hydroxyl stereoisomers of analogue <b>7</b> were docked against CYP2D6 and show similar out-of-range protein–ligand docks, as shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, placing the methylene hydrogen of the ethyl carbamate portion of the molecule >13 Å from the iron(IV)-oxo porphyrin radical cation in the CYP active site.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, A. H.</span></span> <span> </span><span class="NLM_article-title"><i>N,N</i>-Diethylaminosulfur Trifluoride</span>. In  <i>Encyclopedia of Reagents for Organic Synthesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, L. A.</span></span> Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1995</span>, Volume  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1790</span>, <span class="refDoi"> DOI: 10.1002/047084289X.rd175</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2F047084289X.rd175" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=1787-1790&author=A.+H.+Fauqauthor=L.+A.+Paquette&title=Encyclopedia+of+Reagents+for+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2F047084289X.rd175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F047084289X.rd175%26sid%3Dliteratum%253Aachs%26aulast%3DFauq%26aufirst%3DA.%2BH.%26atitle%3DN%252CN-Diethylaminosulfur%2520Trifluoride%26btitle%3DEncyclopedia%2520of%2520Reagents%2520for%2520Organic%2520Synthesis%26aulast%3DPaquette%26aufirst%3DL.%2BA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1995%26volume%3D3%26spage%3D1787%26epage%3D1790%26doi%3D10.1002%2F047084289X.rd175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwell, A. D.</span></span> <span> </span><span class="NLM_article-title">The Role of Fluorine in Medicinal Chemistry</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1080/14756360701425014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1080%2F14756360701425014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=18035820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjtr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=527-540&author=P.+Shahauthor=A.+D.+Westwell&title=The+Role+of+Fluorine+in+Medicinal+Chemistry&doi=10.1080%2F14756360701425014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The role of fluorine in medicinal chemistry</span></div><div class="casAuthors">Shah, Poonam; Westwell, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">527-540</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The small and highly electroneg. fluorine atom can play a remarkable role in medicinal chem.  Selective installation of fluorine into a therapeutic or diagnostic small mol. candidate can enhance a no. of pharmacokinetic and physicochem. properties such as improved metabolic stability and enhanced membrane permeation.  Increased binding affinity of fluorinated drug candidates to target protein has also been documented in a no. of cases.  A further emerging application of the fluorine atom is the use of 18F as a radiolabel tracer atom in the exquisitely sensitive technique of Positron Emission Tomog. (PET) imaging.  This short review aims to bring together these various aspects of the use of fluorine in medicinal chem. applications, citing selected examples from across a variety of therapeutic and diagnostic settings.  The increasingly routine incorporation of fluorine atom(s) into drug candidates suggests a bright future for fluorine in drug discovery and development.  A major challenge moving forward will be how and where to install fluorine in a rational sense to best optimize mol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzZnKkEoXeFLVg90H21EOLACvtfcHk0lhdB_omdOyJEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjtr%252FI&md5=58bc1c42a7525b66772967543256a7d2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1080%2F14756360701425014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360701425014%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DP.%26aulast%3DWestwell%26aufirst%3DA.%2BD.%26atitle%3DThe%2520Role%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2007%26volume%3D22%26spage%3D527%26epage%3D540%26doi%3D10.1080%2F14756360701425014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Roselló, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aceña, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorochinsky, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fustero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloshonok, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">2432</span>– <span class="NLM_lpage">2506</span>, <span class="refDoi"> DOI: 10.1021/cr4002879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4002879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2432-2506&author=J.+Wangauthor=M.+S%C3%A1nchez-Rosell%C3%B3author=J.+L.+Ace%C3%B1aauthor=C.+Del+Pozoauthor=A.+E.+Sorochinskyauthor=S.+Fusteroauthor=V.+A.+Soloshonokauthor=H.+Liu&title=Fluorine+in+Pharmaceutical+Industry%3A+Fluorine-Containing+Drugs+Introduced+to+the+Market+in+the+Last+Decade+%282001%E2%80%932011%29&doi=10.1021%2Fcr4002879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001-2011)</span></div><div class="casAuthors">Wang, Jiang; Sanchez-Rosello, Maria; Acena, Jose Luis; del Pozo, Carlos; Sorochinsky, Alexander E.; Fustero, Santos; Soloshonok, Vadim A.; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2432-2506</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A historic review.  As expected from the fluorine position on the periodic table of elements, it possesses some extreme properties, in particular, ultimate electronegativity and oxidn. potential.  Therefore,elemental fluorine can not be prepd. by chem. reaction, and its isolation in 1886 by Henri Moissan required scientific ingenuity and great personal courage.  His historic effort earned him a Noble Prize (1906), and the developed electrolysis method is still in use for industrial prodn. of fluorine gas.  However, further development of fluorine chem. was extremely sluggish, pursued by a handful of experts capable of handling the violent gas using specially designed lab. equipment.  Industrial-scale prodn. of fluorochems. dates back to late 1930s.  Currently, there are about 200 pharmaceuticals containingfluorine, including the 40 new compds. discussed in this review.  One may agree that the contribution of the past decade indicates a significant 20% increase in the no. of fluorinated drugs on the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTzcNC3MEA7Vg90H21EOLACvtfcHk0lhdB_omdOyJEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I&md5=07faac419cd090503e82c6f00d05c338</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fcr4002879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4002879%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez-Rosell%25C3%25B3%26aufirst%3DM.%26aulast%3DAce%25C3%25B1a%26aufirst%3DJ.%2BL.%26aulast%3DDel%2BPozo%26aufirst%3DC.%26aulast%3DSorochinsky%26aufirst%3DA.%2BE.%26aulast%3DFustero%26aufirst%3DS.%26aulast%3DSoloshonok%26aufirst%3DV.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DFluorine%2520in%2520Pharmaceutical%2520Industry%253A%2520Fluorine-Containing%2520Drugs%2520Introduced%2520to%2520the%2520Market%2520in%2520the%2520Last%2520Decade%2520%25282001%25E2%2580%25932011%2529%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2432%26epage%3D2506%26doi%3D10.1021%2Fcr4002879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span> <i>Baran Diversinates</i>; <a href="https://www.sigmaaldrich.com/chemistry/chemistry-products.html?TablePage=113932507" class="extLink">https://www.sigmaaldrich.com/chemistry/chemistry-products.html?TablePage=113932507</a> (accessed Aug 26, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Baran+Diversinates%3B+https%3A%2F%2Fwww.sigmaaldrich.com%2Fchemistry%2Fchemistry-products.html%3FTablePage%3D113932507+%28accessed+Aug+26%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DBaran%2520Diversinates" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0liuT3Mt_pjEhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiRocco, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudge, M.</span></span> <span> </span><span class="NLM_article-title">Late-Stage Functionalization of Biologically Active Heterocycles Through Photoredox Catalysis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4802</span>– <span class="NLM_lpage">4806</span>, <span class="refDoi"> DOI: 10.1002/anie.201402023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201402023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4802-4806&author=D.+A.+DiRoccoauthor=K.+Dykstraauthor=S.+Krskaauthor=P.+Vachalauthor=D.+V.+Conwayauthor=M.+Tudge&title=Late-Stage+Functionalization+of+Biologically+Active+Heterocycles+Through+Photoredox+Catalysis&doi=10.1002%2Fanie.201402023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60a</span><div class="casTitle"><span class="NLM_cas:atitle">Late-stage functionalization of biologically active heterocycles through photoredox catalysis</span></div><div class="casAuthors">Dirocco Daniel A; Dykstra Kevin; Krska Shane; Vachal Petr; Conway Donald V; Tudge Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4802-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The direct C H functionalization of heterocycles has become an increasingly valuable tool in modern drug discovery.  However, the introduction of small alkyl groups, such as methyl, by this method has not been realized in the context of complex molecule synthesis since existing methods rely on the use of strong oxidants and elevated temperatures to generate the requisite radical species.  Herein, we report the use of stable organic peroxides activated by visible-light photoredox catalysis to achieve the direct methyl-, ethyl-, and cyclopropylation of a variety of biologically active heterocycles.  The simple protocol, mild reaction conditions, and unique tolerability of this method make it an important tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmAsN0YQNtXD69zv1FsJFMfW6udTcc2eZBoaOAj_c4XLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D&md5=ca31296d61c97e944eaaf326a8190458</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402023%26sid%3Dliteratum%253Aachs%26aulast%3DDiRocco%26aufirst%3DD.%2BA.%26aulast%3DDykstra%26aufirst%3DK.%26aulast%3DKrska%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DConway%26aufirst%3DD.%2BV.%26aulast%3DTudge%26aufirst%3DM.%26atitle%3DLate-Stage%2520Functionalization%2520of%2520Biologically%2520Active%2520Heterocycles%2520Through%2520Photoredox%2520Catalysis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4802%26epage%3D4806%26doi%3D10.1002%2Fanie.201402023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit60b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. L.</span></span> <span> </span><span class="NLM_article-title">Introduction of Functionality into Unactivated Carbon-Hydrogen Bonds. Catalytic Generation and Nonconventional Utilization of Organic Radicals</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1055/s-1995-4883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1055%2Fs-1995-4883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK2MXkt1ymsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=127-132&author=C.+L.+Hill&title=Introduction+of+Functionality+into+Unactivated+Carbon-Hydrogen+Bonds.+Catalytic+Generation+and+Nonconventional+Utilization+of+Organic+Radicals&doi=10.1055%2Fs-1995-4883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60bR"><div class="casContent"><span class="casTitleNuber">60b</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of functionality into unactivated carbon-hydrogen bonds. Catalytic generation and nonconventional utilization of organic radicals</span></div><div class="casAuthors">Hill, Craig L.</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-32</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Thieme</span>)
        </div><div class="casAbstract">A review with 50 refs.  Alkanes and other unactivated C-H bond substrates can be catalytically transformed by an emerging class of versatile inorg. clusters called polyoxometalates under economically and environmentally attractive conditions.  "Catalytic" radical generation and redox trapping of alkyl radicals by polyoxometalates in controlled sequences affords routes for the dehydrogenation, alkylation, vinylation, carbonylation and acylation of alkanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD2RlymMIuVrVg90H21EOLACvtfcHk0liuT3Mt_pjEhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkt1ymsro%253D&md5=e8d4eb0c734161dc70a427cd2d8a652b</span></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=10.1055%2Fs-1995-4883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1995-4883%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DC.%2BL.%26atitle%3DIntroduction%2520of%2520Functionality%2520into%2520Unactivated%2520Carbon-Hydrogen%2520Bonds.%2520Catalytic%2520Generation%2520and%2520Nonconventional%2520Utilization%2520of%2520Organic%2520Radicals%26jtitle%3DSynlett%26date%3D1995%26spage%3D127%26epage%3D132%26doi%3D10.1055%2Fs-1995-4883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">A Scalable and Operationally Simple Radical Trifluoromethylation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7919</span>, <span class="refDoi"> DOI: 10.1038/ncomms8919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fncomms8919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26258541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7919&author=J.+W.+Beattyauthor=J.+J.+Douglasauthor=K.+P.+Coleauthor=C.+R.+J.+Stephenson&title=A+Scalable+and+Operationally+Simple+Radical+Trifluoromethylation&doi=10.1038%2Fncomms8919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61aR"><div class="casContent"><span class="casTitleNuber">61a</span><div class="casTitle"><span class="NLM_cas:atitle">A scalable and operationally simple radical trifluoromethylation</span></div><div class="casAuthors">Beatty, Joel W.; Douglas, James J.; Cole, Kevin P.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7919pp.</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The large no. of reagents that was developed for the synthesis of trifluoromethylated compds. was a testament to the importance of the CF3 group as well as the assocd. synthetic challenge.  Current state-of-the-art reagents for appending the CF3 functionality directly were highly effective; however, their use on preparative scale had minimal precedent because they required multistep synthesis for their prepn., and/or were prohibitively expensive for large-scale application.  For a scalable trifluoromethylation methodol., trifluoroacetic acid and its anhydride represented an attractive soln. in terms of cost and availability; however, because of the exceedingly high oxidn. potential of trifluoroacetate, previous endeavours to use this material as a CF3 source was required the use of highly forcing conditions.  A strategy for the use of trifluoroacetic anhydride for a scalable and operationally simple trifluoromethylation reaction using pyridine N-oxide and photoredox catalysis to affect a facile decarboxylation to the CF3 radical was reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwV3yU4_bd1rVg90H21EOLACvtfcHk0liuT3Mt_pjEhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtbrI&md5=7f3391941db196735dfe808c21b7b602</span></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=10.1038%2Fncomms8919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8919%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DDouglas%26aufirst%3DJ.%2BJ.%26aulast%3DCole%26aufirst%3DK.%2BP.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DA%2520Scalable%2520and%2520Operationally%2520Simple%2520Radical%2520Trifluoromethylation%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7919%26doi%3D10.1038%2Fncomms8919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit61b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">Visible Light-Mediated Decarboxylative Alkylation of Pharmaceutically Relevant Heterocycles</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3487</span>– <span class="NLM_lpage">3490</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b01250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b01250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCrsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=3487-3490&author=A.+C.+Sunauthor=E.+J.+McClainauthor=J.+W.+Beattyauthor=C.+R.+J.+Stephenson&title=Visible+Light-Mediated+Decarboxylative+Alkylation+of+Pharmaceutically+Relevant+Heterocycles&doi=10.1021%2Facs.orglett.8b01250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61bR"><div class="casContent"><span class="casTitleNuber">61b</span><div class="casTitle"><span class="NLM_cas:atitle">Visible Light-Mediated Decarboxylative Alkylation of Pharmaceutically Relevant Heterocycles</span></div><div class="casAuthors">Sun, Alexandra C.; McClain, Edward J.; Beatty, Joel W.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3487-3490</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A net redox-neutral method for the decarboxylative alkylation of heteroarenes using photoredox catalysis is reported.  Addnl., this method features the use of simple, com. available carboxylic acid derivs. as alkylating agents, enabling the facile alkylation of a variety of biol. relevant heterocyclic scaffolds under mild conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQZDSFt4d4L7Vg90H21EOLACvtfcHk0lhZ3oEA6oXuNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCrsLzP&md5=301cdc3c326bafc3c0030903a420fc5e</span></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b01250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b01250%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DA.%2BC.%26aulast%3DMcClain%26aufirst%3DE.%2BJ.%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DVisible%2520Light-Mediated%2520Decarboxylative%2520Alkylation%2520of%2520Pharmaceutically%2520Relevant%2520Heterocycles%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D3487%26epage%3D3490%26doi%3D10.1021%2Facs.orglett.8b01250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halperin, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, R.</span></span> <span> </span><span class="NLM_article-title">A Convenient Photocatalytic Fluorination of Unactivated C–H Bonds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4690</span>– <span class="NLM_lpage">4693</span>, <span class="refDoi"> DOI: 10.1002/anie.201400420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201400420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4690-4693&author=S.+D.+Halperinauthor=H.+Fanauthor=S.+Changauthor=R.+E.+Martinauthor=R.+Britton&title=A+Convenient+Photocatalytic+Fluorination+of+Unactivated+C%E2%80%93H+Bonds&doi=10.1002%2Fanie.201400420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient photocatalytic fluorination of unactivated C-H bonds</span></div><div class="casAuthors">Halperin, Shira D.; Fan, Hope; Chang, Stanley; Martin, Rainer E.; Britton, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4690-4693</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A convenient and economic process is reported for direct fluorination of inactivated C-H bonds that exploits the H-abstracting ability of a decatungstate photocatalyst in combination with the mild F transfer reagent N-fluorobenzenesulfonimide.  This operationally straightforward reaction provides direct access to a wide range of fluorinated org. mols., including structurally complex natural products, acyl fluorides, and fluorinated amino acid derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJLMOhWUAEALVg90H21EOLACvtfcHk0lhZ3oEA6oXuNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGltLk%253D&md5=2bc653f8d7c31008e55eb39dce05486f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.201400420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201400420%26sid%3Dliteratum%253Aachs%26aulast%3DHalperin%26aufirst%3DS.%2BD.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DBritton%26aufirst%3DR.%26atitle%3DA%2520Convenient%2520Photocatalytic%2520Fluorination%2520of%2520Unactivated%2520C%25E2%2580%2593H%2520Bonds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4690%26epage%3D4693%26doi%3D10.1002%2Fanie.201400420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="note">a<p class="last">Two control reactions were run without the metalloporphyrin catalyst Cu(TDCIPP), one with cumene hydroperoxide oxidant (2.0 equiv), and one with <i>meta</i>-chloroperoxybenzoic acid oxidant (2.0 equiv). The two control reactions gave matching product profiles; however, product conversion was superior with <i>m</i>CPBA. Therefore, the <i>m</i>CPBA control reaction was submitted for product purification and characterization.</p></div><div class="note">b<p class="last">We have not attempted to investigate or identify the nature of the circumstance(s), which give rise to the <i>N</i>-methyl product <b>24</b>, but have observed <i>N</i>-methylated products on other leads containing nitrogen heterocycles.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="note"><p class="first last">Electrochemical synthesis of analogue <b>21</b> was in good agreement chromatographically (HPLC–MS) and spectroscopically (NMR) to compound <b>21</b> generated from the BMO control reaction with <i>m</i>CPBA (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S87</a> in the Supporting Information).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeedimalla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahneva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youte Tendoung, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, S. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of α-Arylated Cycloalkanones from Congested Trisubstituted Spiro-epoxides: Application of the House–Meinwald Rearrangement for Ring Expansion</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">12357</span>– <span class="NLM_lpage">12373</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.8b01448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.8b01448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2018&pages=12357-12373&author=N.+Jeedimallaauthor=C.+Jacquetauthor=D.+Bahnevaauthor=J.-J.+Youte+Tendoungauthor=S.+P.+Roche&title=Synthesis+of+%CE%B1-Arylated+Cycloalkanones+from+Congested+Trisubstituted+Spiro-epoxides%3A+Application+of+the+House%E2%80%93Meinwald+Rearrangement+for+Ring+Expansion&doi=10.1021%2Facs.joc.8b01448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of α-Arylated Cycloalkanones from Congested Trisubstituted Spiro-epoxides: Application of the House-Meinwald Rearrangement for Ring Expansion</span></div><div class="casAuthors">Jeedimalla, Nagalakshmi; Jacquet, Camille; Bahneva, Diana; Youte Tendoung, Jean-Jacques; Roche, Stephane P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12357-12373</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A three-step sequence for the synthesis of α-arylated cyclohexanones and the most challenging cycloheptanones is reported.  First, an efficient one-pot synthesis of β,β'-disubstituted benzylidene cycloalkanes (styrenes) using the palladium-catalyzed Barluenga reaction from readily available feedstock chems. is described.  Furthermore, an epoxidn. followed by the House-Meinwald rearrangement (HMR) of spiro-epoxides is reported to produce a no. of α-arylated cycloalkanones upon ring expansion.  Reactions catalyzed by bismuth triflate underwent quasi-exclusively ring expansion for all substrates (electronically poor and rich), with yields ranging from 15% to 95%, thus demonstrating the difficulty of achieving ring enlargement for electron-deficient spiro-epoxides.  On the other hand, by means of catalysis with aluminum trichloride, the rearrangement of spiro-epoxides proceeded typically in high yields and with remarkable regioselectivity on a broader substrate scope.  In this case, a switch of regioselectivity was achieved for spiro-epoxides with electron-withdrawing substituents which enable the method to be successfully extended to some chemospecific arene shifts and the synthesis of aldehydes bearing a α-quaternary carbon.  While the HMR has been extensively studied for smaller ring enlargement, we are pleased to report herein that larger cyclohexanones and cycloheptanones can be obtained efficiently from more sterically demanding trisubstituted spiro-epoxides bearing electron-releasing and electron-neutral arene substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodLuZ-7b0MzbVg90H21EOLACvtfcHk0lhZ3oEA6oXuNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzP&md5=8ad704778394a6c9c24ad29a73078536</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.8b01448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.8b01448%26sid%3Dliteratum%253Aachs%26aulast%3DJeedimalla%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DC.%26aulast%3DBahneva%26aufirst%3DD.%26aulast%3DYoute%2BTendoung%26aufirst%3DJ.-J.%26aulast%3DRoche%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520of%2520%25CE%25B1-Arylated%2520Cycloalkanones%2520from%2520Congested%2520Trisubstituted%2520Spiro-epoxides%253A%2520Application%2520of%2520the%2520House%25E2%2580%2593Meinwald%2520Rearrangement%2520for%2520Ring%2520Expansion%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2018%26volume%3D83%26spage%3D12357%26epage%3D12373%26doi%3D10.1021%2Facs.joc.8b01448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasino, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Médebielle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomalla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billard, T.</span></span> <span> </span><span class="NLM_article-title">Trifluoromethylation Reactions with Potassium Trifluoromethanesulfinate Under Electrochemical Oxidation</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_fpage">1697</span>– <span class="NLM_lpage">1699</span>, <span class="refDoi"> DOI: 10.1055/s-2002-34210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1055%2Fs-2002-34210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=1697-1699&author=J.-B.+Tommasinoauthor=A.+Brondexauthor=M.+M%C3%A9debielleauthor=M.+Thomallaauthor=B.+R.+Langloisauthor=T.+Billard&title=Trifluoromethylation+Reactions+with+Potassium+Trifluoromethanesulfinate+Under+Electrochemical+Oxidation&doi=10.1055%2Fs-2002-34210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoromethylation reactions with potassium trifluoromethanesulfinate under electrochemical oxidation</span></div><div class="casAuthors">Tommasino, Jean-Bernard; Brondex, Anne; Medebielle, Maurice; Thomalla, Marc; Langlois, Bernard R.; Billard, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1697-1699</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The electrochem. oxidn. of potassium trifluoromethanesulfinate (CF3SO2K) in the presence of electron-rich aroms. and alkenes provides the corresponding trifluoromethylated products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeNjfRY6Ez7Vg90H21EOLACvtfcHk0ljPEsh0-Wbjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVGitrg%253D&md5=71bdfa9ab4132131369db673d7e8baa0</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1055%2Fs-2002-34210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2002-34210%26sid%3Dliteratum%253Aachs%26aulast%3DTommasino%26aufirst%3DJ.-B.%26aulast%3DBrondex%26aufirst%3DA.%26aulast%3DM%25C3%25A9debielle%26aufirst%3DM.%26aulast%3DThomalla%26aufirst%3DM.%26aulast%3DLanglois%26aufirst%3DB.%2BR.%26aulast%3DBillard%26aufirst%3DT.%26atitle%3DTrifluoromethylation%2520Reactions%2520with%2520Potassium%2520Trifluoromethanesulfinate%2520Under%2520Electrochemical%2520Oxidation%26jtitle%3DSynlett%26date%3D2002%26spage%3D1697%26epage%3D1699%26doi%3D10.1055%2Fs-2002-34210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit66b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smertenko, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datsenko, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignat’ev, N. V.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Oxidation of Sodium Trifluoromethanesulfinate</span>. <i>Russ. J. Electrochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFWqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=46-51&author=E.+A.+Smertenkoauthor=S.+D.+Datsenkoauthor=N.+V.+Ignat%E2%80%99ev&title=Electrochemical+Oxidation+of+Sodium+Trifluoromethanesulfinate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66bR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical oxidation of sodium trifluoromethanesulfinate</span></div><div class="casAuthors">Smertenko, E. A.; Datsenko, S. D.; Ignat'ev, N. V.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Journal of Electrochemistry (Translation of Elektrokhimiya)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-51</span>CODEN:
                <span class="NLM_cas:coden">RJELE3</span>;
        ISSN:<span class="NLM_cas:issn">1023-1935</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">The electrochem. oxidn. of sodium salt of trifluoromethanesulfinic acid on a glassy carbon electrode is studied in the tetrabutylammonium tetrafluoroborate supporting electrolyte in acetonitrile by methods of the rotating disk and the ring-disk electrodes and cyclic voltammetry.  Electrochem. oxidn. of the trifluoromethanesulfinate anion is shown to result in desulfonylation and formation of the trifluoromethyl radical.  The products of trifluoromethoxylation of arom. compds. are found to form in the presence of oxygen during the preparative electrooxidn.  The possibility of using sodium trifluoromethanesulfinate for trifluoromethylation of arom. compds. in the course of anodic oxidn. is demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2ltcxcU-r7Vg90H21EOLACvtfcHk0ljPEsh0-Wbjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFWqtLo%253D&md5=538e85d01aba38fa9f3844df96e7cfd5</span></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmertenko%26aufirst%3DE.%2BA.%26aulast%3DDatsenko%26aufirst%3DS.%2BD.%26aulast%3DIgnat%25E2%2580%2599ev%26aufirst%3DN.%2BV.%26atitle%3DElectrochemical%2520Oxidation%2520of%2520Sodium%2520Trifluoromethanesulfinate%26jtitle%3DRuss.%2520J.%2520Electrochem.%26date%3D1998%26volume%3D34%26spage%3D46%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit66c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inokuma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackmond, D. G.</span></span> <span> </span><span class="NLM_article-title">Radical C-H Functionalization of Heteroarenes Under Electrochemical Control</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11868</span>– <span class="NLM_lpage">11871</span>, <span class="refDoi"> DOI: 10.1002/anie.201407948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201407948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWitrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11868-11871&author=A.+G.+O%E2%80%99Brienauthor=A.+Maruyamaauthor=Y.+Inokumaauthor=M.+Fujitaauthor=P.+S.+Baranauthor=D.+G.+Blackmond&title=Radical+C-H+Functionalization+of+Heteroarenes+Under+Electrochemical+Control&doi=10.1002%2Fanie.201407948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66cR"><div class="casContent"><span class="casTitleNuber">66c</span><div class="casTitle"><span class="NLM_cas:atitle">Radical C-H functionalization of heteroarenes under electrochemical control</span></div><div class="casAuthors">O'Brien, Alexander G.; Maruyama, Akinobu; Inokuma, Yasuhide; Fujita, Makoto; Baran, Phil S.; Blackmond, Donna G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11868-11871</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Electrochem. reactions are shown to be effective for the C-H functionalization of a no. of heterocyclic substrates that are recalcitrant to conventional peroxide radical initiation conditions.  Monitoring reaction progress under electrochem. conditions provides mechanistic insight into the C-H functionalization of a series of heterocycles of interest in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8FisQYHxAELVg90H21EOLACvtfcHk0ljPEsh0-Wbjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWitrrP&md5=6f5d2d0ad8b44a9421c16f23e8dc6cef</span></div><a href="/servlet/linkout?suffix=cit66c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407948%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%2BG.%26aulast%3DMaruyama%26aufirst%3DA.%26aulast%3DInokuma%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26aulast%3DBlackmond%26aufirst%3DD.%2BG.%26atitle%3DRadical%2520C-H%2520Functionalization%2520of%2520Heteroarenes%2520Under%2520Electrochemical%2520Control%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D11868%26epage%3D11871%26doi%3D10.1002%2Fanie.201407948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villani, F. J.</span></span> <span> </span><span class="NLM_article-title">Tricyclic-Substituted Piperidine Antihistamines</span>. U.S. Patent <span class="NLM_patent">4,355,036</span>, October 19, <span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=F.+J.+Villani&title=Tricyclic-Substituted+Piperidine+Antihistamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVillani%26aufirst%3DF.%2BJ.%26atitle%3DTricyclic-Substituted%2520Piperidine%2520Antihistamines%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="note"><p class="first last">Generation of analogue <b>5</b> from BM3 variant MCYP-P1.2-D07 gave a superior HPLC–MS chromatographic profile with regard to conversion and impurity profile compared to compound <b>5</b> generated from <i>Streptomyces violascens</i> ATCC 31560; therefore, MCYP-P1.2-D07 was used during the scale-up to prepare analogue <b>8</b>. Analogue <b>5</b> from MCYP-P1.2-D07 was in good agreement chromatographically (HPLC–MS) and spectroscopically (NMR) to compound <b>5</b> generated from <i>Streptomyces violascens</i> ATCC 3156 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S22</a> in the Supporting Information).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship Between the Inhibition Constant (K<sub>I</sub>) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I<sub>50</sub>) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+Between+the+Inhibition+Constant+%28KI%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lgU5CdEmLV3aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520Between%2520the%2520Inhibition%2520Constant%2520%2528KI%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapinos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M.</span></span> <span> </span><span class="NLM_article-title">Development of a High-Performance, Enterprise-Level, Multimode LC-MS/MS Autosampler for Drug Discovery</span>. <i>Bioanalysis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.4155/bio-2017-0149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.4155%2Fbio-2017-0149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29120233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1643-1654&author=B.+Kapinosauthor=J.+Liuauthor=M.+Piotrowskiauthor=J.+Keeferauthor=B.+Holderauthor=J.+Janiszewskiauthor=H.+Zhangauthor=M.+Troutman&title=Development+of+a+High-Performance%2C+Enterprise-Level%2C+Multimode+LC-MS%2FMS+Autosampler+for+Drug+Discovery&doi=10.4155%2Fbio-2017-0149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery</span></div><div class="casAuthors">Kapinos, Brendon; Liu, JianHua; Piotrowski, Mary; Keefer, Julie; Holder, Brian; Janiszewski, John; Zhang, Hui; Troutman, Matt</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1643-1654</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">This article describes about the development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery in human liver.  Extra-column vol. assessments were made by modulating tubing vols. (length and inner diam.) pre- and postcolumn.  The LC-MS/MS system consisted of an LS-1 autosampler from SoundAnalytics (CT, USA). LC pumping system consisted of two 1290 Infinity series LC from Agilent (CA, USA), the mass spectrometer was a 5500 TripleQuad from Sciex (ON, Canada) and LS-1 was configured with 4-injection ports and four addnl. 2-position A/B, UHPLC rated (15 K) valves from Rheodyne/IDEX (CA, USA).  System control and scheduling was accomplished using LeadScapeTM software from SoundAnalytics.  The author concluded development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery in human liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWh6P-kIwc_rVg90H21EOLACvtfcHk0lgU5CdEmLV3aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWhtg%253D%253D&md5=4562d9af8dde637bb4aabc1d1d42ec61</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.4155%2Fbio-2017-0149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio-2017-0149%26sid%3Dliteratum%253Aachs%26aulast%3DKapinos%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPiotrowski%26aufirst%3DM.%26aulast%3DKeefer%26aufirst%3DJ.%26aulast%3DHolder%26aufirst%3DB.%26aulast%3DJaniszewski%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTroutman%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520High-Performance%252C%2520Enterprise-Level%252C%2520Multimode%2520LC-MS%252FMS%2520Autosampler%2520for%2520Drug%2520Discovery%26jtitle%3DBioanalysis%26date%3D2017%26volume%3D9%26spage%3D1643%26epage%3D1654%26doi%3D10.4155%2Fbio-2017-0149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="note"><p class="first last">The RRCK cell line is also known as MDCKII-LE.</p></div><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a New Permeability Assay Using Low-Efflux MDCKII Cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+New+Permeability+Assay+Using+Low-Efflux+MDCKII+Cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lgU5CdEmLV3aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520New%2520Permeability%2520Assay%2520Using%2520Low-Efflux%2520MDCKII%2520Cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="note"><p class="first last">CP-628374 (MW 687.04 g/mol): (2<i>E</i>)-3-(4-{[(2<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-5-{(1<i>E</i>)-<i>N</i>-[(3-chloro-2,6-difluorobenzyl)oxy]ethanimidoyl}-3,4-dihydroxytetrahydrofuran-2-yl]oxy}-3-hydroxyphenyl)-2-methyl-<i>N</i>[(3a<i>S</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>,7<i>R</i>,7a<i>R</i>)-4,6,7-trihydroxyhexahydro-1,3-benzodioxol-5-yl]prop-2-enamide.</p></div><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span> <span> </span><span class="NLM_article-title">Species Independence in Brain Tissue Binding Using Brain Homogenates</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.038778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+Independence+in+Brain+Tissue+Binding+Using+Brain+Homogenates&doi=10.1124%2Fdmd.111.038778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lhUBX1WK_iusw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520Independence%2520in%2520Brain%2520Tissue%2520Binding%2520Using%2520Brain%2520Homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277%26doi%3D10.1124%2Fdmd.111.038778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c','cit19d','cit19e','cit19f','cit19g'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c','cit25d'],'ref26':['cit26a','cit26b'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29a','cit29b','cit29c'],'ref30':['cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b','cit33c','cit33d','cit33e','cit33f'],'ref34':['cit34a','cit34b','cit34c'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41a','cit41b','cit41c'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':[],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52a','cit52b'],'ref53':['cit53'],'ref54':[],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60a','cit60b'],'ref61':['cit61a','cit61b'],'ref62':['cit62'],'ref63':[],'ref64':[],'ref65':['cit65'],'ref66':['cit66a','cit66b','cit66c'],'ref67':['cit67'],'ref68':[],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Rachel Grainger, <span class="NLM_string-name hlFld-ContribAuthor">Stuart Whibley</span>. </span><span class="cited-content_cbyCitation_article-title">A Perspective on the Analytical Challenges Encountered in High-Throughput Experimentation. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (3)
                                     , 354-364. <a href="https://doi.org/10.1021/acs.oprd.0c00463" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00463%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DA%252BPerspective%252Bon%252Bthe%252BAnalytical%252BChallenges%252BEncountered%252Bin%252BHigh-Throughput%252BExperimentation%26aulast%3DGrainger%26aufirst%3DRachel%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D20012021%26volume%3D25%26issue%3D3%26spage%3D354%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kevin D. Dykstra, Eric Streckfuss, Min Liu, Jian Liu, Younong Yu, Ming Wang, Joseph A. Kozlowski, Robert W. Myers, Alexei V. Buevich, Milana M. Maletic, Petr Vachal, <span class="NLM_string-name hlFld-ContribAuthor">Shane W. Krska</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of HDAC Inhibitor Libraries via Microscale Workflow. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 337-342. <a href="https://doi.org/10.1021/acsmedchemlett.0c00596" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00596%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252BHDAC%252BInhibitor%252BLibraries%252Bvia%252BMicroscale%252BWorkflow%26aulast%3DDykstra%26aufirst%3DKevin%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D10112020%26date%3D27012021%26date%3D08022021%26volume%3D12%26issue%3D3%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth L.  Bell</span>, <span class="hlFld-ContribAuthor ">William  Finnigan</span>, <span class="hlFld-ContribAuthor ">Scott P.  France</span>, <span class="hlFld-ContribAuthor ">Anthony P.  Green</span>, <span class="hlFld-ContribAuthor ">Martin A.  Hayes</span>, <span class="hlFld-ContribAuthor ">Lorna J.  Hepworth</span>, <span class="hlFld-ContribAuthor ">Sarah L.  Lovelock</span>, <span class="hlFld-ContribAuthor ">Haruka  Niikura</span>, <span class="hlFld-ContribAuthor ">Sílvia  Osuna</span>, <span class="hlFld-ContribAuthor ">Elvira  Romero</span>, <span class="hlFld-ContribAuthor ">Katherine S.  Ryan</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Turner</span>, <span class="hlFld-ContribAuthor ">Sabine L.  Flitsch</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Methods Primers</span><span> <strong>2021,</strong> <em>1 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s43586-021-00044-z" title="DOI URL">https://doi.org/10.1038/s43586-021-00044-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s43586-021-00044-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs43586-021-00044-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Methods%2520Primers%26atitle%3DBiocatalysis%26aulast%3DBell%26aufirst%3DElizabeth%2BL.%26date%3D2021%26date%3D2021%26volume%3D1%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anokha S.  Ratnayake</span>, <span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Timothy L.  Foley</span>, <span class="hlFld-ContribAuthor ">Scott L.  Hultgren</span>, <span class="hlFld-ContribAuthor ">Justin  Bellenger</span>, <span class="hlFld-ContribAuthor ">Justin I.  Montgomery</span>, <span class="hlFld-ContribAuthor ">Manjinder S.  Lall</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Tim  Ryder</span>, <span class="hlFld-ContribAuthor ">Dominik K.  Kölmel</span>, <span class="hlFld-ContribAuthor ">Andre  Shavnya</span>, <span class="hlFld-ContribAuthor ">Xidong  Feng</span>, <span class="hlFld-ContribAuthor ">Bruce  Lefker</span>, <span class="hlFld-ContribAuthor ">Laura J.  Byrnes</span>, <span class="hlFld-ContribAuthor ">Parag V.  Sahasrabudhe</span>, <span class="hlFld-ContribAuthor ">Kathleen A.  Farley</span>, <span class="hlFld-ContribAuthor ">Shi  Chen</span>, <span class="hlFld-ContribAuthor ">Jinqiao  Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Toward the assembly and characterization of an encoded library hit confirmation platform: Bead-Assisted Ligand Isolation Mass Spectrometry (BALI-MS). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>41 </em>, 116205. <a href="https://doi.org/10.1016/j.bmc.2021.116205" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116205%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DToward%252Bthe%252Bassembly%252Band%252Bcharacterization%252Bof%252Ban%252Bencoded%252Blibrary%252Bhit%252Bconfirmation%252Bplatform%25253A%252BBead-Assisted%252BLigand%252BIsolation%252BMass%252BSpectrometry%252B%252528BALI-MS%252529%26aulast%3DRatnayake%26aufirst%3DAnokha%2BS.%26date%3D2021%26volume%3D41%26spage%3D116205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>, <span class="hlFld-ContribAuthor ">Upendra A.  Argikar</span>, <span class="hlFld-ContribAuthor ">James P.  Driscoll</span>, <span class="hlFld-ContribAuthor ">Carley J. S.  Heck</span>, <span class="hlFld-ContribAuthor ">Lloyd  King</span>, <span class="hlFld-ContribAuthor ">Klarissa D.  Jackson</span>, <span class="hlFld-ContribAuthor ">Wenying  Jian</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Grover P.  Miller</span>, <span class="hlFld-ContribAuthor ">Valerie  Kramlinger</span>, <span class="hlFld-ContribAuthor ">Ivonne M. C. M.  Rietjens</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Teitelbaum</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Cong  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Novel advances in biotransformation and bioactivation research – 2020 year in review. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2021,</strong> <em>48 </em>, 1-50. <a href="https://doi.org/10.1080/03602532.2021.1916028" title="DOI URL">https://doi.org/10.1080/03602532.2021.1916028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2021.1916028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2021.1916028%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DNovel%252Badvances%252Bin%252Bbiotransformation%252Band%252Bbioactivation%252Bresearch%252B%2525E2%252580%252593%252B2020%252Byear%252Bin%252Breview%26aulast%3DKhojasteh%26aufirst%3DS.%2BCyrus%26date%3D2021%26date%3D2021%26volume%3D48%26spage%3D1%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Late-stage lead diversification (LSLD) to generate lead diversity in an efficient manner for a specific biological target. (B) Diversity-focused synthesis (DFS) explores related areas of chemical space in proximity to regions known to have useful properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Workflow for late-stage lead diversification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Functional group distribution of antihistamine drug loratadine (<b>1</b>) and lead diversification technologies employed for LSLD to access A–D ring system SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Liver microsome and recombinant CYP HPLC–MS chromatograms for human liver microsomes (well 9), rhCYP3A4 (well 18), and rabbit liver microsomes (well 6). M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Modeled pose of loratadine with human CYP2D6. The oxygen atom of the CYP2D6 iron(IV)-oxo porphyrin radical cation is 4 Å from one of the methylene hydrogen atoms of the ethyl carbamate moiety in loratadine. (B) Potential strategies to alter a lead molecule intrinsic clearance (CL<sub>int</sub>) value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Microorganism HPLC–MS chromatograms for <i>Nocardia</i> ATCC 21271a (well 19), <i>M. rouxii</i> UC7470 (well 65), and <i>Streptomyces fradiae</i> (well 15).<a onclick="showRef(event, 'cit30a'); return false;" href="javascript:void(0);" class="ref cit30a">(30a)</a> M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. BM3 variant HPLC–MS chromatograms for MCYP0160 (well 47), MCYP0012 (well 40), and MCYP-P1.2-C11 (well 29). M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Electrochemistry HPLC–MS chromatogram. Electrolysis reaction conditions: graphite anode, stainless steel cathode, Et<sub>4</sub>NBF<sub>4</sub>, 5 V, MeCN/H<sub>2</sub>O, RT, and 1 h. M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Biomimetic metalloporphyrin oxidation HPLC–MS chromatograms. Top chromatogram: reaction conditions with metalloporphyrin Cu(TDCIPP), cumene hydroperoxide, MeOH, and DCM. Bottom chromatogram: reaction conditions without metalloporphyrin, <i>m</i>CPBA, MeOH, and DCM. M +/– number refers to the average mass change difference between the parent and analogue (i.e., Δmass).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Diversity map of product similarity and difference relative to biological technology screened by HPLC–MS, refer to (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_002.xlsx" class="ext-link">Excel S1_Diversity Map</a>) in the Supporting Information to view the entire map. <i>X</i> axis displays product distribution determined by HPLC-MS, shown in yellow (top); <i>Y</i> axis displays well distribution from each biological screening panel: liver microsomes and recombinant CYP (shown in brown), microorganisms (shown in green), and BM3 variants (shown in red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Ratio of liver microsome and recombinant CYP products observed by HPLC–MS relative to similar products detected from other technology screens (e.g., microbes and BM3). Venn diagram representation (bottom).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Modeled pose of analogue <b>7</b> with CYP2D6. The oxygen atom of the CYP2D6 iron(IV)-oxo porphyrin radical cation is 13 Å from one of the methylene hydrogen atoms of the ethyl carbamate moiety in <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>8</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Loratadine Analogues Using Electrochemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. House–Meinwald Type Rearrangement</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/medium/jm0c00483_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Loratadine Analogues Using Electrochemical Trifluoromethylation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00483/20200701/images/large/jm0c00483_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00483&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 72 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fessner, N. D.</span></span> <span> </span><span class="NLM_article-title">P450 Monooxygenases Enable Rapid Late-Stage Diversification of Natural Products <i>via</i> C–H Bond Activation</span>. <i>ChemCatChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2226</span>– <span class="NLM_lpage">2242</span>, <span class="refDoi"> DOI: 10.1002/cctc.201801829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fcctc.201801829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=31423290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BB3MvptVChsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=2226-2242&author=N.+D.+Fessner&title=P450+Monooxygenases+Enable+Rapid+Late-Stage+Diversification+of+Natural+Products+via+C%E2%80%93H+Bond+Activation&doi=10.1002%2Fcctc.201801829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">P450 Monooxygenases Enable Rapid Late-Stage Diversification of Natural Products via C-H Bond Activation</span></div><div class="casAuthors">Fessner Nico D</div><div class="citationInfo"><span class="NLM_cas:title">ChemCatChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2226-2242</span>
        ISSN:<span class="NLM_cas:issn">1867-3880</span>.
    </div><div class="casAbstract">The biological potency of natural products has been exploited for decades.  Their inherent structural complexity and natural diversity might hold the key to efficiently address the urgent need for the development of novel pharmaceuticals.  At the same time, it is that very complexity, which impedes necessary chemical modifications such as structural diversification, to improve the effectiveness of the drug.  For this purpose, Cytochrome P450 enzymes, which possess unique abilities to activate inert sp(3)-hybridised C-H bonds in a late-stage fashion, offer an attractive synthetic tool.  In this review the potential of cytochrome P450 enzymes in chemoenzymatic lead diversification is illustrated discussing studies reporting late-stage functionalisations of natural products and other high-value compounds.  These enzymes were proven to extend the synthetic toolbox significantly by adding to the flexibility and efficacy of synthetic strategies of natural product chemists, and scientists of other related disciplines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKA6ELzGwc_Be4jJGKT5N0fW6udTcc2eYy73sImEYWIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvptVChsQ%253D%253D&md5=5b696d1a586a701591911afdc153ea5a</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1002%2Fcctc.201801829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcctc.201801829%26sid%3Dliteratum%253Aachs%26aulast%3DFessner%26aufirst%3DN.%2BD.%26atitle%3DP450%2520Monooxygenases%2520Enable%2520Rapid%2520Late-Stage%2520Diversification%2520of%2520Natural%2520Products%2520via%2520C%25E2%2580%2593H%2520Bond%2520Activation%26jtitle%3DChemCatChem%26date%3D2019%26volume%3D11%26spage%3D2226%26epage%3D2242%26doi%3D10.1002%2Fcctc.201801829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span> <span> </span><span class="NLM_article-title">Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3626</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00116</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1artbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3626-3640&author=R.+S.+Obachauthor=G.+S.+Walkerauthor=R.+Sharmaauthor=S.+Jenkinsonauthor=T.+P.+Tranauthor=A.+F.+Stepan&title=Lead+Diversification+at+the+Nanomole+Scale+Using+Liver+Microsomes+and+Quantitative+Nuclear+Magnetic+Resonance+Spectroscopy%3A+Application+to+Phosphodiesterase+2+Inhibitors&doi=10.1021%2Facs.jmedchem.8b00116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 Inhibitors</span></div><div class="casAuthors">Obach, R. Scott; Walker, Gregory S.; Sharma, Raman; Jenkinson, Stephen; Tran, Tuan P.; Stepan, Antonia F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3626-3640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we describe a method whereby lead mols. can be converted into several new analogs each using liver microsomes.  Less than one micromole of substrate is incubated with liver microsomes (mouse, rat, hamster, guinea pig, rabbit, dog, monkey, or human) to produce multiple products which are isolated and analyzed by quant. cryomicroprobe NMR (qNMR) spectroscopy.  The solns. from qNMR anal. were then used as stocks that were dild. into biochem. assays.  Nine human phosphodiesterase-2 (PDE2) inhibitors yielded 36 new analogs.  Products were tested for PDE2 inhibition, intrinsic clearance in human hepatocytes, and membrane permeability.  Two of the products (2c and 4b) were 3-10× more potent than their resp. parent compds. and also had improved metabolic stability.  Others offered insights into structure-activity relationships.  Overall, this process of using liver microsomes at a submicromole scale of substrate is a useful approach to rapid and cost-effective late-stage lead diversification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-VoZNHBKsXbVg90H21EOLACvtfcHk0ljt5jFVzi7Vxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1artbs%253D&md5=10c4e199e4c58bd90661851fdc3bc1a6</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00116%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26atitle%3DLead%2520Diversification%2520at%2520the%2520Nanomole%2520Scale%2520Using%2520Liver%2520Microsomes%2520and%2520Quantitative%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%253A%2520Application%2520to%2520Phosphodiesterase%25202%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3626%26epage%3D3640%26doi%3D10.1021%2Facs.jmedchem.8b00116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Late-Stage Microsomal Oxidation Reduces Drug–Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00343</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00343" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Wqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=68-72&author=A.+F.+Stepanauthor=T.+P.+Tranauthor=C.+J.+Helalauthor=M.+S.+Brownauthor=C.+Changauthor=R.+E.+O%E2%80%99Connorauthor=M.+De+Vivoauthor=S.+D.+Doranauthor=E.+L.+Fisherauthor=S.+Jenkinsonauthor=D.+Karanianauthor=B.+L.+Kormosauthor=R.+Sharmaauthor=G.+S.+Walkerauthor=A.+S.+Wrightauthor=E.+X.+Yangauthor=M.+A.+Brodneyauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=R.+S.+Obach&title=Late-Stage+Microsomal+Oxidation+Reduces+Drug%E2%80%93Drug+Interaction+and+Identifies+Phosphodiesterase+2A+Inhibitor+PF-06815189&doi=10.1021%2Facsmedchemlett.7b00343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Late-Stage Microsomal Oxidation Reduces Drug-Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189</span></div><div class="casAuthors">Stepan, Antonia F.; Tran, Tuan P.; Helal, Christopher J.; Brown, Maria S.; Chang, Cheng; O'Connor, Rebecca E.; De Vivo, Michael; Doran, Shawn D.; Fisher, Ethan L.; Jenkinson, Stephen; Karanian, David; Kormos, Bethany L.; Sharma, Raman; Walker, Gregory S.; Wright, Ann S.; Yang, Edward X.; Brodney, Michael A.; Wager, Travis T.; Verhoest, Patrick R.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-72</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Late-stage oxidn. using liver microsomes was applied to phosphodiesterase 2 inhibitor 1 to reduce its clearance by cytochrome P 450 enzymes, introduce renal clearance and minimize the risk for victim drug-drug interactions.  This approach yielded PF-06815189 with improved physicochem. properties and a mixed metabolic profile.  This example highlights the importance of C-H diversification methods to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdLF3o73q1nrVg90H21EOLACvtfcHk0ljt5jFVzi7Vxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Wqsg%253D%253D&md5=86a976a3eebf2bbbb9865ae655909ab7</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00343%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBrown%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DFisher%26aufirst%3DE.%2BL.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DKaranian%26aufirst%3DD.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DYang%26aufirst%3DE.%2BX.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DLate-Stage%2520Microsomal%2520Oxidation%2520Reduces%2520Drug%25E2%2580%2593Drug%2520Interaction%2520and%2520Identifies%2520Phosphodiesterase%25202A%2520Inhibitor%2520PF-06815189%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D68%26epage%3D72%26doi%3D10.1021%2Facsmedchemlett.7b00343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Harnessing Biosynthesis and Quantitative NMR for Late Stage Functionalization of Lead Molecules: Application to the M1 Positive Allosteric Modulator (PAM) Program</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2073</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.04.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2018.04.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29716781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosl2js7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2068-2073&author=M.+A.+Brodneyauthor=R.+Sharmaauthor=J.+T.+Lazzaroauthor=G.+S.+Walkerauthor=R.+S.+Obach&title=Harnessing+Biosynthesis+and+Quantitative+NMR+for+Late+Stage+Functionalization+of+Lead+Molecules%3A+Application+to+the+M1+Positive+Allosteric+Modulator+%28PAM%29+Program&doi=10.1016%2Fj.bmcl.2018.04.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing biosynthesis and quantitative NMR for late stage functionalization of lead molecules: Application to the M1 positive allosteric modulator (PAM) program</span></div><div class="casAuthors">Brodney, Michael A.; Sharma, Raman; Lazzaro, John T.; Walker, Gregory S.; Scott Obach, R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2068-2073</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A facile method for late stage diversification of lead mols. for the M1 PAM program using biosynthesis is described.  Liver microsomes from several species are screened to identify a high turnover system.  Subsequent incubations using less than 1mg of substrate generate nanomole quantities of drug metabolites that are purified, characterized by microcryoprobe NMR spectroscopy, and quantified to known concns. to enable rapid biol. testing.  The late-stage diversification of lead compds. provides rapid SAR feedback to the medicinal chem. design cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzgoofLECNXrVg90H21EOLACvtfcHk0liSRqpqmmh3kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosl2js7o%253D&md5=c6756179776bd4fe9e00aed42aa08acf</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.04.054%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DHarnessing%2520Biosynthesis%2520and%2520Quantitative%2520NMR%2520for%2520Late%2520Stage%2520Functionalization%2520of%2520Lead%2520Molecules%253A%2520Application%2520to%2520the%2520M1%2520Positive%2520Allosteric%2520Modulator%2520%2528PAM%2529%2520Program%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2068%26epage%3D2073%26doi%3D10.1016%2Fj.bmcl.2018.04.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagarajan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S. W.</span></span> <span> </span><span class="NLM_article-title">The Medicinal Chemist’s Toolbox for Late Stage Functionalization of Drug-Like Molecules</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">576</span>, <span class="refDoi"> DOI: 10.1039/C5CS00628G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2FC5CS00628G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26507237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=546-576&author=T.+Cernakauthor=K.+D.+Dykstraauthor=S.+Tyagarajanauthor=P.+Vachalauthor=S.+W.+Krska&title=The+Medicinal+Chemist%E2%80%99s+Toolbox+for+Late+Stage+Functionalization+of+Drug-Like+Molecules&doi=10.1039%2FC5CS00628G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The medicinal chemist's toolbox for late stage functionalization of drug-like molecules</span></div><div class="casAuthors">Cernak, Tim; Dykstra, Kevin D.; Tyagarajan, Sriram; Vachal, Petr; Krska, Shane W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">546-576</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The advent of modern C-H functionalization chemistries has enabled medicinal chemists to consider a synthetic strategy, late stage functionalization (LSF), which utilizes the C-H bonds of drug leads as points of diversification for generating new analogs.  LSF approaches offer the promise of rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the prepn. of biol. probes.  This review details a toolbox of intermol. C-H functionalization chemistries with proven applicability to drug-like mols., classified by regioselectivity patterns, and gives guidance on how to systematically develop LSF strategies using these patterns and other considerations.  In addn., a no. of examples illustrate how LSF approaches have been used to impact actual drug discovery and chem. biol. efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7N9sPaaVAQbVg90H21EOLACvtfcHk0liSRqpqmmh3kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7nN&md5=a52fc5692f5515e5cadab0f2746fd6f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2FC5CS00628G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00628G%26sid%3Dliteratum%253Aachs%26aulast%3DCernak%26aufirst%3DT.%26aulast%3DDykstra%26aufirst%3DK.%2BD.%26aulast%3DTyagarajan%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DKrska%26aufirst%3DS.%2BW.%26atitle%3DThe%2520Medicinal%2520Chemist%25E2%2580%2599s%2520Toolbox%2520for%2520Late%2520Stage%2520Functionalization%2520of%2520Drug-Like%2520Molecules%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D546%26epage%3D576%26doi%3D10.1039%2FC5CS00628G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gesmundo, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauvagnat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandliker, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cernak, T.</span></span> <span> </span><span class="NLM_article-title">Nanoscale Synthesis and Affinity Ranking</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>557</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0056-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fs41586-018-0056-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29686415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=557&publication_year=2018&pages=228-232&author=N.+J.+Gesmundoauthor=B.+Sauvagnatauthor=P.+J.+Curranauthor=M.+P.+Richardsauthor=C.+L.+Andrewsauthor=P.+J.+Dandlikerauthor=T.+Cernak&title=Nanoscale+Synthesis+and+Affinity+Ranking&doi=10.1038%2Fs41586-018-0056-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoscale synthesis and affinity ranking</span></div><div class="casAuthors">Gesmundo, Nathan J.; Sauvagnat, Berengere; Curran, Patrick J.; Richards, Matthew P.; Andrews, Christine L.; Dandliker, Peter J.; Cernak, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">557</span>
        (<span class="NLM_cas:issue">7704</span>),
    <span class="NLM_cas:pages">228-232</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Most drugs are developed through iterative rounds of chem. synthesis and biochem. testing to optimize the affinity of a particular compd. for a protein target of therapeutic interest.  This process is challenging because candidate mols. must be selected from a chem. space of more than 1060 drug-like possibilities1, and a single reaction used to synthesize each mol. has more than 107 plausible permutations of catalysts, ligands, additives and other parameters2.  The merger of a method for high-throughput chem. synthesis with a biochem. assay would facilitate the exploration of this enormous search space and streamline the hunt for new drugs and chem. probes.  Miniaturized high-throughput chem. synthesis3-7 has enabled rapid evaluation of reaction space, but so far the merger of such syntheses with bioassays has been achieved with only low-d. reaction arrays, which analyze only a handful of analogs prepd. under a single reaction condition8-13.  High-d. chem. synthesis approaches that have been coupled to bioassays, including on-bead14, on-surface15, on-DNA16 and mass-encoding technologies17, greatly reduce material requirements, but they require the covalent linkage of substrates to a potentially reactive support, must be performed under high diln. and must operate in a mixt. format.  These reaction attributes limit the application of transition-metal catalysts, which are easily poisoned by the many functional groups present in a complex mixt., and of transformations for which the kinetics require a high concn. of reactant.  Here the authors couple high-throughput nanomole-scale synthesis with a label-free affinity-selection mass spectrometry bioassay.  Each reaction is performed at a 0.1-M concn. in a discrete well to enable transition-metal catalysis while consuming less than 0.05 mg of substrate per reaction.  The affinity-selection mass spectrometry bioassay is then used to rank the affinity of the reaction products to target proteins, removing the need for time-intensive reaction purifn.  This method enables the primary synthesis and testing steps that are crit. to the invention of protein inhibitors to be performed rapidly and with minimal consumption of starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxLWYiSL7lvrVg90H21EOLACvtfcHk0liSRqpqmmh3kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgu7s%253D&md5=f4679d44210c46865e3267896b0170de</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0056-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0056-8%26sid%3Dliteratum%253Aachs%26aulast%3DGesmundo%26aufirst%3DN.%2BJ.%26aulast%3DSauvagnat%26aufirst%3DB.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DRichards%26aufirst%3DM.%2BP.%26aulast%3DAndrews%26aufirst%3DC.%2BL.%26aulast%3DDandliker%26aufirst%3DP.%2BJ.%26aulast%3DCernak%26aufirst%3DT.%26atitle%3DNanoscale%2520Synthesis%2520and%2520Affinity%2520Ranking%26jtitle%3DNature%26date%3D2018%26volume%3D557%26spage%3D228%26epage%3D232%26doi%3D10.1038%2Fs41586-018-0056-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, C. M.</span></span> <span> </span><span class="NLM_article-title">Chemical Space and Biology</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1038/nature03192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnature03192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=15602547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=824-828&author=C.+M.+Dobson&title=Chemical+Space+and+Biology&doi=10.1038%2Fnature03192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical space and biology</span></div><div class="casAuthors">Dobson, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7019</span>),
    <span class="NLM_cas:pages">824-828</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. space - which encompasses all possible small org. mols., including those present in biol. systems - is vast.  So vast, in fact, that so far only a tiny fraction of it has been explored.  Nevertheless, these explorations have greatly enhanced our understanding of biol., and have led to the development of many of today's drugs.  The discovery of new bioactive mols., facilitated by a deeper understanding of the nature of the regions of chem. space that are relevant to biol., will advance our knowledge of biol. processes and lead to new strategies to treat disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolNmRTVWoSDrVg90H21EOLACvtfcHk0lhFhc8uDLDQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jN&md5=b951fff4aa4877682756fb1831bff09d</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1038%2Fnature03192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03192%26sid%3Dliteratum%253Aachs%26aulast%3DDobson%26aufirst%3DC.%2BM.%26atitle%3DChemical%2520Space%2520and%2520Biology%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D824%26epage%3D828%26doi%3D10.1038%2Fnature03192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span> <span> </span><span class="NLM_article-title">Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.1021/ci0255782</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci0255782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Cmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=374-380&author=P.+Ertl&title=Cheminformatics+Analysis+of+Organic+Substituents%3A+Identification+of+the+Most+Common+Substituents%2C+Calculation+of+Substituent+Properties%2C+and+Automatic+Identification+of+Drug-like+Bioisosteric+Groups&doi=10.1021%2Fci0255782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups</span></div><div class="casAuthors">Ertl, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">374-380</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A large set of more than 3 million mols. was processed to find all the org. substituents contained in the set and to identify the most common ones.  During the anal., 849 574 unique substituents were found.  Extrapolated to the no. of known org. mols., this result suggests that about 3.1 million substituents are known.  Based on these findings the size of virtual org. chem. space accessible using currently known synthetic methods is estd. to be between 1020 and 1024 mols.  The extd. substituents were characterized by calcd. electronic, hydrophobic, steric, and hydrogen bonding properties as well as by the drug-likeness index.  Various possible applications of such a large database of drug-like substituents characterized by calcd. properties are discussed and illustrated by ref. to a Web-based tool for automatic identification of bioisosteric groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqODLrwzH2t4LVg90H21EOLACvtfcHk0lhFhc8uDLDQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Cmtbs%253D&md5=9debc7ddfbb1c57ff85b7ff55c44a7d0</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fci0255782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0255782%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26atitle%3DCheminformatics%2520Analysis%2520of%2520Organic%2520Substituents%253A%2520Identification%2520of%2520the%2520Most%2520Common%2520Substituents%252C%2520Calculation%2520of%2520Substituent%2520Properties%252C%2520and%2520Automatic%2520Identification%2520of%2520Drug-like%2520Bioisosteric%2520Groups%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2003%26volume%3D43%26spage%3D374%26epage%3D380%26doi%3D10.1021%2Fci0255782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+Computational+Approaches+to+Estimate+Solubility+and+Permeability+in+Drug+Discovery+and+Development+Settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lhFhc8uDLDQgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520Computational%2520Approaches%2520to%2520Estimate%2520Solubility%2520and%2520Permeability%2520in%2520Drug%2520Discovery%2520and%2520Development%2520Settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">A Planning Strategy for Diversity-Oriented Synthesis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1002/anie.200300626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.200300626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=14694470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVeksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=46-58&author=M.+D.+Burkeauthor=S.+L.+Schreiber&title=A+Planning+Strategy+for+Diversity-Oriented+Synthesis&doi=10.1002%2Fanie.200300626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A planning strategy for diversity-oriented synthesis</span></div><div class="casAuthors">Burke, Martin D.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  In contrast to target-oriented synthesis (TOS) and medicinal or combinatorial chem., which aim to access precise or dense regions of chem. space, diversity-oriented synthesis (DOS) populates chem. space broadly with small-mols., having diverse structures.  The goals of DOS include the development of pathways leading to the efficient (three- to five-step) synthesis of collections of small mols. having skeletal and stereochem. diversity with defined coordinates in chem. space.  Ideally, these pathways also yield compds. having the potential to attach appendages site- and stereoselectively to a variety of attachment sites during a post-screening, maturation stage.  The diverse skeletons and stereochemistries ensure that the appendages can be positioned in multiple orientations about the surface of the mols.  TOS as well as medicinal and combinatorial chemistries have been advanced by the development of retrosynthetic anal.  Although the distinct goals of DOS do not permit the application of retrosynthetic concepts and thinking, these foundations are being built on, by using parallel logic, to develop a complementary procedure known as forward-synthetic anal.  This anal. facilitates synthetic planning, communication, and teaching in this evolving discipline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8zavQvQH3GLVg90H21EOLACvtfcHk0lgLIIoGE0eOlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVeksQ%253D%253D&md5=e556604e2e248ff7a86121d8c2383182</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200300626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200300626%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DM.%2BD.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DA%2520Planning%2520Strategy%2520for%2520Diversity-Oriented%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D46%26epage%3D58%26doi%3D10.1002%2Fanie.200300626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Diversity-Oriented Synthesis; A Challenge for Synthetic Chemists</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">3867</span>– <span class="NLM_lpage">3870</span>, <span class="refDoi"> DOI: 10.1039/b310752n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fb310752n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=14664374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=3867-3870&author=D.+R.+Spring&title=Diversity-Oriented+Synthesis%3B+A+Challenge+for+Synthetic+Chemists&doi=10.1039%2Fb310752n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity-oriented synthesis; a challenge for synthetic chemists</span></div><div class="casAuthors">Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3867-3870</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The efficient, simultaneous synthesis of structurally diverse compds., better known as diversity-oriented synthesis (DOS), is not obvious, and remains a challenge to synthetic chem.  This account details why DOS has such enormous implications for the discovery of small mols. with desired properties, such as catalysts, synthetic reagents, biol. probes and new drugs.  Also, the evolution behind the current state-of-play of DOS was described.  A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxtlduQ_YJhrVg90H21EOLACvtfcHk0lgLIIoGE0eOlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslyjsL8%253D&md5=5e15b4e967f4631adfd4ce6aa56ce303</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1039%2Fb310752n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb310752n%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DDiversity-Oriented%2520Synthesis%253B%2520A%2520Challenge%2520for%2520Synthetic%2520Chemists%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D3867%26epage%3D3870%26doi%3D10.1039%2Fb310752n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Lipophilic Efficiency as an Important Metric in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6401</span>– <span class="NLM_lpage">6420</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6401-6420&author=T.+W.+Johnsonauthor=R.+A.+Gallegoauthor=M.+P.+Edwards&title=Lipophilic+Efficiency+as+an+Important+Metric+in+Drug+Design&doi=10.1021%2Facs.jmedchem.8b00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic Efficiency as an Important Metric in Drug Design</span></div><div class="casAuthors">Johnson, Ted W.; Gallego, Rebecca A.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6401-6420</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chem. lead optimization programs.  In this perspective, using literature drug discovery examples, we discuss the concept of rigorously applying LipE to guide medicinal chem. lead optimization toward drug candidates with potential for superior in vivo efficacy and safety, esp. when guided by physiochem. property-based optimization (PPBO).  Also highlighted are examples of small structural modifications such as addn. of single atoms, small functional groups, and cyclizations that produce large increases in LipE.  Understanding the factors that may contribute to LipE changes through anal. of ligand-protein crystal structures and using structure-based drug design (SBDD) to increase LipE by design is also discussed.  Herein we advocate for use of LipE anal. coupled with PPBO and SBDD as an efficient mechanism for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ8DOcOj6GrVg90H21EOLACvtfcHk0lgLIIoGE0eOlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVahsbg%253D&md5=29f38880914fa75c33be3a640ace4309</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DGallego%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DLipophilic%2520Efficiency%2520as%2520an%2520Important%2520Metric%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6401%26epage%3D6420%26doi%3D10.1021%2Facs.jmedchem.8b00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, W. R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isidro-Llobet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Diversity-Oriented Synthesis as a Tool for the Discovery of Novel Biologically Active Small Molecules</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">80</span>, <span class="refDoi"> DOI: 10.1038/ncomms1081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fncomms1081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=20865796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BC3cfks1Wkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=80&author=W.+R.+J.+D.+Gallowayauthor=A.+Isidro-Llobetauthor=D.+R.+Spring&title=Diversity-Oriented+Synthesis+as+a+Tool+for+the+Discovery+of+Novel+Biologically+Active+Small+Molecules&doi=10.1038%2Fncomms1081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules</span></div><div class="casAuthors">Galloway Warren R J D; Isidro-Llobet Albert; Spring David R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Biologically active molecules can be identified through the screening of small-molecule libraries.  Deficiencies in current compound collections are evidenced by the continuing decline in drug-discovery successes.  Typically, such collections are comprised of large numbers of structurally similar compounds.  A general consensus has emerged that library size is not everything; library diversity, in terms of molecular structure and thus function, is crucial.  Diversity-oriented synthesis (DOS) aims to generate such structural diversity in an efficient manner.  Recent years have witnessed significant achievements in the field, which help to validate the usefulness of DOS as a tool for the discovery of novel, biologically interesting small molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYIC7Rtvwk7pPq5LRczm8ffW6udTcc2eYDTbRthiFAOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfks1Wkuw%253D%253D&md5=acc40b2415f866b55aa684f0608c3b68</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fncomms1081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1081%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DW.%2BR.%2BJ.%2BD.%26aulast%3DIsidro-Llobet%26aufirst%3DA.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DDiversity-Oriented%2520Synthesis%2520as%2520a%2520Tool%2520for%2520the%2520Discovery%2520of%2520Novel%2520Biologically%2520Active%2520Small%2520Molecules%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D80%26doi%3D10.1038%2Fncomms1081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Galloway, W. R. J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spring, D. R.</span></span> <span> </span><span class="NLM_article-title">Is Synthesis the Main Hurdle for the Generation of Diversity in Compound Libraries for Screening?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1517/17460440902916606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1517%2F17460440902916606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23485081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Srtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=467-472&author=W.+R.+J.+D.+Gallowayauthor=D.+R.+Spring&title=Is+Synthesis+the+Main+Hurdle+for+the+Generation+of+Diversity+in+Compound+Libraries+for+Screening%3F&doi=10.1517%2F17460440902916606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Is synthesis the main hurdle for the generation of diversity in compound libraries for screening?</span></div><div class="casAuthors">Galloway, Warren R. J. D.; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">467-472</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  'Diversity' is often cited as a crucial consideration when generating compd. collections for biol. screening.  However, what exactly does one mean by 'diversity' and why is it important.  How can diversity be incorporated into compd. collections and what are the theor. and tech. challenges this poses.  In this editorial, we comment on various factors involved in the creation of structurally, and most crucially, functionally diverse compd. libraries.  In particular, we highlight the central role played by org. synthesis and discuss the value of diversity-driven synthetic approaches in the search for new biol. active mols. with potentially exciting and unusual biol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMN31tpuOvPrVg90H21EOLACvtfcHk0liekSBJe6k94Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Srtbg%253D&md5=5348abee4faa4bea326069ee96f2f096</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1517%2F17460440902916606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460440902916606%26sid%3Dliteratum%253Aachs%26aulast%3DGalloway%26aufirst%3DW.%2BR.%2BJ.%2BD.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DIs%2520Synthesis%2520the%2520Main%2520Hurdle%2520for%2520the%2520Generation%2520of%2520Diversity%2520in%2520Compound%2520Libraries%2520for%2520Screening%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2009%26volume%3D4%26spage%3D467%26epage%3D472%26doi%3D10.1517%2F17460440902916606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span> <span> </span><span class="NLM_article-title">Expanding the Medicinal Chemistry Synthetic Toolbox</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnrd.2018.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=30140018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=709-727&author=J.+Bostr%C3%B6mauthor=D.+G.+Brownauthor=R.+J.+Youngauthor=G.+M.+Keser%C3%BC&title=Expanding+the+Medicinal+Chemistry+Synthetic+Toolbox&doi=10.1038%2Fnrd.2018.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the medicinal chemistry synthetic toolbox</span></div><div class="casAuthors">Bostrom Jonas; Brown Dean G; Young Robert J; Keseru Gyorgy M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">709-727</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The key objectives of medicinal chemistry are to efficiently design and synthesize bioactive compounds that have the potential to become safe and efficacious drugs.  Most medicinal chemistry programmes rely on screening compound collections populated by a range of molecules derived from a set of known and robust chemistry reactions.  Analysis of the role of synthetic organic chemistry in subsequent hit and lead optimization efforts suggests that only a few reactions dominate.  Thus, the uptake of new synthetic methodologies in drug discovery is limited.  Starting from the known limitations of reaction parameters, synthesis design tools, synthetic strategies and innovative chemistries, here we highlight opportunities for the expansion of the medicinal chemists' synthetic toolbox.  More intense crosstalk between synthetic and medicinal chemists in industry and academia should enable enhanced impact of new methodologies in future drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy8c_ueHSwcYMcDoIzZtNkfW6udTcc2eaBhoAvWGO207ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3htlWisw%253D%253D&md5=d87e988602808139597576ced56faa88</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.116%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DExpanding%2520the%2520Medicinal%2520Chemistry%2520Synthetic%2520Toolbox%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D709%26epage%3D727%26doi%3D10.1038%2Fnrd.2018.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span> <span> </span><span class="NLM_article-title">Organic Synthesis Provides Opportunities to Transform Drug Discovery</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0021-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fs41557-018-0021-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29568051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=383-394&author=D.+C.+Blakemoreauthor=L.+Castroauthor=I.+Churcherauthor=D.+C.+Reesauthor=A.+W.+Thomasauthor=D.+M.+Wilsonauthor=A.+Wood&title=Organic+Synthesis+Provides+Opportunities+to+Transform+Drug+Discovery&doi=10.1038%2Fs41557-018-0021-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Organic synthesis provides opportunities to transform drug discovery</span></div><div class="casAuthors">Blakemore, David C.; Castro, Luis; Churcher, Ian; Rees, David C.; Thomas, Andrew W.; Wilson, David M.; Wood, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite decades of ground-breaking research in academia, org. synthesis is still a rate-limiting factor in drug-discovery projects.  Here we present some current challenges in synthetic org. chem. from the perspective of the pharmaceutical industry and highlight problematic steps that, if overcome, would find extensive application in the discovery of transformational medicines.  Significant synthesis challenges arise from the fact that drug mols. typically contain amines and N-heterocycles, as well as unprotected polar groups.  There is also a need for new reactions that enable non-traditional disconnections, more C-H bond activation and late-stage functionalization, as well as stereoselectively substituted aliph. heterocyclic ring synthesis, C-X or C-C bond formation.  We also emphasize that syntheses compatible with biomacromols. will find increasing use, while new technologies such as machine-assisted approaches and artificial intelligence for synthesis planning have the potential to dramatically accelerate the drug-discovery process.  We believe that increasing collaboration between academic and industrial chemists is crucial to address the challenges outlined here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonqR_RxjClS7Vg90H21EOLACvtfcHk0ljNx85D2nFshQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Sktrk%253D&md5=f6269ea8193e28416fd86fe8afbcea3f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0021-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0021-z%26sid%3Dliteratum%253Aachs%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DA.%2BW.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DWood%26aufirst%3DA.%26atitle%3DOrganic%2520Synthesis%2520Provides%2520Opportunities%2520to%2520Transform%2520Drug%2520Discovery%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D383%26epage%3D394%26doi%3D10.1038%2Fs41557-018-0021-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandrell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairaudeau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennie, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, A.</span></span> <span> </span><span class="NLM_article-title">An Analysis of the Attrition of Drug Candidates from Four Major Pharmaceutical Companies</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">475</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nrd4609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnrd4609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26091267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=475-486&author=M.+J.+Waringauthor=J.+Arrowsmithauthor=A.+R.+Leachauthor=P.+D.+Leesonauthor=S.+Mandrellauthor=R.+M.+Owenauthor=G.+Pairaudeauauthor=W.+D.+Pennieauthor=S.+D.+Pickettauthor=J.+Wangauthor=O.+Wallaceauthor=A.+Weir&title=An+Analysis+of+the+Attrition+of+Drug+Candidates+from+Four+Major+Pharmaceutical+Companies&doi=10.1038%2Fnrd4609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the attrition of drug candidates from four major pharmaceutical companies</span></div><div class="casAuthors">Waring, Michael J.; Arrowsmith, John; Leach, Andrew R.; Leeson, Paul D.; Mandrell, Sam; Owen, Robert M.; Pairaudeau, Garry; Pennie, William D.; Pickett, Stephen D.; Wang, Jibo; Wallace, Owen; Weir, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">475-486</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pharmaceutical industry remains under huge pressure to address the high attrition rates in drug development.  Attempts to reduce the no. of efficacy- and safety-related failures by analyzing possible links to the physicochem. properties of small-mol. drug candidates have been inconclusive because of the limited size of data sets from individual companies.  Here, we describe the compilation and anal. of combined data on the attrition of drug candidates from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline and Pfizer.  The anal. reaffirms that control of physicochem. properties during compd. optimization is beneficial in identifying compds. of candidate drug quality and indicates for the first time a link between the physicochem. properties of compds. and clin. failure due to safety issues.  The results also suggest that further control of physicochem. properties is unlikely to have a significant effect on attrition rates and that addnl. work is required to address safety-related failures.  Further cross-company collaborations will be crucial to future progress in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsLfBWrLC3ZLVg90H21EOLACvtfcHk0ljNx85D2nFshQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeju7jM&md5=1fdc374d32816b1e91438152299dd1b1</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnrd4609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4609%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DMandrell%26aufirst%3DS.%26aulast%3DOwen%26aufirst%3DR.%2BM.%26aulast%3DPairaudeau%26aufirst%3DG.%26aulast%3DPennie%26aufirst%3DW.%2BD.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWeir%26aufirst%3DA.%26atitle%3DAn%2520Analysis%2520of%2520the%2520Attrition%2520of%2520Drug%2520Candidates%2520from%2520Four%2520Major%2520Pharmaceutical%2520Companies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D475%26epage%3D486%26doi%3D10.1038%2Fnrd4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Improving Drug Candidates by Design: A Focus on Physicochemical Properties as a Means of Improving Compound Disposition and Safety</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/tx200211v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200211v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1420-1456&author=N.+A.+Meanwell&title=Improving+Drug+Candidates+by+Design%3A+A+Focus+on+Physicochemical+Properties+as+a+Means+of+Improving+Compound+Disposition+and+Safety&doi=10.1021%2Ftx200211v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1420-1456</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of small mol. drug candidates from the discovery phase to a marketed product continues to be a challenging enterprise with very low success rates that have fostered the perception of poor productivity by the pharmaceutical industry.  Although there have been significant advances in preclin. profiling that have improved compd. triaging and altered the underlying reasons for compd. attrition, the failure rates have not appreciably changed.  As part of an effort to more deeply understand the reasons for candidate failure, there has been considerable interest in analyzing the physicochem. properties of marketed drugs for the purpose of comparing with drugs in discovery and development as a means capturing recent trends in drug design.  The scenario that has emerged is one in which contemporary drug discovery is thought to be focused too heavily on advancing candidates with profiles that are most easily satisfied by mols. with increased mol. wt. and higher overall lipophilicity.  The preponderance of mols. expressing these properties is frequently a function of increased arom. ring count when compared with that of the drugs launched in the latter half of the 20th century and may reflect a preoccupation with maximizing target affinity rather than taking a more holistic approach to drug design.  These attributes not only present challenges for formulation and absorption but also may influence the manifestation of toxicity during development.  By providing some definition around the optimal physicochem. properties assocd. with marketed drugs, guidelines for drug design have been developed that are based largely on calcd. parameters and which may readily be applied by medicinal chemists as an aid to understanding candidate quality.  The physicochem. properties of a mol. that are consistent with the potential for good oral absorption were initially defined by Lipinski, with addnl. insights allowing further refinement, while deeper analyses have explored the correlation with metabolic stability and toxicity.  These insights have been augmented by careful analyses of physicochem. aspects of drug-target interactions, with thermodn. profiling indicating that the signature of best-in-class drugs is a dependence on enthalpy to drive binding energetics rather than entropy, which is dependent on lipophilicity.  Optimization of the entropic contribution to the binding energy of a ligand to its target is generally much easier than refining the enthalpic element.  Consequently, in the absence of a fundamental understanding of the thermodn. complexion of an interaction, the design of mols. with increased lipophilicity becomes almost inevitable.  The application of ligand efficiency, a measure of affinity per heavy atom, group efficiency, which assesses affinity in the context of structural changes, and lipophilic ligand efficiency, which relates potency to lipophilicity, offer less sophisticated but practically useful anal. algorithms to assess the quality of drug-target interactions.  These parameters are readily calcd. and can be applied to lead optimization programs in a fashion that helps to maximize potency while minimizing the kind of lipophilic burden that has been dubbed "mol. obesity".  Several recently described lead optimization campaigns provide illustrative, informative, and productive examples of the effect of paying close attention to carefully controlling physicochem. properties by monitoring ligand efficiency and lipophilic ligand efficiency.  However, to be successful during the lead optimization phase, drug candidate identification programs will need to adopt a holistic approach that integrates multiple parameters, many of which will have unique dependencies on both the drug target and the specific chemotype under prosecution.  Nevertheless, there are many important drug targets that necessitate working in space beyond that which has been defined by the retrospective analyses of marketed drugs and which will require adaptation of some of the guideposts that are useful in directing lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQrUfIwZiIR7Vg90H21EOLACvtfcHk0ljNx85D2nFshQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlCitLs%253D&md5=9ddcf6dc81bf8ab0441df5037979ff4e</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Ftx200211v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200211v%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DImproving%2520Drug%2520Candidates%2520by%2520Design%253A%2520A%2520Focus%2520on%2520Physicochemical%2520Properties%2520as%2520a%2520Means%2520of%2520Improving%2520Compound%2520Disposition%2520and%2520Safety%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1420%26epage%3D1456%26doi%3D10.1021%2Ftx200211v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of Fluorinated Analogs of Drugs Using Human Cytochrome P450 Enzymes Followed by Deoxyfluorination and Quantitative Nuclear Magnetic Resonance Spectroscopy to Improve Metabolic Stability</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1124/dmd.116.069310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.116.069310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26921388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFelurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=634-646&author=R.+S.+Obachauthor=G.+S.+Walkerauthor=M.+A.+Brodney&title=Biosynthesis+of+Fluorinated+Analogs+of+Drugs+Using+Human+Cytochrome+P450+Enzymes+Followed+by+Deoxyfluorination+and+Quantitative+Nuclear+Magnetic+Resonance+Spectroscopy+to+Improve+Metabolic+Stability&doi=10.1124%2Fdmd.116.069310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of fluorinated analogs of drugs using human cytochrome P450 enzymes followed by deoxyfluorination and quantitative nuclear magnetic resonance spectroscopy to improve metabolic stability</span></div><div class="casAuthors">Obach, R. Scott; Walker, Gregory S.; Brodney, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">634-646</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Replacement of hydrogen with fluorine is a useful drug design strategy when decreases in cytochrome P 450 (P 450) metabolic lability are needed.  In this paper, a facile two-step method of inserting fluorine into metabolically labile sites of drug mols. is described that utilizes less than 1 mg of starting material and quant. NMR spectroscopy to ascertain the structures and concns. of products.  In the first step, hydroxyl metabolites are biosynthesized using human P 450 enzymes, and in the second step these metabolites are subjected to deoxyfluorination using diethylaminosulfur trifluoride (DAST).  The method is demonstrated using midazolam, celecoxib, ramelteon, and risperidone as examples and CYP3A5, 2C9, 1A2, and 2D6 to catalyze the hydroxylations.  The drugs and their fluoro analogs were tested for metabolic lability. 9-Fluororisperidone and 49-fluorocelecoxib were 16 and 4 times more metabolically stable than risperidone and celecoxib, resp., and 2-fluororamelteon and ramelteon were metabolized at the same rate. 19-Fluoromidazolam wasmetabolized at the same rate as midazolam by CYP3A4 but was more stable in CYP3A5 incubations.  The P 450-catalyzed sites of metab. of the fluorine-contg. analogs were detd.  Some of themetabolites arose via metab. at the fluorine-substituted carbon, wherein the fluorine was lost to yield aldehydes.  In summary, this method offers an approach whereby fluorine can be substituted in metabolically labile sites, and the products can be tested to det. whether an enhancement in metabolic stability was obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8_453Jbx0VrVg90H21EOLACvtfcHk0ljxc_3CKwRgcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFelurvI&md5=ec9f4046db98d96b7cd2b7bd16c8d3d4</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.116.069310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.116.069310%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DBiosynthesis%2520of%2520Fluorinated%2520Analogs%2520of%2520Drugs%2520Using%2520Human%2520Cytochrome%2520P450%2520Enzymes%2520Followed%2520by%2520Deoxyfluorination%2520and%2520Quantitative%2520Nuclear%2520Magnetic%2520Resonance%2520Spectroscopy%2520to%2520Improve%2520Metabolic%2520Stability%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D634%26epage%3D646%26doi%3D10.1124%2Fdmd.116.069310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spracklin, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Biosynthesis of Drug Metabolites and Quantitation Using NMR Spectroscopy for Use in Pharmacologic and Drug Metabolism Studies</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1627</span>– <span class="NLM_lpage">1639</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.059204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.114.059204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25053618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1627-1639&author=G.+S.+Walkerauthor=J.+N.+Baumanauthor=T.+F.+Ryderauthor=E.+B.+Smithauthor=D.+K.+Spracklinauthor=R.+S.+Obach&title=Biosynthesis+of+Drug+Metabolites+and+Quantitation+Using+NMR+Spectroscopy+for+Use+in+Pharmacologic+and+Drug+Metabolism+Studies&doi=10.1124%2Fdmd.114.059204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies</span></div><div class="casAuthors">Walker, Gregory S.; Bauman, Jonathan N.; Ryder, Tim F.; Smith, Evan B.; Spracklin, Douglas K.; Scott Obach, R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1627-1639, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The contribution of drug metabolites to the pharmacol. and toxicol. activity of a drug can be important; however, for a variety of reasons metabolites can frequently be difficult to synthesize.  To meet the need of having samples of drug metabolites for further study, we have developed biosynthetic methods coupled with quant. NMR spectroscopy (qNMR) to generate solns. of metabolites of known structure and concn.  These quant. samples can be used in a variety of ways when a synthetic sample is unavailable, including pharmacol. assays, stds. for in vitro work to help establish clearance pathways, and/or as anal. stds. for bioanal. work to ascertain exposure, among others.  We illustrate five examples of metabolite biosynthesis and qNMR.  The types of metabolites include one glucuronide and four oxidative products.  Concns. of the isolated metabolite stock solns. ranged from 0.048 to 8.3 mM, with vols. from approx. 0.04 to 0.150 mL in hexadeutarated dimethylsulfoxide.  These specific quantified isolates were used as stds. in the drug discovery setting as substrates in pharmacol. assays, for bioanal. assays to establish exposure, and in variety of routine absorption, distribution, metab., and excretion assays, such as protein binding and detg. blood-toplasma ratios.  The methods used to generate these materials are described in detail with the objective that these methods can be generally used for metabolite biosynthesis and isolation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIcWqizvGukLVg90H21EOLACvtfcHk0ljxc_3CKwRgcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yqur3N&md5=8d763ea8c23f07f680949c005e2ea7c7</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.059204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.059204%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DBiosynthesis%2520of%2520Drug%2520Metabolites%2520and%2520Quantitation%2520Using%2520NMR%2520Spectroscopy%2520for%2520Use%2520in%2520Pharmacologic%2520and%2520Drug%2520Metabolism%2520Studies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1627%26epage%3D1639%26doi%3D10.1124%2Fdmd.114.059204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumpp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gindro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfender, J.-L.</span></span> <span> </span><span class="NLM_article-title">Metabolite Induction via Microorganism Co-Culture: A Potential Way to Enhance Chemical Diversity for Drug Discovery</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1204</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2014.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.biotechadv.2014.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=24651031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2gsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=1180-1204&author=S.+Bertrandauthor=N.+Bohniauthor=S.+Schneeauthor=O.+Schumppauthor=K.+Gindroauthor=J.-L.+Wolfender&title=Metabolite+Induction+via+Microorganism+Co-Culture%3A+A+Potential+Way+to+Enhance+Chemical+Diversity+for+Drug+Discovery&doi=10.1016%2Fj.biotechadv.2014.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolite induction via microorganism co-culture: A potential way to enhance chemical diversity for drug discovery</span></div><div class="casAuthors">Bertrand, Samuel; Bohni, Nadine; Schnee, Sylvain; Schumpp, Olivier; Gindro, Katia; Wolfender, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1180-1204</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Microorganisms have a long track record as important sources of novel bioactive natural products, particularly in the field of drug discovery.  While microbes have been shown to biosynthesize a wide array of mols., recent advances in genome sequencing have revealed that such organisms have the potential to yield even more structurally diverse secondary metabolites.  Thus, many microbial gene clusters may be silent under std. lab. growth conditions.  In the last ten years, several methods have been developed to aid in the activation of these cryptic biosynthetic pathways.  In addn. to the techniques that demand prior knowledge of the genome sequences of the studied microorganisms, several genome sequence-independent tools have been developed.  One of these approaches is microorganism co-culture, involving the cultivation of two or more microorganisms in the same confined environment.  Microorganism co-culture is inspired by the natural microbe communities that are omnipresent in nature.  Within these communities, microbes interact through signaling or defense mols.  Such compds., produced dynamically, are of potential interest as new leads for drug discovery.  Microorganism co-culture can be achieved in either solid or liq. media and has recently been used increasingly extensively to study natural interactions and discover new bioactive metabolites.  Because of the complexity of microbial exts., advanced anal. methods (e.g., mass spectrometry methods and metabolomics) are key for the successful detection and identification of co-culture-induced metabolites.This review focuses on co-culture studies that aim to increase the diversity of metabolites obtained from microbes.  The various strategies are summarized with a special emphasis on the multiple methods of performing co-culture expts.  The anal. approaches for studying these interaction phenomena are discussed, and the chem. diversity and biol. activity obsd. among the induced metabolites are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFaWmpVIckBLVg90H21EOLACvtfcHk0ljxc_3CKwRgcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2gsbw%253D&md5=45abf8847b4e28778064914bc6b3f49d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2014.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2014.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBohni%26aufirst%3DN.%26aulast%3DSchnee%26aufirst%3DS.%26aulast%3DSchumpp%26aufirst%3DO.%26aulast%3DGindro%26aufirst%3DK.%26aulast%3DWolfender%26aufirst%3DJ.-L.%26atitle%3DMetabolite%2520Induction%2520via%2520Microorganism%2520Co-Culture%253A%2520A%2520Potential%2520Way%2520to%2520Enhance%2520Chemical%2520Diversity%2520for%2520Drug%2520Discovery%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2014%26volume%3D32%26spage%3D1180%26epage%3D1204%26doi%3D10.1016%2Fj.biotechadv.2014.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawayama, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulanthaivel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">A Panel of Cytochrome P450 BM3 Variants To Produce Drug Metabolites and Diversify Lead Compounds</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">11723</span>– <span class="NLM_lpage">11729</span>, <span class="refDoi"> DOI: 10.1002/chem.200900643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fchem.200900643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=19774562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlansL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=11723-11729&author=A.+M.+Sawayamaauthor=M.+M.+Y.+Chenauthor=P.+Kulanthaivelauthor=M.-S.+Kuoauthor=H.+Hemmerleauthor=F.+H.+Arnold&title=A+Panel+of+Cytochrome+P450+BM3+Variants+To+Produce+Drug+Metabolites+and+Diversify+Lead+Compounds&doi=10.1002%2Fchem.200900643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds</span></div><div class="casAuthors">Sawayama, Andrew M.; Chen, Michael M. Y.; Kulanthaivel, Palaniappan; Kuo, Ming-Shang; Hemmerle, Horst; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">11723-11729, S11723/1-S11723/9</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Herein we demonstrate that a small panel of variants of cytochrome P 450 BM3 from Bacillus megaterium covers the breadth of reactivity of human P450s by producing 12 of 13 mammalian metabolites for two marketed drugs, verapamil and astemizole, and one research compd.  The most active enzymes support prepn. of individual metabolites for preclin. bioactivity and toxicol. evaluations.  Underscoring their potential utility in drug lead diversification, engineered P 450 BM3 variants also produce novel metabolites by catalyzing reactions at carbon centers beyond those targeted by animal and human P450s.  Prodn. of a specific metabolite can be improved by directed evolution of the enzyme catalyst.  Some variants are more active on the more hydrophobic parent drug than on its metabolites, which limits prodn. of multiply-hydroxylated species, a preference that appears to depend on the evolutionary history of the P 450 variant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVDy3kQSK4I7Vg90H21EOLACvtfcHk0lg0X2w9ZJjTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlansL3E&md5=0808a8225260167607422a1cfc62596a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fchem.200900643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200900643%26sid%3Dliteratum%253Aachs%26aulast%3DSawayama%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DM.%2BM.%2BY.%26aulast%3DKulanthaivel%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DM.-S.%26aulast%3DHemmerle%26aufirst%3DH.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DA%2520Panel%2520of%2520Cytochrome%2520P450%2520BM3%2520Variants%2520To%2520Produce%2520Drug%2520Metabolites%2520and%2520Diversify%2520Lead%2520Compounds%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D11723%26epage%3D11729%26doi%3D10.1002%2Fchem.200900643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvete, M. J. F.</span></span> <span> </span><span class="NLM_article-title">Metalloporphyrins: Bioinspired Oxidation Catalysts</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">10784</span>– <span class="NLM_lpage">10808</span>, <span class="refDoi"> DOI: 10.1021/acscatal.8b01871</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.8b01871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2rs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=10784-10808&author=M.+M.+Pereiraauthor=L.+D.+Diasauthor=M.+J.+F.+Calvete&title=Metalloporphyrins%3A+Bioinspired+Oxidation+Catalysts&doi=10.1021%2Facscatal.8b01871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloporphyrins: Bioinspired Oxidation Catalysts</span></div><div class="casAuthors">Pereira, Mariette M.; Dias, Lucas D.; Calvete, Mario J. F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10784-10808</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The use of metalloporphyrins as bioinspired oxidn. catalysts is an evolving topic of research.  By understanding the cytochrome P 450 mechanism of action, chemists were able to mimic several types of oxidn. reactions using metalloporphyrins as catalysts.  At 1st, homogeneous systems presented the most amenable strategy for oxidizing a vast array of substrates; however, current environmental concerns have directed research in this field to the design, synthesis, and application of heterogeneous catalysts, as well as avoiding the use of highly pollutant cooxidants and/or co-catalysts.  The past decade (from 2008) was reviewed concerning the use of solely mol. O2 as an environmentally benign oxidant source, in oxidn. reactions catalyzed by bioinspired metalloporphyrin analogs.  A comprehensive review was not intended; instead the most important and illustrative examples for this period are highlighted.  The application of such catalysts on the oxidn. reactions of many relevant substrates using homogeneous and heterogeneous metalloporphyrin-based catalysts, mostly using inorg. supports for more accessible re-use protocols are emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp636vrj7-PY7Vg90H21EOLACvtfcHk0lg0X2w9ZJjTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2rs77J&md5=268ba517841cd7645848e121b547d0f4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facscatal.8b01871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.8b01871%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DM.%2BM.%26aulast%3DDias%26aufirst%3DL.%2BD.%26aulast%3DCalvete%26aufirst%3DM.%2BJ.%2BF.%26atitle%3DMetalloporphyrins%253A%2520Bioinspired%2520Oxidation%2520Catalysts%26jtitle%3DACS%2520Catal.%26date%3D2018%26volume%3D8%26spage%3D10784%26epage%3D10808%26doi%3D10.1021%2Facscatal.8b01871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">13230</span>– <span class="NLM_lpage">13319</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=13230-13319&author=M.+Yanauthor=Y.+Kawamataauthor=P.+S.+Baran&title=Synthetic+Organic+Electrochemical+Methods+Since+2000%3A+On+the+Verge+of+a+Renaissance&doi=10.1021%2Facs.chemrev.7b00397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance</span></div><div class="casAuthors">Yan, Ming; Kawamata, Yu; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13230-13319</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses advances in synthetic org. electrochem. since 2000.  Enabling methods and synthetic applications are analyzed alongside innate advantages as well as future challenges of electroorg. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoosmLKvAW1Z7Vg90H21EOLACvtfcHk0lg0X2w9ZJjTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WntbzJ&md5=21205e55da92db4e7d27aa393fed486d</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00397%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DM.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DSynthetic%2520Organic%2520Electrochemical%2520Methods%2520Since%25202000%253A%2520On%2520the%2520Verge%2520of%2520a%2520Renaissance%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D13230%26epage%3D13319%26doi%3D10.1021%2Facs.chemrev.7b00397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandić, Z.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Methods in Drug Discovery and Development</span>. <i>Bulg. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">73</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=65-73&author=Z.+Mandi%C4%87&title=Electrochemical+Methods+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandi%25C4%2587%26aufirst%3DZ.%26atitle%3DElectrochemical%2520Methods%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DBulg.%2520Chem.%2520Commun.%26date%3D2017%26volume%3D49%26spage%3D65%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duncton, M. A. J.</span></span> <span> </span><span class="NLM_article-title">Minisci Reactions: Versatile CH-Functionalizations for Medicinal Chemists</span>. <i>Med. Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1039/C1MD00134E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fc1md00134e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1135-1161&author=M.+A.+J.+Duncton&title=Minisci+Reactions%3A+Versatile+CH-Functionalizations+for+Medicinal+Chemists&doi=10.1039%2FC1MD00134E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Minisci reactions. Versatile CH-functionalizations for medicinal chemists</span></div><div class="casAuthors">Duncton, Matthew A. J.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1135-1161</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The addn. of a radical to a heteroarom. base is commonly referred to as a Minsici reaction.  Such reactions constitute a broad-set of selective CH-functionalization processes.  This review described some of the major applications of Minisci reactions and related processes to medicinal or biol. chem., and highlights some potential developments within this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4rms5MglIuLVg90H21EOLACvtfcHk0lhtfyhc6HY_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E&md5=49d9076c79e5caf19d21b8fbd74ff0c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2Fc1md00134e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00134e%26sid%3Dliteratum%253Aachs%26aulast%3DDuncton%26aufirst%3DM.%2BA.%2BJ.%26atitle%3DMinisci%2520Reactions%253A%2520Versatile%2520CH-Functionalizations%2520for%2520Medicinal%2520Chemists%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D1135%26epage%3D1161%26doi%3D10.1039%2FC1MD00134E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deGruyter, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span> <span> </span><span class="NLM_article-title">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2256</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2256-2264&author=J.+M.+Smithauthor=J.+A.+Dixonauthor=J.+N.+deGruyterauthor=P.+S.+Baran&title=Alkyl+Sulfinates%3A+Radical+Precursors+Enabling+Drug+Discovery&doi=10.1021%2Facs.jmedchem.8b01303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl Sulfinates: Radical Precursors Enabling Drug Discovery</span></div><div class="casAuthors">Smith, Joel M.; Dixon, Janice A.; deGruyter, Justine N.; Baran, Phil S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2256-2264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The modern constraints of drug discovery demand a rigorous validation process of all new reactions prior to widespread implementation.  To this end, sulfinates (now marketed as Diversinates) have seen alacritous adoption by the medicinal chem. community, as evidenced by the recent outpour of both patent and primary reports.  Featuring more than 50 examples, this review seeks to highlight those particularly compelling cases published in the past 5 years, with an eye toward the identification of robust and predictable trends in reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7GM4tNW5QcLVg90H21EOLACvtfcHk0lhtfyhc6HY_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqtL3I&md5=2c10a6e03d53de995f00614fb8c4bd85</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01303%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DDixon%26aufirst%3DJ.%2BA.%26aulast%3DdeGruyter%26aufirst%3DJ.%2BN.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26atitle%3DAlkyl%2520Sulfinates%253A%2520Radical%2520Precursors%2520Enabling%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2256%26epage%3D2264%26doi%3D10.1021%2Facs.jmedchem.8b01303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAtee, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">Illuminating Photoredox Catalysis</span>. <i>Trends Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.trechm.2019.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.trechm.2019.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2019&pages=111-125&author=R.+C.+McAteeauthor=E.+J.+McClainauthor=C.+R.+J.+Stephenson&title=Illuminating+Photoredox+Catalysis&doi=10.1016%2Fj.trechm.2019.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating Photoredox Catalysis</span></div><div class="casAuthors">McAtee, Rory C.; McClain, Edward J.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-125</span>CODEN:
                <span class="NLM_cas:coden">TCRHBQ</span>;
        ISSN:<span class="NLM_cas:issn">2589-5974</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Over the past decade, photoredox catalysis has risen to the forefront of synthetic org. chem. as an indispensable tool for selective small-mol. activation and chem.-bond formation.  This cutting-edge platform allows photosensitizers to convert visible light into chem. energy, prompting generation of reactive radical intermediates.  In this , we highlight some of the recent key contributions in the field, including elucidating the impact of the chosen light arrays, promoting fundamental cross-coupling steps, selectively functionalizing aliph. amines, engaging complementary mechanistic paradigms, and applications in industry.  With such a wide breadth of reactivity already realized, the presence of photoredox catalysis in all sectors of org. chem. is expected for years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQ-TKUkBDa7Vg90H21EOLACvtfcHk0lhtfyhc6HY_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1CqtL%252FK&md5=45ffb329a2d146cc8caa3a75b4b5a6d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.trechm.2019.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trechm.2019.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DMcAtee%26aufirst%3DR.%2BC.%26aulast%3DMcClain%26aufirst%3DE.%2BJ.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DIlluminating%2520Photoredox%2520Catalysis%26jtitle%3DTrends%2520Chem.%26date%3D2019%26volume%3D1%26spage%3D111%26epage%3D125%26doi%3D10.1016%2Fj.trechm.2019.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenn, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steacy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, A. K.</span></span> <span> </span><span class="NLM_article-title">Onset of Action for Loratadine Tablets for the Symptomatic Control of Seasonal Allergic Rhinitis in Adults Challenged with Ragweed Pollen in the Environmental Exposure Unit: A Post Hoc Analysis of Total Symptom Score</span>. <i>Allergy, Asthma, Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s13223-017-0227-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1186%2Fs13223-017-0227-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29371864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsFeqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=5&author=M.+W.+Tennauthor=L.+M.+Steacyauthor=C.+C.+Ngauthor=A.+K.+Ellis&title=Onset+of+Action+for+Loratadine+Tablets+for+the+Symptomatic+Control+of+Seasonal+Allergic+Rhinitis+in+Adults+Challenged+with+Ragweed+Pollen+in+the+Environmental+Exposure+Unit%3A+A+Post+Hoc+Analysis+of+Total+Symptom+Score&doi=10.1186%2Fs13223-017-0227-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom score</span></div><div class="casAuthors">Tenn, Mark W.; Steacy, Lisa M.; Ng, Charlene C.; Ellis, Anne K.</div><div class="citationInfo"><span class="NLM_cas:title">Allergy, Asthma, & Clinical Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5/1-5/7</span>CODEN:
                <span class="NLM_cas:coden">AACIB3</span>;
        ISSN:<span class="NLM_cas:issn">1710-1492</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Loratadine is a second-generation, non-sedating antihistamine used for the relief of allergic rhinitis symptoms.  Previous studies reported that when loratadine was encapsulated, the onset of action for symptom relief was 180 min.  However, unmodified loratadine tablets were not evaluated at that time.  Using data from a previously published Environmental Exposure Unit (EEU) study comparing azelastine nasal spray with loratadine tablets, cetirizine tablets, and placebo, this post hoc anal. dets. the onset of action of loratadine tablets (i.e. unmodified) by analyzing the total symptom score for the relief of nasal and ocular seasonal allergic rhinitis (SAR) symptoms.  Methods: A Phase IV, randomized, single-center, double-blind, placebo-controlled, double-dummy, four-way crossover study was conducted in the EEU.  Seventy participants were randomized sequentially into one of the four treatments during ragweed pollen exposure.  Nasal and ocular symptom scores were self-reported by the participants and recorded.  The original study anal. was carried out by evaluating the nasal symptom scores only.  For this post hoc anal., both nasal and ocular data from the loratadine and placebo treatment arms were analyzed.  The primary endpoint for this anal. was the onset of action of loratadine as measured by the change in total symptom score (TSS) from baseline in comparison to placebo.  The onset of ocular symptom relief using the total ocular symptom score (TOSS) was also reported.  Results: Loratadine tablets demonstrated a significant and durable improvement in both TSS (P = .005) and TOSS (P = .013) at 75 min post-treatment administration compared to placebo.  The mean proportion of participants reporting none or mild for all component symptoms of TSS and TOSS at 75 min and thereafter was significantly higher in the loratadine (TSS, P = .0005; TOSS, P ≤ .0001) vs. placebo treatment arm.  Conclusions: The onset of action of loratadine tablets was 75 min for the relief of nasal and ocular symptoms in adults with SAR.  These results suggest a faster onset of action for loratadine tablets (75 min) compared to previously reported studies which were conducted with modified (i.e. gelatin-encapsulated) loratadine tablets (180 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz16AQrvmeLrVg90H21EOLACvtfcHk0li5CxbRB1QNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsFeqtLc%253D&md5=9b31d0ae41472cecb46ded2529834600</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs13223-017-0227-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13223-017-0227-4%26sid%3Dliteratum%253Aachs%26aulast%3DTenn%26aufirst%3DM.%2BW.%26aulast%3DSteacy%26aufirst%3DL.%2BM.%26aulast%3DNg%26aufirst%3DC.%2BC.%26aulast%3DEllis%26aufirst%3DA.%2BK.%26atitle%3DOnset%2520of%2520Action%2520for%2520Loratadine%2520Tablets%2520for%2520the%2520Symptomatic%2520Control%2520of%2520Seasonal%2520Allergic%2520Rhinitis%2520in%2520Adults%2520Challenged%2520with%2520Ragweed%2520Pollen%2520in%2520the%2520Environmental%2520Exposure%2520Unit%253A%2520A%2520Post%2520Hoc%2520Analysis%2520of%2520Total%2520Symptom%2520Score%26jtitle%3DAllergy%252C%2520Asthma%252C%2520Clin.%2520Immunol.%26date%3D2018%26volume%3D14%26spage%3D5%26doi%3D10.1186%2Fs13223-017-0227-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahbaz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, T. A.</span></span> <span> </span><span class="NLM_article-title">Superacid Cyclodehydration of Ketones in the Production of Tricyclic Antihistamines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2242</span>– <span class="NLM_lpage">2244</span>, <span class="refDoi"> DOI: 10.1021/jo00270a041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00270a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaL1MXhvFalsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=2242-2244&author=D.+P.+Schumacherauthor=B.+L.+Murphyauthor=J.+E.+Clarkauthor=P.+Tahbazauthor=T.+A.+Mann&title=Superacid+Cyclodehydration+of+Ketones+in+the+Production+of+Tricyclic+Antihistamines&doi=10.1021%2Fjo00270a041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Superacid cyclodehydration of ketones in the production of tricyclic antihistamines</span></div><div class="casAuthors">Schumacher, Doris P.; Murphy, Bruce L.; Clark, Jon E.; Tahbaz, Pete; Mann, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2242-4</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A novel and practical synthesis of loratadine is described.  2-Cyano-3-methylpyridine is alkylated, converted to a piperidyl ketone and, in the key step, cyclized by a superacid to the tricyclic ring structure common to azatadine-related antihistamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq852FoEwXY_bVg90H21EOLACvtfcHk0li5CxbRB1QNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhvFalsLc%253D&md5=f8184eccec313400a56630d1847a1b06</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjo00270a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00270a041%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DD.%2BP.%26aulast%3DMurphy%26aufirst%3DB.%2BL.%26aulast%3DClark%26aufirst%3DJ.%2BE.%26aulast%3DTahbaz%26aufirst%3DP.%26aulast%3DMann%26aufirst%3DT.%2BA.%26atitle%3DSuperacid%2520Cyclodehydration%2520of%2520Ketones%2520in%2520the%2520Production%2520of%2520Tricyclic%2520Antihistamines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D2242%26epage%3D2244%26doi%3D10.1021%2Fjo00270a041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Doran, H. J.</span>; <span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">Process for Preparing Tricyclic Compounds Having Antihistaminic Activity</span>. PCT Int. Appl., <span class="NLM_patent">US 6,271,378B1</span>, Jun 29, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=H.+J.+Doran&author=P.+M.+O%E2%80%99Neill&title=Process+for+Preparing+Tricyclic+Compounds+Having+Antihistaminic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DH.%2BJ.%26atitle%3DProcess%2520for%2520Preparing%2520Tricyclic%2520Compounds%2520Having%2520Antihistaminic%2520Activity%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cuboni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devigny, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogeland, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomplun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buschauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsboer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">Loratadine and Analogues: Discovery and Preliminary Structure–Activity Relationship of Inhibitors of the Amino Acid Transporter B<sup>0</sup>AT2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9473</span>– <span class="NLM_lpage">9479</span>, <span class="refDoi"> DOI: 10.1021/jm501086v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501086v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKgtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9473-9479&author=S.+Cuboniauthor=C.+Devignyauthor=B.+Hoogelandauthor=A.+Strasserauthor=S.+Pomplunauthor=B.+Haugerauthor=G.+H%C3%B6fnerauthor=K.+T.+Wannerauthor=M.+Ederauthor=A.+Buschauerauthor=F.+Holsboerauthor=F.+Hausch&title=Loratadine+and+Analogues%3A+Discovery+and+Preliminary+Structure%E2%80%93Activity+Relationship+of+Inhibitors+of+the+Amino+Acid+Transporter+B0AT2&doi=10.1021%2Fjm501086v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B0AT2</span></div><div class="casAuthors">Cuboni, Serena; Devigny, Christian; Hoogeland, Bastiaan; Strasser, Andrea; Pomplun, Sebastian; Hauger, Barbara; Hoefner, Georg; Wanner, Klaus T.; Eder, Matthias; Buschauer, Armin; Holsboer, Florian; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9473-9479</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">B0AT2, encoded by the SLC6A15 gene, is a transporter for neutral amino acids that has recently been implicated in mood and metabolic disorders.  It is predominantly expressed in the brain, but little is otherwise known about its function.  To identify inhibitors for this transporter, the authors screened a library of 3133 different bioactive compds.  Loratadine, a clin. used histamine H1 receptor antagonist, was identified as a selective inhibitor of B0AT2 with an IC50 of 4 μM while being less active or inactive against several other members of the SLC6 family.  Reversible inhibition of B0AT2 was confirmed by electrophysiol.  A series of loratadine analogs were synthesized to gain insight into the structure-activity relationships.  The studies provide the first chem. tool for B0AT2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpckWwJiFRLgbVg90H21EOLACvtfcHk0li5CxbRB1QNAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKgtrnJ&md5=278c20af492323a57bd7c4004a6dcc72</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm501086v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501086v%26sid%3Dliteratum%253Aachs%26aulast%3DCuboni%26aufirst%3DS.%26aulast%3DDevigny%26aufirst%3DC.%26aulast%3DHoogeland%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DPomplun%26aufirst%3DS.%26aulast%3DHauger%26aufirst%3DB.%26aulast%3DH%25C3%25B6fner%26aufirst%3DG.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DBuschauer%26aufirst%3DA.%26aulast%3DHolsboer%26aufirst%3DF.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DLoratadine%2520and%2520Analogues%253A%2520Discovery%2520and%2520Preliminary%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Inhibitors%2520of%2520the%2520Amino%2520Acid%2520Transporter%2520B0AT2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9473%26epage%3D9479%26doi%3D10.1021%2Fjm501086v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si-Ma, L.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.-K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antihistamine Evaluations of Novel Loratadine Analogues</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">4456</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2011.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21733682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVSkur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4454-4456&author=Y.+Wangauthor=J.+Wangauthor=Y.+Linauthor=L.-F.+Si-Maauthor=D.-h.+Wangauthor=L.-G.+Chenauthor=D.-K.+Liu&title=Synthesis+and+Antihistamine+Evaluations+of+Novel+Loratadine+Analogues&doi=10.1016%2Fj.bmcl.2011.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antihistamine evaluations of novel loratadine analogues</span></div><div class="casAuthors">Wang, Yue; Wang, Juan; Lin, Yan; Si-Ma, Li-Feng; Wang, Dong-hua; Chen, Li-Gong; Liu, Deng-Ke</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4454-4456</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of loratadine analogs I( R = HOCH2CH2, HOCH2CH2CH2, R-HOCH2CHCH3, S-HOCH2CHCH3, R-HOCH2CHCH2CH3, S-HOCH2CHCH2CH3, R-C6H5CHCH3, S-C6H5CHCH3) contg. hydroxyl group and chiral center were synthesized.  The effect of the synthesized compds. on the histamine-induced contractions of guinea-pig ileum muscles was studied.  In addn., the in vivo asthma-relieving effect of the analogs in the histamine induced asthmatic reaction in guinea-pigs was detd.  Most of the compds. exhibited definite H1 antihistamine activity.  The S-enantiomers, compds. I(R = S-HOCH2CHCH3, S-HOCH2CHCH2CH3, S-C6H5CHCH3) are more potent than the R-enantiomers, compds. I( R = R-HOCH2CHCH3, R-HOCH2CHCH2CH3, R-C6H5CHCH3).  Compd. I( R = HOCH2CH2CH2) was the most active one among the eight synthesized compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD50B7M8Uf0bVg90H21EOLACvtfcHk0lgmYdyfklLqtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVSkur4%253D&md5=725b91d834bd7103afd66185a65daa1c</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DSi-Ma%26aufirst%3DL.-F.%26aulast%3DWang%26aufirst%3DD.-h.%26aulast%3DChen%26aufirst%3DL.-G.%26aulast%3DLiu%26aufirst%3DD.-K.%26atitle%3DSynthesis%2520and%2520Antihistamine%2520Evaluations%2520of%2520Novel%2520Loratadine%2520Analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4454%26epage%3D4456%26doi%3D10.1016%2Fj.bmcl.2011.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, C. A.</span></span> <span> </span><span class="NLM_article-title">Antihistamines and Allergy</span>. <i>Aust. Prescr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.18773/austprescr.2018.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.18773%2Faustprescr.2018.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=42-45&author=K.+L.+Randallauthor=C.+A.+Hawkins&title=Antihistamines+and+Allergy&doi=10.18773%2Faustprescr.2018.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=10.18773%2Faustprescr.2018.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18773%252Faustprescr.2018.013%26sid%3Dliteratum%253Aachs%26aulast%3DRandall%26aufirst%3DK.%2BL.%26aulast%3DHawkins%26aufirst%3DC.%2BA.%26atitle%3DAntihistamines%2520and%2520Allergy%26jtitle%3DAust.%2520Prescr.%26date%3D2018%26volume%3D41%26spage%3D42%26epage%3D45%26doi%3D10.18773%2Faustprescr.2018.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Church, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of Antihistamines</span>. <i>Indian J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.4103/0019-5154.110832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.4103%2F0019-5154.110832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23723474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BC3snotl2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=219-224&author=M.+K.+Churchauthor=D.+S.+Church&title=Pharmacology+of+Antihistamines&doi=10.4103%2F0019-5154.110832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19fR"><div class="casContent"><span class="casTitleNuber">19f</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of antihistamines</span></div><div class="casAuthors">Church Martin K; Church Diana S</div><div class="citationInfo"><span class="NLM_cas:title">Indian journal of dermatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">H1-antihistamines, the mainstay of treatment for urticaria, were developed from anticholinergic drugs more than 70 years ago.  They act as inverse agonists rather than antagonists of histamine H1-receptors which are members of the G-protein family.  The older first generation H1-antihistamines penetrate readily into the brain to cause sedation, drowsiness, fatigue and impaired concentration and memory causing detrimental effects on learning and examination performance in children and on impairment of the ability of adults to work and drive.  Their use should be discouraged.  The newer second-generation H1-antihistamines are safer, cause less sedation and are more efficacious.  Three drugs widely used for symptomatic relief in urticaria, desloratadine, levocetirizine and fexofenadine are highlighted in this review.  Of these levocetirizine and fexofenadine are the most potent in humans in vivo.  However, levocetirizine may cause somnolence in susceptible individuals, whereas fexofenadine has a relatively short duration of action and may be required to be given twice daily for all round daily protection.  Although desloratadine is less potent, it has the advantages of rarely causing somnolence and having a long duration of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkA18dqept1EH3Rlp_k91zfW6udTcc2eYBjtTwwhd1gLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snotl2hsA%253D%253D&md5=867adc1094106d91708347063af8a9d9</span></div><a href="/servlet/linkout?suffix=cit19f&amp;dbid=16384&amp;doi=10.4103%2F0019-5154.110832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0019-5154.110832%26sid%3Dliteratum%253Aachs%26aulast%3DChurch%26aufirst%3DM.%2BK.%26aulast%3DChurch%26aufirst%3DD.%2BS.%26atitle%3DPharmacology%2520of%2520Antihistamines%26jtitle%3DIndian%2520J.%2520Dermatol.%26date%3D2013%26volume%3D58%26spage%3D219%26epage%3D224%26doi%3D10.4103%2F0019-5154.110832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Anthes, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilchrest, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, R. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfeder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span> <span> </span><span class="NLM_article-title">Biochemical Characterization of Desloratadine, a Potent Antagonist of the Human Histamine H<sub>1</sub> Receptor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1016/s0014-2999(02)02049-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2FS0014-2999%2802%2902049-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=12167464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVWltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2002&pages=229-237&author=J.+C.+Anthesauthor=H.+Gilchrestauthor=C.+Richardauthor=S.+Eckelauthor=D.+Heskauthor=R.+E.+Westauthor=S.+M.+Williamsauthor=S.+Greenfederauthor=M.+Billahauthor=W.+Kreutnerauthor=R.+W.+Egan&title=Biochemical+Characterization+of+Desloratadine%2C+a+Potent+Antagonist+of+the+Human+Histamine+H1+Receptor&doi=10.1016%2Fs0014-2999%2802%2902049-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19gR"><div class="casContent"><span class="casTitleNuber">19g</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor</span></div><div class="casAuthors">Anthes, John C.; Gilchrest, Helen; Richard, Christian; Eckel, Stephen; Hesk, Dave; West, Robert E.; Williams, Shirley M.; Greenfeder, Scott; Billah, Motasim; Kreutner, William; Egan, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">229-237</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have characterized desloratadine (5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene), CAS 100643-71-8) as a potent antagonist of the human histamine H1 receptor.  [3H]Desloratadine bound to membranes expressing the recombinant human histamine H1 receptor in Chinese hamster ovary cells (CHO-H1) in a specific and saturable manner with a Kd of 1.1±0.2 nM, a Bmax of 7.9±2.0 pmol/mg protein, and an assocn. rate const. of 0.011 nM-1 min-1.  The Kd calcd. from the kinetic measurements was 1.5 nM.  Dissocn. of [3H]desloratadine from the human histamine H1 receptor was slow, with only 37% of the binding reversed at 6 h in the presence of 5 μM unlabeled desloratadine.  Seventeen histamine H1-receptor antagonists were evaluated in competition-binding studies.  Desloratadine had a Ki of 0.9±0.1 nM in these competition studies.  In CHO-H1 cells, histamine stimulation resulted in a concn.-dependent increase in [Ca2+]i with an EC50 of 170±30 nM.  After a 90-min preincubation with desloratadine, the histamine-stimulated increase in [Ca2+]i was shifted to the right, with a depression of the maximal response at higher concns. of antagonist.  The apparent Kb value was 0.2±0.14 nM with a slope of 1.6±0.1.  The slow dissocn. from the receptor and noncompetitive antagonism suggests that desloratadine may be a pseudoirreversible antagonist of the human histamine H1 receptor.  The mechanism of desloratadine antagonism of the human histamine H1 receptor may help to explain the high potency and 24-h duration of action obsd. in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6H8IJZE7hrbVg90H21EOLACvtfcHk0lgmYdyfklLqtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVWltbo%253D&md5=cd55fee981b04e2ec5ee45c339f4a37c</span></div><a href="/servlet/linkout?suffix=cit19g&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902049-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902049-6%26sid%3Dliteratum%253Aachs%26aulast%3DAnthes%26aufirst%3DJ.%2BC.%26aulast%3DGilchrest%26aufirst%3DH.%26aulast%3DRichard%26aufirst%3DC.%26aulast%3DEckel%26aufirst%3DS.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DWest%26aufirst%3DR.%2BE.%26aulast%3DWilliams%26aufirst%3DS.%2BM.%26aulast%3DGreenfeder%26aufirst%3DS.%26aulast%3DBillah%26aufirst%3DM.%26aulast%3DKreutner%26aufirst%3DW.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26atitle%3DBiochemical%2520Characterization%2520of%2520Desloratadine%252C%2520a%2520Potent%2520Antagonist%2520of%2520the%2520Human%2520Histamine%2520H1%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D449%26spage%3D229%26epage%3D237%26doi%3D10.1016%2Fs0014-2999%2802%2902049-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, R.</span></span> <span> </span><span class="NLM_article-title">Cytochromes P450 as Versatile Biocatalysts</span>. <i>J. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.jbiotec.2006.01.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.jbiotec.2006.01.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=16516322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltl2isLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=128-145&author=R.+Bernhardt&title=Cytochromes+P450+as+Versatile+Biocatalysts&doi=10.1016%2Fj.jbiotec.2006.01.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochromes P 450 as versatile biocatalysts</span></div><div class="casAuthors">Bernhardt, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-145</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 isoforms are ubiquitously distributed enzymes, which were discovered ∼50 yr ago and which possess high complexity and display a broad field of activity.  They are hemoproteins encoded by a superfamily of genes converting a broad variety of substrates and catalyzing a variety of interesting chem. reactions.  This enzyme family is involved in the biotransformation of drugs, the bioconversion of xenobiotics, the metab. of chem. carcinogens, the biosynthesis of physiol. important compds. such as steroids, fatty acids, eicosanoids, fat-sol. vitamins, bile acids, the conversion of alkanes, terpenes, and arom. compds. as well as the degrdn. of herbicides and insecticides.  There is also a broad versatility of reactions catalyzed by cytochromes P 450 (P 450) such as carbon hydroxylation, heteroatom oxygenation, dealkylation, epoxidn., arom. hydroxylation, redn., and dehalogenation.  More than 5000 different P 450 genes have been cloned to date.  Members of the same gene family are defined as usually having ≥40% sequence identity to a P 450 protein from any other family.  Mammalian sequences within the same subfamily are always >55% identical.  The nos. of individual P 450 enzymes in different species differ significantly, showing the highest nos. obsd. so far in plants.  The structure-function relations of cytochromes P 450 are far from being well understood and their catalytic power has so far hardly been used for biotechnol. processes.  Nevertheless, the set of interesting reactions being catalyzed by these systems and the availability of new genetic engineering techniques allowing investigators to heterologously express them and to improve and change their activity, stability, and selectivity, as well as the increasing interest of industry in life sciences makes them promising candidates for biotechnol. application in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsLIpgi6AM7Vg90H21EOLACvtfcHk0liUMBEHo0nVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltl2isLw%253D&md5=f43290591c64c0559af7c8fbd57807e2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2006.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2006.01.026%26sid%3Dliteratum%253Aachs%26aulast%3DBernhardt%26aufirst%3DR.%26atitle%3DCytochromes%2520P450%2520as%2520Versatile%2520Biocatalysts%26jtitle%3DJ.%2520Biotechnol.%26date%3D2006%26volume%3D124%26spage%3D128%26epage%3D145%26doi%3D10.1016%2Fj.jbiotec.2006.01.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacologically Active Metabolites of Currently Marketed Drugs: Potential Resources for New Drug Discovery and Development</span>. <i>Yakugaku Zasshi</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1325</span>– <span class="NLM_lpage">1337</span>, <span class="refDoi"> DOI: 10.1248/yakushi.130.1325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1248%2Fyakushi.130.1325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=20930485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2010&pages=1325-1337&author=M.+J.+Kangauthor=W.+H.+Songauthor=B.+H.+Shimauthor=S.+Y.+Ohauthor=H.+Y.+Leeauthor=E.+Y.+Chungauthor=Y.+Sohnauthor=J.+Lee&title=Pharmacologically+Active+Metabolites+of+Currently+Marketed+Drugs%3A+Potential+Resources+for+New+Drug+Discovery+and+Development&doi=10.1248%2Fyakushi.130.1325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmaceutical active metabolites of currently marketed drugs: potential resources for new drug discovery and development</span></div><div class="casAuthors">Kang, Myung Joo; Song, Woo Heon; Shim, Byung Ho; Oh, Seung Youn; Lee, Hyun Young; Chung, Eun Young; Sohn, Yesung; Lee, Jaehwi</div><div class="citationInfo"><span class="NLM_cas:title">Yakugaku Zasshi</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1325-1337</span>CODEN:
                <span class="NLM_cas:coden">YKKZAJ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6903</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Biotransformation is the major clearance mechanism of therapeutic agents from the body.  Biotransformation is known not only to facilitate the elimination of drugs by changing the mol. structure to more hydrophilic, but also lead to pharmacol. inactivation of therapeutic compds.  However, in some cases, the biotransformation of drugs can lead to the generation of pharmacol. active metabolites, responsible for the pharmacol. actions.  This review provides an update of the kinds of pharmacol. active metabolites and some of their individual pharmacol. and pharmacokinetic aspects, and describes their importance as resources for drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNPw5yjo1kLVg90H21EOLACvtfcHk0liUMBEHo0nVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhtrbM&md5=a575b7cd528e35b325829fbdd5a1ceb8</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1248%2Fyakushi.130.1325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fyakushi.130.1325%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DM.%2BJ.%26aulast%3DSong%26aufirst%3DW.%2BH.%26aulast%3DShim%26aufirst%3DB.%2BH.%26aulast%3DOh%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DChung%26aufirst%3DE.%2BY.%26aulast%3DSohn%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DPharmacologically%2520Active%2520Metabolites%2520of%2520Currently%2520Marketed%2520Drugs%253A%2520Potential%2520Resources%2520for%2520New%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DYakugaku%2520Zasshi%26date%3D2010%26volume%3D130%26spage%3D1325%26epage%3D1337%26doi%3D10.1248%2Fyakushi.130.1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span>; <span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Chapter 10. Alcohols and Phenols: Absorption, Distribution, Metabolism and Excretion</span>. In  <i>Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, T.</span></span> Ed.; <span class="NLM_publisher-name">The Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>, <span class="NLM_year">2010</span>; Chapter 10, pp  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">485</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2F9781849731102-00460" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=460-485&author=Z.+Miao&author=R.+S.+Obachauthor=T.+David&title=Metabolism%2C+Pharmacokinetics+and+Toxicity+of+Functional+Groups%3A+Impact+of+Chemical+Building+Blocks+on+ADMET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1039%2F9781849731102-00460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849731102-00460%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%26atitle%3DChapter%252010.%2520Alcohols%2520and%2520Phenols%253A%2520Absorption%252C%2520Distribution%252C%2520Metabolism%2520and%2520Excretion%26btitle%3DMetabolism%252C%2520Pharmacokinetics%2520and%2520Toxicity%2520of%2520Functional%2520Groups%253A%2520Impact%2520of%2520Chemical%2520Building%2520Blocks%2520on%2520ADMET%26aulast%3DDavid%26aufirst%3DT.%26pub%3DThe%2520Royal%2520Society%2520of%2520Chemistry%26date%3D2010%26spage%3D460%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.3390/molecules21010075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.3390%2Fmolecules21010075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26771590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCiu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=75&author=F.+Maoauthor=W.+Niauthor=X.+Xuauthor=H.+Wangauthor=J.+Wangauthor=M.+Jiauthor=J.+Li&title=Chemical+Structure-Related+Drug-Like+Criteria+of+Global+Approved+Drugs&doi=10.3390%2Fmolecules21010075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical structure-related drug-like criteria of global approved drugs</span></div><div class="casAuthors">Mao, Fei; Ni, Wei; Xu, Xiang; Wang, Hui; Wang, Jing; Ji, Min; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75/1-75/18</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The chem. structure of a drug dets. its physicochem. properties, further dets. its ADME/Tox properties, and ultimately affects its pharmacol. activity.  Medicinal chemists can regulate the pharmacol. activity of drug mols. by modifying their structure.  Ring systems and functional groups are important components of a drug.  The proportion of non-hydrocarbon atoms among non-hydrogen atoms reflects the heavy atoms proportion of a drug.  The three factors have considerable potential for the assessment of the drug-like properties of org. mols.  However, to the best of our knowledge, there have been no studies to systematically analyze the simultaneous effects of the no. of arom. and non-arom. rings, the no. of some special functional groups and the proportion of heavy atoms on the drug-like properties of an org. mol.  To this end, the nos. of arom. and non-arom. rings, the nos. of some special functional groups and the heavy atoms proportion of 6891 global approved small drugs have been comprehensively analyzed.  We first uncovered three important structure-related criteria closely related to drug-likeness, namely: (1) the best nos. of arom. and non-arom. rings are 2 and 1, resp.; (2) the best functional groups of candidate drugs are usually -OH, -COOR and -COOH in turn, but not -CONHOH, -SH, -CHO and -SO3H.  In addn., the -F functional group is beneficial to CNS drugs, and -NH2 functional group is beneficial to anti-infective drugs and anti-cancer drugs; (3) the best R value intervals of candidate drugs are in the range of 0.05-0.50 (preferably 0.10-0.35), and R value of the candidate CNS drugs should be as small as possible in this interval.  We envision that the three chem. structure-related criteria may be applicable in a prospective manner for the identification of novel candidate drugs and will provide a theor. foundation for designing new chem. entities with good drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkob7QCZSGz7Vg90H21EOLACvtfcHk0liUMBEHo0nVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCiu7bN&md5=70082d974f1a4da534cd662708751c88</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21010075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21010075%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DChemical%2520Structure-Related%2520Drug-Like%2520Criteria%2520of%2520Global%2520Approved%2520Drugs%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D75%26doi%3D10.3390%2Fmolecules21010075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunne, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, F.</span></span> <span> </span><span class="NLM_article-title">Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic Compounds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFarsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=643-647&author=T.+Henkelauthor=R.+M.+Brunneauthor=H.+M%C3%BCllerauthor=F.+Reichel&title=Statistical+Investigation+into+the+Structural+Complementarity+of+Natural+Products+and+Synthetic+Compounds&doi=10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Statistical investigation into the structural complementarity of natural products and synthetic compounds</span></div><div class="casAuthors">Henkel, Thomas; Brunne, Roger M.; Muller, Hartwig; Reichel, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-647</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A first effort to describe statistical the differences between the structural properties of natural products and synthetic substances so as to derive statements into the complementarity of these pools of structures is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKkl3JHxGCrVg90H21EOLACvtfcHk0liUMBEHo0nVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFarsL4%253D&md5=80db970c39804f8e9ad80f3ec90f824c</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990301%252938%253A5%253C643%253A%253AAID-ANIE643%253E3.0.CO%253B2-G%26sid%3Dliteratum%253Aachs%26aulast%3DHenkel%26aufirst%3DT.%26aulast%3DBrunne%26aufirst%3DR.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DH.%26aulast%3DReichel%26aufirst%3DF.%26atitle%3DStatistical%2520Investigation%2520into%2520the%2520Structural%2520Complementarity%2520of%2520Natural%2520Products%2520and%2520Synthetic%2520Compounds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D643%26epage%3D647%26doi%3D10.1002%2F%28SICI%291521-3773%2819990301%2938%3A5%3C643%3A%3AAID-ANIE643%3E3.0.CO%3B2-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Hydroxyl Group Transformation: An Elusive Target</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2484</span>– <span class="NLM_lpage">2493</span>, <span class="refDoi"> DOI: 10.1039/c2mb25122a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fc2mb25122a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=22695722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ygtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=2484-2493&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Chemoselective+Hydroxyl+Group+Transformation%3A+An+Elusive+Target&doi=10.1039%2Fc2mb25122a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective hydroxyl group transformation: an elusive target</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2484-2493</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The selective reaction of one functional group in the presence of others is not a trivial task.  A noteworthy amt. of research has been dedicated to the chemoselective reaction of the hydroxyl moiety.  This group is prevalent in many biol. important mols. including natural products and proteins.  However, targeting the hydroxyl group is difficult for many reasons including its relatively low nucleophilicity in comparison to other ubiquitous functional groups such as amines and thiols.  Addnl., many of the developed chemoselective reactions cannot be used in the presence of water.  Despite these complications, chemoselective transformation of the hydroxyl moiety has been utilized in the synthesis of complex natural product derivs., the reaction of tyrosine residues in proteins, the isolation of natural products and is the mechanism of action of myriad drugs.  Here, methods for selective targeting of this group, as well as applications of several devised methods, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorgmeIXY9utrVg90H21EOLACvtfcHk0liPPcC5N6DjxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ygtbjE&md5=8043a8039b2a72b28424285b2e6af793</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1039%2Fc2mb25122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2mb25122a%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DChemoselective%2520Hydroxyl%2520Group%2520Transformation%253A%2520An%2520Elusive%2520Target%26jtitle%3DMol.%2520BioSyst.%26date%3D2012%26volume%3D8%26spage%3D2484%26epage%3D2493%26doi%3D10.1039%2Fc2mb25122a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbaida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span> <span> </span><span class="NLM_article-title">Metabolism of Loratadine and Further Characterization of its In Vitro Metabolites</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.2174/187231209789352067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.2174%2F187231209789352067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=19702548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=162-170&author=A.+Ghosalauthor=S.+Guptaauthor=R.+Ramanathanauthor=Y.+Yuanauthor=X.+Luauthor=A.+D.+Suauthor=N.+Alvarezauthor=S.+Zbaidaauthor=S.+K.+Chowdhuryauthor=K.+B.+Alton&title=Metabolism+of+Loratadine+and+Further+Characterization+of+its+In+Vitro+Metabolites&doi=10.2174%2F187231209789352067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of loratadine and further characterization of its in vitro metabolites</span></div><div class="casAuthors">Ghosal, Anima; Gupta, Samir; Ramanathan, Ragu; Yuan, Yuan; Lu, Xiaowen; Su, Ai Duen; Alvarez, Narciso; Zbaida, Shmuel; Chowdhury, Swapan K.; Alton, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">162-170</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The present study demonstrated that in addn. to CYP3A4 and CYP2D6, the metab. of loratadine is also catalyzed by CYP1A1, CYP2C19, and to a lesser extent by CYP1A2, CYP2B6, CYP2C8, CYP2C9, and CYP3A5.  The biotransformation of loratadine was assocd. with the formation of desloratadine (DL) and further hydroxylation of both DL and the parent drug (loratadine).  Based on the inhibition and correlation studies contribution of CYP2C19 in the formation of the major circulating metabolite DL seems to be minor.  Reported clin. results suggest that the steady state mean (%CV) blood plasma Cmax and AUC24h of loratadine were 4.73 ng/mL (119%) and 24.1 ng/h/mL (157%), resp., after dosing with 10 mg loratadine tablets for 10 days.  High inter-subject variability in loratadine steady-state data is probably due to the phenotypical characteristics of CYP2D6, CYP2C19, and CYP3A4.  The relative abundance of CYP3A4 in the human liver exceeds that of CYP2C19 and CYP2D6 and therefore the contribution of CYP3A4 in the metab. of loratadine should be major (∼70%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol66G9K5W8mbVg90H21EOLACvtfcHk0lgvOrbFmT0k0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtL3L&md5=16479ac7032473e758af940ecf238940</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F187231209789352067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231209789352067%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DRamanathan%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DA.%2BD.%26aulast%3DAlvarez%26aufirst%3DN.%26aulast%3DZbaida%26aufirst%3DS.%26aulast%3DChowdhury%26aufirst%3DS.%2BK.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26atitle%3DMetabolism%2520of%2520Loratadine%2520and%2520Further%2520Characterization%2520of%2520its%2520In%2520Vitro%2520Metabolites%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2009%26volume%3D3%26spage%3D162%26epage%3D170%26doi%3D10.2174%2F187231209789352067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, W. G.</span></span> <span> </span><span class="NLM_article-title">Drug Metabolite Profiling and Identification by High-Resolution Mass Spectrometry</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">25419</span>– <span class="NLM_lpage">25425</span>, <span class="refDoi"> DOI: 10.1074/jbc.R110.200055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1074%2Fjbc.R110.200055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21632546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFCksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=25419-25425&author=M.+Zhuauthor=H.+Zhangauthor=W.+G.+Humphreys&title=Drug+Metabolite+Profiling+and+Identification+by+High-Resolution+Mass+Spectrometry&doi=10.1074%2Fjbc.R110.200055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Metabolite Profiling and Identification by High-resolution Mass Spectrometry</span></div><div class="casAuthors">Zhu, Mingshe; Zhang, Haiying; Humphreys, W. Griffith</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">25419-25425</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mass spectrometry plays a key role in drug metabolite identification, an integral part of drug discovery and development.  The development of high-resoln. (HR) MS instrumentation with improved accuracy and stability, along with new data processing techniques, has improved the quality and productivity of metabolite identification processes.  In this minireview, HR-MS-based targeted and non-targeted acquisition methods and data mining techniques (e.g. mass defect, product ion, and isotope pattern filters and background subtraction) that facilitate metabolite identification are examd.  Methods are presented that enable multiple metabolite identification tasks with a single LC/HR-MS platform and/or anal.  Also, application of HR-MS-based strategies to key metabolite identification activities and future developments in the field are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7PH0QxYyoe7Vg90H21EOLACvtfcHk0lgvOrbFmT0k0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFCksbg%253D&md5=ca2ea7f00927382051c12bc3f0f62abf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R110.200055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R110.200055%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DDrug%2520Metabolite%2520Profiling%2520and%2520Identification%2520by%2520High-Resolution%2520Mass%2520Spectrometry%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D25419%26epage%3D25425%26doi%3D10.1074%2Fjbc.R110.200055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gehlhaar, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkhivker, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejto, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freer, S. T.</span></span> <span> </span><span class="NLM_article-title">Molecular Recognition of the Inhibitor AG-1343 by HIV-1 Protease: Conformationally Flexible Docking by Evolutionary Programming</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/1074-5521(95)90050-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+R.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+Recognition+of+the+Inhibitor+AG-1343+by+HIV-1+Protease%3A+Conformationally+Flexible+Docking+by+Evolutionary+Programming&doi=10.1016%2F1074-5521%2895%2990050-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0ljt-vhGFE48JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BR.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520Recognition%2520of%2520the%2520Inhibitor%2520AG-1343%2520by%2520HIV-1%2520Protease%253A%2520Conformationally%2520Flexible%2520Docking%2520by%2520Evolutionary%2520Programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324%26doi%3D10.1016%2F1074-5521%2895%2990050-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luty, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. W.</span></span> <span> </span><span class="NLM_article-title">Discovering High-Affinity Ligands from the Computationally Predicted Structures and Affinities of Small Molecules Bound to a Target: A Virtual Screening Approach</span>. <i>Perspect. Drug Discovery Des.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1023/A:1008741308684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1023%2FA%3A1008741308684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=209-230&author=T.+J.+Marroneauthor=B.+A.+Lutyauthor=P.+W.+Rose&title=Discovering+High-Affinity+Ligands+from+the+Computationally+Predicted+Structures+and+Affinities+of+Small+Molecules+Bound+to+a+Target%3A+A+Virtual+Screening+Approach&doi=10.1023%2FA%3A1008741308684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span></div><div class="casAuthors">Marrone, Tami J.; Luty, Brock A.; Rose, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-230</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We describe a "virtual NMR screening" method to assist in the design of inhibitors that occupy different sites within a target.  We dock small mols. into the active site of an enzyme and score them.  Keeping the tightest-binding lead fixed in space, we dock and score other small mols. in its presence.  Using this approach, linker groups are used to join the compds. together to form a high-affinity inhibitor.  We present validation of our computational approach by reproducing exptl. results for FKBP and stromelysin.  Docking simulations are not subject to exptl. problems such as proteolysis, protein or compd. insoly., or enzyme size.  Because docking is fast and our scoring method can distinguish between high- and low-affinity inhibitors, this docking procedure shows promise as integral part of a drug-design strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql26ToXhh4jbVg90H21EOLACvtfcHk0ljt-vhGFE48JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSg&md5=cea3010bea46c3636970ece8ee764ae2</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008741308684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008741308684%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DT.%2BJ.%26aulast%3DLuty%26aufirst%3DB.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26atitle%3DDiscovering%2520High-Affinity%2520Ligands%2520from%2520the%2520Computationally%2520Predicted%2520Structures%2520and%2520Affinities%2520of%2520Small%2520Molecules%2520Bound%2520to%2520a%2520Target%253A%2520A%2520Virtual%2520Screening%2520Approach%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D20%26spage%3D209%26epage%3D230%26doi%3D10.1023%2FA%3A1008741308684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Polak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribiere, G.</span></span> <span> </span><span class="NLM_article-title">Note sur la Convergence de Methodes de Directions Conjuguees</span>. <i>Revue Francaise Inf. Rech. Oper., Serie Rouge</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_fpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1969&pages=35&author=E.+Polakauthor=G.+Ribiere&title=Note+sur+la+Convergence+de+Methodes+de+Directions+Conjuguees"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolak%26aufirst%3DE.%26aulast%3DRibiere%26aufirst%3DG.%26atitle%3DNote%2520sur%2520la%2520Convergence%2520de%2520Methodes%2520de%2520Directions%2520Conjuguees%26jtitle%3DRevue%2520Francaise%2520Inf.%2520Rech.%2520Oper.%252C%2520Serie%2520Rouge%26date%3D1969%26spage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, N. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caufield, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrickson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Still, W. C.</span></span> <span> </span><span class="NLM_article-title">Macromodel—An Integrated Software System for Modeling Organic and Bioorganic Molecules Using Molecular Mechanics</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1002/jcc.540110405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fjcc.540110405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK3cXktl2msLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+J.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=Macromodel%E2%80%94An+Integrated+Software+System+for+Modeling+Organic+and+Bioorganic+Molecules+Using+Molecular+Mechanics&doi=10.1002%2Fjcc.540110405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25dR"><div class="casContent"><span class="casTitleNuber">25d</span><div class="casTitle"><span class="NLM_cas:atitle">MacroModel - an integrated software system for modeling organic and bioorganic molecules using molecular mechanics</span></div><div class="casAuthors">Mohamadi, Fariborz; Richards, Nigel G. J.; Guida, Wayne C.; Liskamp, Rob; Lipton, Mark; Caufield, Craig; Chang, George; Hendrickson, Thomas; Still, W. Clark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">440-67</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    </div><div class="casAbstract">An integrated mol. modeling system for designing and studying org. and bioorg. mols. and their mol. complexes using mol. mechanics is described.  The graphically controlled, atom-based system allows the construction, display and manipulation of mols. and complexes having as many as 10,000 atoms and provides interactive, state-of-the-art mol. mechanics on any subset of up to 1000 atoms.  The system semiautomates the graphical construction and anal. of complex structures ranging from polycyclic org. mols. to biopolymers to mixed mol. complexes.  Emphasis was placed on providing effective searches of conformational space by a no. of different methods and on highly optimized mol. mechanics energy calcns. using widely used force fields which are supplied as external files.  Little experience is required to operate the system effectively and even novices can use it to carry out sophisticated modeling operations.  The software has been designed to run on Digital Equipment Corporation VAX computers interfaced to a variety of graphics devices ranging from inexpensive monochrome terminals to the sophisticated graphics displays of the Evans & Sutherland PS300 series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_k-tSmgbgvrVg90H21EOLACvtfcHk0lia9U4xFHsi1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktl2msLw%253D&md5=c3fdf59a2e97bbdd48dbb10cfc90fc91</span></div><a href="/servlet/linkout?suffix=cit25d&amp;dbid=16384&amp;doi=10.1002%2Fjcc.540110405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.540110405%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%2BJ.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacromodel%25E2%2580%2594An%2520Integrated%2520Software%2520System%2520for%2520Modeling%2520Organic%2520and%2520Bioorganic%2520Molecules%2520Using%2520Molecular%2520Mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467%26doi%3D10.1002%2Fjcc.540110405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sjögren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernäs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gråsjö, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredberg, U.</span></span> <span> </span><span class="NLM_article-title">The Multiple Depletion Curves Method Provides Accurate Estimates of Intrinsic Clearance (CLint), Maximum Velocity of the Metabolic Reaction (Vmax), and Michaelis Constant (Km): Accuracy and Robustness Evaluated Through Experimental Data and Monte Carlo Simulations</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.021477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.108.021477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=18824525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FgtFyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=47-58&author=E.+Sj%C3%B6grenauthor=H.+Lennern%C3%A4sauthor=T.+B.+Anderssonauthor=J.+Gr%C3%A5sj%C3%B6author=U.+Bredberg&title=The+Multiple+Depletion+Curves+Method+Provides+Accurate+Estimates+of+Intrinsic+Clearance+%28CLint%29%2C+Maximum+Velocity+of+the+Metabolic+Reaction+%28Vmax%29%2C+and+Michaelis+Constant+%28Km%29%3A+Accuracy+and+Robustness+Evaluated+Through+Experimental+Data+and+Monte+Carlo+Simulations&doi=10.1124%2Fdmd.108.021477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple depletion curves method provides accurate estimates of intrinsic clearance (CLint), maximum velocity of the metabolic reaction (Vmax), and Michaelis constant (Km): accuracy and robustness evaluated through experimental data and Monte Carlo simulations</span></div><div class="casAuthors">Sjogren Erik; Lennernas Hans; Andersson Tommy B; Grasjo Johan; Bredberg Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Drug metabolism and disposition: the biological fate of chemicals</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The use of multiple depletion curves for the estimation of maximum velocity of the metabolic reaction (V(max)), the Michaelis constant (K(m)), and intrinsic clearance (CL(int)) was thoroughly evaluated by means of experimental data and through a series of Monte Carlo simulations.  The enzyme kinetics of seven compounds were determined using the multiple depletion curves method (MDCM), the traditional initial formation rate of metabolite method (IFRMM), and the "in vitro t(1/2)" method, and the parameter estimates that were derived from the three methods were compared.  The impact of a change in enzyme activity during the incubation period on the parameter estimates and the possibility to correct for this were also investigated.  The MDCM was in good overall agreement with the IFRMM.  Correction for a change in enzyme activity was possible and resulted in a better concordance in CL(int) estimates.  The robustness of the method in coping with different rates of substrate turnover and variable starting concentrations were also demonstrated through Monte Carlo simulations.  Furthermore, the limitations imposed by assumptions inherent in the in vitro t(1/2) method were demonstrated both experimentally and by simulations.  This study demonstrates that the MDCM is a robust and efficient method for estimating enzyme kinetic variables with high accuracy and precision.  The method may potentially be used in a wide range of applications, from pure enzyme kinetics to in vitro-based predictions of the pharmacokinetics of compounds with multiple and/or unknown metabolic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGu__Ax4NV_cvLc4ARHEmzfW6udTcc2eZkymatieS8s7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FgtFyjtA%253D%253D&md5=dfc3250aa3e0c75c6eccdd667d0e0884</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.021477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.021477%26sid%3Dliteratum%253Aachs%26aulast%3DSj%25C3%25B6gren%26aufirst%3DE.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26aulast%3DAndersson%26aufirst%3DT.%2BB.%26aulast%3DGr%25C3%25A5sj%25C3%25B6%26aufirst%3DJ.%26aulast%3DBredberg%26aufirst%3DU.%26atitle%3DThe%2520Multiple%2520Depletion%2520Curves%2520Method%2520Provides%2520Accurate%2520Estimates%2520of%2520Intrinsic%2520Clearance%2520%2528CLint%2529%252C%2520Maximum%2520Velocity%2520of%2520the%2520Metabolic%2520Reaction%2520%2528Vmax%2529%252C%2520and%2520Michaelis%2520Constant%2520%2528Km%2529%253A%2520Accuracy%2520and%2520Robustness%2520Evaluated%2520Through%2520Experimental%2520Data%2520and%2520Monte%2520Carlo%2520Simulations%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D47%26epage%3D58%26doi%3D10.1124%2Fdmd.108.021477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A.-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarimont, C.</span></span> <span> </span><span class="NLM_article-title">Improving the Decision-Making Process in the Structural Modification of Drug Candidates: Enhancing Metabolic Stability</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A.-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+Decision-Making+Process+in+the+Structural+Modification+of+Drug+Candidates%3A+Enhancing+Metabolic+Stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0lia9U4xFHsi1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520Decision-Making%2520Process%2520in%2520the%2520Structural%2520Modification%2520of%2520Drug%2520Candidates%253A%2520Enhancing%2520Metabolic%2520Stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Demain, A. L.</span></span> <span> </span><span class="NLM_article-title">Importance of Microbial Natural Products and the Need to Revitalize Their Discovery</span>. <i>J. Ind. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1007/s10295-013-1325-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1007%2Fs10295-013-1325-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23990168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2qtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=185-201&author=A.+L.+Demain&title=Importance+of+Microbial+Natural+Products+and+the+Need+to+Revitalize+Their+Discovery&doi=10.1007%2Fs10295-013-1325-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of microbial natural products and the need to revitalize their discovery</span></div><div class="casAuthors">Demain, Arnold L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Industrial Microbiology & Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-201</span>CODEN:
                <span class="NLM_cas:coden">JIMBFL</span>;
        ISSN:<span class="NLM_cas:issn">1367-5435</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Microbes are the leading producers of useful natural products.  Natural products from microbes and plants make excellent drugs.  Significant portions of the microbial genomes are devoted to prodn. of these useful secondary metabolites.  A single microbe can make a no. of secondary metabolites, as high as 50 compds.  The most useful products include antibiotics, anticancer agents, immunosuppressants, but products for many other applications, e.g., antivirals, anthelmintics, enzyme inhibitors, nutraceuticals, polymers, surfactants, bioherbicides, and vaccines were commercialized.  Unfortunately, due to the decrease in natural product discovery efforts, drug discovery has decreased in the past 20 years.  The reasons include excessive costs for clin. trials, too short a window before the products become generics, difficulty in discovery of antibiotics against resistant organisms, and short treatment times by patients for products such as antibiotics.  Despite these difficulties, technol. to discover new drugs has advanced, e.g., combinatorial chem. of natural product scaffolds, discoveries in biodiversity, genome mining, and systems biol.  Of great help would be government extension of the time before products become generic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmSFHGHgLym7Vg90H21EOLACvtfcHk0lgegQi3wjH1dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2qtrrI&md5=657e82af420b3e01942df70b6f691c59</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1007%2Fs10295-013-1325-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10295-013-1325-z%26sid%3Dliteratum%253Aachs%26aulast%3DDemain%26aufirst%3DA.%2BL.%26atitle%3DImportance%2520of%2520Microbial%2520Natural%2520Products%2520and%2520the%2520Need%2520to%2520Revitalize%2520Their%2520Discovery%26jtitle%3DJ.%2520Ind.%2520Microbiol.%2520Biotechnol.%26date%3D2014%26volume%3D41%26spage%3D185%26epage%3D201%26doi%3D10.1007%2Fs10295-013-1325-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span> <span> </span><span class="NLM_article-title">Natural Products: A Continuing Source of Novel Drug Leads</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1830</i></span>,  <span class="NLM_fpage">3670</span>– <span class="NLM_lpage">3695</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bbagen.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23428572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1830&publication_year=2013&pages=3670-3695&author=G.+M.+Craggauthor=D.+J.+Newman&title=Natural+Products%3A+A+Continuing+Source+of+Novel+Drug+Leads&doi=10.1016%2Fj.bbagen.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products: A continuing source of novel drug leads</span></div><div class="casAuthors">Cragg, Gordon M.; Newman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1830</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3670-3695</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nature has been a source of medicinal products for millennia, with many useful drugs developed from plant sources.  Following discovery of the penicillins, drug discovery from microbial sources occurred and diving techniques in the 1970s opened the seas.  Combinatorial chem. (late 1980s), shifted the focus of drug discovery efforts from Nature to the lab. bench.  This review traces natural products drug discovery, outlining important drugs from natural sources that revolutionized treatment of serious diseases.  It is clear Nature will continue to be a major source of new structural leads, and effective drug development depends on multidisciplinary collaborations.  The explosion of genetic information led not only to novel screens, but the genetic techniques permitted the implementation of combinatorial biosynthetic technol. and genome mining.  The knowledge gained has allowed unknown mols. to be identified.  These novel bioactive structures can be optimized by using combinatorial chem. generating new drug candidates for many diseases.  The advent of genetic techniques that permitted the isolation /expression of biosynthetic cassettes from microbes may well be the new frontier for natural products lead discovery.  It is now apparent that biodiversity may be much greater in those organisms.  The nos. of potential species involved in the microbial world are many orders of magnitude greater than those of plants and multi-celled animals.  Coupling these nos. to the no. of currently unexpressed biosynthetic clusters now identified (> 10 per species) the potential of microbial diversity remains essentially untapped.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zi-u3aGY-7Vg90H21EOLACvtfcHk0lgegQi3wjH1dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFCmtbY%253D&md5=f3242db81842ceeaca0dc51a0c741c23</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DCragg%26aufirst%3DG.%2BM.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520Products%253A%2520A%2520Continuing%2520Source%2520of%2520Novel%2520Drug%2520Leads%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1830%26spage%3D3670%26epage%3D3695%26doi%3D10.1016%2Fj.bbagen.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hypha
Discovery</span> <i>Lead Compound Diversification
and Late Stage Functionalization</i>. <a href="https://www.hyphadiscovery.co.uk/our-services/lead-diversification/" class="extLink">https://www.hyphadiscovery.co.uk/our-services/lead-diversification/</a> (accessed May 19, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hypha%0ADiscovery+Lead+Compound+Diversification%0Aand+Late+Stage+Functionalization.+https%3A%2F%2Fwww.hyphadiscovery.co.uk%2Four-services%2Flead-diversification%2F+%28accessed+May+19%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DLead%2520Compound%2520Diversification%250Aand%2520Late%2520Stage%2520Functionalization" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchini, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arruda, M. F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campelo, P. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grégio, A. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, E. A. R.</span></span> <span> </span><span class="NLM_article-title">Microbial Biotransformation to Obtain New Antifungals</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2015.01433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.3389%2Ffmicb.2015.01433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25653648" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-12&author=L.+F.+Bianchiniauthor=M.+F.+C.+Arrudaauthor=S.+R.+Vieiraauthor=P.+M.+S.+Campeloauthor=A.+M.+T.+Gr%C3%A9gioauthor=E.+A.+R.+Rosa&title=Microbial+Biotransformation+to+Obtain+New+Antifungals&doi=10.3389%2Ffmicb.2015.01433"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2015.01433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2015.01433%26sid%3Dliteratum%253Aachs%26aulast%3DBianchini%26aufirst%3DL.%2BF.%26aulast%3DArruda%26aufirst%3DM.%2BF.%2BC.%26aulast%3DVieira%26aufirst%3DS.%2BR.%26aulast%3DCampelo%26aufirst%3DP.%2BM.%2BS.%26aulast%3DGr%25C3%25A9gio%26aufirst%3DA.%2BM.%2BT.%26aulast%3DRosa%26aufirst%3DE.%2BA.%2BR.%26atitle%3DMicrobial%2520Biotransformation%2520to%2520Obtain%2520New%2520Antifungals%26jtitle%3DFront.%2520Microbiol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D12%26doi%3D10.3389%2Ffmicb.2015.01433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hegazy, M.-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ElShamy, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, A.-E.-H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalel, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reda, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaheen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawfik, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahat, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shams, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Azim, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammouda, F. M.</span></span> <span> </span><span class="NLM_article-title">Microbial Biotransformation as a Tool for Drug Development Based on Natural Products From Mevalonic Acid Pathway: A Review</span>. <i>J. Adv. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.jare.2014.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.jare.2014.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25685541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFehtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=17-33&author=M.-E.+F.+Hegazyauthor=T.+A.+Mohamedauthor=A.+I.+ElShamyauthor=A.-E.-H.+H.+Mohamedauthor=U.+A.+Mahalelauthor=E.+H.+Redaauthor=A.+M.+Shaheenauthor=W.+A.+Tawfikauthor=A.+A.+Shahatauthor=K.+A.+Shamsauthor=N.+S.+Abdel-Azimauthor=F.+M.+Hammouda&title=Microbial+Biotransformation+as+a+Tool+for+Drug+Development+Based+on+Natural+Products+From+Mevalonic+Acid+Pathway%3A+A+Review&doi=10.1016%2Fj.jare.2014.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial biotransformation as a tool for drug development based on natural products from mevalonic acid pathway: A review</span></div><div class="casAuthors">Hegazy, Mohamed-Elamir F.; Mohamed, Tarik A.; El Shamy, Abdelsamed I.; Mohamed, Abou-El-Hamd H.; Mahalel, Usama A.; Reda, Eman H.; Shaheen, Alaa M.; Tawfik, Wafaa A.; Shahat, Abdelaaty A.; Shams, Khalid A.; Abdel-Azim, Nahla S.; Hammouda, Fayza M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Advanced Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-33</span>CODEN:
                <span class="NLM_cas:coden">JAROES</span>;
        ISSN:<span class="NLM_cas:issn">2090-1224</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Natural products are structurally and biol. interesting metabolites, but they have been isolated in minute amts.  The syntheses of such natural products help in obtaining them in bulk amts.  The recognition of microbial biotransformation as important manufg. tool has increased in chem. and pharmaceutical industries.  In recent years, microbial transformation is increasing significantly from limited interest into highly active area in green chem. including prepn. of pharmaceutical products.  This is the first review published on the usage of microbial biocatalysts for some natural product classes and natural product drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fFrRQU_OcbVg90H21EOLACvtfcHk0lgegQi3wjH1dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFehtb0%253D&md5=901531913943ef0eed1bf8de9a8c54e0</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.jare.2014.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jare.2014.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DHegazy%26aufirst%3DM.-E.%2BF.%26aulast%3DMohamed%26aufirst%3DT.%2BA.%26aulast%3DElShamy%26aufirst%3DA.%2BI.%26aulast%3DMohamed%26aufirst%3DA.-E.-H.%2BH.%26aulast%3DMahalel%26aufirst%3DU.%2BA.%26aulast%3DReda%26aufirst%3DE.%2BH.%26aulast%3DShaheen%26aufirst%3DA.%2BM.%26aulast%3DTawfik%26aufirst%3DW.%2BA.%26aulast%3DShahat%26aufirst%3DA.%2BA.%26aulast%3DShams%26aufirst%3DK.%2BA.%26aulast%3DAbdel-Azim%26aufirst%3DN.%2BS.%26aulast%3DHammouda%26aufirst%3DF.%2BM.%26atitle%3DMicrobial%2520Biotransformation%2520as%2520a%2520Tool%2520for%2520Drug%2520Development%2520Based%2520on%2520Natural%2520Products%2520From%2520Mevalonic%2520Acid%2520Pathway%253A%2520A%2520Review%26jtitle%3DJ.%2520Adv.%2520Res.%26date%3D2015%26volume%3D6%26spage%3D17%26epage%3D33%26doi%3D10.1016%2Fj.jare.2014.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Restaino, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marseglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parrilli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiraldi, C.</span></span> <span> </span><span class="NLM_article-title">Biotechnological Transformation of Hydrocortisone to 16α-Hydroxy Hydrocortisone by Streptomyces roseochromogenes</span>. <i>Appl. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1299</span>, <span class="refDoi"> DOI: 10.1007/s00253-013-5384-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1007%2Fs00253-013-5384-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=24327211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFeis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2014&pages=1291-1299&author=O.+F.+Restainoauthor=M.+Marsegliaauthor=C.+De+Castroauthor=P.+Dianaauthor=P.+Forniauthor=M.+Parrilliauthor=M.+De+Rosaauthor=C.+Schiraldi&title=Biotechnological+Transformation+of+Hydrocortisone+to+16%CE%B1-Hydroxy+Hydrocortisone+by+Streptomyces+roseochromogenes&doi=10.1007%2Fs00253-013-5384-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29cR"><div class="casContent"><span class="casTitleNuber">29c</span><div class="casTitle"><span class="NLM_cas:atitle">Biotechnological transformation of hydrocortisone to 16α-hydroxy hydrocortisone by Streptomyces roseochromogenes</span></div><div class="casAuthors">Restaino, Odile Francesca; Marseglia, Mariacarmela; De Castro, Cristina; Diana, Paola; Forni, Pasquale; Parrilli, Michelangelo; De Rosa, Mario; Schiraldi, Chiara</div><div class="citationInfo"><span class="NLM_cas:title">Applied Microbiology and Biotechnology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1291-1299</span>CODEN:
                <span class="NLM_cas:coden">AMBIDG</span>;
        ISSN:<span class="NLM_cas:issn">0175-7598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Streptomyces roseochromogenes is able to hydroxylate steroid compds. in different positions of their cycloalkane rings thanks to a cytochrome P 450 multi-enzyme complex.  In this paper, the hydroxylation of the hydrocortisone in the 16α position, performed by bacterial whole cells, was investigated in both shake flask and fermn. conditions; the best settings for both cellular growth and transformation reaction were studied by investigating the optimal medium compn., the kinetic of conversion, the most suitable substrate concn. and the preferred addn. timing.  Using newly formulated malt ext.- and yeast ext.-based media, a 16α-hydrohydrocortisone concn. of 0.2 ± 0.01 g L-1 was reached in shake flasks.  Batch expts. in a 2-L fermentor established the reproducibility and robustness of the biotransformation, while a pulsed batch fermn. strategy allowed the prodn. to increase up to 0.508 ± 0.01 g L-1.  Byproduct formation was investigated, and two new derivates of the hydrocortisone obtained during the bacterial transformation reaction and unknown so far, a C-20 hydroxy derivate and a C-21 N-acetamide one, were detd. by NMR analyses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoojZceq7clt7Vg90H21EOLACvtfcHk0lhmRkKTMAp2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFeis7vP&md5=f4e737dd477925095c7b58ef3d84d6ad</span></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1007%2Fs00253-013-5384-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00253-013-5384-x%26sid%3Dliteratum%253Aachs%26aulast%3DRestaino%26aufirst%3DO.%2BF.%26aulast%3DMarseglia%26aufirst%3DM.%26aulast%3DDe%2BCastro%26aufirst%3DC.%26aulast%3DDiana%26aufirst%3DP.%26aulast%3DForni%26aufirst%3DP.%26aulast%3DParrilli%26aufirst%3DM.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DSchiraldi%26aufirst%3DC.%26atitle%3DBiotechnological%2520Transformation%2520of%2520Hydrocortisone%2520to%252016%25CE%25B1-Hydroxy%2520Hydrocortisone%2520by%2520Streptomyces%2520roseochromogenes%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2014%26volume%3D98%26spage%3D1291%26epage%3D1299%26doi%3D10.1007%2Fs00253-013-5384-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note">a<p class="last">Product <i>m/z</i> 413c (M + 30) is observed in well 28 generated from <i>Streptomyces setae</i> ATCC 33774, not shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>.</p></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, W. d. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durán-Patrón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupo, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonato, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collado, I. G.</span></span> <span> </span><span class="NLM_article-title">Stereoselective Biotransformations Using Fungi as Biocatalysts</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2009.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.tetasy.2009.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1SgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=385-397&author=K.+B.+Borgesauthor=W.+d.+S.+Borgesauthor=R.+Dur%C3%A1n-Patr%C3%B3nauthor=M.+T.+Pupoauthor=P.+S.+Bonatoauthor=I.+G.+Collado&title=Stereoselective+Biotransformations+Using+Fungi+as+Biocatalysts&doi=10.1016%2Fj.tetasy.2009.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective biotransformations using fungi as biocatalysts</span></div><div class="casAuthors">Borges, Keyller Bastos; Borges, Warley de Souza; Duran-Patron, Rosa; Pupo, Monica Tallarico; Bonato, Pierina Sueli; Collado, Isidro Gonzalez</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-397</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  The development of novel biocatalytic methods is a continuously growing area of chem., microbiol., and genetic engineering due to the fact that biocatalysts are selective, easy-to-handle, and environmentally friendly.  A wide range of reactions are catalyzed by microorganisms.  Fungi can be considered as a promising source of new biocatalysts, mainly for chiral reactions.  Chemo-, regio-, and stereoselective processes are very important in the synthesis of many chem., pharmaceutical, and agrochem. intermediates; active pharmaceuticals; and food ingredients.  This report reviews stereoselective reactions mediated by fungi, such as stereoselective hydroxylation, sulfoxidn., epoxidn., Baeyer-Villiger oxidn., deracemization, and stereo- and enantioselective redn. of ketones, published between 2000 and 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1f0sZFMm4erVg90H21EOLACvtfcHk0lhmRkKTMAp2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1SgsLY%253D&md5=12e54b1a8b219488bd92f55a8083f9d8</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2009.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2009.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DBorges%26aufirst%3DK.%2BB.%26aulast%3DBorges%26aufirst%3DW.%2Bd.%2BS.%26aulast%3DDur%25C3%25A1n-Patr%25C3%25B3n%26aufirst%3DR.%26aulast%3DPupo%26aufirst%3DM.%2BT.%26aulast%3DBonato%26aufirst%3DP.%2BS.%26aulast%3DCollado%26aufirst%3DI.%2BG.%26atitle%3DStereoselective%2520Biotransformations%2520Using%2520Fungi%2520as%2520Biocatalysts%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2009%26volume%3D20%26spage%3D385%26epage%3D397%26doi%3D10.1016%2Fj.tetasy.2009.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manikandan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 Structure, Function and Clinical Significance: A Review</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.2174/1389450118666170125144557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.2174%2F1389450118666170125144557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=28124606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Okuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=38-54&author=P.+Manikandanauthor=S.+Nagini&title=Cytochrome+P450+Structure%2C+Function+and+Clinical+Significance%3A+A+Review&doi=10.2174%2F1389450118666170125144557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 Structure, Function and Clinical Significance: A Review</span></div><div class="casAuthors">Manikandan, Palrasu; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-54</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: The cytochrome P 450 (CYP) enzymes are membrane-bound hemoproteins that play a pivotal role in the detoxification of xenobiotics, cellular metab. and homeostasis.  Induction or inhibition of CYP enzymes is a major mechanism that underlies drug-drug interactions.  CYP enzymes can be transcriptionally activated by various xenobiotics and endogenous substrates through receptor-dependent mechanisms.  CYP enzyme inhibition is a principal mechanism for metab.- based drug-drug interactions.  Many chemotherapeutic drugs can cause drug interactions due to their ability to either inhibit or induce the CYP enzyme system.  Predictions based on in silico analyses followed by validation have identified several microRNAs that regulate CYPs.  Genetic polymorphisms and epigenetic changes in CYP genes may be responsible for inter-individual and interethnic variations in disease susceptibility and the therapeutic efficacy of drugs.  Objective: The present review is a comprehensive compilation of cytochrome P 450 structure, function, pharmacogenetics, pharmacoepigenetics and clin. significance.  Conclusion: Knowledge about the substrates, inducers, and inhibitors of CYP isoforms, as well as the polymorphisms of CYP enzymes may be used as an aid by clinicians to det. therapeutic strategy, and treatment doses for drugs that are metabolized by CYP gene products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrATPQ72JwoKrVg90H21EOLACvtfcHk0lhmRkKTMAp2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Okuro%253D&md5=5e51feccd96c123917b1ff46c8235b5b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1389450118666170125144557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450118666170125144557%26sid%3Dliteratum%253Aachs%26aulast%3DManikandan%26aufirst%3DP.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DCytochrome%2520P450%2520Structure%252C%2520Function%2520and%2520Clinical%2520Significance%253A%2520A%2520Review%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2018%26volume%3D19%26spage%3D38%26epage%3D54%26doi%3D10.2174%2F1389450118666170125144557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span> <i>Directed Evolution of Enzymes and Binding Proteins</i>. <a href="https://www.nobelprize.org/uploads/2018/10/advanced-chemistryprize-2018.pdf" class="extLink">https://www.nobelprize.org/uploads/2018/10/advanced-chemistryprize-2018.pdf</a> (accessed May 24, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Directed+Evolution+of+Enzymes+and+Binding+Proteins.+https%3A%2F%2Fwww.nobelprize.org%2Fuploads%2F2018%2F10%2Fadvanced-chemistryprize-2018.pdf+%28accessed+May+24%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DDirected%2520Evolution%2520of%2520Enzymes%2520and%2520Binding%2520Proteins" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Directed Evolution: Bringing New Chemistry to Life</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4143</span>– <span class="NLM_lpage">4148</span>, <span class="refDoi"> DOI: 10.1002/anie.201708408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201708408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOjsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=4143-4148&author=F.+H.+Arnold&title=Directed+Evolution%3A+Bringing+New+Chemistry+to+Life&doi=10.1002%2Fanie.201708408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Directed evolution: Bringing new chemistry to life</span></div><div class="casAuthors">Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4143-4148</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Directed evolution mimics evolution by artificial selection, and is accelerated in the lab. setting by focusing on individual genes expressed in fast-growing microorganisms.  We start with existing proteins (sourced from Nature or engineered), introduce mutations, and then screen for the progeny proteins with enhanced activity (or other desirable traits).  We use the improved enzymes as parents for the next round of mutation and screening, recombining beneficial mutations as needed, and continuing until we reach the target level of performance.  Thus, the evolution of Nature's enzymes can lead to the discovery of new reactivity, transformations not known in biol., and reactivity inaccessible by small-mol. catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJP45IjkyderVg90H21EOLACvtfcHk0ljyMMbEp-ggxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOjsrvO&md5=d174f0faf8c21667000cdf19ed7c14e8</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201708408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201708408%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DDirected%2520Evolution%253A%2520Bringing%2520New%2520Chemistry%2520to%2520Life%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D4143%26epage%3D4148%26doi%3D10.1002%2Fanie.201708408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Behrendorff, J. B. Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillam, E. M. J.</span></span> <span> </span><span class="NLM_article-title">Directed Evolution of Cytochrome P450 Enzymes for Biocatalysis: Exploiting the Catalytic Versatility of Enzymes with Relaxed Substrate Specificity</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>467</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1042/BJ20141493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1042%2FBJ20141493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25793416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVOrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=2015&pages=1-15&author=J.+B.+Y.+H.+Behrendorffauthor=W.+Huangauthor=E.+M.+J.+Gillam&title=Directed+Evolution+of+Cytochrome+P450+Enzymes+for+Biocatalysis%3A+Exploiting+the+Catalytic+Versatility+of+Enzymes+with+Relaxed+Substrate+Specificity&doi=10.1042%2FBJ20141493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity</span></div><div class="casAuthors">Behrendorff, James B. Y. H.; Huang, Weiliang; Gillam, Elizabeth M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">467</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 enzymes are renowned for their ability to insert oxygen into an enormous variety of compds. with a high degree of chemo- and regio-selectivity under mild conditions.  This property has been exploited in Nature for an enormous variety of physiol. functions, and representatives of this ancient enzyme family have been identified in all kingdoms of life.  The catalytic versatility of P450s makes them well suited for repurposing for the synthesis of fine chems. such as drugs.  Although these enzymes have not evolved in Nature to perform the reactions required for modern chem. industries, many P450s show relaxed substrate specificity and exhibit some degree of activity towards non-natural substrates of relevance to applications such as drug development.  Directed evolution and other protein engineering methods can be used to improve upon this low level of activity and convert these promiscuous generalist enzymes into specialists capable of mediating reactions of interest with exquisite regio- and stereo-selectivity.  Although there are some notable successes in exploiting P450s from natural sources in metabolic engineering, and P450s have been proven repeatedly to be excellent material for engineering, there are few examples to date of practical application of engineered P450s.  The purpose of the present review is to illustrate the progress that has been made in altering properties of P450s such as substrate range, cofactor preference and stability, and outline some of the remaining challenges that must be overcome for industrial application of these powerful biocatalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpohdYIZZzqirVg90H21EOLACvtfcHk0ljyMMbEp-ggxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVOrsrw%253D&md5=918c99e8dbf124e03b4a56956c016607</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1042%2FBJ20141493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20141493%26sid%3Dliteratum%253Aachs%26aulast%3DBehrendorff%26aufirst%3DJ.%2BB.%2BY.%2BH.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DGillam%26aufirst%3DE.%2BM.%2BJ.%26atitle%3DDirected%2520Evolution%2520of%2520Cytochrome%2520P450%2520Enzymes%2520for%2520Biocatalysis%253A%2520Exploiting%2520the%2520Catalytic%2520Versatility%2520of%2520Enzymes%2520with%2520Relaxed%2520Substrate%2520Specificity%26jtitle%3DBiochem.%2520J.%26date%3D2015%26volume%3D467%26spage%3D1%26epage%3D15%26doi%3D10.1042%2FBJ20141493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Heel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodani, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerowitz, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Non-Natural Olefin Cyclopropanation Catalyzed by Diverse Cytochrome P450s and Other Hemoproteins</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2556</span>– <span class="NLM_lpage">2562</span>, <span class="refDoi"> DOI: 10.1002/cbic.201402286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fcbic.201402286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=25294253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVaksbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=2556-2562&author=T.+Heelauthor=J.+A.+McIntoshauthor=S.+C.+Dodaniauthor=J.+T.+Meyerowitzauthor=F.+H.+Arnold&title=Non-Natural+Olefin+Cyclopropanation+Catalyzed+by+Diverse+Cytochrome+P450s+and+Other+Hemoproteins&doi=10.1002%2Fcbic.201402286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Non-natural Olefin Cyclopropanation Catalyzed by Diverse Cytochrome P450s and Other Hemoproteins</span></div><div class="casAuthors">Heel, Thomas; McIntosh, John A.; Dodani, Sheel C.; Meyerowitz, Joseph T.; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2556-2562</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Recent work has shown that engineered variants of cytochrome P 450BM3 (CYP102A1) efficiently catalyze non-natural reactions, including carbene and nitrene transfer reactions.  Given the broad substrate range of natural P 450 enzymes, we set out to explore if this diversity could be leveraged to generate a broad panel of new catalysts for olefin cyclopropanation (i.e., carbene transfer).  Here, we took a step towards this goal by characterizing the carbene transfer activities of four new wild-type P450s that have different native substrates.  All four were active and exhibited a range of product selectivities in the model reaction: cyclopropanation of styrene by using Et diazoacetate (EDA).  Previous work on P 450BM3 demonstrated that mutation of the axial coordinating cysteine, universally conserved among P 450 enzymes, to a serine residue, increased activity for this non-natural reaction.  The equivalent mutation in the selected P450s was found to activate carbene transfer chem. both in vitro and in vivo.  Furthermore, serum albumins complexed with hemin were also found to be efficient in vitro cyclopropanation catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE9hmIWPy6WbVg90H21EOLACvtfcHk0ljyMMbEp-ggxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVaksbvL&md5=e7d61896a5b164d705c2516367a784da</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402286%26sid%3Dliteratum%253Aachs%26aulast%3DHeel%26aufirst%3DT.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BA.%26aulast%3DDodani%26aufirst%3DS.%2BC.%26aulast%3DMeyerowitz%26aufirst%3DJ.%2BT.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DNon-Natural%2520Olefin%2520Cyclopropanation%2520Catalyzed%2520by%2520Diverse%2520Cytochrome%2520P450s%2520and%2520Other%2520Hemoproteins%26jtitle%3DChemBioChem%26date%3D2014%26volume%3D15%26spage%3D2556%26epage%3D2562%26doi%3D10.1002%2Fcbic.201402286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Engineering Cytochrome P450 Biocatalysts for Biotechnology, Medicine and Bioremediation</span>. <i>Expert Opin. Drug. Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1517/17425250903431040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1517%2F17425250903431040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=20064075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=115-131&author=S.+Kumar&title=Engineering+Cytochrome+P450+Biocatalysts+for+Biotechnology%2C+Medicine+and+Bioremediation&doi=10.1517%2F17425250903431040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33dR"><div class="casContent"><span class="casTitleNuber">33d</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation</span></div><div class="casAuthors">Kumar, Santosh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-131</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Cytochrome P 450 enzymes comprise a superfamily of heme monooxygenases that are of considerable interest for the: (i) synthesis of novel drugs and drug metabolites; (ii) targeted cancer gene therapy; (iii) biosensor design; and (iv) bioremediation.  However, their applications are limited because cytochrome P 450, esp. mammalian P 450 enzymes, show a low turnover rate and stability, and require a complex source of electrons through cytochrome P 450 reductase and NADPH.  Areas covered in this review: In this review, we discuss the recent progress towards the use of P 450 enzymes in a variety of the above-mentioned applications.  We also present alternate and cost-effective ways to perform P 450-mediated reaction, esp. using peroxides.  Furthermore, we expand upon the current progress in P 450 engineering approaches describing several recent examples that are utilized to enhance heterologous expression, stability, catalytic efficiency and utilization of alternate oxidants.What the reader will gain: The review provides a comprehensive knowledge in the design of P 450 biocatalysts for potentially practical purposes.  Finally, we provide a prospective on the future aspects of P 450 engineering and its applications in biotechnol., medicine and bioremediation.  Take home message: Because of its wide applications, academic and pharmaceutical researchers, environmental scientists and healthcare providers are expected to gain current knowledge and future prospects of the practical use of P 450 biocatalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9w0ZIMkOQXrVg90H21EOLACvtfcHk0ljyMMbEp-ggxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyhs70%253D&md5=39cb4ecda860ae801373e3c2a684916b</span></div><a href="/servlet/linkout?suffix=cit33d&amp;dbid=16384&amp;doi=10.1517%2F17425250903431040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903431040%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DEngineering%2520Cytochrome%2520P450%2520Biocatalysts%2520for%2520Biotechnology%252C%2520Medicine%2520and%2520Bioremediation%26jtitle%3DExpert%2520Opin.%2520Drug.%2520Metab.%2520Toxicol.%26date%3D2010%26volume%3D6%26spage%3D115%26epage%3D131%26doi%3D10.1517%2F17425250903431040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rentmeister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasan, R.</span></span> <span> </span><span class="NLM_article-title">Chemo-Enzymatic Fluorination of Unactivated Organic Compounds</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1038/nchembio.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fnchembio.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=19011638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=26-28&author=A.+Rentmeisterauthor=F.+H.+Arnoldauthor=R.+Fasan&title=Chemo-Enzymatic+Fluorination+of+Unactivated+Organic+Compounds&doi=10.1038%2Fnchembio.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33eR"><div class="casContent"><span class="casTitleNuber">33e</span><div class="casTitle"><span class="NLM_cas:atitle">Chemo-enzymatic fluorination of unactivated organic compounds</span></div><div class="casAuthors">Rentmeister, Andrea; Arnold, Frances H.; Fasan, Rudi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-28</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A versatile strategy that combines cytochrome P 450-catalyzed oxygenation with deoxofluorination to achieve mono- and polyfluorination of nonactive sites in a variety of org. scaffolds, was described.  This procedure was applied for the rapid identification of fluorinated derivs. with enhanced membrane permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCBe4hN_oEC7Vg90H21EOLACvtfcHk0li2ODoHFEHS7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWhu7fJ&md5=9fa9f13be2acbc1a2ec3ba826a1576d0</span></div><a href="/servlet/linkout?suffix=cit33e&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.128%26sid%3Dliteratum%253Aachs%26aulast%3DRentmeister%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26aulast%3DFasan%26aufirst%3DR.%26atitle%3DChemo-Enzymatic%2520Fluorination%2520of%2520Unactivated%2520Organic%2520Compounds%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D26%26epage%3D28%26doi%3D10.1038%2Fnchembio.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Cytochromes P450 and Drug Discovery</span>. <i>Curr. Opin. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1016/j.copbio.2007.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.copbio.2007.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=18006294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislOrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=504-512&author=D.+C.+Lambauthor=M.+R.+Watermanauthor=S.+L.+Kellyauthor=F.+P.+Guengerich&title=Cytochromes+P450+and+Drug+Discovery&doi=10.1016%2Fj.copbio.2007.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33fR"><div class="casContent"><span class="casTitleNuber">33f</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochromes P450 and drug discovery</span></div><div class="casAuthors">Lamb, David C.; Waterman, Michael R.; Kelly, Steven L.; Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">504-512</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cytochromes P 450 (CYP) are a superfamily of haem-contg. proteins distributed widely throughout nature.  Historically, they have a central role in drug metab. and following the advent of genomics they have been shown to have key roles in the biosynthesis of natural products which are used as medicines.  Herein, we provide an overview of CYP systems with particular emphasis on their role as drug targets, their involvement in drug biosynthesis and potential strategies for developing new derivs. of drugs based on CYP engineering.  The applied importance of CYPs for medicinal and biotechnol. applications will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfIt8WFtdfv7Vg90H21EOLACvtfcHk0li2ODoHFEHS7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislOrtw%253D%253D&md5=387294e46f8975cddc369a1198c033c3</span></div><a href="/servlet/linkout?suffix=cit33f&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2007.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2007.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DD.%2BC.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26aulast%3DKelly%26aufirst%3DS.%2BL.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DCytochromes%2520P450%2520and%2520Drug%2520Discovery%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2007%26volume%3D18%26spage%3D504%26epage%3D512%26doi%3D10.1016%2Fj.copbio.2007.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffreys, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poddar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golovanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girvan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voice, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, A. W.</span></span> <span> </span><span class="NLM_article-title">Novel Insights into P450 BM3 Interactions with FDA-Approved Antifungal Azole Drugs</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1577</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-37330-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fs41598-018-37330-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=30733479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BB3cfgsVSltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1577&author=L.+N.+Jeffreysauthor=H.+Poddarauthor=M.+Golovanovaauthor=C.+W.+Levyauthor=H.+M.+Girvanauthor=K.+J.+McLeanauthor=M.+W.+Voiceauthor=D.+Leysauthor=A.+W.+Munro&title=Novel+Insights+into+P450+BM3+Interactions+with+FDA-Approved+Antifungal+Azole+Drugs&doi=10.1038%2Fs41598-018-37330-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs</span></div><div class="casAuthors">Jeffreys Laura N; Poddar Harshwardhan; Golovanova Marina; Girvan Hazel M; McLean Kirsty J; Leys David; Munro Andrew W; Levy Colin W; Voice Michael W</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1577</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Flavocytochrome P450 BM3 is a natural fusion protein constructed of cytochrome P450 and NADPH-cytochrome P450 reductase domains.  P450 BM3 binds and oxidizes several mid- to long-chain fatty acids, typically hydroxylating these lipids at the ω-1, ω-2 and ω-3 positions.  However, protein engineering has led to variants of this enzyme that are able to bind and oxidize diverse compounds, including steroids, terpenes and various human drugs.  The wild-type P450 BM3 enzyme binds inefficiently to many azole antifungal drugs.  However, we show that the BM3 A82F/F87V double mutant (DM) variant binds substantially tighter to numerous azole drugs than does the wild-type BM3, and that their binding occurs with more extensive heme spectral shifts indicative of complete binding of several azoles to the BM3 DM heme iron.  We report here the first crystal structures of P450 BM3 bound to azole antifungal drugs - with the BM3 DM heme domain bound to the imidazole drugs clotrimazole and tioconazole, and to the triazole drugs fluconazole and voriconazole.  This is the first report of any protein structure bound to the azole drug tioconazole, as well as the first example of voriconazole heme iron ligation through a pyrimidine nitrogen from its 5-fluoropyrimidine ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVcbY-xv2TiAWRJ3OJdH_qfW6udTcc2eYzTnUgg0Kp5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfgsVSltw%253D%253D&md5=caa30f8e61dc8fdeeb70a336c2a6a5c0</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-37330-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-37330-y%26sid%3Dliteratum%253Aachs%26aulast%3DJeffreys%26aufirst%3DL.%2BN.%26aulast%3DPoddar%26aufirst%3DH.%26aulast%3DGolovanova%26aufirst%3DM.%26aulast%3DLevy%26aufirst%3DC.%2BW.%26aulast%3DGirvan%26aufirst%3DH.%2BM.%26aulast%3DMcLean%26aufirst%3DK.%2BJ.%26aulast%3DVoice%26aufirst%3DM.%2BW.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DMunro%26aufirst%3DA.%2BW.%26atitle%3DNovel%2520Insights%2520into%2520P450%2520BM3%2520Interactions%2520with%2520FDA-Approved%2520Antifungal%2520Azole%2520Drugs%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D1577%26doi%3D10.1038%2Fs41598-018-37330-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Catalysts on Demand: Selective Oxidations by Laboratory-Evolved Cytochrome P450 BM3</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.2533/chimia.2009.309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.2533%2Fchimia.2009.309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=309-312&author=J.+C.+Lewisauthor=F.+H.+Arnold&title=Catalysts+on+Demand%3A+Selective+Oxidations+by+Laboratory-Evolved+Cytochrome+P450+BM3&doi=10.2533%2Fchimia.2009.309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Catalysts on demand: selective oxidations by laboratory-evolved cytochrome P450 BM3</span></div><div class="casAuthors">Lewis, Jared C.; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">309-312</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review of the authors on research.  Efficient catalysts for selective oxidn. of C-H bonds using atm. oxygen are highly desirable to decrease the economic and environmental costs assocd. with conventional oxidn. processes.  We have used methods of directed evolution to generate variants of bacterial cytochrome P 450 BM3 that catalyze hydroxylation and epoxidn. of a wide range of non-native substrates.  This fatty acid hydroxylase was converted to a propane monooxygenase (PMO) capable of hydroxylating propane at rates comparable to that of BM3 on its natural substrates.  Variants along the PMO evolutionary lineage showed broadened substrate scope; these became the starting points for evolution of a wide array of enzymes that can hydroxylate and derivatize org. scaffolds.  This work demonstrates how a single member of enzyme family is readily converted by evolution into a whole family of catalysts for org. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq53979gJHgCrVg90H21EOLACvtfcHk0lheL7UDgxA6Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVylu7w%253D&md5=b5c1099a2b4eb4e0e7ff30415cacd97a</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2009.309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2009.309%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DJ.%2BC.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DCatalysts%2520on%2520Demand%253A%2520Selective%2520Oxidations%2520by%2520Laboratory-Evolved%2520Cytochrome%2520P450%2520BM3%26jtitle%3DChimia%26date%3D2009%26volume%3D63%26spage%3D309%26epage%3D312%26doi%3D10.2533%2Fchimia.2009.309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit34c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Otey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, F. H.</span></span> <span> </span><span class="NLM_article-title">Preparation of Human Metabolites of Propranolol Using Laboratory-Evolved Bacterial Cytochromes P450</span>. <i>Biotechnol. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1002/bit.20744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fbit.20744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=16224788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2006&pages=494-499&author=C.+R.+Oteyauthor=G.+Bandaraauthor=J.+Lalondeauthor=K.+Takahashiauthor=F.+H.+Arnold&title=Preparation+of+Human+Metabolites+of+Propranolol+Using+Laboratory-Evolved+Bacterial+Cytochromes+P450&doi=10.1002%2Fbit.20744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34cR"><div class="casContent"><span class="casTitleNuber">34c</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450</span></div><div class="casAuthors">Otey, Christopher R.; Bandara, Geethani; Lalonde, James; Takahashi, Katsuyuki; Arnold, Frances H.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology and Bioengineering</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">494-499</span>CODEN:
                <span class="NLM_cas:coden">BIBIAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3592</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Testing the toxicities and biol. activities of the human metabolites of drugs is important for development of safe and effective pharmaceuticals.  Producing these metabolites using human cytochrome P450s is difficult, however, because the human enzymes are costly, poorly stable, and slow.  We have used directed evolution to generate variants of P 450 BM3 from Bacillus megaterium that function via the "peroxide shunt" pathway, using hydrogen peroxide in place of the reductase domain, oxygen and NADPH.  Here, we report further evolution of the P 450 BM3 heme domain peroxygenase to enhance prodn. of the authentic human metabolites of propranolol by this biocatalytic route.  This system offers a versatile, cost-effective, and scaleable route to the synthesis of drug metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHhXZ5DpXo7LVg90H21EOLACvtfcHk0lgMhrcTqq0nqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KrsLk%253D&md5=88c4e34d4d1b7a770fa165077c2dc727</span></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1002%2Fbit.20744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbit.20744%26sid%3Dliteratum%253Aachs%26aulast%3DOtey%26aufirst%3DC.%2BR.%26aulast%3DBandara%26aufirst%3DG.%26aulast%3DLalonde%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DArnold%26aufirst%3DF.%2BH.%26atitle%3DPreparation%2520of%2520Human%2520Metabolites%2520of%2520Propranolol%2520Using%2520Laboratory-Evolved%2520Bacterial%2520Cytochromes%2520P450%26jtitle%3DBiotechnol.%2520Bioeng.%26date%3D2006%26volume%3D93%26spage%3D494%26epage%3D499%26doi%3D10.1002%2Fbit.20744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Di Nardo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilardi, G.</span></span> <span> </span><span class="NLM_article-title">Optimization of the Bacterial Cytochrome P450 BM3 System for the Production of Human Drug Metabolites</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">15901</span>– <span class="NLM_lpage">15924</span>, <span class="refDoi"> DOI: 10.3390/ijms131215901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.3390%2Fijms131215901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=23443101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyisbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=15901-15924&author=G.+Di+Nardoauthor=G.+Gilardi&title=Optimization+of+the+Bacterial+Cytochrome+P450+BM3+System+for+the+Production+of+Human+Drug+Metabolites&doi=10.3390%2Fijms131215901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites</span></div><div class="casAuthors">Di Nardo, Giovanna; Gilardi, Gianfranco</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15901-15924</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Drug metab. in human liver is a process involving many different enzymes.  Among them, a no. of cytochromes P 450 isoforms catalyze the oxidn. of most of the drugs com. available.  Each P 450 isoform acts on more than one drug, and one drug may be oxidized by more than one enzyme.  As a result, multiple products may be obtained from the same drug, and as the metabolites can be biol. active and may cause adverse drug reactions (ADRs), the metabolic profile of a new drug has to be known before this can be commercialized.  Therefore, the metabolites of a certain drug must be identified, synthesized and tested for toxicity.  Their synthesis must be in sufficient quantities to be used for metabolic tests.  This review focuses on the progresses done in the field of the optimization of a bacterial self-sufficient and efficient cytochrome P 450, P 450 BM3 from Bacillus megaterium, used for the prodn. of metabolites of human enzymes.  The progress made in the improvement of its catalytic performance towards drugs, the substitution of the costly NADPH cofactor and its immobilization and scale-up of the process for industrial application are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRaEnf4Mm3HbVg90H21EOLACvtfcHk0lhOu5glqzP2Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyisbzL&md5=8643ee1e3efe25b968d196e221dc88bd</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.3390%2Fijms131215901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms131215901%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BNardo%26aufirst%3DG.%26aulast%3DGilardi%26aufirst%3DG.%26atitle%3DOptimization%2520of%2520the%2520Bacterial%2520Cytochrome%2520P450%2520BM3%2520System%2520for%2520the%2520Production%2520of%2520Human%2520Drug%2520Metabolites%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26spage%3D15901%26epage%3D15924%26doi%3D10.3390%2Fijms131215901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Fueyo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Biocatalytic Oxidation Reactions: A Chemist’s Perspective</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9238</span>– <span class="NLM_lpage">9261</span>, <span class="refDoi"> DOI: 10.1002/anie.201800343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201800343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KqtLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=9238-9261&author=J.+Dongauthor=E.+Fern%C3%A1ndez-Fueyoauthor=F.+Hollmannauthor=C.+E.+Paulauthor=M.+Pesicauthor=S.+Schmidtauthor=Y.+Wangauthor=S.+Younesauthor=W.+Zhang&title=Biocatalytic+Oxidation+Reactions%3A+A+Chemist%E2%80%99s+Perspective&doi=10.1002%2Fanie.201800343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Biocatalytic Oxidation Reactions: A Chemist's Perspective</span></div><div class="casAuthors">Dong, JiaJia; Fernandez-Fueyo, Elena; Hollmann, Frank; Paul, Caroline E.; Pesic, Milja; Schmidt, Sandy; Wang, Yonghua; Younes, Sabry; Zhang, Wuyuan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9238-9261</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Oxidn. chem. using enzymes is approaching maturity and practical applicability in org. synthesis.  Oxidoreductases (enzymes catalyzing redox reactions) enable chemists to perform highly selective and efficient transformations ranging from simple alc. oxidns. to stereoselective halogenations of non-activated C-H bonds.  For many of these reactions, no "classical" chem. counterpart is known.  Hence oxidoreductases open up shorter synthesis routes based on a more direct access to the target products.  The generally very mild reaction conditions may also reduce the environmental impact of biocatalytic reactions compared to classical counterparts.  In this Review, we critically summarize the most important recent developments in the field of biocatalytic oxidn. chem. and identify the most pressing bottlenecks as well as promising solns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU2yAEnskYFLVg90H21EOLACvtfcHk0lhOu5glqzP2Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KqtLnK&md5=5e219249fd4b424279f569e70d5c26b1</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201800343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201800343%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DFern%25C3%25A1ndez-Fueyo%26aufirst%3DE.%26aulast%3DHollmann%26aufirst%3DF.%26aulast%3DPaul%26aufirst%3DC.%2BE.%26aulast%3DPesic%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYounes%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DBiocatalytic%2520Oxidation%2520Reactions%253A%2520A%2520Chemist%25E2%2580%2599s%2520Perspective%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26spage%3D9238%26epage%3D9261%26doi%3D10.1002%2Fanie.201800343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaluzna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitges, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straatman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Tegelen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schürmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mink, D.</span></span> <span> </span><span class="NLM_article-title">Enabling Selective and Sustainable P450 Oxygenation Technology. Production of 4-Hydroxy-α-isophorone on Kilogram Scale</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.5b00282</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.5b00282" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFejs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=814-819&author=I.+Kaluznaauthor=T.+Schmitgesauthor=H.+Straatmanauthor=D.+van+Tegelenauthor=M.+M%C3%BCllerauthor=M.+Sch%C3%BCrmannauthor=D.+Mink&title=Enabling+Selective+and+Sustainable+P450+Oxygenation+Technology.+Production+of+4-Hydroxy-%CE%B1-isophorone+on+Kilogram+Scale&doi=10.1021%2Facs.oprd.5b00282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Enabling Selective and Sustainable P450 Oxygenation Technology. Production of 4-Hydroxy-α-isophorone on Kilogram Scale</span></div><div class="casAuthors">Kaluzna, Iwona; Schmitges, Thomas; Straatman, Harrie; van Tegelen, Dennis; Mueller, Monika; Schuermann, Martin; Mink, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">814-819</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of P 450 platform technol. has enabled the sustainable prodn. of an oxygenated intermediate, 4-hydroxy-α-isophorone, on kilogram scale.  Application of a cytochrome P 450 enzyme resulted in an unprecedented product concn. of 10 g/L and a space-time yield of 1.5 g/L/h.  These findings are highly relevant for the economical evaluation of cytochrome P 450 technol. and, addnl., provide access to an alternative and cost-effective route toward 4-hydroxy-α-isophorone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGWLZLVX3Fq7Vg90H21EOLACvtfcHk0lhOu5glqzP2Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFejs7g%253D&md5=4f5aa8df3faa0abcd18fe1a26d1cb1b4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.5b00282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.5b00282%26sid%3Dliteratum%253Aachs%26aulast%3DKaluzna%26aufirst%3DI.%26aulast%3DSchmitges%26aufirst%3DT.%26aulast%3DStraatman%26aufirst%3DH.%26aulast%3Dvan%2BTegelen%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DSch%25C3%25BCrmann%26aufirst%3DM.%26aulast%3DMink%26aufirst%3DD.%26atitle%3DEnabling%2520Selective%2520and%2520Sustainable%2520P450%2520Oxygenation%2520Technology.%2520Production%2520of%25204-Hydroxy-%25CE%25B1-isophorone%2520on%2520Kilogram%2520Scale%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2016%26volume%3D20%26spage%3D814%26epage%3D819%26doi%3D10.1021%2Facs.oprd.5b00282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span> <i>Codexis Screening Kits and Biocatalysts</i>. <a href="https://www.codexis.com/products/screening-kits/" class="extLink">https://www.codexis.com/products/screening-kits/</a>(accessed May 25, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Codexis+Screening+Kits+and+Biocatalysts.+https%3A%2F%2Fwww.codexis.com%2Fproducts%2Fscreening-kits%2F%28accessed+May+25%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCodexis%2520Screening%2520Kits%2520and%2520Biocatalysts" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellsworth, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritz, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baska, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burford, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnghar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnia, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelleymounter, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of Pyrazine Carboxamide CB1 Antagonists: The Introduction of a Hydroxyl Group Improves the Pharmaceutical Properties and In Vivo Efficacy of the Series</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3978</span>– <span class="NLM_lpage">3982</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.04.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2007.04.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=17513109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVClu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3978-3982&author=B.+A.+Ellsworthauthor=Y.+Wangauthor=Y.+Zhuauthor=A.+Pendriauthor=S.+W.+Gerritzauthor=C.+Sunauthor=K.+E.+Carlsonauthor=L.+Kangauthor=R.+A.+Baskaauthor=Y.+Yangauthor=Q.+Huangauthor=N.+T.+Burfordauthor=M.+J.+Cullenauthor=S.+Johngharauthor=K.+Behniaauthor=M.+A.+Pelleymounterauthor=W.+N.+Washburnauthor=W.+R.+Ewing&title=Discovery+of+Pyrazine+Carboxamide+CB1+Antagonists%3A+The+Introduction+of+a+Hydroxyl+Group+Improves+the+Pharmaceutical+Properties+and+In+Vivo+Efficacy+of+the+Series&doi=10.1016%2Fj.bmcl.2007.04.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series</span></div><div class="casAuthors">Ellsworth, Bruce A.; Wang, Ying; Zhu, Yeheng; Pendri, Annapurna; Gerritz, Samuel W.; Sun, Chongqing; Carlson, Kenneth E.; Kang, Liya; Baska, Rose A.; Yang, Yifan; Huang, Qi; Burford, Neil T.; Cullen, Mary Jane; Johnghar, Susan; Behnia, Kamelia; Pelleymounter, Mary Ann; Washburn, William N.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3978-3982</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Structure-activity relationships for a series of pyrazine carboxamide CB1 antagonists are reported.  Pharmaceutical properties of the series are improved via inclusion of hydroxyl-contg. sidechains.  This structural modification sufficiently improved ADME properties of an orally inactive series such that food intake redn. was achieved in rat feeding models.  Compd. 35 (I) elicits a 46% redn. in food intake in ad libitum fed rats 4-h post-dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqp2iSxEZT2bVg90H21EOLACvtfcHk0ljuqrRXthbDQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVClu7k%253D&md5=723258b8fb296b9d23ff228d0ce7d15d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.04.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.04.087%26sid%3Dliteratum%253Aachs%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DGerritz%26aufirst%3DS.%2BW.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DKang%26aufirst%3DL.%26aulast%3DBaska%26aufirst%3DR.%2BA.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DJohnghar%26aufirst%3DS.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DPelleymounter%26aufirst%3DM.%2BA.%26aulast%3DWashburn%26aufirst%3DW.%2BN.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DDiscovery%2520of%2520Pyrazine%2520Carboxamide%2520CB1%2520Antagonists%253A%2520The%2520Introduction%2520of%2520a%2520Hydroxyl%2520Group%2520Improves%2520the%2520Pharmaceutical%2520Properties%2520and%2520In%2520Vivo%2520Efficacy%2520of%2520the%2520Series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3978%26epage%3D3982%26doi%3D10.1016%2Fj.bmcl.2007.04.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brajša, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivekovic, D.</span></span> <span> </span><span class="NLM_article-title">New Derivatives of Tylosin: Chemical and Electrochemical Oxidation Products of Desmycosin</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.55.807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.7164%2Fantibiotics.55.807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=12458770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFGrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2002&pages=807-813&author=Z.+Mandicauthor=A.+Narandaauthor=P.+Novakauthor=K.+Braj%C5%A1aauthor=M.+Derekauthor=D.+Ivekovic&title=New+Derivatives+of+Tylosin%3A+Chemical+and+Electrochemical+Oxidation+Products+of+Desmycosin&doi=10.7164%2Fantibiotics.55.807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">New derivatives of tylosin: chemical and electrochemical oxidation products of desmycosin</span></div><div class="casAuthors">Mandic, Z.; Naranda, A.; Novak, P.; Brajsa, K.; Derek, M.; Ivekovic, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">807-813</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Chem. and electrochem. oxidn. of dienonic moiety of desmycosin were carried out.  Successive chem. oxidn. of desmycosin with m-chloroperbenzoic acid afforded a family of 12,13-dihydro-12,13-dihydroxy derivs.  Indirect electrochem. oxidn. via hypobromite as an intermediate gave rise to the new bicyclo deriv. of desmycosin, 13-hydroxy-3-dehydroxy-3,12-oxa-desmycosin (I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZAakAAYyf0rVg90H21EOLACvtfcHk0ljuqrRXthbDQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFGrt70%253D&md5=004e04e7e82534ff099e36481ab20a87</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.55.807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.55.807%26sid%3Dliteratum%253Aachs%26aulast%3DMandic%26aufirst%3DZ.%26aulast%3DNaranda%26aufirst%3DA.%26aulast%3DNovak%26aufirst%3DP.%26aulast%3DBraj%25C5%25A1a%26aufirst%3DK.%26aulast%3DDerek%26aufirst%3DM.%26aulast%3DIvekovic%26aufirst%3DD.%26atitle%3DNew%2520Derivatives%2520of%2520Tylosin%253A%2520Chemical%2520and%2520Electrochemical%2520Oxidation%2520Products%2520of%2520Desmycosin%26jtitle%3DJ.%2520Antibiot.%26date%3D2002%26volume%3D55%26spage%3D807%26epage%3D813%26doi%3D10.7164%2Fantibiotics.55.807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopotar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivekovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkalcec, M.</span></span> <span> </span><span class="NLM_article-title">Tylosin Derivatives. V. Electrochemical Opening of Oxirane Ring</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1145</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.1143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.7164%2Fantibiotics.52.1143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10695679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1143-1145&author=Z.+Mandicauthor=A.+Narandaauthor=N.+Lopotarauthor=L.+Duicauthor=D.+Ivekovicauthor=M.+Tkalcec&title=Tylosin+Derivatives.+V.+Electrochemical+Opening+of+Oxirane+Ring&doi=10.7164%2Fantibiotics.52.1143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Tylosin derivatives V. Electrochemical opening of oxirane ring</span></div><div class="casAuthors">Mandic, Z.; Naranda, A.; Lopotar, N.; Duic, Lj.; Ivekovic, D.; Tkalcec, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1143-1145</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">The authors report the electrochem. redn. of 12,13-epoxy-12,13-dihydrotylosin at a mercury electrode.  The mechanism of redn. is investigated by cyclic voltammetry and preparative scale electrolysis is carried out for the isolation and identification of products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx8w-pKhG-B7Vg90H21EOLACvtfcHk0ljuqrRXthbDQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslGgtw%253D%253D&md5=4e5aa916f83be37483a85d4e77cd85bc</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.1143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.1143%26sid%3Dliteratum%253Aachs%26aulast%3DMandic%26aufirst%3DZ.%26aulast%3DNaranda%26aufirst%3DA.%26aulast%3DLopotar%26aufirst%3DN.%26aulast%3DDuic%26aufirst%3DL.%26aulast%3DIvekovic%26aufirst%3DD.%26aulast%3DTkalcec%26aufirst%3DM.%26atitle%3DTylosin%2520Derivatives.%2520V.%2520Electrochemical%2520Opening%2520of%2520Oxirane%2520Ring%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D1143%26epage%3D1145%26doi%3D10.7164%2Fantibiotics.52.1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jurva, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Generation of Drug Metabolites with Applications in Drug Discovery and Development</span>. <i>TrAC, Trends Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.trac.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.trac.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=92-99&author=U.+Jurvaauthor=L.+Weidolf&title=Electrochemical+Generation+of+Drug+Metabolites+with+Applications+in+Drug+Discovery+and+Development&doi=10.1016%2Fj.trac.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical generation of drug metabolites with applications in drug discovery and development</span></div><div class="casAuthors">Jurva, Ulrik; Weidolf, Lars</div><div class="citationInfo"><span class="NLM_cas:title">TrAC, Trends in Analytical Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-99</span>CODEN:
                <span class="NLM_cas:coden">TTAEDJ</span>;
        ISSN:<span class="NLM_cas:issn">0165-9936</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Detailed understanding of the biotransformation of drugs into stable or reactive metabolites is important during all stages of drug discovery and development.  Structural characterization of metabolites in the early stages allows for design of new mols. with, e.g., reduced metabolic clearance or decreased risk to form reactive metabolites.  In the later stages, detailed understanding of metabolic pathways is equally important for, e.g., safety assessment.  Over the past decade, we explored the potential of electrochem. (EC) in drug discovery and development.  One consequence of the mechanistic differences between EC and enzymic oxidns. is that some, but not all, metabolic pathways can be mimicked by EC.  We therefore conclude that EC cannot replace traditional metab. studies in biol. systems.  Instead, we see EC as a particularly useful complementary technique for synthesis of metabolite stds., investigations of bioactivation pathways, and study of interactions of reactive metabolites with biol. macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc-5rhXZnnErVg90H21EOLACvtfcHk0lgm0oWo4bbmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCjt7c%253D&md5=56d07d01b49d25ed7baca82cacdc5312</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.trac.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trac.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DJurva%26aufirst%3DU.%26aulast%3DWeidolf%26aufirst%3DL.%26atitle%3DElectrochemical%2520Generation%2520of%2520Drug%2520Metabolites%2520with%2520Applications%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DTrAC%252C%2520Trends%2520Anal.%2520Chem.%26date%3D2015%26volume%3D70%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.trac.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fődi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignácz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decsi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Béni, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Túrós, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiser, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszthy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, G. T.</span></span> <span> </span><span class="NLM_article-title">Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">9385</span>– <span class="NLM_lpage">9392</span>, <span class="refDoi"> DOI: 10.1002/chem.201800892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fchem.201800892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29736963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFalt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=9385-9392&author=T.+F%C5%91diauthor=G.+Ign%C3%A1czauthor=B.+Decsiauthor=Z.+B%C3%A9niauthor=G.+I.+T%C3%BAr%C3%B3sauthor=J.+Kupaiauthor=D.+B.+Weiserauthor=I.+Greinerauthor=P.+Huszthyauthor=G.+T.+Balogh&title=Biomimetic+Synthesis+of+Drug+Metabolites+in+Batch+and+Continuous-Flow+Reactors&doi=10.1002%2Fchem.201800892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors</span></div><div class="casAuthors">Fodi, Tamas; Ignacz, Gergo; Decsi, Balazs; Beni, Zoltan; Turos, Gyoergy I.; Kupai, Jozsef; Weiser, Diana Balogh; Greiner, Istvan; Huszthy, Peter; Balogh, Gyoergy T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9385-9392</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A medium-throughput screening (MTS) of biomimetic drug metabolite synthesis is developed by using an iron porphyrin catalyst.  The microplate method, in combination with HPLC-MS anal., was a useful tool for process development and parameter optimization in the prodn. of targeted metabolites and/or oxidn. products of forty-three different drug substances.  In the case of the biomimetic oxidn. of amiodarone, the high quantity and purity of the isolated products enabled detailed HRMS and NMR spectroscopic studies.  In addn. to identification of known metabolites, several new oxidn. products of the drug that was studied were characterized.  Fast degrdn. and poor recovery of the catalyst under batch conditions was overcome by immobilization of 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrin iron(III) chloride (FeTSPP) on the surface of 3-aminopropyl-functionalized silica by electrostatic interaction.  The supported catalyst was successfully applied in a packed-bed reactor under continuous-flow reaction conditions for the large-scale synthesis of amiodarone metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCv5flyf3P2bVg90H21EOLACvtfcHk0lgm0oWo4bbmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFalt7zJ&md5=d7b360c29349b507262409d5f112ec86</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201800892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201800892%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C5%2591di%26aufirst%3DT.%26aulast%3DIgn%25C3%25A1cz%26aufirst%3DG.%26aulast%3DDecsi%26aufirst%3DB.%26aulast%3DB%25C3%25A9ni%26aufirst%3DZ.%26aulast%3DT%25C3%25BAr%25C3%25B3s%26aufirst%3DG.%2BI.%26aulast%3DKupai%26aufirst%3DJ.%26aulast%3DWeiser%26aufirst%3DD.%2BB.%26aulast%3DGreiner%26aufirst%3DI.%26aulast%3DHuszthy%26aufirst%3DP.%26aulast%3DBalogh%26aufirst%3DG.%2BT.%26atitle%3DBiomimetic%2520Synthesis%2520of%2520Drug%2520Metabolites%2520in%2520Batch%2520and%2520Continuous-Flow%2520Reactors%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2018%26volume%3D24%26spage%3D9385%26epage%3D9392%26doi%3D10.1002%2Fchem.201800892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baglia, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaragoza, J. P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. P.</span></span> <span> </span><span class="NLM_article-title">Biomimetic Reactivity of Oxygen-Derived Manganese and Iron Porphyrinoid Complexes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">13320</span>– <span class="NLM_lpage">13352</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Wntb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=13320-13352&author=R.+A.+Bagliaauthor=J.+P.+T.+Zaragozaauthor=D.+P.+Goldberg&title=Biomimetic+Reactivity+of+Oxygen-Derived+Manganese+and+Iron+Porphyrinoid+Complexes&doi=10.1021%2Facs.chemrev.7b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic Reactivity of Oxygen-Derived Manganese and Iron Porphyrinoid Complexes</span></div><div class="casAuthors">Baglia, Regina A.; Zaragoza, Jan Paulo T.; Goldberg, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13320-13352</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review; heme proteins utilize the heme cofactor, an iron porphyrin, to perform a diverse range of reactions including dioxygen binding and transport, electron transfer, and oxidn./oxygenations.  These reactions share several key metalloporphyrin intermediates, typically derived from dioxygen and its congeners such as hydrogen peroxide.  These species are composed of metal-dioxygen, metal-superoxo, metal-peroxo, and metal-oxo adducts.  A wide variety of synthetic metalloporphyrinoid complexes have been synthesized to generate and stabilize these intermediates.  These complexes have been studied to det. the spectroscopic features, structures, and reactivities of such species in controlled and well-defined environments.  In this Review, we summarize recent findings on the reactivity of these species with common porphyrinoid scaffolds employed for biomimetic studies.  The proposed mechanisms of action are emphasized.  This Review is organized by structural type of metal-oxygen intermediate and broken into subsections based on the metal (manganese and iron) and porphyrinoid ligand (porphyrin, corrole, and corrolazine).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTYCfdgfpjJrVg90H21EOLACvtfcHk0lgm0oWo4bbmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Wntb%252FL&md5=5f122ca5811a8dd96927f32dc9c98e82</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00180%26sid%3Dliteratum%253Aachs%26aulast%3DBaglia%26aufirst%3DR.%2BA.%26aulast%3DZaragoza%26aufirst%3DJ.%2BP.%2BT.%26aulast%3DGoldberg%26aufirst%3DD.%2BP.%26atitle%3DBiomimetic%2520Reactivity%2520of%2520Oxygen-Derived%2520Manganese%2520and%2520Iron%2520Porphyrinoid%2520Complexes%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D13320%26epage%3D13352%26doi%3D10.1021%2Facs.chemrev.7b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit41c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, V. K.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-S.</span></span> <span> </span><span class="NLM_article-title">Selective Functionalisation of Saturated C–H Bonds with Metalloporphyrincatalysts</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1950</span>– <span class="NLM_lpage">1975</span>, <span class="refDoi"> DOI: 10.1039/c0cs00142b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1039%2Fc0cs00142b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21387046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFegsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=1950-1975&author=C.-M.+Cheauthor=V.+K.-Y.+Loauthor=C.-Y.+Zhouauthor=J.-S.+Huang&title=Selective+Functionalisation+of+Saturated+C%E2%80%93H+Bonds+with+Metalloporphyrincatalysts&doi=10.1039%2Fc0cs00142b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">Selective functionalisation of saturated C-H bonds with metalloporphyrin catalysts</span></div><div class="casAuthors">Che, Chi-Ming; Lo, Vanessa Kar-Yan; Zhou, Cong-Ying; Huang, Jie-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1950-1975</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This crit. review focused on metalloporphyrin-catalyzed satd. C-H bond functionalization reported since the year 2000, including C-O, C-N and C-C bond formation via hydroxylation, amination, and carbenoid insertion, resp., together with a brief description of previous achievements in this area.  Among the metalloporphyrin-catalyzed reactions highlighted herein are the hydroxylation of steroids, cycloalkanes, and benzylic hydrocarbons; intermol. amination of steroids, cycloalkanes, and benzylic or allylic hydrocarbons; intramol. amination of sulfamate esters and org. azides; intermol. carbenoid insertion into benzylic, allylic or alkane C-H bonds; and intramol. carbenoid C-H insertion of tosylhydrazones.  These metalloporphyrin-catalyzed satd. C-H bond functionalization reactions feature high regio-, diastereo- or enantioselectivity and/or high product turnover nos.  Mechanistic studies suggest the involvement of metal-oxo, -imido (or nitrene), and -carbene porphyrin complexes in the reactions.  The reactivity of such metal-ligand multiple bonded species towards satd. C-H bonds, including mechanistic studies through both exptl. and theor. means, is also discussed (244 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgRmpGNgIGbbVg90H21EOLACvtfcHk0lg9k6jhgQUQcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFegsb4%253D&md5=47eb169a66277be18fbfa3e38285ba60</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1039%2Fc0cs00142b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cs00142b%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DC.-M.%26aulast%3DLo%26aufirst%3DV.%2BK.-Y.%26aulast%3DZhou%26aufirst%3DC.-Y.%26aulast%3DHuang%26aufirst%3DJ.-S.%26atitle%3DSelective%2520Functionalisation%2520of%2520Saturated%2520C%25E2%2580%2593H%2520Bonds%2520with%2520Metalloporphyrincatalysts%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D1950%26epage%3D1975%26doi%3D10.1039%2Fc0cs00142b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Abid Masood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morao, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancy, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span> <span> </span><span class="NLM_article-title">Lead Diversification. Application to Existing Drug Molecules: Mifepristone 1 and Antalarmin 8</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.10.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2011.10.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=22104142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XivV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=723-728&author=M.+Abid+Masoodauthor=E.+Farrantauthor=I.+Moraoauthor=M.+Bazinauthor=M.+Perezauthor=M.+E.+Bunnageauthor=S.-A.+Fancyauthor=T.+Peakman&title=Lead+Diversification.+Application+to+Existing+Drug+Molecules%3A+Mifepristone+1+and+Antalarmin+8&doi=10.1016%2Fj.bmcl.2011.10.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Lead diversification. Application to existing drug molecules: Mifepristone 2 and antalarmin 8</span></div><div class="casAuthors">Abid Masood, M.; Farrant, Elizabeth; Morao, Inaki; Bazin, Marc; Perez, Manuel; Bunnage, Mark E.; Fancy, Sally-Ann; Peakman, Torren</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">723-728</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of C-H functionalization plate-based chem. screens and other C-H activation protocols were developed for the chem. diversification of drug mols.  In this Letter, metalloporphyrin and other catalytic oxidn. systems are described in addn. to chlorination.  Mifepristone and antalarmin are used as substrates.  The products obtained and the biol. data demonstrate the potential utility of this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQ8bpgUtDZ7Vg90H21EOLACvtfcHk0lg9k6jhgQUQcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivV2isQ%253D%253D&md5=37b5441091b585585a19428e1b8f20e2</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.10.066%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%2BMasood%26aufirst%3DM.%26aulast%3DFarrant%26aufirst%3DE.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DBazin%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DFancy%26aufirst%3DS.-A.%26aulast%3DPeakman%26aufirst%3DT.%26atitle%3DLead%2520Diversification.%2520Application%2520to%2520Existing%2520Drug%2520Molecules%253A%2520Mifepristone%25201%2520and%2520Antalarmin%25208%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D723%26epage%3D728%26doi%3D10.1016%2Fj.bmcl.2011.10.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Masood, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancy, S.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitzel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, T.</span></span> <span> </span><span class="NLM_article-title">Lead Diversification 2: Application to P38, gMTP and Lead Compounds</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.bmcl.2011.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=22172703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1255-1262&author=M.+A.+Masoodauthor=M.+Bazinauthor=M.+E.+Bunnageauthor=A.+Calabreseauthor=M.+Coxauthor=S.-A.+Fancyauthor=E.+Farrantauthor=D.+W.+Pearceauthor=M.+Perezauthor=L.+Hitzelauthor=T.+Peakman&title=Lead+Diversification+2%3A+Application+to+P38%2C+gMTP+and+Lead+Compounds&doi=10.1016%2Fj.bmcl.2011.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Diversification 2: Application to P38, gMTP and lead compounds</span></div><div class="casAuthors">Masood, M. Abid; Bazin, Marc; Bunnage, Mark E.; Calabrese, Andrew; Cox, Mark; Fancy, Sally-Ann; Farrant, Elizabeth; Pearce, David W.; Perez, Manuel; Hitzel, Laure; Peakman, Torren</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1255-1262</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lead Diversification is a new technol. platform developed at Pfizer for the functionalization of drug mols. using C-H activation.  We describe its application to some drug programs such as P38 and gMTP and the development of some new plate based screens including a fluorination screen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaEWGowjCGerVg90H21EOLACvtfcHk0lg9k6jhgQUQcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFartA%253D%253D&md5=2437212fcc6cde93ac62ddf669cd8d95</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DMasood%26aufirst%3DM.%2BA.%26aulast%3DBazin%26aufirst%3DM.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DM.%26aulast%3DFancy%26aufirst%3DS.-A.%26aulast%3DFarrant%26aufirst%3DE.%26aulast%3DPearce%26aufirst%3DD.%2BW.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DHitzel%26aufirst%3DL.%26aulast%3DPeakman%26aufirst%3DT.%26atitle%3DLead%2520Diversification%25202%253A%2520Application%2520to%2520P38%252C%2520gMTP%2520and%2520Lead%2520Compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1255%26epage%3D1262%26doi%3D10.1016%2Fj.bmcl.2011.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murahashi, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirabayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komiya, N.</span></span> <span> </span><span class="NLM_article-title">Manganese-Catalyzed Enantioselective Oxidation of C–H Bonds of Alkanes and Silyl Ethers to Optically Active Ketones</span>. <i>Tetrahedron: Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3527</span>– <span class="NLM_lpage">3535</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2005.08.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2Fj.tetasy.2005.08.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1GitbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=3527-3535&author=S.+I.+Murahashiauthor=S.+Nojiauthor=T.+Hirabayashiauthor=N.+Komiya&title=Manganese-Catalyzed+Enantioselective+Oxidation+of+C%E2%80%93H+Bonds+of+Alkanes+and+Silyl+Ethers+to+Optically+Active+Ketones&doi=10.1016%2Fj.tetasy.2005.08.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Manganese-catalyzed enantioselective oxidation of C-H bonds of alkanes and silyl ethers to optically active ketones</span></div><div class="casAuthors">Murahashi, Shun-Ichi; Noji, Satoru; Hirabayashi, Tatsuo; Komiya, Naruyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3527-3535</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The (salen)manganese(III) complex-catalyzed oxidn. of C-H bonds of sym. alkanes and sym. 1,3- and 1,4-disilyl ethers with iodosylbenzene gave the corresponding optically active ketones (≤ 70% ee) and β- and γ-siloxy ketones (≤ 93% ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0e4HI2JX17Vg90H21EOLACvtfcHk0ljPIf8ongVu_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1GitbzP&md5=4210b99108dc91ea5a61ff80feb4fac4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2005.08.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2005.08.056%26sid%3Dliteratum%253Aachs%26aulast%3DMurahashi%26aufirst%3DS.%2BI.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DHirabayashi%26aufirst%3DT.%26aulast%3DKomiya%26aufirst%3DN.%26atitle%3DManganese-Catalyzed%2520Enantioselective%2520Oxidation%2520of%2520C%25E2%2580%2593H%2520Bonds%2520of%2520Alkanes%2520and%2520Silyl%2520Ethers%2520to%2520Optically%2520Active%2520Ketones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2005%26volume%3D16%26spage%3D3527%26epage%3D3535%26doi%3D10.1016%2Fj.tetasy.2005.08.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernadou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, B.</span></span> <span> </span><span class="NLM_article-title">Biomimetic Chemical Catalysts in the Oxidative Activation of Drugs</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1002/adsc.200303191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fadsc.200303191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1ensb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2004&pages=171-184&author=J.+Bernadouauthor=B.+Meunier&title=Biomimetic+Chemical+Catalysts+in+the+Oxidative+Activation+of+Drugs&doi=10.1002%2Fadsc.200303191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic chemical catalysts in the oxidative activation of drugs</span></div><div class="casAuthors">Bernadou, Jean; Meunier, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">2+3</span>),
    <span class="NLM_cas:pages">171-184</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  An overview of the biomimetic catalysts used in the oxidative activation of drugs is given, with an emphasis on the use of synthetic metalloporphyrins as models of cytochrome P 450 to mimic the in vivo metab. of pharmaceuticals.  In addn., a special focus is directed towards the recent results from the authors' group on the oxidative activation of isoniazid, an antitubercular drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeyVJ-gPZePrVg90H21EOLACvtfcHk0ljPIf8ongVu_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1ensb0%253D&md5=f42510049c4ee8e0a498d9d2028cf6ed</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200303191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200303191%26sid%3Dliteratum%253Aachs%26aulast%3DBernadou%26aufirst%3DJ.%26aulast%3DMeunier%26aufirst%3DB.%26atitle%3DBiomimetic%2520Chemical%2520Catalysts%2520in%2520the%2520Oxidative%2520Activation%2520of%2520Drugs%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2004%26volume%3D346%26spage%3D171%26epage%3D184%26doi%3D10.1002%2Fadsc.200303191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Frontier Scientific</span> <i>Pure and (not so) simple</i>; <a href="http://www.frontiersci.com/" class="extLink">http://www.frontiersci.com/</a> (accessed Jul 2, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Frontier+Scientific+Pure+and+%28not+so%29+simple%3B+http%3A%2F%2Fwww.frontiersci.com%2F+%28accessed+Jul+2%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DPure%2520and%2520%2528not%2520so%2529%2520simple" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="note"><p class="first last">Product (<i>m/z</i> 413c (M + 32) was also observed by HPLC–MS in the BM3 screen by variants MCYP0012, MCYP0036, MCYP0052, MCYP0057, and MCYP-P1.2-A07.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span> <i>TCI 1.7 mm MicroCryoProbe</i>. <a href="https://www.bruker.com/products/mr/nmr/probes/cryoprobes/microcryoprobe.html" class="extLink">https://www.bruker.com/products/mr/nmr/probes/cryoprobes/microcryoprobe.html</a> (accessed June 7, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+TCI+1.7+mm+MicroCryoProbe.+https%3A%2F%2Fwww.bruker.com%2Fproducts%2Fmr%2Fnmr%2Fprobes%2Fcryoprobes%2Fmicrocryoprobe.html+%28accessed+June+7%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DTCI%25201.7%2520mm%2520MicroCryoProbe" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, D. C.</span></span> <span> </span><span class="NLM_article-title">Survey of ERETIC2 NMR for Quantification</span>. <i>J. Korean Magn. Reson. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.6564/JKMRS.2013.17.2.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.6564%2FJKMRS.2013.17.2.098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=98-104&author=R.+S.+Hongauthor=K.+H.+Hwangauthor=S.+Kimauthor=H.+E.+Choauthor=H.+J.+Leeauthor=J.+T.+Hongauthor=D.+C.+Moon&title=Survey+of+ERETIC2+NMR+for+Quantification&doi=10.6564%2FJKMRS.2013.17.2.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.6564%2FJKMRS.2013.17.2.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6564%252FJKMRS.2013.17.2.098%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DR.%2BS.%26aulast%3DHwang%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DH.%2BE.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DJ.%2BT.%26aulast%3DMoon%26aufirst%3DD.%2BC.%26atitle%3DSurvey%2520of%2520ERETIC2%2520NMR%2520for%2520Quantification%26jtitle%3DJ.%2520Korean%2520Magn.%2520Reson.%2520Soc.%26date%3D2013%26volume%3D17%26spage%3D98%26epage%3D104%26doi%3D10.6564%2FJKMRS.2013.17.2.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, A. K.</span></span> <span> </span><span class="NLM_article-title">Hydroxylated Metabolites of Loratadine: An Example of Conformational Diastereomers Due to Atropisomerism</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3341</span>– <span class="NLM_lpage">3350</span>, <span class="refDoi"> DOI: 10.1021/jo00297a065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00297a065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK3cXitFKlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=3341-3350&author=J.+J.+Piwinskiauthor=J.+K.+Wongauthor=T.+M.+Chanauthor=M.+J.+Greenauthor=A.+K.+Ganguly&title=Hydroxylated+Metabolites+of+Loratadine%3A+An+Example+of+Conformational+Diastereomers+Due+to+Atropisomerism&doi=10.1021%2Fjo00297a065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxylated metabolites of loratadine:  an example of conformational diastereomers due to atropisomerism</span></div><div class="casAuthors">Piwinski, John J.; Wong, Jesse K.; Chan, Tze Ming; Green, Michael J.; Ganguly, Ashit K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3341-50</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The structures of two metabolites of the nonsedating antihistamine loratadine were confirmed by synthesis.  The metabolites I (R = H, R1 = OH; R = OH, R1 = H) were prepd. from tricyclic ketone II in seven steps.  Each of these compds. exist as a pair of conformational diastereomers which interconvert slowly at room temp.  These conformers arise due to the restricted conformational mobility inherent to the diaryl[a,d]cycloheptane ring system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMQum_KO-t9LVg90H21EOLACvtfcHk0ljPIf8ongVu_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFKlt7w%253D&md5=a9fe6a4632a582ce5cea198b78b6ee5e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo00297a065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00297a065%26sid%3Dliteratum%253Aachs%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26aulast%3DWong%26aufirst%3DJ.%2BK.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DGanguly%26aufirst%3DA.%2BK.%26atitle%3DHydroxylated%2520Metabolites%2520of%2520Loratadine%253A%2520An%2520Example%2520of%2520Conformational%2520Diastereomers%2520Due%2520to%2520Atropisomerism%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D3341%26epage%3D3350%26doi%3D10.1021%2Fjo00297a065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Jean, D. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6020</span>, <span class="refDoi"> DOI: 10.1021/jm300343m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&author=D.+J.+St.%0AJeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery&doi=10.1021%2Fjm300343m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0lj67WBWDX6qXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6002%26epage%3D6020%26doi%3D10.1021%2Fjm300343m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyderman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulmatycki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alton, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Statkevich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, J. E.</span></span> <span> </span><span class="NLM_article-title">Disposition of Loratadine in Healthy Volunteers</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">769</span>, <span class="refDoi"> DOI: 10.1080/00498250701463317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1080%2F00498250701463317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=753-769&author=R.+Ramanathanauthor=L.+Reydermanauthor=K.+Kulmatyckiauthor=A.-D.+Suauthor=N.+Alvarezauthor=S.+K.+Chowdhuryauthor=K.+B.+Altonauthor=M.+A.+Wirthauthor=R.+P.+Clementauthor=P.+Statkevichauthor=J.+E.+Patrick&title=Disposition+of+Loratadine+in+Healthy+Volunteers&doi=10.1080%2F00498250701463317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1080%2F00498250701463317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250701463317%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DR.%26aulast%3DReyderman%26aufirst%3DL.%26aulast%3DKulmatycki%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DA.-D.%26aulast%3DAlvarez%26aufirst%3DN.%26aulast%3DChowdhury%26aufirst%3DS.%2BK.%26aulast%3DAlton%26aufirst%3DK.%2BB.%26aulast%3DWirth%26aufirst%3DM.%2BA.%26aulast%3DClement%26aufirst%3DR.%2BP.%26aulast%3DStatkevich%26aufirst%3DP.%26aulast%3DPatrick%26aufirst%3DJ.%2BE.%26atitle%3DDisposition%2520of%2520Loratadine%2520in%2520Healthy%2520Volunteers%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D37%26spage%3D753%26epage%3D769%26doi%3D10.1080%2F00498250701463317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">See, S.</span></span> <span> </span><span class="NLM_article-title">Desloratadine for Allergic Rhinitis</span>. <i>Am. Fam. Physician</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2015</span>– <span class="NLM_lpage">2016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=14655812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BD3srntl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=2015-2016&author=S.+See&title=Desloratadine+for+Allergic+Rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52aR"><div class="casContent"><span class="casTitleNuber">52a</span><div class="casTitle"><span class="NLM_cas:atitle">Desloratadine for allergic rhinitis</span></div><div class="casAuthors">See Sharon</div><div class="citationInfo"><span class="NLM_cas:title">American family physician</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2015-6</span>
        ISSN:<span class="NLM_cas:issn">0002-838X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAe2RuMd0aiEPI-fCgwosgfW6udTcc2ea59dF2q_h257ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srntl2gtw%253D%253D&md5=cb4348d12859dfbc4f18c86ff56f8333</span></div><a href="/servlet/linkout?suffix=cit52a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSee%26aufirst%3DS.%26atitle%3DDesloratadine%2520for%2520Allergic%2520Rhinitis%26jtitle%3DAm.%2520Fam.%2520Physician%26date%3D2003%26volume%3D68%26spage%3D2015%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit52b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, F. E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prenner, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fin, A.,  Jr.</span></span>; <span class="NLM_contrib-group">Desloratadine Study Group</span> <span> </span><span class="NLM_article-title">Efficacy and Safety of Desloratadine in the Treatment of Perennial Allergic Rhinitis</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1067/mai.2003.168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1067%2Fmai.2003.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=12642846" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2003&pages=617-622&author=F.+E.+R.+Simonauthor=B.+M.+Prennerauthor=A.+Finauthor=Desloratadine+Study+Group&title=Efficacy+and+Safety+of+Desloratadine+in+the+Treatment+of+Perennial+Allergic+Rhinitis&doi=10.1067%2Fmai.2003.168"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52b&amp;dbid=16384&amp;doi=10.1067%2Fmai.2003.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2003.168%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DF.%2BE.%2BR.%26aulast%3DPrenner%26aufirst%3DB.%2BM.%26aulast%3DFin%26aufirst%3DA.%26aulast%3D%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520Desloratadine%2520in%2520the%2520Treatment%2520of%2520Perennial%2520Allergic%2520Rhinitis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2003%26volume%3D111%26spage%3D617%26epage%3D622%26doi%3D10.1067%2Fmai.2003.168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkop, B.</span></span> <span> </span><span class="NLM_article-title">Rearrangements of Dehydroproline Derivatives</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1715</span>, <span class="refDoi"> DOI: 10.1021/ja00868a043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00868a043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaF38XktlKhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1962&pages=1709-1715&author=A.+V.+Robertsonauthor=J.+E.+Francisauthor=B.+Witkop&title=Rearrangements+of+Dehydroproline+Derivatives&doi=10.1021%2Fja00868a043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Rearrangements of dehydroproline derivatives</span></div><div class="casAuthors">Robertson, Alexander V.; Francis, John E.; Witkop, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1709-15</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. ibid. 1702-9. With 2 moles N-bromosuccinimide (I) at pH 7-9, N-carbobenzyloxy-3,4dehydro-DL-prolinamide (II) was converted to N-carbobenzyloxy-2,5-dihydroxy-Δ3-pyrroline (III).  The postulated mechanism for the reaction involved Hofmann rearrangement, C-bromination, and hydrolysis.  II with alkali yielded 3,4-dehydro-DL-proline hydantoin (IV).  The position of the double bond in the product was established by nuclear magnetic resonance measurements and by retention of optical activity with L-II.  N-(p-Tolylsulfonyl)-3,4dehydroproline Me ester (V) with NaOMe gave Me pyrrole2-carboxylate (VI).  3,4-Dehydro-DL-proline (VII) with MeI and NaOH yielded 2,3-dehydro-DL-stachydrine (VIII).  With Ag2O, the methylation was accomplished without migration of the double bond.  II(4.0g.), 152. Na2HPO4, 120 ml. MeCN, and 400 ml. H2O stirred and treated portionwise with 6.0 g. I gave 15.0 millimoles NH3 (ninhydrin analysis) and 62% III, m. 81-2° (EtOAc-cyclohexane), or after storage 122-4°, characterized by infrared, ultraviolet, and nuclear magnetic resonance analysis.  The 2 forms showed minor differences in the infrared and nuclear magnetic resonance spectra.  III diacetate (IX), prepd. with Ac2O in C5H5N, m. 94-5° (ether-cyclohexane).  IX gave a higher acetyl value than calcd., owing to decompn. of III to volatile acids during analysis.  III (1 g.) in CHCl3 and 10 g. MnO2 stirred 3 days and the product hydrogenated over Pd gave 108 mg. succinimide.  III (2 g.) in tetrahydrofuran treated with 400 mg. LiBH4 yielded 780 mg. benzyl carbamate, m. 82-4° (ether-hexane).  III (2 g.) in AcOH and 1.2 g. CrO3 in H2O cooled and kept 1 hr.gave 90 mg. N-carbobenzyloxymaleamic acid, m. 150-1° (C6H6), hydrogenated over Pd to succinamic acid, m, 152-5° (EtOH).  II (500 mg.) and 10 ml. N NaOH heated on a steam bath yielded 117 mg. IV m. 153-4° (C6H6), also prepd. from VII and KCNO.  L-VII and KCNO gave L-IV, [α]20D - 191° (EtOH), hydrogenated over Pd to L-proline hydantoin, [α]20D -128° (EtOH).  V (281 mg.) and 5 ml. N NaOMe in MeOH refluxed 1 hr. gave, with elimination of p-toluenesulfinate, 115 mg. VI, m. 71.53°.  N-Benzoyldehydro-DL-proline Me ester (IXa) with NaOMe yielded N-benzoyldehydroproline. N-(p-Tolylsulfonyl)-3,4-dehydro-DL-prolinamide and N-(p-tolylsulfonyl)-3,4-dehydro-DL-prolylglycine, but not N-(p-tolylsulfonyl)-3,4-dehydroproline with aq. NaOH were aromatized, as indicated by the appearance of an ultraviolet peak at 265 mμ.  VII (5.0 g.) in MeOH with dry HCl at 4° gave 5.67 g. Me ester hydrochloride, m. 134-6° (sublimed), which (682 mg.) in 10 ml. C5H5N at 60° with 1.7 g. p-phenylazobenzoyl chloride gave 345 mg. orange powder, m. above 260°, and red p-phenylazobenzoyldehydro-DL-proline Meester (X), m. 112-14° (Me2CO-ether).  X with NH3 in MeOH gave 81% orange-red amide, m. 204.5° (MeOH-Me2CO).  Neither aromatization or migration of the double bond in IXa or X could be induced, even with NaH in refluxing toluene.  DL-Proline Me ester hydrochloride m. 121-2.5° (MeOH-C6H6). p-Phenylazobenzoyl-DL-proline Me ester, m. 104-6°.  VII(1.3 g.), 1.3 g. NaOH, 20ml. MeOH, and 3 ml. MeI refluxed 24 hrs. with addnl. portions of MeI yielded VIII, isolated as the hydrochloride, m. 180-2° (decompn.) (MeOH-Me2CO).  VIII picrate m. 173-5°. Hydrogenation of VIII.HCl in H2O over Adams catalyst gave DL-stachydrine, isolated as the picrate, m. 190-2° (decompn.) (197-8° prepd. from DL-proline).  VII (1.0 g.), 2.00 g. Ag2O, and 20 ml. anhyd. MeOH agitated 30 min., treated with 6 ml. MeI, and stirred 1 hr. gave 3,4-dehydro-DL-stachydrine (XI), sepd. as 1.68 g. picrate, m. 140-1° and 173-5° (EtOH).  XI.HCl m. 180-2° (decompn.) (MeOHMe2CO).  XI picrate heated to 150° yielded VIII picrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlv2zQOkTAI7Vg90H21EOLACvtfcHk0lj67WBWDX6qXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38XktlKhsbo%253D&md5=925a208bab5d066f4c36e967c0bba0c6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja00868a043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00868a043%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DA.%2BV.%26aulast%3DFrancis%26aufirst%3DJ.%2BE.%26aulast%3DWitkop%26aufirst%3DB.%26atitle%3DRearrangements%2520of%2520Dehydroproline%2520Derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1962%26volume%3D84%26spage%3D1709%26epage%3D1715%26doi%3D10.1021%2Fja00868a043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="note"><p class="first last">Stereoconfiguration of analogue <b>7</b> in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> is represented by ethyl (2<i>R</i>,6<i>S</i>,<i>E</i>)-4-(8-chloro-5,6-dihydro-11<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]pyridin-11-ylidene)-2,6-dihydroxypiperidine-1-carboxylate. The other hydroxyl stereoisomers of analogue <b>7</b> were docked against CYP2D6 and show similar out-of-range protein–ligand docks, as shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, placing the methylene hydrogen of the ethyl carbamate portion of the molecule >13 Å from the iron(IV)-oxo porphyrin radical cation in the CYP active site.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, A. H.</span></span> <span> </span><span class="NLM_article-title"><i>N,N</i>-Diethylaminosulfur Trifluoride</span>. In  <i>Encyclopedia of Reagents for Organic Synthesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquette, L. A.</span></span> Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1995</span>, Volume  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1790</span>, <span class="refDoi"> DOI: 10.1002/047084289X.rd175</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2F047084289X.rd175" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=1787-1790&author=A.+H.+Fauqauthor=L.+A.+Paquette&title=Encyclopedia+of+Reagents+for+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2F047084289X.rd175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F047084289X.rd175%26sid%3Dliteratum%253Aachs%26aulast%3DFauq%26aufirst%3DA.%2BH.%26atitle%3DN%252CN-Diethylaminosulfur%2520Trifluoride%26btitle%3DEncyclopedia%2520of%2520Reagents%2520for%2520Organic%2520Synthesis%26aulast%3DPaquette%26aufirst%3DL.%2BA.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1995%26volume%3D3%26spage%3D1787%26epage%3D1790%26doi%3D10.1002%2F047084289X.rd175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwell, A. D.</span></span> <span> </span><span class="NLM_article-title">The Role of Fluorine in Medicinal Chemistry</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1080/14756360701425014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1080%2F14756360701425014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=18035820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjtr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=527-540&author=P.+Shahauthor=A.+D.+Westwell&title=The+Role+of+Fluorine+in+Medicinal+Chemistry&doi=10.1080%2F14756360701425014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The role of fluorine in medicinal chemistry</span></div><div class="casAuthors">Shah, Poonam; Westwell, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">527-540</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The small and highly electroneg. fluorine atom can play a remarkable role in medicinal chem.  Selective installation of fluorine into a therapeutic or diagnostic small mol. candidate can enhance a no. of pharmacokinetic and physicochem. properties such as improved metabolic stability and enhanced membrane permeation.  Increased binding affinity of fluorinated drug candidates to target protein has also been documented in a no. of cases.  A further emerging application of the fluorine atom is the use of 18F as a radiolabel tracer atom in the exquisitely sensitive technique of Positron Emission Tomog. (PET) imaging.  This short review aims to bring together these various aspects of the use of fluorine in medicinal chem. applications, citing selected examples from across a variety of therapeutic and diagnostic settings.  The increasingly routine incorporation of fluorine atom(s) into drug candidates suggests a bright future for fluorine in drug discovery and development.  A major challenge moving forward will be how and where to install fluorine in a rational sense to best optimize mol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzZnKkEoXeFLVg90H21EOLACvtfcHk0lhfbpzpDuqvaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjtr%252FI&md5=58bc1c42a7525b66772967543256a7d2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1080%2F14756360701425014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360701425014%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DP.%26aulast%3DWestwell%26aufirst%3DA.%2BD.%26atitle%3DThe%2520Role%2520of%2520Fluorine%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2007%26volume%3D22%26spage%3D527%26epage%3D540%26doi%3D10.1080%2F14756360701425014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Roselló, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aceña, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorochinsky, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fustero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloshonok, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">2432</span>– <span class="NLM_lpage">2506</span>, <span class="refDoi"> DOI: 10.1021/cr4002879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4002879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2432-2506&author=J.+Wangauthor=M.+S%C3%A1nchez-Rosell%C3%B3author=J.+L.+Ace%C3%B1aauthor=C.+Del+Pozoauthor=A.+E.+Sorochinskyauthor=S.+Fusteroauthor=V.+A.+Soloshonokauthor=H.+Liu&title=Fluorine+in+Pharmaceutical+Industry%3A+Fluorine-Containing+Drugs+Introduced+to+the+Market+in+the+Last+Decade+%282001%E2%80%932011%29&doi=10.1021%2Fcr4002879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001-2011)</span></div><div class="casAuthors">Wang, Jiang; Sanchez-Rosello, Maria; Acena, Jose Luis; del Pozo, Carlos; Sorochinsky, Alexander E.; Fustero, Santos; Soloshonok, Vadim A.; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2432-2506</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A historic review.  As expected from the fluorine position on the periodic table of elements, it possesses some extreme properties, in particular, ultimate electronegativity and oxidn. potential.  Therefore,elemental fluorine can not be prepd. by chem. reaction, and its isolation in 1886 by Henri Moissan required scientific ingenuity and great personal courage.  His historic effort earned him a Noble Prize (1906), and the developed electrolysis method is still in use for industrial prodn. of fluorine gas.  However, further development of fluorine chem. was extremely sluggish, pursued by a handful of experts capable of handling the violent gas using specially designed lab. equipment.  Industrial-scale prodn. of fluorochems. dates back to late 1930s.  Currently, there are about 200 pharmaceuticals containingfluorine, including the 40 new compds. discussed in this review.  One may agree that the contribution of the past decade indicates a significant 20% increase in the no. of fluorinated drugs on the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTzcNC3MEA7Vg90H21EOLACvtfcHk0lhfbpzpDuqvaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I&md5=07faac419cd090503e82c6f00d05c338</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fcr4002879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4002879%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez-Rosell%25C3%25B3%26aufirst%3DM.%26aulast%3DAce%25C3%25B1a%26aufirst%3DJ.%2BL.%26aulast%3DDel%2BPozo%26aufirst%3DC.%26aulast%3DSorochinsky%26aufirst%3DA.%2BE.%26aulast%3DFustero%26aufirst%3DS.%26aulast%3DSoloshonok%26aufirst%3DV.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DFluorine%2520in%2520Pharmaceutical%2520Industry%253A%2520Fluorine-Containing%2520Drugs%2520Introduced%2520to%2520the%2520Market%2520in%2520the%2520Last%2520Decade%2520%25282001%25E2%2580%25932011%2529%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2432%26epage%3D2506%26doi%3D10.1021%2Fcr4002879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span> <i>Baran Diversinates</i>; <a href="https://www.sigmaaldrich.com/chemistry/chemistry-products.html?TablePage=113932507" class="extLink">https://www.sigmaaldrich.com/chemistry/chemistry-products.html?TablePage=113932507</a> (accessed Aug 26, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Baran+Diversinates%3B+https%3A%2F%2Fwww.sigmaaldrich.com%2Fchemistry%2Fchemistry-products.html%3FTablePage%3D113932507+%28accessed+Aug+26%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DBaran%2520Diversinates" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lgNctgnt_zxJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiRocco, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykstra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudge, M.</span></span> <span> </span><span class="NLM_article-title">Late-Stage Functionalization of Biologically Active Heterocycles Through Photoredox Catalysis</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4802</span>– <span class="NLM_lpage">4806</span>, <span class="refDoi"> DOI: 10.1002/anie.201402023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201402023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4802-4806&author=D.+A.+DiRoccoauthor=K.+Dykstraauthor=S.+Krskaauthor=P.+Vachalauthor=D.+V.+Conwayauthor=M.+Tudge&title=Late-Stage+Functionalization+of+Biologically+Active+Heterocycles+Through+Photoredox+Catalysis&doi=10.1002%2Fanie.201402023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60aR"><div class="casContent"><span class="casTitleNuber">60a</span><div class="casTitle"><span class="NLM_cas:atitle">Late-stage functionalization of biologically active heterocycles through photoredox catalysis</span></div><div class="casAuthors">Dirocco Daniel A; Dykstra Kevin; Krska Shane; Vachal Petr; Conway Donald V; Tudge Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4802-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The direct C H functionalization of heterocycles has become an increasingly valuable tool in modern drug discovery.  However, the introduction of small alkyl groups, such as methyl, by this method has not been realized in the context of complex molecule synthesis since existing methods rely on the use of strong oxidants and elevated temperatures to generate the requisite radical species.  Herein, we report the use of stable organic peroxides activated by visible-light photoredox catalysis to achieve the direct methyl-, ethyl-, and cyclopropylation of a variety of biologically active heterocycles.  The simple protocol, mild reaction conditions, and unique tolerability of this method make it an important tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmAsN0YQNtXD69zv1FsJFMfW6udTcc2eY_0hZCqH_pfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crotFCnsQ%253D%253D&md5=ca31296d61c97e944eaaf326a8190458</span></div><a href="/servlet/linkout?suffix=cit60a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402023%26sid%3Dliteratum%253Aachs%26aulast%3DDiRocco%26aufirst%3DD.%2BA.%26aulast%3DDykstra%26aufirst%3DK.%26aulast%3DKrska%26aufirst%3DS.%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DConway%26aufirst%3DD.%2BV.%26aulast%3DTudge%26aufirst%3DM.%26atitle%3DLate-Stage%2520Functionalization%2520of%2520Biologically%2520Active%2520Heterocycles%2520Through%2520Photoredox%2520Catalysis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4802%26epage%3D4806%26doi%3D10.1002%2Fanie.201402023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit60b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. L.</span></span> <span> </span><span class="NLM_article-title">Introduction of Functionality into Unactivated Carbon-Hydrogen Bonds. Catalytic Generation and Nonconventional Utilization of Organic Radicals</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1055/s-1995-4883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1055%2Fs-1995-4883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK2MXkt1ymsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=127-132&author=C.+L.+Hill&title=Introduction+of+Functionality+into+Unactivated+Carbon-Hydrogen+Bonds.+Catalytic+Generation+and+Nonconventional+Utilization+of+Organic+Radicals&doi=10.1055%2Fs-1995-4883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60bR"><div class="casContent"><span class="casTitleNuber">60b</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of functionality into unactivated carbon-hydrogen bonds. Catalytic generation and nonconventional utilization of organic radicals</span></div><div class="casAuthors">Hill, Craig L.</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-32</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Thieme</span>)
        </div><div class="casAbstract">A review with 50 refs.  Alkanes and other unactivated C-H bond substrates can be catalytically transformed by an emerging class of versatile inorg. clusters called polyoxometalates under economically and environmentally attractive conditions.  "Catalytic" radical generation and redox trapping of alkyl radicals by polyoxometalates in controlled sequences affords routes for the dehydrogenation, alkylation, vinylation, carbonylation and acylation of alkanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD2RlymMIuVrVg90H21EOLACvtfcHk0lgNctgnt_zxJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkt1ymsro%253D&md5=e8d4eb0c734161dc70a427cd2d8a652b</span></div><a href="/servlet/linkout?suffix=cit60b&amp;dbid=16384&amp;doi=10.1055%2Fs-1995-4883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1995-4883%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DC.%2BL.%26atitle%3DIntroduction%2520of%2520Functionality%2520into%2520Unactivated%2520Carbon-Hydrogen%2520Bonds.%2520Catalytic%2520Generation%2520and%2520Nonconventional%2520Utilization%2520of%2520Organic%2520Radicals%26jtitle%3DSynlett%26date%3D1995%26spage%3D127%26epage%3D132%26doi%3D10.1055%2Fs-1995-4883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">A Scalable and Operationally Simple Radical Trifluoromethylation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">7919</span>, <span class="refDoi"> DOI: 10.1038/ncomms8919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1038%2Fncomms8919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=26258541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=7919&author=J.+W.+Beattyauthor=J.+J.+Douglasauthor=K.+P.+Coleauthor=C.+R.+J.+Stephenson&title=A+Scalable+and+Operationally+Simple+Radical+Trifluoromethylation&doi=10.1038%2Fncomms8919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61aR"><div class="casContent"><span class="casTitleNuber">61a</span><div class="casTitle"><span class="NLM_cas:atitle">A scalable and operationally simple radical trifluoromethylation</span></div><div class="casAuthors">Beatty, Joel W.; Douglas, James J.; Cole, Kevin P.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7919pp.</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The large no. of reagents that was developed for the synthesis of trifluoromethylated compds. was a testament to the importance of the CF3 group as well as the assocd. synthetic challenge.  Current state-of-the-art reagents for appending the CF3 functionality directly were highly effective; however, their use on preparative scale had minimal precedent because they required multistep synthesis for their prepn., and/or were prohibitively expensive for large-scale application.  For a scalable trifluoromethylation methodol., trifluoroacetic acid and its anhydride represented an attractive soln. in terms of cost and availability; however, because of the exceedingly high oxidn. potential of trifluoroacetate, previous endeavours to use this material as a CF3 source was required the use of highly forcing conditions.  A strategy for the use of trifluoroacetic anhydride for a scalable and operationally simple trifluoromethylation reaction using pyridine N-oxide and photoredox catalysis to affect a facile decarboxylation to the CF3 radical was reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwV3yU4_bd1rVg90H21EOLACvtfcHk0ljmK7MaK18UQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtbrI&md5=7f3391941db196735dfe808c21b7b602</span></div><a href="/servlet/linkout?suffix=cit61a&amp;dbid=16384&amp;doi=10.1038%2Fncomms8919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms8919%26sid%3Dliteratum%253Aachs%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DDouglas%26aufirst%3DJ.%2BJ.%26aulast%3DCole%26aufirst%3DK.%2BP.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DA%2520Scalable%2520and%2520Operationally%2520Simple%2520Radical%2520Trifluoromethylation%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D7919%26doi%3D10.1038%2Fncomms8919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit61b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, C. R. J.</span></span> <span> </span><span class="NLM_article-title">Visible Light-Mediated Decarboxylative Alkylation of Pharmaceutically Relevant Heterocycles</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3487</span>– <span class="NLM_lpage">3490</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b01250</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b01250" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCrsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=3487-3490&author=A.+C.+Sunauthor=E.+J.+McClainauthor=J.+W.+Beattyauthor=C.+R.+J.+Stephenson&title=Visible+Light-Mediated+Decarboxylative+Alkylation+of+Pharmaceutically+Relevant+Heterocycles&doi=10.1021%2Facs.orglett.8b01250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61bR"><div class="casContent"><span class="casTitleNuber">61b</span><div class="casTitle"><span class="NLM_cas:atitle">Visible Light-Mediated Decarboxylative Alkylation of Pharmaceutically Relevant Heterocycles</span></div><div class="casAuthors">Sun, Alexandra C.; McClain, Edward J.; Beatty, Joel W.; Stephenson, Corey R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3487-3490</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A net redox-neutral method for the decarboxylative alkylation of heteroarenes using photoredox catalysis is reported.  Addnl., this method features the use of simple, com. available carboxylic acid derivs. as alkylating agents, enabling the facile alkylation of a variety of biol. relevant heterocyclic scaffolds under mild conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQZDSFt4d4L7Vg90H21EOLACvtfcHk0ljmK7MaK18UQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCrsLzP&md5=301cdc3c326bafc3c0030903a420fc5e</span></div><a href="/servlet/linkout?suffix=cit61b&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b01250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b01250%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DA.%2BC.%26aulast%3DMcClain%26aufirst%3DE.%2BJ.%26aulast%3DBeatty%26aufirst%3DJ.%2BW.%26aulast%3DStephenson%26aufirst%3DC.%2BR.%2BJ.%26atitle%3DVisible%2520Light-Mediated%2520Decarboxylative%2520Alkylation%2520of%2520Pharmaceutically%2520Relevant%2520Heterocycles%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D3487%26epage%3D3490%26doi%3D10.1021%2Facs.orglett.8b01250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halperin, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, R.</span></span> <span> </span><span class="NLM_article-title">A Convenient Photocatalytic Fluorination of Unactivated C–H Bonds</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4690</span>– <span class="NLM_lpage">4693</span>, <span class="refDoi"> DOI: 10.1002/anie.201400420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201400420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGltLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=4690-4693&author=S.+D.+Halperinauthor=H.+Fanauthor=S.+Changauthor=R.+E.+Martinauthor=R.+Britton&title=A+Convenient+Photocatalytic+Fluorination+of+Unactivated+C%E2%80%93H+Bonds&doi=10.1002%2Fanie.201400420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient photocatalytic fluorination of unactivated C-H bonds</span></div><div class="casAuthors">Halperin, Shira D.; Fan, Hope; Chang, Stanley; Martin, Rainer E.; Britton, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4690-4693</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A convenient and economic process is reported for direct fluorination of inactivated C-H bonds that exploits the H-abstracting ability of a decatungstate photocatalyst in combination with the mild F transfer reagent N-fluorobenzenesulfonimide.  This operationally straightforward reaction provides direct access to a wide range of fluorinated org. mols., including structurally complex natural products, acyl fluorides, and fluorinated amino acid derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJLMOhWUAEALVg90H21EOLACvtfcHk0ljmK7MaK18UQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGltLk%253D&md5=2bc653f8d7c31008e55eb39dce05486f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.201400420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201400420%26sid%3Dliteratum%253Aachs%26aulast%3DHalperin%26aufirst%3DS.%2BD.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DBritton%26aufirst%3DR.%26atitle%3DA%2520Convenient%2520Photocatalytic%2520Fluorination%2520of%2520Unactivated%2520C%25E2%2580%2593H%2520Bonds%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D4690%26epage%3D4693%26doi%3D10.1002%2Fanie.201400420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="note">a<p class="last">Two control reactions were run without the metalloporphyrin catalyst Cu(TDCIPP), one with cumene hydroperoxide oxidant (2.0 equiv), and one with <i>meta</i>-chloroperoxybenzoic acid oxidant (2.0 equiv). The two control reactions gave matching product profiles; however, product conversion was superior with <i>m</i>CPBA. Therefore, the <i>m</i>CPBA control reaction was submitted for product purification and characterization.</p></div><div class="note">b<p class="last">We have not attempted to investigate or identify the nature of the circumstance(s), which give rise to the <i>N</i>-methyl product <b>24</b>, but have observed <i>N</i>-methylated products on other leads containing nitrogen heterocycles.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="note"><p class="first last">Electrochemical synthesis of analogue <b>21</b> was in good agreement chromatographically (HPLC–MS) and spectroscopically (NMR) to compound <b>21</b> generated from the BMO control reaction with <i>m</i>CPBA (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S87</a> in the Supporting Information).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeedimalla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacquet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahneva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youte Tendoung, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, S. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of α-Arylated Cycloalkanones from Congested Trisubstituted Spiro-epoxides: Application of the House–Meinwald Rearrangement for Ring Expansion</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">12357</span>– <span class="NLM_lpage">12373</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.8b01448</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.8b01448" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2018&pages=12357-12373&author=N.+Jeedimallaauthor=C.+Jacquetauthor=D.+Bahnevaauthor=J.-J.+Youte+Tendoungauthor=S.+P.+Roche&title=Synthesis+of+%CE%B1-Arylated+Cycloalkanones+from+Congested+Trisubstituted+Spiro-epoxides%3A+Application+of+the+House%E2%80%93Meinwald+Rearrangement+for+Ring+Expansion&doi=10.1021%2Facs.joc.8b01448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of α-Arylated Cycloalkanones from Congested Trisubstituted Spiro-epoxides: Application of the House-Meinwald Rearrangement for Ring Expansion</span></div><div class="casAuthors">Jeedimalla, Nagalakshmi; Jacquet, Camille; Bahneva, Diana; Youte Tendoung, Jean-Jacques; Roche, Stephane P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12357-12373</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A three-step sequence for the synthesis of α-arylated cyclohexanones and the most challenging cycloheptanones is reported.  First, an efficient one-pot synthesis of β,β'-disubstituted benzylidene cycloalkanes (styrenes) using the palladium-catalyzed Barluenga reaction from readily available feedstock chems. is described.  Furthermore, an epoxidn. followed by the House-Meinwald rearrangement (HMR) of spiro-epoxides is reported to produce a no. of α-arylated cycloalkanones upon ring expansion.  Reactions catalyzed by bismuth triflate underwent quasi-exclusively ring expansion for all substrates (electronically poor and rich), with yields ranging from 15% to 95%, thus demonstrating the difficulty of achieving ring enlargement for electron-deficient spiro-epoxides.  On the other hand, by means of catalysis with aluminum trichloride, the rearrangement of spiro-epoxides proceeded typically in high yields and with remarkable regioselectivity on a broader substrate scope.  In this case, a switch of regioselectivity was achieved for spiro-epoxides with electron-withdrawing substituents which enable the method to be successfully extended to some chemospecific arene shifts and the synthesis of aldehydes bearing a α-quaternary carbon.  While the HMR has been extensively studied for smaller ring enlargement, we are pleased to report herein that larger cyclohexanones and cycloheptanones can be obtained efficiently from more sterically demanding trisubstituted spiro-epoxides bearing electron-releasing and electron-neutral arene substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodLuZ-7b0MzbVg90H21EOLACvtfcHk0ljmK7MaK18UQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzP&md5=8ad704778394a6c9c24ad29a73078536</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.8b01448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.8b01448%26sid%3Dliteratum%253Aachs%26aulast%3DJeedimalla%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DC.%26aulast%3DBahneva%26aufirst%3DD.%26aulast%3DYoute%2BTendoung%26aufirst%3DJ.-J.%26aulast%3DRoche%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520of%2520%25CE%25B1-Arylated%2520Cycloalkanones%2520from%2520Congested%2520Trisubstituted%2520Spiro-epoxides%253A%2520Application%2520of%2520the%2520House%25E2%2580%2593Meinwald%2520Rearrangement%2520for%2520Ring%2520Expansion%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2018%26volume%3D83%26spage%3D12357%26epage%3D12373%26doi%3D10.1021%2Facs.joc.8b01448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasino, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Médebielle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomalla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billard, T.</span></span> <span> </span><span class="NLM_article-title">Trifluoromethylation Reactions with Potassium Trifluoromethanesulfinate Under Electrochemical Oxidation</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_fpage">1697</span>– <span class="NLM_lpage">1699</span>, <span class="refDoi"> DOI: 10.1055/s-2002-34210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1055%2Fs-2002-34210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=1697-1699&author=J.-B.+Tommasinoauthor=A.+Brondexauthor=M.+M%C3%A9debielleauthor=M.+Thomallaauthor=B.+R.+Langloisauthor=T.+Billard&title=Trifluoromethylation+Reactions+with+Potassium+Trifluoromethanesulfinate+Under+Electrochemical+Oxidation&doi=10.1055%2Fs-2002-34210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66aR"><div class="casContent"><span class="casTitleNuber">66a</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoromethylation reactions with potassium trifluoromethanesulfinate under electrochemical oxidation</span></div><div class="casAuthors">Tommasino, Jean-Bernard; Brondex, Anne; Medebielle, Maurice; Thomalla, Marc; Langlois, Bernard R.; Billard, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1697-1699</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The electrochem. oxidn. of potassium trifluoromethanesulfinate (CF3SO2K) in the presence of electron-rich aroms. and alkenes provides the corresponding trifluoromethylated products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSeNjfRY6Ez7Vg90H21EOLACvtfcHk0lj_c9T-HdJ25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVGitrg%253D&md5=71bdfa9ab4132131369db673d7e8baa0</span></div><a href="/servlet/linkout?suffix=cit66a&amp;dbid=16384&amp;doi=10.1055%2Fs-2002-34210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2002-34210%26sid%3Dliteratum%253Aachs%26aulast%3DTommasino%26aufirst%3DJ.-B.%26aulast%3DBrondex%26aufirst%3DA.%26aulast%3DM%25C3%25A9debielle%26aufirst%3DM.%26aulast%3DThomalla%26aufirst%3DM.%26aulast%3DLanglois%26aufirst%3DB.%2BR.%26aulast%3DBillard%26aufirst%3DT.%26atitle%3DTrifluoromethylation%2520Reactions%2520with%2520Potassium%2520Trifluoromethanesulfinate%2520Under%2520Electrochemical%2520Oxidation%26jtitle%3DSynlett%26date%3D2002%26spage%3D1697%26epage%3D1699%26doi%3D10.1055%2Fs-2002-34210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit66b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Smertenko, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datsenko, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignat’ev, N. V.</span></span> <span> </span><span class="NLM_article-title">Electrochemical Oxidation of Sodium Trifluoromethanesulfinate</span>. <i>Russ. J. Electrochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFWqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1998&pages=46-51&author=E.+A.+Smertenkoauthor=S.+D.+Datsenkoauthor=N.+V.+Ignat%E2%80%99ev&title=Electrochemical+Oxidation+of+Sodium+Trifluoromethanesulfinate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66bR"><div class="casContent"><span class="casTitleNuber">66b</span><div class="casTitle"><span class="NLM_cas:atitle">Electrochemical oxidation of sodium trifluoromethanesulfinate</span></div><div class="casAuthors">Smertenko, E. A.; Datsenko, S. D.; Ignat'ev, N. V.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Journal of Electrochemistry (Translation of Elektrokhimiya)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-51</span>CODEN:
                <span class="NLM_cas:coden">RJELE3</span>;
        ISSN:<span class="NLM_cas:issn">1023-1935</span>.
    
            (<span class="NLM_cas:orgname">MAIK Nauka/Interperiodica Publishing</span>)
        </div><div class="casAbstract">The electrochem. oxidn. of sodium salt of trifluoromethanesulfinic acid on a glassy carbon electrode is studied in the tetrabutylammonium tetrafluoroborate supporting electrolyte in acetonitrile by methods of the rotating disk and the ring-disk electrodes and cyclic voltammetry.  Electrochem. oxidn. of the trifluoromethanesulfinate anion is shown to result in desulfonylation and formation of the trifluoromethyl radical.  The products of trifluoromethoxylation of arom. compds. are found to form in the presence of oxygen during the preparative electrooxidn.  The possibility of using sodium trifluoromethanesulfinate for trifluoromethylation of arom. compds. in the course of anodic oxidn. is demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2ltcxcU-r7Vg90H21EOLACvtfcHk0lj_c9T-HdJ25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFWqtLo%253D&md5=538e85d01aba38fa9f3844df96e7cfd5</span></div><a href="/servlet/linkout?suffix=cit66b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmertenko%26aufirst%3DE.%2BA.%26aulast%3DDatsenko%26aufirst%3DS.%2BD.%26aulast%3DIgnat%25E2%2580%2599ev%26aufirst%3DN.%2BV.%26atitle%3DElectrochemical%2520Oxidation%2520of%2520Sodium%2520Trifluoromethanesulfinate%26jtitle%3DRuss.%2520J.%2520Electrochem.%26date%3D1998%26volume%3D34%26spage%3D46%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit66c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inokuma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baran, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackmond, D. G.</span></span> <span> </span><span class="NLM_article-title">Radical C-H Functionalization of Heteroarenes Under Electrochemical Control</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11868</span>– <span class="NLM_lpage">11871</span>, <span class="refDoi"> DOI: 10.1002/anie.201407948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fanie.201407948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWitrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11868-11871&author=A.+G.+O%E2%80%99Brienauthor=A.+Maruyamaauthor=Y.+Inokumaauthor=M.+Fujitaauthor=P.+S.+Baranauthor=D.+G.+Blackmond&title=Radical+C-H+Functionalization+of+Heteroarenes+Under+Electrochemical+Control&doi=10.1002%2Fanie.201407948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66cR"><div class="casContent"><span class="casTitleNuber">66c</span><div class="casTitle"><span class="NLM_cas:atitle">Radical C-H functionalization of heteroarenes under electrochemical control</span></div><div class="casAuthors">O'Brien, Alexander G.; Maruyama, Akinobu; Inokuma, Yasuhide; Fujita, Makoto; Baran, Phil S.; Blackmond, Donna G.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11868-11871</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Electrochem. reactions are shown to be effective for the C-H functionalization of a no. of heterocyclic substrates that are recalcitrant to conventional peroxide radical initiation conditions.  Monitoring reaction progress under electrochem. conditions provides mechanistic insight into the C-H functionalization of a series of heterocycles of interest in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8FisQYHxAELVg90H21EOLACvtfcHk0lj_c9T-HdJ25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWitrrP&md5=6f5d2d0ad8b44a9421c16f23e8dc6cef</span></div><a href="/servlet/linkout?suffix=cit66c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201407948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201407948%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%2BG.%26aulast%3DMaruyama%26aufirst%3DA.%26aulast%3DInokuma%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DBaran%26aufirst%3DP.%2BS.%26aulast%3DBlackmond%26aufirst%3DD.%2BG.%26atitle%3DRadical%2520C-H%2520Functionalization%2520of%2520Heteroarenes%2520Under%2520Electrochemical%2520Control%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D11868%26epage%3D11871%26doi%3D10.1002%2Fanie.201407948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villani, F. J.</span></span> <span> </span><span class="NLM_article-title">Tricyclic-Substituted Piperidine Antihistamines</span>. U.S. Patent <span class="NLM_patent">4,355,036</span>, October 19, <span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=F.+J.+Villani&title=Tricyclic-Substituted+Piperidine+Antihistamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVillani%26aufirst%3DF.%2BJ.%26atitle%3DTricyclic-Substituted%2520Piperidine%2520Antihistamines%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="note"><p class="first last">Generation of analogue <b>5</b> from BM3 variant MCYP-P1.2-D07 gave a superior HPLC–MS chromatographic profile with regard to conversion and impurity profile compared to compound <b>5</b> generated from <i>Streptomyces violascens</i> ATCC 31560; therefore, MCYP-P1.2-D07 was used during the scale-up to prepare analogue <b>8</b>. Analogue <b>5</b> from MCYP-P1.2-D07 was in good agreement chromatographically (HPLC–MS) and spectroscopically (NMR) to compound <b>5</b> generated from <i>Streptomyces violascens</i> ATCC 3156 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf" class="ext-link">Figure S22</a> in the Supporting Information).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship Between the Inhibition Constant (K<sub>I</sub>) and the Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I<sub>50</sub>) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+Between+the+Inhibition+Constant+%28KI%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lhfKGmTYOVf7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520Between%2520the%2520Inhibition%2520Constant%2520%2528KI%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapinos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piotrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M.</span></span> <span> </span><span class="NLM_article-title">Development of a High-Performance, Enterprise-Level, Multimode LC-MS/MS Autosampler for Drug Discovery</span>. <i>Bioanalysis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1643</span>– <span class="NLM_lpage">1654</span>, <span class="refDoi"> DOI: 10.4155/bio-2017-0149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.4155%2Fbio-2017-0149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=29120233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1643-1654&author=B.+Kapinosauthor=J.+Liuauthor=M.+Piotrowskiauthor=J.+Keeferauthor=B.+Holderauthor=J.+Janiszewskiauthor=H.+Zhangauthor=M.+Troutman&title=Development+of+a+High-Performance%2C+Enterprise-Level%2C+Multimode+LC-MS%2FMS+Autosampler+for+Drug+Discovery&doi=10.4155%2Fbio-2017-0149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery</span></div><div class="casAuthors">Kapinos, Brendon; Liu, JianHua; Piotrowski, Mary; Keefer, Julie; Holder, Brian; Janiszewski, John; Zhang, Hui; Troutman, Matt</div><div class="citationInfo"><span class="NLM_cas:title">Bioanalysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1643-1654</span>CODEN:
                <span class="NLM_cas:coden">BIOAB4</span>;
        ISSN:<span class="NLM_cas:issn">1757-6180</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">This article describes about the development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery in human liver.  Extra-column vol. assessments were made by modulating tubing vols. (length and inner diam.) pre- and postcolumn.  The LC-MS/MS system consisted of an LS-1 autosampler from SoundAnalytics (CT, USA). LC pumping system consisted of two 1290 Infinity series LC from Agilent (CA, USA), the mass spectrometer was a 5500 TripleQuad from Sciex (ON, Canada) and LS-1 was configured with 4-injection ports and four addnl. 2-position A/B, UHPLC rated (15 K) valves from Rheodyne/IDEX (CA, USA).  System control and scheduling was accomplished using LeadScapeTM software from SoundAnalytics.  The author concluded development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery in human liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWh6P-kIwc_rVg90H21EOLACvtfcHk0lgaVyFVjxX99w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWhtg%253D%253D&md5=4562d9af8dde637bb4aabc1d1d42ec61</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.4155%2Fbio-2017-0149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fbio-2017-0149%26sid%3Dliteratum%253Aachs%26aulast%3DKapinos%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPiotrowski%26aufirst%3DM.%26aulast%3DKeefer%26aufirst%3DJ.%26aulast%3DHolder%26aufirst%3DB.%26aulast%3DJaniszewski%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTroutman%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520High-Performance%252C%2520Enterprise-Level%252C%2520Multimode%2520LC-MS%252FMS%2520Autosampler%2520for%2520Drug%2520Discovery%26jtitle%3DBioanalysis%26date%3D2017%26volume%3D9%26spage%3D1643%26epage%3D1654%26doi%3D10.4155%2Fbio-2017-0149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="note"><p class="first last">The RRCK cell line is also known as MDCKII-LE.</p></div><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a New Permeability Assay Using Low-Efflux MDCKII Cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+New+Permeability+Assay+Using+Low-Efflux+MDCKII+Cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lgaVyFVjxX99w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520New%2520Permeability%2520Assay%2520Using%2520Low-Efflux%2520MDCKII%2520Cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="note"><p class="first last">CP-628374 (MW 687.04 g/mol): (2<i>E</i>)-3-(4-{[(2<i>S</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-5-{(1<i>E</i>)-<i>N</i>-[(3-chloro-2,6-difluorobenzyl)oxy]ethanimidoyl}-3,4-dihydroxytetrahydrofuran-2-yl]oxy}-3-hydroxyphenyl)-2-methyl-<i>N</i>[(3a<i>S</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>,7<i>R</i>,7a<i>R</i>)-4,6,7-trihydroxyhexahydro-1,3-benzodioxol-5-yl]prop-2-enamide.</p></div><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span> <span> </span><span class="NLM_article-title">Species Independence in Brain Tissue Binding Using Brain Homogenates</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1124/dmd.111.038778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+Independence+in+Brain+Tissue+Binding+Using+Brain+Homogenates&doi=10.1124%2Fdmd.111.038778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lg3Z6P7uufOsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520Independence%2520in%2520Brain%2520Tissue%2520Binding%2520Using%2520Brain%2520Homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277%26doi%3D10.1124%2Fdmd.111.038778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i66"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00483">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_31482"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00483?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00483</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Lead diversification screening panels; HPLC–MS screening results; cyclic voltammetry reading; protein–ligand docking protocols; and <sup>1</sup>H NMR, COSY, HSQC, HMBC, and NOE spectra of intermediates and final products (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf">PDF</a>)</p><p>Diversity map (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_002.xlsx">XLSX</a>)</p><p>Molecular formula strings of compounds <b>1</b>–<b>27</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_003.xlsx">XLSX</a>)</p><p class="last">HPLC–MS chromatograms of compounds <b>1</b>–<b>27</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_004.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_001.pdf">jm0c00483_si_001.pdf (13.27 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_002.xlsx">jm0c00483_si_002.xlsx (35.65 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_003.xlsx">jm0c00483_si_003.xlsx (13.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00483/suppl_file/jm0c00483_si_004.pdf">jm0c00483_si_004.pdf (1.72 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00483&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00483%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00483" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799e94998ffd956","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
